id,initials,age,age_grp,sex,frailty,CrCl,specimen_date,organism,antimicrobial,susceptibility_result,source
1,CB,57,"[44,64)",F,7,NA,2024-01-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2,EV,78,"[74,84)",F,8,NA,2024-01-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3,SJ,90,"[84,Inf)",M,6,NA,2024-01-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4,VL,84,"[84,Inf)",F,7,NA,2024-01-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5,WJ,76,"[74,84)",F,6,NA,2024-01-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6,TV,71,"[64,74)",M,7,NA,2024-01-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7,UY,75,"[74,84)",M,6,NA,2024-01-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8,PW,91,"[84,Inf)",F,9,NA,2024-01-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
9,TG,84,"[84,Inf)",M,8,NA,2024-01-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
10,KS,79,"[74,84)",M,6,NA,2024-01-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
11,XC,47,"[44,64)",F,4,NA,2024-01-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
12,AO,80,"[74,84)",F,6,NA,2024-01-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
13,UJ,49,"[44,64)",F,6,NA,2024-01-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
14,EA,73,"[64,74)",F,7,NA,2024-01-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
15,VX,99,"[84,Inf)",F,7,NA,2024-01-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
16,OQ,72,"[64,74)",F,6,NA,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
17,ZO,97,"[84,Inf)",M,9,NA,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
18,PQ,89,"[84,Inf)",M,7,36.79978680089201,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
19,LG,83,"[74,84)",M,6,NA,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
20,FN,62,"[44,64)",F,5,NA,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
21,LF,37,"[14,44)",M,5,NA,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
22,IO,53,"[44,64)",M,3,NA,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
23,QT,91,"[84,Inf)",M,8,NA,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
24,NX,44,"[44,64)",M,4,NA,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
25,TX,69,"[64,74)",F,7,NA,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
26,KX,75,"[74,84)",F,5,NA,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
27,XW,72,"[64,74)",M,5,NA,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
28,XE,92,"[84,Inf)",M,9,71.2473710876522,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
29,BU,72,"[64,74)",M,7,69.24206352949348,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
30,BD,52,"[44,64)",F,6,NA,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
31,EA,44,"[44,64)",M,4,NA,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
32,SI,65,"[64,74)",M,6,71.47804033212857,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
33,IH,65,"[64,74)",M,6,NA,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
34,IW,68,"[64,74)",M,7,NA,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
35,XL,44,"[44,64)",M,2,NA,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
36,WX,95,"[84,Inf)",M,8,NA,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
37,XX,34,"[14,44)",M,1,NA,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
38,QE,81,"[74,84)",M,8,NA,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
39,NJ,74,"[74,84)",F,8,96.2988192386465,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
40,CR,67,"[64,74)",M,5,NA,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
41,QG,51,"[44,64)",M,3,77.70195894693745,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
42,WI,64,"[64,74)",F,7,NA,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
43,BF,90,"[84,Inf)",F,8,NA,2024-01-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
44,HF,53,"[44,64)",F,4,NA,2024-01-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
45,RM,79,"[74,84)",M,8,79.05142851608404,2024-01-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
46,YV,97,"[84,Inf)",M,7,NA,2024-01-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
47,ZG,71,"[64,74)",M,7,NA,2024-01-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
48,HP,76,"[74,84)",F,8,50.04079805285525,2024-01-03,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
49,KH,63,"[44,64)",M,5,NA,2024-01-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
50,DM,2,"[1,14)",M,NA,NA,2024-01-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
51,PU,73,"[64,74)",M,8,NA,2024-01-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
52,JL,85,"[84,Inf)",M,8,NA,2024-01-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
53,XO,47,"[44,64)",F,6,83.12355792034182,2024-01-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
54,PF,69,"[64,74)",M,6,79.23861050938669,2024-01-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
55,KH,72,"[64,74)",M,9,NA,2024-01-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
56,CY,61,"[44,64)",F,5,NA,2024-01-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
57,TK,82,"[74,84)",F,7,NA,2024-01-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
58,KO,85,"[84,Inf)",M,9,NA,2024-01-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
59,OI,54,"[44,64)",F,3,NA,2024-01-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
60,MV,62,"[44,64)",F,6,NA,2024-01-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
61,NA,51,"[44,64)",M,6,NA,2024-01-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
62,RP,91,"[84,Inf)",M,7,53.13125592141999,2024-01-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
63,AU,78,"[74,84)",M,6,NA,2024-01-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
64,MK,81,"[74,84)",M,5,59.41300185533892,2024-01-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
65,CM,87,"[84,Inf)",F,7,NA,2024-01-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
66,FY,52,"[44,64)",M,5,NA,2024-01-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
67,UH,82,"[74,84)",M,7,NA,2024-01-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
68,OR,45,"[44,64)",M,3,NA,2024-01-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
69,MH,85,"[84,Inf)",M,8,NA,2024-01-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
70,BM,65,"[64,74)",M,6,NA,2024-01-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
71,ZI,75,"[74,84)",M,7,NA,2024-01-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
72,WG,82,"[74,84)",M,8,45.67692561695059,2024-01-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
73,GA,61,"[44,64)",F,5,NA,2024-01-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
74,TZ,51,"[44,64)",F,5,NA,2024-01-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
75,GR,72,"[64,74)",M,5,64.58627284049801,2024-01-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
76,GQ,0,"[0,1)",M,NA,NA,2024-01-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
77,XV,86,"[84,Inf)",M,8,NA,2024-01-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
78,UU,74,"[74,84)",F,6,73.61177365921012,2024-01-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
79,QN,41,"[14,44)",M,5,NA,2024-01-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
80,PW,46,"[44,64)",M,5,NA,2024-01-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
81,IT,75,"[74,84)",M,7,NA,2024-01-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
82,QX,73,"[64,74)",M,7,NA,2024-01-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
83,UV,79,"[74,84)",M,7,55.28438977726656,2024-01-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
84,GV,65,"[64,74)",M,7,NA,2024-01-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
85,MY,67,"[64,74)",M,7,86.15256639813323,2024-01-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
86,ID,78,"[74,84)",M,5,NA,2024-01-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
87,XG,58,"[44,64)",F,7,NA,2024-01-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
88,PQ,43,"[14,44)",M,4,NA,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
89,SF,69,"[64,74)",M,6,NA,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
90,DT,92,"[84,Inf)",M,8,NA,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
91,XW,77,"[74,84)",M,5,44.919615562189335,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
92,WX,22,"[14,44)",M,2,NA,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
93,WX,86,"[84,Inf)",F,6,NA,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
94,QM,43,"[14,44)",M,5,NA,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
95,MD,57,"[44,64)",M,4,NA,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
96,UD,55,"[44,64)",F,5,NA,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
97,WS,77,"[74,84)",M,7,NA,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
98,DZ,65,"[64,74)",F,6,NA,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
99,BS,44,"[44,64)",F,4,NA,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
100,LK,72,"[64,74)",F,7,NA,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
101,OX,70,"[64,74)",M,8,68.38331859679577,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
102,DE,57,"[44,64)",M,6,NA,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
103,OP,54,"[44,64)",M,4,NA,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
104,ZI,93,"[84,Inf)",M,8,NA,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
105,VH,87,"[84,Inf)",F,7,NA,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
106,ZG,70,"[64,74)",M,7,86.3603655515619,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
107,QD,79,"[74,84)",F,7,58.48683251888745,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
108,CJ,68,"[64,74)",M,5,NA,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
109,LR,92,"[84,Inf)",M,9,NA,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
110,BB,69,"[64,74)",M,5,NA,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
111,ZR,69,"[64,74)",F,5,66.91462160439029,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
112,HE,70,"[64,74)",M,5,NA,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
113,PL,65,"[64,74)",M,5,NA,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
114,VT,67,"[64,74)",F,6,95.12953672984621,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
115,YO,51,"[44,64)",M,5,96.43923311661167,2024-01-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
116,LN,70,"[64,74)",F,6,NA,2024-01-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
117,DN,64,"[64,74)",M,6,NA,2024-01-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
118,BJ,89,"[84,Inf)",F,7,NA,2024-01-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
119,JO,75,"[74,84)",F,7,47.19704632495884,2024-01-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
120,DP,74,"[74,84)",M,8,78.69217647955001,2024-01-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
121,YN,71,"[64,74)",M,6,NA,2024-01-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
122,RQ,67,"[64,74)",F,7,NA,2024-01-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
123,JT,81,"[74,84)",M,9,NA,2024-01-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
124,MX,70,"[64,74)",M,6,NA,2024-01-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
125,ND,58,"[44,64)",M,3,93.51534370906519,2024-01-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
126,MY,77,"[74,84)",F,6,NA,2024-01-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
127,JL,86,"[84,Inf)",M,9,NA,2024-01-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
128,KM,90,"[84,Inf)",M,9,NA,2024-01-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
129,LI,91,"[84,Inf)",M,8,NA,2024-01-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
130,VS,81,"[74,84)",M,7,NA,2024-01-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
131,RL,85,"[84,Inf)",M,6,NA,2024-01-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
132,OP,60,"[44,64)",F,6,NA,2024-01-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
133,VN,86,"[84,Inf)",M,9,47.339503772091604,2024-01-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
134,LL,61,"[44,64)",M,5,NA,2024-01-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
135,MT,71,"[64,74)",M,7,NA,2024-01-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
136,PC,51,"[44,64)",F,4,NA,2024-01-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
137,RF,59,"[44,64)",M,5,86.65802348630558,2024-01-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
138,PK,64,"[64,74)",M,5,NA,2024-01-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
139,OD,89,"[84,Inf)",M,8,NA,2024-01-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
140,BN,86,"[84,Inf)",M,9,51.82729362355746,2024-01-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
141,DO,74,"[74,84)",F,7,45.66547076289772,2024-01-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
142,AO,71,"[64,74)",F,7,137.16686809138739,2024-01-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
143,UO,42,"[14,44)",M,2,NA,2024-01-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
144,NX,50,"[44,64)",M,5,NA,2024-01-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
145,CA,78,"[74,84)",F,7,NA,2024-01-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
146,WL,61,"[44,64)",M,5,104.34809587839176,2024-01-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
147,PY,63,"[44,64)",M,6,NA,2024-01-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
148,FJ,90,"[84,Inf)",M,9,32.39076286403297,2024-01-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
149,US,60,"[44,64)",F,5,NA,2024-01-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
150,ZQ,63,"[44,64)",F,4,NA,2024-01-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
151,MZ,96,"[84,Inf)",M,9,NA,2024-01-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
152,DI,88,"[84,Inf)",M,8,NA,2024-01-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
153,MV,77,"[74,84)",F,7,NA,2024-01-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
154,RO,54,"[44,64)",F,6,NA,2024-01-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
155,UU,82,"[74,84)",F,7,49.78091792909711,2024-01-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
156,MV,32,"[14,44)",M,4,NA,2024-01-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
157,GD,83,"[74,84)",M,8,NA,2024-01-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
158,MV,84,"[84,Inf)",M,8,57.160030644352105,2024-01-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
159,BG,74,"[74,84)",M,6,78.28413063255942,2024-01-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
160,RN,0,"[0,1)",F,NA,NA,2024-01-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
161,VT,89,"[84,Inf)",M,8,NA,2024-01-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
162,OX,75,"[74,84)",M,6,NA,2024-01-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
163,WC,96,"[84,Inf)",F,8,NA,2024-01-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
164,ZL,71,"[64,74)",F,7,63.26928294745055,2024-01-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
165,XA,54,"[44,64)",M,4,NA,2024-01-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
166,BZ,75,"[74,84)",M,8,NA,2024-01-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
167,ZA,81,"[74,84)",M,8,39.87735249251135,2024-01-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
168,KL,59,"[44,64)",M,5,84.76084524545483,2024-01-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
169,FM,59,"[44,64)",M,7,NA,2024-01-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
170,DF,68,"[64,74)",M,7,92.5052589255736,2024-01-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
171,KQ,47,"[44,64)",M,5,NA,2024-01-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
172,LO,88,"[84,Inf)",M,9,NA,2024-01-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
173,AU,81,"[74,84)",M,8,NA,2024-01-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
174,YD,46,"[44,64)",M,7,144.7861362378001,2024-01-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
175,KP,84,"[84,Inf)",M,6,40.96654862604688,2024-01-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
176,WU,44,"[44,64)",F,4,NA,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
177,NF,80,"[74,84)",M,8,NA,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
178,EQ,74,"[74,84)",F,5,111.4892447424197,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
179,PH,77,"[74,84)",F,5,41.3088980148737,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
180,DC,63,"[44,64)",M,5,75.22163695857492,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
181,KO,58,"[44,64)",M,6,NA,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
182,SR,68,"[64,74)",M,4,NA,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
183,LS,76,"[74,84)",M,7,NA,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
184,GI,83,"[74,84)",F,8,NA,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
185,IA,50,"[44,64)",M,4,NA,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
186,DK,75,"[74,84)",F,7,NA,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
187,NF,94,"[84,Inf)",M,8,49.253685234934274,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
188,PE,86,"[84,Inf)",M,8,NA,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
189,OR,53,"[44,64)",M,5,NA,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
190,OQ,90,"[84,Inf)",M,8,36.11541390524287,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
191,FD,73,"[64,74)",M,7,NA,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
192,FZ,71,"[64,74)",M,7,128.46480541602182,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
193,WK,69,"[64,74)",M,7,NA,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
194,BM,78,"[74,84)",M,6,NA,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
195,HB,63,"[44,64)",M,6,NA,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
196,MN,81,"[74,84)",F,7,NA,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
197,WX,60,"[44,64)",M,5,106.27369300717756,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
198,JN,50,"[44,64)",F,6,NA,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
199,EB,52,"[44,64)",M,4,NA,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
200,FT,54,"[44,64)",M,5,NA,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
201,LF,50,"[44,64)",F,6,NA,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
202,UD,65,"[64,74)",F,6,NA,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
203,PZ,91,"[84,Inf)",M,8,NA,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
204,CW,66,"[64,74)",F,5,NA,2024-01-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
205,GM,79,"[74,84)",M,8,39.10120790059082,2024-01-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
206,RO,95,"[84,Inf)",F,9,32.96531353748015,2024-01-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
207,YZ,75,"[74,84)",M,7,40.26956028276142,2024-01-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
208,XK,88,"[84,Inf)",M,7,NA,2024-01-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
209,MS,56,"[44,64)",M,5,NA,2024-01-10,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
210,OY,58,"[44,64)",M,6,NA,2024-01-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
211,SU,78,"[74,84)",M,7,NA,2024-01-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
212,LR,83,"[74,84)",F,8,NA,2024-01-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
213,UV,68,"[64,74)",F,6,NA,2024-01-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
214,QZ,78,"[74,84)",M,6,63.892966651939915,2024-01-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
215,LC,69,"[64,74)",F,6,NA,2024-01-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
216,ZP,65,"[64,74)",M,6,NA,2024-01-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
217,NZ,92,"[84,Inf)",M,6,NA,2024-01-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
218,AE,60,"[44,64)",M,6,NA,2024-01-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
219,RE,44,"[44,64)",M,4,NA,2024-01-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
220,HN,26,"[14,44)",M,2,132.8519717601459,2024-01-10,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
221,EJ,69,"[64,74)",M,8,NA,2024-01-10,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
222,DG,0,"[0,1)",M,NA,NA,2024-01-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
223,DF,83,"[74,84)",M,9,68.97935794202256,2024-01-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
224,BV,40,"[14,44)",M,2,117.11951921115545,2024-01-10,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
225,QJ,98,"[84,Inf)",F,8,NA,2024-01-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
226,UN,49,"[44,64)",F,5,NA,2024-01-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
227,FU,64,"[64,74)",F,7,NA,2024-01-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
228,CE,53,"[44,64)",M,4,NA,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
229,KF,94,"[84,Inf)",M,8,NA,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
230,MQ,69,"[64,74)",M,7,NA,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
231,YG,77,"[74,84)",M,7,NA,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
232,XH,74,"[74,84)",M,6,NA,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
233,BG,59,"[44,64)",M,6,NA,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
234,EU,73,"[64,74)",M,7,NA,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
235,AX,84,"[84,Inf)",M,6,NA,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
236,PR,49,"[44,64)",M,5,NA,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
237,OX,56,"[44,64)",M,7,NA,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
238,LS,62,"[44,64)",M,6,NA,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
239,JI,71,"[64,74)",M,6,NA,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
240,DT,79,"[74,84)",M,8,NA,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
241,YN,0,"[0,1)",M,NA,NA,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
242,BX,69,"[64,74)",M,6,92.47975445459029,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
243,JJ,50,"[44,64)",F,5,NA,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
244,HH,67,"[64,74)",F,6,NA,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
245,BF,93,"[84,Inf)",M,8,NA,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
246,JL,68,"[64,74)",M,7,73.39151007328711,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
247,HE,78,"[74,84)",M,6,NA,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
248,GF,78,"[74,84)",M,8,NA,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
249,PW,67,"[64,74)",M,6,NA,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
250,US,72,"[64,74)",M,5,NA,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
251,EV,70,"[64,74)",M,5,NA,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
252,ND,86,"[84,Inf)",M,7,NA,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
253,CR,69,"[64,74)",M,6,NA,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
254,RF,41,"[14,44)",M,2,NA,2024-01-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
255,RF,47,"[44,64)",M,4,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
256,KG,78,"[74,84)",M,6,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
257,MT,66,"[64,74)",F,5,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
258,OL,64,"[64,74)",F,7,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
259,NO,97,"[84,Inf)",F,8,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
260,II,59,"[44,64)",M,7,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
261,LN,42,"[14,44)",F,3,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
262,IC,93,"[84,Inf)",M,7,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
263,DL,1,"[1,14)",M,NA,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
264,TZ,66,"[64,74)",M,6,74.22229994176945,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
265,DY,45,"[44,64)",M,5,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
266,SR,86,"[84,Inf)",M,9,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
267,JA,79,"[74,84)",F,7,51.7927548576772,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
268,IW,74,"[74,84)",M,8,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
269,PN,45,"[44,64)",M,3,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
270,UD,70,"[64,74)",M,6,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
271,YF,78,"[74,84)",M,6,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
272,OS,59,"[44,64)",F,5,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
273,NO,58,"[44,64)",M,7,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
274,RG,81,"[74,84)",M,7,52.111630216814504,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
275,YX,75,"[74,84)",M,5,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
276,WH,89,"[84,Inf)",M,9,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
277,LE,0,"[0,1)",F,NA,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
278,LT,67,"[64,74)",M,5,59.61662248731114,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
279,PC,47,"[44,64)",M,6,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
280,WG,70,"[64,74)",F,6,53.58764701547821,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
281,FU,70,"[64,74)",M,9,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
282,AC,63,"[44,64)",M,7,73.88237636621092,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
283,EZ,84,"[84,Inf)",M,7,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
284,TT,76,"[74,84)",M,8,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
285,OV,50,"[44,64)",F,6,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
286,SU,77,"[74,84)",F,7,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
287,TD,91,"[84,Inf)",M,9,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
288,LG,69,"[64,74)",F,5,NA,2024-01-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
289,ZZ,68,"[64,74)",F,8,92.43434706393525,2024-01-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
290,HG,73,"[64,74)",M,6,NA,2024-01-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
291,WU,65,"[64,74)",M,7,NA,2024-01-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
292,HE,84,"[84,Inf)",M,7,NA,2024-01-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
293,IS,85,"[84,Inf)",M,9,NA,2024-01-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
294,QB,81,"[74,84)",M,7,NA,2024-01-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
295,ZL,89,"[84,Inf)",M,8,NA,2024-01-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
296,UX,76,"[74,84)",F,5,53.45402556339493,2024-01-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
297,RS,59,"[44,64)",F,6,68.30202969097806,2024-01-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
298,ZN,87,"[84,Inf)",M,7,NA,2024-01-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
299,GR,65,"[64,74)",M,4,97.77752029962483,2024-01-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
300,FL,64,"[64,74)",F,7,NA,2024-01-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
301,HT,70,"[64,74)",M,7,NA,2024-01-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
302,GL,62,"[44,64)",F,4,NA,2024-01-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
303,VW,66,"[64,74)",F,5,NA,2024-01-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
304,FA,36,"[14,44)",M,3,119.5038222624748,2024-01-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
305,ZV,50,"[44,64)",F,4,NA,2024-01-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
306,SH,67,"[64,74)",M,7,NA,2024-01-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
307,GG,85,"[84,Inf)",M,9,NA,2024-01-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
308,DQ,67,"[64,74)",F,6,NA,2024-01-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
309,MY,75,"[74,84)",M,6,NA,2024-01-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
310,VN,85,"[84,Inf)",M,9,NA,2024-01-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
311,LA,75,"[74,84)",M,6,NA,2024-01-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
312,KL,69,"[64,74)",F,7,NA,2024-01-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
313,QN,73,"[64,74)",M,5,NA,2024-01-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
314,IW,69,"[64,74)",M,6,NA,2024-01-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
315,GP,68,"[64,74)",M,5,NA,2024-01-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
316,RD,47,"[44,64)",F,4,NA,2024-01-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
317,EV,53,"[44,64)",F,6,NA,2024-01-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
318,HX,71,"[64,74)",M,7,NA,2024-01-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
319,CL,74,"[74,84)",M,6,NA,2024-01-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
320,CD,69,"[64,74)",F,6,52.94497604183707,2024-01-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
321,RD,67,"[64,74)",M,7,NA,2024-01-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
322,MT,76,"[74,84)",M,5,NA,2024-01-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
323,QH,54,"[44,64)",F,5,NA,2024-01-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
324,GN,56,"[44,64)",M,5,NA,2024-01-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
325,BP,87,"[84,Inf)",M,8,53.914088190411285,2024-01-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
326,QC,60,"[44,64)",F,6,NA,2024-01-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
327,JT,67,"[64,74)",F,6,NA,2024-01-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
328,JX,73,"[64,74)",M,6,71.66889471435536,2024-01-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
329,AP,27,"[14,44)",F,1,NA,2024-01-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
330,RP,62,"[44,64)",F,7,NA,2024-01-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
331,YY,75,"[74,84)",M,7,NA,2024-01-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
332,HA,95,"[84,Inf)",M,8,NA,2024-01-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
333,YY,71,"[64,74)",M,6,NA,2024-01-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
334,VW,63,"[44,64)",F,7,NA,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
335,GN,76,"[74,84)",M,7,45.01959683121448,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
336,TE,82,"[74,84)",M,7,NA,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
337,VN,63,"[44,64)",F,3,104.22682043411515,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
338,LB,0,"[0,1)",M,NA,NA,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
339,VV,47,"[44,64)",M,4,NA,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
340,QK,72,"[64,74)",F,5,NA,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
341,RE,69,"[64,74)",F,6,NA,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
342,JN,65,"[64,74)",F,7,73.06894931513604,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
343,IZ,58,"[44,64)",M,5,NA,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
344,JF,79,"[74,84)",M,6,NA,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
345,ZP,59,"[44,64)",M,5,NA,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
346,UM,50,"[44,64)",F,5,NA,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
347,JM,78,"[74,84)",F,7,NA,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
348,RZ,66,"[64,74)",F,6,96.68145958928604,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
349,PM,70,"[64,74)",M,6,85.82066366928294,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
350,PR,86,"[84,Inf)",M,8,NA,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
351,SJ,81,"[74,84)",M,6,NA,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
352,MS,57,"[44,64)",F,5,NA,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
353,EJ,70,"[64,74)",M,6,71.25059438121886,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
354,SJ,61,"[44,64)",M,6,84.30533576167475,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
355,QX,69,"[64,74)",M,7,NA,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
356,ZG,97,"[84,Inf)",M,8,NA,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
357,WL,66,"[64,74)",M,7,NA,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
358,IA,72,"[64,74)",M,7,81.45974579686961,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
359,HI,58,"[44,64)",F,6,NA,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
360,ZU,73,"[64,74)",M,7,NA,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
361,NC,63,"[44,64)",F,6,NA,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
362,FR,88,"[84,Inf)",F,9,NA,2024-01-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
363,OK,92,"[84,Inf)",M,7,50.4418794060152,2024-01-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
364,KQ,37,"[14,44)",M,4,NA,2024-01-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
365,TI,53,"[44,64)",F,4,NA,2024-01-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
366,VM,57,"[44,64)",M,5,NA,2024-01-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
367,HU,82,"[74,84)",M,8,NA,2024-01-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
368,BH,51,"[44,64)",M,6,NA,2024-01-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
369,FE,82,"[74,84)",M,7,104.77458210297405,2024-01-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
370,HL,60,"[44,64)",F,7,NA,2024-01-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
371,MW,59,"[44,64)",F,6,NA,2024-01-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
372,AZ,73,"[64,74)",M,6,65.18039966832545,2024-01-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
373,HP,31,"[14,44)",F,2,130.85096731432728,2024-01-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
374,GO,65,"[64,74)",F,8,NA,2024-01-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
375,HU,49,"[44,64)",F,6,NA,2024-01-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
376,CA,85,"[84,Inf)",F,6,NA,2024-01-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
377,WR,68,"[64,74)",F,6,67.63091203664827,2024-01-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
378,WD,42,"[14,44)",M,3,NA,2024-01-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
379,YD,56,"[44,64)",M,3,NA,2024-01-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
380,FC,67,"[64,74)",M,6,NA,2024-01-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
381,AX,62,"[44,64)",M,5,NA,2024-01-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
382,CT,73,"[64,74)",M,6,NA,2024-01-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
383,IT,85,"[84,Inf)",M,8,NA,2024-01-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
384,IG,64,"[64,74)",F,6,NA,2024-01-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
385,EC,83,"[74,84)",F,8,NA,2024-01-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
386,HV,66,"[64,74)",M,6,NA,2024-01-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
387,UN,75,"[74,84)",M,5,NA,2024-01-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
388,PB,68,"[64,74)",M,7,NA,2024-01-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
389,JD,45,"[44,64)",F,6,NA,2024-01-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
390,CF,67,"[64,74)",M,6,73.88388364713957,2024-01-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
391,HH,92,"[84,Inf)",M,9,NA,2024-01-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
392,JF,87,"[84,Inf)",F,8,NA,2024-01-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
393,OO,59,"[44,64)",M,7,NA,2024-01-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
394,XS,81,"[74,84)",F,8,NA,2024-01-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
395,PZ,67,"[64,74)",F,5,NA,2024-01-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
396,QC,68,"[64,74)",M,5,NA,2024-01-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
397,TC,1,"[1,14)",F,NA,NA,2024-01-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
398,ZT,76,"[74,84)",F,6,NA,2024-01-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
399,YQ,63,"[44,64)",F,5,NA,2024-01-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
400,AB,68,"[64,74)",F,7,65.0118092995755,2024-01-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
401,CZ,72,"[64,74)",M,6,NA,2024-01-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
402,JY,90,"[84,Inf)",M,8,NA,2024-01-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
403,BK,94,"[84,Inf)",M,8,NA,2024-01-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
404,FQ,70,"[64,74)",M,6,NA,2024-01-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
405,TM,72,"[64,74)",F,8,NA,2024-01-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
406,BK,74,"[74,84)",M,6,NA,2024-01-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
407,PT,95,"[84,Inf)",M,8,NA,2024-01-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
408,YJ,68,"[64,74)",M,4,84.8336722227497,2024-01-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
409,UF,1,"[1,14)",M,NA,NA,2024-01-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
410,KZ,58,"[44,64)",F,5,NA,2024-01-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
411,BI,93,"[84,Inf)",F,8,NA,2024-01-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
412,GT,51,"[44,64)",M,6,NA,2024-01-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
413,TD,73,"[64,74)",M,6,NA,2024-01-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
414,ZB,61,"[44,64)",F,7,NA,2024-01-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
415,YC,74,"[74,84)",M,6,NA,2024-01-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
416,PU,71,"[64,74)",M,7,NA,2024-01-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
417,YF,68,"[64,74)",M,5,NA,2024-01-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
418,IX,68,"[64,74)",F,7,52.005829007111245,2024-01-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
419,DX,90,"[84,Inf)",M,7,NA,2024-01-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
420,WW,47,"[44,64)",M,4,NA,2024-01-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
421,AZ,67,"[64,74)",M,6,NA,2024-01-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
422,IT,74,"[74,84)",M,7,62.93024846039406,2024-01-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
423,RM,73,"[64,74)",F,7,NA,2024-01-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
424,AJ,38,"[14,44)",M,4,101.5993208324542,2024-01-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
425,BV,76,"[74,84)",F,6,NA,2024-01-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
426,IE,69,"[64,74)",M,5,NA,2024-01-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
427,GF,75,"[74,84)",M,7,NA,2024-01-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
428,JL,80,"[74,84)",F,8,NA,2024-01-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
429,NI,55,"[44,64)",F,4,NA,2024-01-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
430,HY,78,"[74,84)",F,8,NA,2024-01-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
431,RO,67,"[64,74)",M,6,NA,2024-01-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
432,QU,95,"[84,Inf)",M,8,NA,2024-01-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
433,HB,74,"[74,84)",M,8,NA,2024-01-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
434,NH,75,"[74,84)",F,7,NA,2024-01-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
435,HL,70,"[64,74)",M,7,84.42489562196273,2024-01-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
436,UG,85,"[84,Inf)",M,7,NA,2024-01-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
437,EJ,83,"[74,84)",M,7,NA,2024-01-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
438,RD,65,"[64,74)",M,6,NA,2024-01-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
439,NK,72,"[64,74)",M,6,NA,2024-01-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
440,IH,82,"[74,84)",M,5,NA,2024-01-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
441,BE,65,"[64,74)",M,7,NA,2024-01-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
442,LX,73,"[64,74)",M,6,NA,2024-01-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
443,GC,60,"[44,64)",M,6,NA,2024-01-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
444,TZ,59,"[44,64)",M,6,85.22470634255812,2024-01-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
445,SK,91,"[84,Inf)",M,6,NA,2024-01-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
446,CM,56,"[44,64)",M,4,NA,2024-01-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
447,UP,90,"[84,Inf)",M,8,NA,2024-01-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
448,LN,84,"[84,Inf)",M,8,47.28901626448184,2024-01-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
449,MW,58,"[44,64)",M,6,NA,2024-01-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
450,GR,56,"[44,64)",M,4,NA,2024-01-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
451,FA,75,"[74,84)",F,7,NA,2024-01-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
452,CO,44,"[44,64)",F,4,NA,2024-01-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
453,SK,84,"[84,Inf)",M,8,NA,2024-01-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
454,XY,91,"[84,Inf)",M,9,NA,2024-01-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
455,GI,39,"[14,44)",M,4,NA,2024-01-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
456,RD,59,"[44,64)",M,4,NA,2024-01-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
457,TH,76,"[74,84)",M,6,NA,2024-01-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
458,RY,80,"[74,84)",M,7,NA,2024-01-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
459,SW,50,"[44,64)",M,5,NA,2024-01-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
460,GZ,94,"[84,Inf)",M,9,NA,2024-01-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
461,JE,59,"[44,64)",F,6,NA,2024-01-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
462,GU,70,"[64,74)",M,6,NA,2024-01-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
463,CR,73,"[64,74)",M,8,66.97491214901022,2024-01-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
464,YP,83,"[74,84)",M,7,NA,2024-01-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
465,MI,62,"[44,64)",M,8,NA,2024-01-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
466,BS,72,"[64,74)",M,8,NA,2024-01-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
467,ES,54,"[44,64)",F,5,NA,2024-01-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
468,LD,70,"[64,74)",M,5,NA,2024-01-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
469,AP,70,"[64,74)",M,6,NA,2024-01-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
470,FC,71,"[64,74)",M,7,NA,2024-01-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
471,TM,73,"[64,74)",M,6,69.49509077590234,2024-01-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
472,PY,80,"[74,84)",M,8,NA,2024-01-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
473,FL,71,"[64,74)",M,5,NA,2024-01-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
474,LI,63,"[44,64)",F,5,NA,2024-01-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
475,HC,1,"[1,14)",F,NA,NA,2024-01-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
476,ZC,83,"[74,84)",M,8,45.0737970714872,2024-01-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
477,BG,51,"[44,64)",F,6,NA,2024-01-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
478,QW,67,"[64,74)",F,6,NA,2024-01-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
479,DI,60,"[44,64)",M,6,NA,2024-01-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
480,YB,66,"[64,74)",M,6,NA,2024-01-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
481,DL,82,"[74,84)",M,9,NA,2024-01-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
482,DR,66,"[64,74)",M,5,NA,2024-01-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
483,FM,91,"[84,Inf)",M,9,NA,2024-01-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
484,FU,51,"[44,64)",F,5,NA,2024-01-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
485,SN,76,"[74,84)",M,8,NA,2024-01-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
486,JW,11,"[1,14)",M,NA,NA,2024-01-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
487,MG,59,"[44,64)",F,6,75.31017165186451,2024-01-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
488,LA,60,"[44,64)",M,5,NA,2024-01-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
489,WU,78,"[74,84)",F,7,NA,2024-01-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
490,BQ,42,"[14,44)",F,3,66.32173325351752,2024-01-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
491,RC,55,"[44,64)",F,5,NA,2024-01-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
492,IL,55,"[44,64)",F,5,NA,2024-01-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
493,HS,78,"[74,84)",M,6,NA,2024-01-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
494,SK,53,"[44,64)",F,5,NA,2024-01-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
495,EH,46,"[44,64)",M,3,NA,2024-01-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
496,TX,43,"[14,44)",M,6,NA,2024-01-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
497,MS,57,"[44,64)",M,5,NA,2024-01-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
498,KA,1,"[1,14)",F,NA,NA,2024-01-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
499,ME,80,"[74,84)",M,8,NA,2024-01-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
500,YL,55,"[44,64)",M,4,NA,2024-01-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
501,GL,59,"[44,64)",F,5,NA,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
502,UA,87,"[84,Inf)",M,8,NA,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
503,PW,50,"[44,64)",F,3,NA,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
504,PF,61,"[44,64)",M,7,NA,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
505,JB,57,"[44,64)",M,6,NA,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
506,EZ,73,"[64,74)",M,6,86.34469499898262,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
507,JI,48,"[44,64)",M,4,NA,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
508,PP,60,"[44,64)",M,5,NA,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
509,ML,0,"[0,1)",M,NA,NA,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
510,RF,54,"[44,64)",F,5,NA,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
511,GF,77,"[74,84)",M,8,NA,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
512,TP,91,"[84,Inf)",M,8,NA,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
513,PC,77,"[74,84)",M,8,NA,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
514,KQ,59,"[44,64)",F,5,NA,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
515,VY,36,"[14,44)",M,5,NA,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
516,MW,81,"[74,84)",M,9,57.6165902371398,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
517,BC,68,"[64,74)",M,7,NA,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
518,SU,2,"[1,14)",M,NA,NA,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
519,IQ,77,"[74,84)",M,7,47.85168227867755,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
520,FI,82,"[74,84)",M,7,NA,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
521,YV,86,"[84,Inf)",M,7,NA,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
522,PQ,82,"[74,84)",M,6,NA,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
523,BI,35,"[14,44)",M,4,NA,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
524,NF,41,"[14,44)",F,3,NA,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
525,HN,80,"[74,84)",M,7,NA,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
526,JE,78,"[74,84)",M,7,58.47546328584239,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
527,GI,64,"[64,74)",M,6,NA,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
528,YV,76,"[74,84)",F,6,NA,2024-01-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
529,JP,62,"[44,64)",M,7,NA,2024-01-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
530,OI,42,"[14,44)",F,4,NA,2024-01-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
531,QC,57,"[44,64)",F,6,NA,2024-01-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
532,GL,66,"[64,74)",M,5,NA,2024-01-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
533,SX,87,"[84,Inf)",M,7,NA,2024-01-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
534,ZK,79,"[74,84)",F,9,NA,2024-01-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
535,GY,76,"[74,84)",M,9,50.08461122841513,2024-01-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
536,ZA,60,"[44,64)",F,5,NA,2024-01-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
537,LV,48,"[44,64)",M,5,121.65395347825357,2024-01-23,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
538,TL,51,"[44,64)",F,3,NA,2024-01-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
539,CD,65,"[64,74)",F,6,NA,2024-01-23,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
540,RH,100,"[84,Inf)",F,8,NA,2024-01-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
541,CU,73,"[64,74)",M,7,NA,2024-01-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
542,SQ,68,"[64,74)",F,7,NA,2024-01-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
543,RY,86,"[84,Inf)",M,9,34.73253774611858,2024-01-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
544,DB,63,"[44,64)",F,5,NA,2024-01-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
545,XX,60,"[44,64)",M,7,NA,2024-01-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
546,RY,62,"[44,64)",M,7,NA,2024-01-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
547,NK,43,"[14,44)",M,5,NA,2024-01-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
548,FI,59,"[44,64)",M,4,75.28025752387077,2024-01-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
549,PS,74,"[74,84)",M,7,NA,2024-01-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
550,ZL,46,"[44,64)",M,3,100.9499514879057,2024-01-23,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
551,OU,49,"[44,64)",M,7,NA,2024-01-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
552,DY,78,"[74,84)",F,8,NA,2024-01-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
553,YP,87,"[84,Inf)",M,8,NA,2024-01-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
554,KQ,74,"[74,84)",M,8,NA,2024-01-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
555,PK,57,"[44,64)",F,5,NA,2024-01-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
556,HT,70,"[64,74)",F,6,NA,2024-01-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
557,TW,74,"[74,84)",M,5,NA,2024-01-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
558,NN,78,"[74,84)",M,6,NA,2024-01-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
559,JR,94,"[84,Inf)",F,8,NA,2024-01-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
560,PS,58,"[44,64)",M,4,NA,2024-01-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
561,BF,44,"[44,64)",M,4,NA,2024-01-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
562,ZI,82,"[74,84)",M,8,NA,2024-01-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
563,WZ,82,"[74,84)",M,7,NA,2024-01-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
564,NO,78,"[74,84)",M,8,52.856666809770935,2024-01-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
565,FJ,46,"[44,64)",M,4,NA,2024-01-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
566,JY,75,"[74,84)",M,8,NA,2024-01-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
567,WP,66,"[64,74)",M,6,NA,2024-01-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
568,RM,75,"[74,84)",F,6,NA,2024-01-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
569,TC,32,"[14,44)",M,1,88.59179837881518,2024-01-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
570,AW,84,"[84,Inf)",M,8,63.069406131202754,2024-01-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
571,PP,63,"[44,64)",F,6,67.65844364031808,2024-01-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
572,NX,51,"[44,64)",M,6,NA,2024-01-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
573,PE,35,"[14,44)",M,2,NA,2024-01-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
574,ZH,69,"[64,74)",F,5,NA,2024-01-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
575,FK,81,"[74,84)",M,8,NA,2024-01-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
576,VS,93,"[84,Inf)",M,9,NA,2024-01-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
577,EI,79,"[74,84)",M,8,NA,2024-01-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
578,PI,62,"[44,64)",M,5,NA,2024-01-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
579,RC,59,"[44,64)",F,5,NA,2024-01-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
580,BK,59,"[44,64)",M,5,NA,2024-01-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
581,GW,59,"[44,64)",F,3,51.47969924130909,2024-01-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
582,SF,80,"[74,84)",M,8,53.075896927267884,2024-01-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
583,EQ,74,"[74,84)",M,7,67.93531143254094,2024-01-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
584,JC,87,"[84,Inf)",M,7,NA,2024-01-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
585,DY,83,"[74,84)",M,5,36.474138253725116,2024-01-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
586,RM,71,"[64,74)",F,8,85.24569145620981,2024-01-26,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
587,IF,61,"[44,64)",M,5,NA,2024-01-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
588,WM,48,"[44,64)",M,5,NA,2024-01-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
589,OE,85,"[84,Inf)",M,9,NA,2024-01-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
590,WB,92,"[84,Inf)",M,8,NA,2024-01-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
591,JT,36,"[14,44)",F,2,NA,2024-01-26,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
592,KN,0,"[0,1)",M,NA,NA,2024-01-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
593,ID,43,"[14,44)",F,3,NA,2024-01-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
594,VD,57,"[44,64)",M,5,NA,2024-01-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
595,MP,67,"[64,74)",M,6,88.57693297503214,2024-01-26,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
596,AA,68,"[64,74)",M,7,NA,2024-01-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
597,NS,76,"[74,84)",M,8,115.29326218048335,2024-01-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
598,HJ,85,"[84,Inf)",M,7,NA,2024-01-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
599,KT,94,"[84,Inf)",M,7,NA,2024-01-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
600,BX,77,"[74,84)",F,7,NA,2024-01-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
601,HC,78,"[74,84)",F,8,NA,2024-01-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
602,FA,65,"[64,74)",M,5,NA,2024-01-26,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
603,KP,83,"[74,84)",M,7,NA,2024-01-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
604,JQ,74,"[74,84)",F,9,NA,2024-01-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
605,OG,67,"[64,74)",F,6,NA,2024-01-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
606,LX,0,"[0,1)",M,NA,NA,2024-01-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
607,PB,61,"[44,64)",M,5,NA,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
608,ZJ,98,"[84,Inf)",M,9,NA,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
609,SJ,66,"[64,74)",M,5,NA,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
610,ED,58,"[44,64)",F,6,NA,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
611,HW,86,"[84,Inf)",M,8,NA,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
612,HM,78,"[74,84)",F,7,NA,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
613,UD,60,"[44,64)",F,4,NA,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
614,SE,71,"[64,74)",F,7,NA,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
615,RB,27,"[14,44)",M,3,NA,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
616,KF,54,"[44,64)",M,5,NA,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
617,UO,42,"[14,44)",M,4,NA,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
618,JP,72,"[64,74)",F,7,NA,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
619,UT,93,"[84,Inf)",M,7,NA,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
620,MD,73,"[64,74)",M,6,59.36121664475919,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
621,RN,78,"[74,84)",M,7,NA,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
622,AU,53,"[44,64)",M,5,NA,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
623,CT,76,"[74,84)",M,6,NA,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
624,IZ,73,"[64,74)",M,6,NA,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
625,EG,73,"[64,74)",M,5,NA,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
626,AF,95,"[84,Inf)",M,7,NA,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
627,HW,89,"[84,Inf)",M,7,37.24381839913141,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
628,JK,70,"[64,74)",M,7,75.59766699603897,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
629,JN,80,"[74,84)",F,8,NA,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
630,RK,86,"[84,Inf)",M,9,NA,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
631,FY,78,"[74,84)",M,7,NA,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
632,UD,60,"[44,64)",M,5,114.15699301886036,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
633,UP,77,"[74,84)",M,7,80.47793884179882,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
634,MS,45,"[44,64)",M,5,142.30612346940816,2024-01-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
635,OE,48,"[44,64)",F,5,NA,2024-01-28,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
636,HG,0,"[0,1)",M,NA,NA,2024-01-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
637,KI,71,"[64,74)",F,6,NA,2024-01-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
638,XQ,84,"[84,Inf)",M,7,NA,2024-01-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
639,AI,65,"[64,74)",M,5,NA,2024-01-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
640,DF,74,"[74,84)",M,6,NA,2024-01-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
641,ZT,56,"[44,64)",F,7,122.48660760111922,2024-01-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
642,RO,41,"[14,44)",F,3,87.53840210926765,2024-01-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
643,IS,44,"[44,64)",M,3,NA,2024-01-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
644,SH,82,"[74,84)",F,7,NA,2024-01-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
645,FN,56,"[44,64)",M,5,NA,2024-01-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
646,VQ,91,"[84,Inf)",M,9,30.87257128335424,2024-01-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
647,MT,75,"[74,84)",F,7,NA,2024-01-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
648,AB,70,"[64,74)",M,7,63.61401241594791,2024-01-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
649,LU,58,"[44,64)",M,7,90.94850856858002,2024-01-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
650,EF,85,"[84,Inf)",F,7,NA,2024-01-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
651,ID,26,"[14,44)",M,2,NA,2024-01-28,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
652,IA,80,"[74,84)",M,8,NA,2024-01-28,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
653,KR,87,"[84,Inf)",M,7,48.69615821923714,2024-01-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
654,VJ,94,"[84,Inf)",M,9,NA,2024-01-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
655,SV,77,"[74,84)",M,8,NA,2024-01-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
656,SO,73,"[64,74)",M,7,NA,2024-01-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
657,QI,52,"[44,64)",M,5,NA,2024-01-29,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
658,NW,93,"[84,Inf)",M,9,NA,2024-01-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
659,JY,81,"[74,84)",M,7,NA,2024-01-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
660,SR,83,"[74,84)",M,8,NA,2024-01-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
661,AC,59,"[44,64)",M,5,NA,2024-01-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
662,NI,75,"[74,84)",M,7,NA,2024-01-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
663,EZ,54,"[44,64)",F,6,NA,2024-01-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
664,WD,60,"[44,64)",M,5,68.17918506297808,2024-01-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
665,QS,51,"[44,64)",M,4,NA,2024-01-29,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
666,WY,89,"[84,Inf)",M,8,NA,2024-01-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
667,AZ,87,"[84,Inf)",M,7,35.71873677780636,2024-01-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
668,ZT,74,"[74,84)",M,6,NA,2024-01-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
669,WG,49,"[44,64)",M,4,93.08996220099684,2024-01-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
670,OL,68,"[64,74)",M,5,NA,2024-01-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
671,BU,62,"[44,64)",F,5,126.6255870005959,2024-01-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
672,OB,72,"[64,74)",F,7,NA,2024-01-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
673,VI,77,"[74,84)",F,4,59.70535932882141,2024-01-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
674,FI,88,"[84,Inf)",M,6,NA,2024-01-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
675,DU,77,"[74,84)",M,8,NA,2024-01-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
676,OT,82,"[74,84)",M,7,NA,2024-01-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
677,OJ,80,"[74,84)",F,7,NA,2024-01-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
678,SE,66,"[64,74)",F,7,NA,2024-01-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
679,XI,70,"[64,74)",M,5,NA,2024-01-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
680,NC,82,"[74,84)",M,7,NA,2024-01-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
681,OB,68,"[64,74)",F,5,NA,2024-01-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
682,NP,90,"[84,Inf)",M,8,NA,2024-01-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
683,TP,0,"[0,1)",M,NA,NA,2024-01-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
684,KD,39,"[14,44)",M,4,NA,2024-01-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
685,YC,70,"[64,74)",M,5,NA,2024-01-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
686,YK,50,"[44,64)",M,3,NA,2024-01-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
687,XW,89,"[84,Inf)",M,7,NA,2024-01-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
688,OM,78,"[74,84)",M,7,NA,2024-01-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
689,YX,70,"[64,74)",M,7,NA,2024-01-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
690,PJ,72,"[64,74)",M,6,NA,2024-01-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
691,SX,79,"[74,84)",F,6,NA,2024-01-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
692,UD,67,"[64,74)",M,7,NA,2024-01-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
693,JN,96,"[84,Inf)",F,9,NA,2024-01-31,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
694,RL,95,"[84,Inf)",M,9,NA,2024-01-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
695,VD,47,"[44,64)",F,5,NA,2024-01-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
696,CD,60,"[44,64)",M,6,NA,2024-01-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
697,YZ,34,"[14,44)",M,2,NA,2024-01-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
698,ZP,36,"[14,44)",M,3,NA,2024-01-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
699,NZ,87,"[84,Inf)",M,6,NA,2024-01-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
700,TU,85,"[84,Inf)",M,6,NA,2024-01-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
701,DO,64,"[64,74)",M,7,NA,2024-01-31,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
702,CM,43,"[14,44)",F,4,NA,2024-01-31,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
703,ZM,61,"[44,64)",M,6,NA,2024-01-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
704,JM,90,"[84,Inf)",M,8,NA,2024-01-31,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
705,YN,38,"[14,44)",F,3,NA,2024-01-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
706,BK,64,"[64,74)",F,6,NA,2024-01-31,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
707,GH,85,"[84,Inf)",M,8,NA,2024-01-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
708,MY,77,"[74,84)",M,8,NA,2024-01-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
709,ZS,63,"[44,64)",M,5,NA,2024-01-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
710,WB,91,"[84,Inf)",M,9,NA,2024-01-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
711,OL,78,"[74,84)",F,8,98.97411004096034,2024-01-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
712,CV,61,"[44,64)",F,6,117.38883891232257,2024-01-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
713,VD,53,"[44,64)",F,5,NA,2024-01-31,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
714,DP,55,"[44,64)",M,5,70.9427322299101,2024-01-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
715,NG,74,"[74,84)",M,5,NA,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
716,XS,69,"[64,74)",M,6,NA,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
717,LD,82,"[74,84)",M,7,NA,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
718,SJ,77,"[74,84)",F,7,NA,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
719,ET,84,"[84,Inf)",F,7,35.70949894976151,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
720,CC,67,"[64,74)",F,5,NA,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
721,XW,62,"[44,64)",M,7,NA,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
722,ZV,30,"[14,44)",M,3,NA,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
723,WT,58,"[44,64)",M,5,NA,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
724,BV,57,"[44,64)",M,5,NA,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
725,RG,80,"[74,84)",M,7,NA,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
726,FA,86,"[84,Inf)",M,7,NA,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
727,CJ,93,"[84,Inf)",M,8,NA,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
728,HK,48,"[44,64)",F,4,NA,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
729,ZB,55,"[44,64)",M,6,NA,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
730,GR,78,"[74,84)",M,7,NA,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
731,NA,63,"[44,64)",M,4,NA,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
732,NW,68,"[64,74)",M,7,NA,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
733,ZJ,71,"[64,74)",M,7,NA,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
734,KU,64,"[64,74)",F,6,93.39374038505825,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
735,WK,68,"[64,74)",M,6,NA,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
736,XV,55,"[44,64)",M,6,NA,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
737,LW,93,"[84,Inf)",M,6,NA,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
738,VZ,74,"[74,84)",M,6,NA,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
739,LX,96,"[84,Inf)",M,7,30.241783419091238,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
740,YE,81,"[74,84)",M,7,NA,2024-02-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
741,AU,82,"[74,84)",M,8,63.43951763050867,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
742,OJ,77,"[74,84)",M,6,NA,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
743,WP,67,"[64,74)",F,8,NA,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
744,KA,70,"[64,74)",F,5,NA,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
745,JQ,73,"[64,74)",M,4,NA,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
746,PV,80,"[74,84)",M,8,NA,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
747,XP,58,"[44,64)",M,7,NA,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
748,FR,49,"[44,64)",M,3,105.06565027247373,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
749,DN,83,"[74,84)",M,8,NA,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
750,KH,59,"[44,64)",M,4,68.5413957158002,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
751,LM,70,"[64,74)",M,5,NA,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
752,HX,50,"[44,64)",M,5,NA,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
753,EH,92,"[84,Inf)",M,8,NA,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
754,LG,44,"[44,64)",F,4,NA,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
755,HY,17,"[14,44)",M,NA,NA,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
756,HH,86,"[84,Inf)",M,6,NA,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
757,PU,58,"[44,64)",M,8,92.63666976938418,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
758,CT,50,"[44,64)",F,5,NA,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
759,ST,50,"[44,64)",M,5,NA,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
760,DF,56,"[44,64)",M,5,115.73847705417143,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
761,OP,76,"[74,84)",M,7,NA,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
762,UL,78,"[74,84)",M,7,52.00871106428382,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
763,WD,48,"[44,64)",M,4,NA,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
764,AI,65,"[64,74)",M,7,95.38720094069971,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
765,RI,79,"[74,84)",F,7,91.63590199092707,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
766,WU,55,"[44,64)",M,5,77.6356941420705,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
767,WU,82,"[74,84)",F,7,NA,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
768,NT,57,"[44,64)",F,5,NA,2024-02-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
769,ZV,53,"[44,64)",M,4,NA,2024-02-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
770,NZ,49,"[44,64)",M,5,NA,2024-02-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
771,MD,71,"[64,74)",M,8,72.99262968144492,2024-02-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
772,ET,53,"[44,64)",M,6,NA,2024-02-03,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
773,RS,80,"[74,84)",M,6,NA,2024-02-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
774,BV,85,"[84,Inf)",M,8,NA,2024-02-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
775,ET,79,"[74,84)",M,7,NA,2024-02-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
776,IB,68,"[64,74)",F,6,NA,2024-02-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
777,EA,80,"[74,84)",M,6,NA,2024-02-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
778,ZW,82,"[74,84)",M,7,NA,2024-02-03,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
779,TS,64,"[64,74)",F,7,NA,2024-02-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
780,GH,80,"[74,84)",M,7,NA,2024-02-03,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
781,WU,83,"[74,84)",M,8,NA,2024-02-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
782,QQ,70,"[64,74)",F,6,NA,2024-02-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
783,TD,63,"[44,64)",F,5,NA,2024-02-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
784,ET,43,"[14,44)",F,4,NA,2024-02-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
785,GD,47,"[44,64)",F,3,NA,2024-02-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
786,PW,86,"[84,Inf)",M,7,NA,2024-02-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
787,SZ,84,"[84,Inf)",M,8,NA,2024-02-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
788,JP,69,"[64,74)",F,6,NA,2024-02-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
789,XT,82,"[74,84)",M,7,NA,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
790,CH,81,"[74,84)",M,7,NA,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
791,GW,51,"[44,64)",F,5,NA,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
792,LS,59,"[44,64)",M,2,NA,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
793,JZ,94,"[84,Inf)",M,8,NA,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
794,NX,76,"[74,84)",M,6,NA,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
795,IK,51,"[44,64)",M,5,NA,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
796,NK,57,"[44,64)",F,5,NA,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
797,IU,71,"[64,74)",F,7,69.67500773400874,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
798,GX,59,"[44,64)",F,4,NA,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
799,XL,82,"[74,84)",M,7,NA,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
800,RS,73,"[64,74)",M,8,NA,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
801,EB,54,"[44,64)",M,6,NA,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
802,VI,39,"[14,44)",M,4,NA,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
803,UU,65,"[64,74)",F,6,NA,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
804,CZ,75,"[74,84)",M,6,NA,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
805,NI,50,"[44,64)",F,4,126.11029045705894,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
806,AU,66,"[64,74)",M,5,NA,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
807,NG,58,"[44,64)",M,4,NA,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
808,BR,31,"[14,44)",M,3,NA,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
809,SF,62,"[44,64)",M,6,NA,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
810,YL,91,"[84,Inf)",M,8,NA,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
811,WQ,86,"[84,Inf)",F,6,NA,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
812,AT,76,"[74,84)",M,7,68.92190246643723,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
813,FS,98,"[84,Inf)",M,9,NA,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
814,LG,0,"[0,1)",M,NA,NA,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
815,CS,75,"[74,84)",M,5,68.54030660680888,2024-02-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
816,PN,93,"[84,Inf)",M,7,41.042704587756134,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
817,WJ,69,"[64,74)",M,7,66.93813187130706,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
818,LQ,50,"[44,64)",M,4,NA,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
819,SZ,79,"[74,84)",F,6,NA,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
820,LL,87,"[84,Inf)",F,6,NA,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
821,HF,72,"[64,74)",M,5,NA,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
822,GP,83,"[74,84)",M,8,NA,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
823,PD,78,"[74,84)",M,7,NA,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
824,MG,78,"[74,84)",M,7,NA,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
825,QT,53,"[44,64)",F,6,NA,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
826,AW,69,"[64,74)",M,6,NA,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
827,DE,96,"[84,Inf)",M,8,NA,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
828,EU,56,"[44,64)",M,4,NA,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
829,PW,71,"[64,74)",M,5,NA,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
830,CN,93,"[84,Inf)",M,7,NA,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
831,XF,85,"[84,Inf)",M,8,NA,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
832,ZK,77,"[74,84)",M,7,NA,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
833,SZ,89,"[84,Inf)",M,9,NA,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
834,CW,75,"[74,84)",F,6,NA,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
835,VL,93,"[84,Inf)",M,8,NA,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
836,SU,45,"[44,64)",M,5,NA,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
837,MN,95,"[84,Inf)",M,8,NA,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
838,HK,45,"[44,64)",F,5,NA,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
839,LO,61,"[44,64)",M,5,NA,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
840,YT,71,"[64,74)",F,5,NA,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
841,QT,65,"[64,74)",F,7,118.16312242665447,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
842,AN,95,"[84,Inf)",M,8,NA,2024-02-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
843,WO,63,"[44,64)",M,6,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
844,JF,90,"[84,Inf)",M,6,33.69990062071708,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
845,RF,54,"[44,64)",M,5,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
846,BB,76,"[74,84)",F,6,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
847,GS,30,"[14,44)",M,3,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
848,TO,86,"[84,Inf)",M,8,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
849,EB,94,"[84,Inf)",M,8,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
850,HX,48,"[44,64)",M,5,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
851,SO,70,"[64,74)",M,8,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
852,OX,79,"[74,84)",M,7,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
853,JQ,92,"[84,Inf)",F,8,36.626302327369245,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
854,MK,86,"[84,Inf)",F,8,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
855,CS,46,"[44,64)",M,5,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
856,EB,58,"[44,64)",M,5,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
857,UJ,80,"[74,84)",M,7,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
858,HR,1,"[1,14)",M,NA,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
859,IO,80,"[74,84)",M,8,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
860,DJ,77,"[74,84)",M,8,54.96894923646035,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
861,WK,73,"[64,74)",F,6,146.35361673082187,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
862,ID,64,"[64,74)",M,3,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
863,WC,56,"[44,64)",F,4,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
864,OB,40,"[14,44)",F,4,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
865,UB,70,"[64,74)",M,5,73.41486656755065,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
866,XQ,75,"[74,84)",F,7,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
867,QY,1,"[1,14)",M,NA,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
868,QW,60,"[44,64)",M,6,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
869,OL,88,"[84,Inf)",F,9,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
870,NZ,57,"[44,64)",M,6,103.77513068822905,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
871,KF,67,"[64,74)",M,6,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
872,NY,75,"[74,84)",M,8,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
873,QG,48,"[44,64)",M,4,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
874,RI,54,"[44,64)",M,5,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
875,RS,63,"[44,64)",F,6,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
876,JS,94,"[84,Inf)",M,7,NA,2024-02-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
877,DB,91,"[84,Inf)",F,7,27.435770240878508,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
878,EB,0,"[0,1)",F,NA,NA,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
879,GV,82,"[74,84)",M,7,NA,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
880,XQ,66,"[64,74)",M,4,NA,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
881,GT,77,"[74,84)",F,6,NA,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
882,GV,1,"[1,14)",M,NA,NA,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
883,AP,77,"[74,84)",M,7,59.39972944952176,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
884,WN,78,"[74,84)",F,6,NA,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
885,DN,63,"[44,64)",M,6,76.97429472469065,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
886,MB,63,"[44,64)",M,7,87.42921019047884,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
887,CM,97,"[84,Inf)",F,8,NA,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
888,RG,76,"[74,84)",M,8,NA,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
889,EQ,63,"[44,64)",F,6,NA,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
890,EU,74,"[74,84)",M,6,NA,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
891,IA,44,"[44,64)",M,3,NA,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
892,WF,96,"[84,Inf)",M,8,41.174088581996955,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
893,VT,80,"[74,84)",M,9,NA,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
894,PM,93,"[84,Inf)",F,9,NA,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
895,SE,0,"[0,1)",M,NA,NA,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
896,PP,70,"[64,74)",M,6,NA,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
897,CM,46,"[44,64)",F,3,NA,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
898,QB,68,"[64,74)",M,6,NA,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
899,DD,66,"[64,74)",M,5,NA,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
900,AC,73,"[64,74)",M,6,NA,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
901,YS,75,"[74,84)",M,7,NA,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
902,XI,73,"[64,74)",F,7,54.88738674978652,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
903,EV,53,"[44,64)",M,3,NA,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
904,PZ,85,"[84,Inf)",M,8,NA,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
905,YV,0,"[0,1)",M,NA,NA,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
906,FM,79,"[74,84)",M,6,71.36825373057303,2024-02-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
907,EB,55,"[44,64)",F,6,NA,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
908,ZS,54,"[44,64)",M,5,NA,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
909,NY,84,"[84,Inf)",M,8,NA,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
910,YI,61,"[44,64)",M,6,NA,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
911,CS,63,"[44,64)",F,7,153.45446123099885,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
912,EW,75,"[74,84)",M,5,NA,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
913,OI,60,"[44,64)",M,5,NA,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
914,HV,40,"[14,44)",M,5,NA,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
915,OR,73,"[64,74)",F,6,NA,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
916,NG,72,"[64,74)",F,7,NA,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
917,OX,54,"[44,64)",F,5,NA,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
918,IN,49,"[44,64)",M,4,NA,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
919,BT,59,"[44,64)",M,6,NA,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
920,EI,84,"[84,Inf)",M,9,NA,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
921,VI,59,"[44,64)",M,4,90.29616433349669,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
922,UA,56,"[44,64)",M,5,NA,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
923,LC,51,"[44,64)",F,5,NA,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
924,SS,77,"[74,84)",M,8,NA,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
925,FE,94,"[84,Inf)",M,9,NA,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
926,VA,88,"[84,Inf)",M,7,NA,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
927,HY,71,"[64,74)",M,6,NA,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
928,VK,39,"[14,44)",M,5,92.77990744213875,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
929,WY,48,"[44,64)",F,5,NA,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
930,GV,90,"[84,Inf)",M,7,NA,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
931,SE,75,"[74,84)",M,7,NA,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
932,OL,70,"[64,74)",F,5,NA,2024-02-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
933,LB,77,"[74,84)",F,8,NA,2024-02-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
934,UP,85,"[84,Inf)",M,8,38.121978770257456,2024-02-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
935,VB,32,"[14,44)",M,3,NA,2024-02-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
936,GN,77,"[74,84)",F,7,33.15878191899371,2024-02-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
937,JW,61,"[44,64)",F,6,NA,2024-02-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
938,UC,95,"[84,Inf)",F,7,NA,2024-02-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
939,GQ,84,"[84,Inf)",M,8,NA,2024-02-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
940,OW,88,"[84,Inf)",F,8,NA,2024-02-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
941,CZ,55,"[44,64)",M,5,NA,2024-02-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
942,ZL,79,"[74,84)",M,5,NA,2024-02-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
943,PE,79,"[74,84)",M,8,NA,2024-02-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
944,XJ,52,"[44,64)",M,4,NA,2024-02-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
945,ZI,62,"[44,64)",F,5,79.52910200293316,2024-02-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
946,UE,40,"[14,44)",M,6,NA,2024-02-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
947,RT,82,"[74,84)",M,8,NA,2024-02-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
948,NR,56,"[44,64)",F,5,NA,2024-02-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
949,EF,61,"[44,64)",F,5,58.65514923271062,2024-02-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
950,YE,73,"[64,74)",F,6,NA,2024-02-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
951,II,66,"[64,74)",F,7,NA,2024-02-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
952,OP,94,"[84,Inf)",M,9,NA,2024-02-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
953,NQ,91,"[84,Inf)",M,7,NA,2024-02-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
954,TY,75,"[74,84)",M,6,NA,2024-02-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
955,OB,46,"[44,64)",M,3,NA,2024-02-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
956,AF,53,"[44,64)",M,5,NA,2024-02-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
957,XV,76,"[74,84)",M,5,NA,2024-02-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
958,PS,72,"[64,74)",F,6,NA,2024-02-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
959,PU,32,"[14,44)",M,3,NA,2024-02-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
960,TK,85,"[84,Inf)",M,6,41.51094914178572,2024-02-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
961,FF,54,"[44,64)",F,4,NA,2024-02-10,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
962,NT,88,"[84,Inf)",M,9,37.36439200372741,2024-02-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
963,RJ,70,"[64,74)",M,8,NA,2024-02-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
964,DO,63,"[44,64)",M,6,NA,2024-02-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
965,AF,64,"[64,74)",M,7,NA,2024-02-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
966,QO,39,"[14,44)",F,4,NA,2024-02-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
967,YI,68,"[64,74)",M,4,NA,2024-02-10,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
968,HP,67,"[64,74)",F,6,NA,2024-02-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
969,BP,75,"[74,84)",F,7,120.43483687895171,2024-02-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
970,JT,48,"[44,64)",F,3,NA,2024-02-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
971,ZA,96,"[84,Inf)",F,9,NA,2024-02-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
972,FH,50,"[44,64)",F,6,NA,2024-02-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
973,JO,58,"[44,64)",M,6,NA,2024-02-10,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
974,SH,35,"[14,44)",M,3,NA,2024-02-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
975,JY,89,"[84,Inf)",M,9,NA,2024-02-10,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
976,QU,58,"[44,64)",F,6,NA,2024-02-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
977,LL,87,"[84,Inf)",F,8,NA,2024-02-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
978,OP,61,"[44,64)",F,3,NA,2024-02-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
979,BI,74,"[74,84)",F,5,NA,2024-02-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
980,TD,95,"[84,Inf)",M,8,NA,2024-02-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
981,XR,65,"[64,74)",F,5,NA,2024-02-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
982,ME,54,"[44,64)",M,5,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
983,DG,65,"[64,74)",F,7,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
984,JW,89,"[84,Inf)",M,9,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
985,EV,58,"[44,64)",F,5,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
986,TE,50,"[44,64)",F,6,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
987,AJ,79,"[74,84)",M,6,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
988,KT,97,"[84,Inf)",M,9,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
989,MC,67,"[64,74)",M,5,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
990,YF,57,"[44,64)",M,5,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
991,IG,65,"[64,74)",F,7,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
992,RC,65,"[64,74)",F,6,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
993,SX,84,"[84,Inf)",M,7,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
994,MP,89,"[84,Inf)",M,8,45.16361546638772,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
995,AW,64,"[64,74)",M,6,82.47412230584503,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
996,DM,75,"[74,84)",M,6,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
997,QH,73,"[64,74)",F,6,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
998,EX,92,"[84,Inf)",M,8,42.436317703045646,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
999,WS,84,"[84,Inf)",M,8,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1000,VP,59,"[44,64)",F,6,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1001,DX,54,"[44,64)",M,4,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1002,MD,84,"[84,Inf)",F,7,33.57937504794811,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1003,ON,54,"[44,64)",M,4,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1004,EJ,0,"[0,1)",M,NA,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1005,WC,70,"[64,74)",M,7,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1006,YY,94,"[84,Inf)",F,9,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1007,AC,79,"[74,84)",M,7,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1008,LY,75,"[74,84)",M,5,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1009,IC,90,"[84,Inf)",M,8,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1010,LZ,77,"[74,84)",M,8,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1011,IR,87,"[84,Inf)",M,8,NA,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1012,DG,94,"[84,Inf)",M,9,40.25940363480245,2024-02-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1013,QR,83,"[74,84)",F,9,NA,2024-02-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1014,MF,95,"[84,Inf)",M,9,NA,2024-02-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1015,VQ,55,"[44,64)",M,4,NA,2024-02-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1016,JX,79,"[74,84)",F,8,NA,2024-02-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1017,TQ,84,"[84,Inf)",M,7,55.77183615622915,2024-02-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1018,HZ,44,"[44,64)",M,3,NA,2024-02-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1019,VU,0,"[0,1)",F,NA,NA,2024-02-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1020,AB,51,"[44,64)",F,3,NA,2024-02-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1021,GJ,80,"[74,84)",M,7,NA,2024-02-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1022,DV,66,"[64,74)",F,7,NA,2024-02-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1023,HN,48,"[44,64)",M,4,NA,2024-02-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1024,IS,83,"[74,84)",M,7,NA,2024-02-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1025,GB,94,"[84,Inf)",M,8,NA,2024-02-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1026,YX,84,"[84,Inf)",M,6,60.28806731686565,2024-02-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1027,IA,67,"[64,74)",M,7,121.52738974161966,2024-02-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1028,MQ,61,"[44,64)",M,5,NA,2024-02-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1029,EM,83,"[74,84)",M,8,NA,2024-02-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1030,FP,82,"[74,84)",M,7,NA,2024-02-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1031,IL,66,"[64,74)",M,6,91.16599537248888,2024-02-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1032,VI,72,"[64,74)",M,7,NA,2024-02-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1033,EW,47,"[44,64)",M,5,NA,2024-02-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1034,NV,56,"[44,64)",F,6,104.84477335229063,2024-02-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1035,UR,41,"[14,44)",M,4,NA,2024-02-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1036,NF,90,"[84,Inf)",F,9,49.85170334951746,2024-02-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1037,YX,53,"[44,64)",F,6,NA,2024-02-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1038,JU,59,"[44,64)",F,6,65.14876226863005,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1039,EJ,67,"[64,74)",M,6,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1040,BM,81,"[74,84)",M,7,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1041,ST,76,"[74,84)",M,6,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1042,UB,75,"[74,84)",M,8,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1043,LF,84,"[84,Inf)",M,8,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1044,CQ,70,"[64,74)",F,5,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1045,WB,83,"[74,84)",M,6,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1046,NJ,48,"[44,64)",M,5,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1047,IE,78,"[74,84)",M,8,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1048,HV,74,"[74,84)",M,5,101.10238784315803,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1049,NV,75,"[74,84)",F,8,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1050,KL,80,"[74,84)",M,6,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1051,VD,77,"[74,84)",M,8,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1052,OH,61,"[44,64)",F,5,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1053,FH,92,"[84,Inf)",M,8,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1054,HH,44,"[44,64)",F,4,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1055,LO,51,"[44,64)",M,4,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1056,AW,64,"[64,74)",M,7,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1057,BY,77,"[74,84)",M,8,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1058,GP,91,"[84,Inf)",M,7,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1059,QK,64,"[64,74)",M,6,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1060,UB,77,"[74,84)",M,6,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1061,NT,59,"[44,64)",M,4,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1062,YX,61,"[44,64)",M,6,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1063,MV,96,"[84,Inf)",F,7,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1064,UB,95,"[84,Inf)",M,9,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1065,FE,87,"[84,Inf)",M,6,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1066,ED,68,"[64,74)",F,5,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1067,DM,59,"[44,64)",M,5,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1068,CS,70,"[64,74)",M,6,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1069,BY,84,"[84,Inf)",F,6,NA,2024-02-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1070,NR,57,"[44,64)",F,4,NA,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1071,JB,60,"[44,64)",M,4,NA,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1072,XA,90,"[84,Inf)",M,8,NA,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1073,RZ,51,"[44,64)",F,5,126.32315599971,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1074,MF,67,"[64,74)",M,6,83.3746869131559,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1075,DQ,83,"[74,84)",M,9,NA,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1076,WG,60,"[44,64)",M,6,102.90154032592521,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1077,QQ,75,"[74,84)",M,7,NA,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1078,KI,84,"[84,Inf)",M,5,NA,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1079,AH,89,"[84,Inf)",M,7,NA,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1080,FV,1,"[1,14)",M,NA,NA,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1081,BO,46,"[44,64)",F,3,113.41962143053485,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1082,VN,66,"[64,74)",F,5,NA,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1083,VC,94,"[84,Inf)",M,8,NA,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1084,XM,87,"[84,Inf)",M,7,NA,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1085,RS,53,"[44,64)",F,4,NA,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1086,IF,90,"[84,Inf)",M,8,34.98265201954812,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1087,QQ,98,"[84,Inf)",F,7,NA,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1088,US,25,"[14,44)",F,4,NA,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1089,ZO,54,"[44,64)",F,4,NA,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1090,LE,77,"[74,84)",F,8,34.38451779740724,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1091,OS,74,"[74,84)",F,6,NA,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1092,BE,39,"[14,44)",F,2,73.62152823770232,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1093,RR,49,"[44,64)",M,5,NA,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1094,IQ,68,"[64,74)",M,5,NA,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1095,QO,61,"[44,64)",M,5,103.81935013161636,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1096,FN,86,"[84,Inf)",M,8,NA,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1097,DE,67,"[64,74)",M,7,NA,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1098,HJ,81,"[74,84)",M,8,NA,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1099,SO,58,"[44,64)",M,4,NA,2024-02-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1100,BT,74,"[74,84)",M,7,NA,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1101,PS,88,"[84,Inf)",M,7,NA,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1102,YE,59,"[44,64)",M,6,NA,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1103,ST,72,"[64,74)",M,7,NA,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1104,IN,78,"[74,84)",F,6,NA,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1105,WP,31,"[14,44)",M,2,NA,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1106,JB,55,"[44,64)",F,5,NA,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1107,TS,83,"[74,84)",M,7,NA,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1108,XX,36,"[14,44)",M,3,87.72022206152114,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1109,OV,59,"[44,64)",F,5,155.76192437362087,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1110,YW,74,"[74,84)",F,7,NA,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1111,GY,87,"[84,Inf)",M,7,NA,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1112,CD,73,"[64,74)",M,7,NA,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1113,IE,77,"[74,84)",F,6,NA,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1114,TT,88,"[84,Inf)",M,9,53.154379373513976,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1115,QN,86,"[84,Inf)",M,9,NA,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1116,WI,84,"[84,Inf)",M,7,50.124491398402725,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1117,NE,68,"[64,74)",M,6,NA,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1118,UW,34,"[14,44)",M,2,NA,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1119,AN,65,"[64,74)",M,6,NA,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1120,CC,77,"[74,84)",M,7,NA,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1121,KQ,76,"[74,84)",F,7,NA,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1122,VZ,82,"[74,84)",M,7,NA,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1123,ZF,40,"[14,44)",M,3,NA,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1124,AM,51,"[44,64)",M,4,NA,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1125,IW,90,"[84,Inf)",M,6,NA,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1126,QT,79,"[74,84)",M,9,NA,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1127,JJ,72,"[64,74)",M,6,NA,2024-02-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1128,ZR,54,"[44,64)",M,5,NA,2024-02-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1129,TF,84,"[84,Inf)",M,7,42.79278425326546,2024-02-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1130,UN,77,"[74,84)",M,7,NA,2024-02-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1131,PD,74,"[74,84)",M,7,66.70579890343483,2024-02-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1132,DI,70,"[64,74)",M,7,NA,2024-02-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1133,AD,79,"[74,84)",M,9,NA,2024-02-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1134,LQ,77,"[74,84)",M,6,NA,2024-02-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1135,TV,84,"[84,Inf)",F,7,40.62201865612467,2024-02-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1136,YI,65,"[64,74)",F,5,NA,2024-02-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1137,WO,70,"[64,74)",F,7,NA,2024-02-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1138,DE,85,"[84,Inf)",M,9,55.89202097157496,2024-02-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1139,HS,95,"[84,Inf)",F,6,NA,2024-02-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1140,ED,76,"[74,84)",M,5,NA,2024-02-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1141,CX,79,"[74,84)",M,7,NA,2024-02-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1142,MO,62,"[44,64)",M,5,NA,2024-02-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1143,LF,89,"[84,Inf)",F,7,34.76508557371662,2024-02-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1144,LV,61,"[44,64)",F,5,NA,2024-02-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1145,HG,54,"[44,64)",F,5,116.14732297084413,2024-02-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1146,CZ,68,"[64,74)",F,6,NA,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1147,NZ,82,"[74,84)",M,7,NA,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1148,FH,67,"[64,74)",F,5,89.62076423204059,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1149,FE,59,"[44,64)",F,4,NA,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1150,RD,82,"[74,84)",F,8,34.29289909731626,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1151,JG,36,"[14,44)",M,3,NA,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1152,MY,59,"[44,64)",F,6,73.02375211505145,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1153,YS,85,"[84,Inf)",M,7,NA,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1154,IW,68,"[64,74)",M,6,NA,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1155,GN,0,"[0,1)",M,NA,NA,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1156,GT,83,"[74,84)",F,7,NA,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1157,FH,50,"[44,64)",F,4,NA,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1158,MM,83,"[74,84)",F,6,NA,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1159,UR,66,"[64,74)",M,7,116.81638345650656,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1160,BC,83,"[74,84)",M,6,54.835749877938646,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1161,GE,73,"[64,74)",M,8,NA,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1162,UH,39,"[14,44)",F,4,NA,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1163,TJ,63,"[44,64)",M,5,NA,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1164,VI,69,"[64,74)",M,6,NA,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1165,NQ,85,"[84,Inf)",F,7,NA,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1166,UF,79,"[74,84)",F,7,47.16439916513886,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1167,VT,37,"[14,44)",M,4,NA,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1168,GS,48,"[44,64)",M,4,134.7972775260651,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1169,IV,71,"[64,74)",F,6,74.12888932175659,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1170,VH,63,"[44,64)",M,5,NA,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1171,VI,71,"[64,74)",M,8,NA,2024-02-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1172,UG,53,"[44,64)",M,3,NA,2024-02-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1173,XH,76,"[74,84)",M,6,NA,2024-02-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1174,JA,56,"[44,64)",M,4,NA,2024-02-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1175,OW,70,"[64,74)",M,6,NA,2024-02-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1176,EJ,65,"[64,74)",M,6,NA,2024-02-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1177,DO,51,"[44,64)",M,5,NA,2024-02-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1178,BD,66,"[64,74)",F,6,NA,2024-02-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1179,ZF,73,"[64,74)",F,8,115.98537852289849,2024-02-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1180,YA,56,"[44,64)",M,5,NA,2024-02-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1181,JE,71,"[64,74)",M,6,NA,2024-02-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1182,ZQ,64,"[64,74)",F,7,NA,2024-02-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1183,LF,69,"[64,74)",M,5,60.815279723929386,2024-02-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1184,JC,91,"[84,Inf)",M,8,NA,2024-02-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1185,XE,79,"[74,84)",M,6,NA,2024-02-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1186,BK,77,"[74,84)",M,8,46.17817894629227,2024-02-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1187,NA,60,"[44,64)",M,5,NA,2024-02-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1188,UT,90,"[84,Inf)",M,8,NA,2024-02-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1189,YN,1,"[1,14)",F,NA,NA,2024-02-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1190,SO,75,"[74,84)",M,5,NA,2024-02-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1191,XH,79,"[74,84)",F,6,NA,2024-02-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1192,OV,63,"[44,64)",F,7,NA,2024-02-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1193,RX,61,"[44,64)",M,6,NA,2024-02-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1194,FE,56,"[44,64)",M,5,NA,2024-02-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1195,RH,86,"[84,Inf)",M,7,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1196,MF,68,"[64,74)",F,7,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1197,IT,94,"[84,Inf)",F,9,40.52286813990767,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1198,GI,62,"[44,64)",F,5,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1199,DQ,69,"[64,74)",M,7,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1200,IP,74,"[74,84)",M,7,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1201,GR,48,"[44,64)",F,4,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1202,MY,87,"[84,Inf)",M,9,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1203,EI,29,"[14,44)",M,2,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1204,DI,45,"[44,64)",M,5,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1205,LO,66,"[64,74)",M,5,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1206,ZY,43,"[14,44)",F,4,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1207,BA,71,"[64,74)",M,7,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1208,YV,38,"[14,44)",F,3,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1209,YO,89,"[84,Inf)",M,9,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1210,UA,84,"[84,Inf)",M,9,39.890231681172864,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1211,VG,85,"[84,Inf)",F,6,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1212,TY,65,"[64,74)",F,4,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1213,LD,95,"[84,Inf)",M,8,42.318658222029875,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1214,NF,81,"[74,84)",M,8,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1215,LT,62,"[44,64)",F,8,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1216,VC,52,"[44,64)",M,6,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1217,AB,72,"[64,74)",M,7,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1218,MJ,72,"[64,74)",F,6,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1219,NT,97,"[84,Inf)",M,8,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1220,HY,57,"[44,64)",M,7,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1221,MJ,76,"[74,84)",M,6,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1222,YQ,59,"[44,64)",M,7,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1223,DG,90,"[84,Inf)",M,9,NA,2024-02-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1224,ZZ,44,"[44,64)",M,4,102.68604869543837,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1225,WI,54,"[44,64)",M,5,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1226,ZN,73,"[64,74)",F,7,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1227,VT,57,"[44,64)",M,6,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1228,PJ,59,"[44,64)",M,4,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1229,TL,52,"[44,64)",M,5,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1230,LH,51,"[44,64)",F,4,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1231,CZ,64,"[64,74)",M,6,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1232,WO,78,"[74,84)",F,8,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1233,BF,82,"[74,84)",F,7,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1234,SJ,71,"[64,74)",M,6,84.19439482024497,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1235,GB,79,"[74,84)",M,8,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1236,HZ,45,"[44,64)",M,5,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1237,NI,77,"[74,84)",F,7,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1238,ZJ,80,"[74,84)",F,8,39.70414789008237,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1239,OL,62,"[44,64)",F,7,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1240,JI,95,"[84,Inf)",M,7,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1241,CX,64,"[64,74)",M,6,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1242,CI,84,"[84,Inf)",M,7,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1243,PW,73,"[64,74)",M,8,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1244,AI,59,"[44,64)",M,4,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1245,HR,72,"[64,74)",M,7,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1246,SS,84,"[84,Inf)",M,6,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1247,FW,75,"[74,84)",F,8,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1248,ZM,75,"[74,84)",M,8,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1249,NP,54,"[44,64)",M,5,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1250,UA,72,"[64,74)",F,6,100.4682049003538,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1251,RK,51,"[44,64)",F,4,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1252,DV,53,"[44,64)",M,6,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1253,YC,85,"[84,Inf)",F,7,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1254,NQ,84,"[84,Inf)",M,8,NA,2024-02-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1255,GX,83,"[74,84)",M,5,NA,2024-02-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1256,QF,74,"[74,84)",M,6,NA,2024-02-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1257,LM,85,"[84,Inf)",M,9,NA,2024-02-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1258,RW,68,"[64,74)",F,8,NA,2024-02-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1259,UH,69,"[64,74)",F,7,NA,2024-02-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1260,EM,89,"[84,Inf)",M,8,42.81974476831266,2024-02-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1261,WW,93,"[84,Inf)",M,8,NA,2024-02-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1262,AB,50,"[44,64)",F,4,67.01017056160468,2024-02-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1263,ZF,55,"[44,64)",F,4,NA,2024-02-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1264,TL,55,"[44,64)",F,6,NA,2024-02-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1265,FW,0,"[0,1)",M,NA,NA,2024-02-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1266,UB,74,"[74,84)",F,7,67.02525422052547,2024-02-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1267,NF,87,"[84,Inf)",M,7,NA,2024-02-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1268,CM,64,"[64,74)",M,6,NA,2024-02-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1269,BU,71,"[64,74)",M,6,NA,2024-02-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1270,QT,81,"[74,84)",M,8,NA,2024-02-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1271,SA,73,"[64,74)",M,7,NA,2024-02-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1272,QI,64,"[64,74)",F,5,NA,2024-02-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1273,HX,74,"[74,84)",M,8,NA,2024-02-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1274,ZG,91,"[84,Inf)",F,7,75.65016773566087,2024-02-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1275,FS,55,"[44,64)",M,5,NA,2024-02-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1276,VD,65,"[64,74)",F,6,NA,2024-02-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1277,OB,86,"[84,Inf)",M,9,NA,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1278,NT,89,"[84,Inf)",M,8,NA,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1279,RW,64,"[64,74)",M,7,NA,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1280,RF,61,"[44,64)",F,6,NA,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1281,CQ,72,"[64,74)",M,6,NA,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1282,UZ,61,"[44,64)",F,5,58.90257958689254,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1283,YB,78,"[74,84)",M,7,NA,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1284,VZ,68,"[64,74)",M,5,NA,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1285,TV,96,"[84,Inf)",M,8,NA,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1286,XZ,53,"[44,64)",M,4,NA,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1287,RI,87,"[84,Inf)",F,7,NA,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1288,IJ,69,"[64,74)",M,6,NA,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1289,AX,59,"[44,64)",M,6,NA,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1290,YR,67,"[64,74)",M,6,69.65519523238714,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1291,NR,79,"[74,84)",M,8,NA,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1292,NZ,78,"[74,84)",F,9,NA,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1293,JM,78,"[74,84)",M,7,NA,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1294,RW,47,"[44,64)",M,4,NA,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1295,YT,53,"[44,64)",F,5,NA,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1296,JW,75,"[74,84)",M,7,55.01624588056972,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1297,PO,77,"[74,84)",M,6,NA,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1298,DW,50,"[44,64)",M,3,NA,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1299,PR,28,"[14,44)",M,3,NA,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1300,VG,35,"[14,44)",M,3,111.1135577541141,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1301,FL,84,"[84,Inf)",F,7,33.15126619746541,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1302,OD,77,"[74,84)",F,7,43.79996560743921,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1303,PT,70,"[64,74)",F,6,NA,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1304,EU,47,"[44,64)",M,4,NA,2024-02-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1305,RD,78,"[74,84)",F,7,NA,2024-02-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1306,ZS,92,"[84,Inf)",M,8,NA,2024-02-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1307,DG,69,"[64,74)",M,6,NA,2024-02-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1308,MS,68,"[64,74)",M,7,NA,2024-02-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1309,BT,77,"[74,84)",M,7,NA,2024-02-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1310,TH,43,"[14,44)",M,5,NA,2024-02-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1311,WE,54,"[44,64)",M,5,NA,2024-02-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1312,EZ,0,"[0,1)",M,NA,NA,2024-02-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1313,BY,40,"[14,44)",M,4,NA,2024-02-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1314,SV,39,"[14,44)",M,1,NA,2024-02-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1315,YS,72,"[64,74)",M,6,NA,2024-02-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1316,PI,68,"[64,74)",F,5,NA,2024-02-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1317,FJ,85,"[84,Inf)",M,8,NA,2024-02-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1318,BB,86,"[84,Inf)",M,8,NA,2024-02-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1319,ND,82,"[74,84)",M,8,NA,2024-02-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1320,FP,75,"[74,84)",M,6,42.76755481311327,2024-02-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1321,ZV,71,"[64,74)",F,4,NA,2024-02-23,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1322,HQ,81,"[74,84)",M,8,44.37628963656813,2024-02-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1323,OG,91,"[84,Inf)",M,8,NA,2024-02-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1324,FQ,66,"[64,74)",M,6,NA,2024-02-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1325,QN,40,"[14,44)",F,4,84.35154838159127,2024-02-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1326,TN,92,"[84,Inf)",M,8,NA,2024-02-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1327,IM,53,"[44,64)",M,7,NA,2024-02-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1328,CI,57,"[44,64)",M,5,NA,2024-02-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1329,JA,86,"[84,Inf)",M,8,NA,2024-02-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1330,AM,75,"[74,84)",F,6,NA,2024-02-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1331,JF,51,"[44,64)",M,4,NA,2024-02-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1332,RT,78,"[74,84)",F,7,NA,2024-02-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1333,HX,89,"[84,Inf)",M,9,NA,2024-02-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1334,KG,86,"[84,Inf)",M,8,NA,2024-02-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1335,EI,86,"[84,Inf)",M,6,NA,2024-02-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1336,JF,70,"[64,74)",M,7,NA,2024-02-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1337,TI,30,"[14,44)",F,1,NA,2024-02-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1338,FU,53,"[44,64)",M,5,NA,2024-02-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1339,MQ,96,"[84,Inf)",F,8,NA,2024-02-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1340,LP,62,"[44,64)",M,7,NA,2024-02-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1341,IX,90,"[84,Inf)",M,6,NA,2024-02-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1342,JS,58,"[44,64)",M,6,NA,2024-02-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1343,RG,73,"[64,74)",M,8,NA,2024-02-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1344,VR,79,"[74,84)",M,7,NA,2024-02-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1345,SC,92,"[84,Inf)",M,7,NA,2024-02-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1346,SO,71,"[64,74)",M,6,82.31551611241363,2024-02-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1347,PJ,73,"[64,74)",F,7,NA,2024-02-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1348,NH,70,"[64,74)",F,7,NA,2024-02-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1349,YY,64,"[64,74)",M,7,NA,2024-02-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1350,FB,60,"[44,64)",M,7,61.96481121352567,2024-02-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1351,WA,25,"[14,44)",M,1,NA,2024-02-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1352,BQ,58,"[44,64)",F,5,NA,2024-02-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1353,KP,48,"[44,64)",M,4,NA,2024-02-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1354,XM,53,"[44,64)",M,5,96.48719756067284,2024-02-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1355,WN,73,"[64,74)",M,6,NA,2024-02-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1356,MI,94,"[84,Inf)",M,8,NA,2024-02-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1357,WU,30,"[14,44)",M,4,NA,2024-02-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1358,BL,64,"[64,74)",M,5,NA,2024-02-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1359,FD,84,"[84,Inf)",F,8,NA,2024-02-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1360,ET,84,"[84,Inf)",M,8,52.307965857546115,2024-02-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1361,UD,75,"[74,84)",M,6,NA,2024-02-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1362,QU,59,"[44,64)",F,6,81.45903860446542,2024-02-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1363,RZ,67,"[64,74)",M,4,NA,2024-02-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1364,HB,71,"[64,74)",F,6,96.84473399281664,2024-02-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1365,PA,77,"[74,84)",M,7,NA,2024-02-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1366,MK,87,"[84,Inf)",M,9,62.47830669278435,2024-02-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1367,TI,80,"[74,84)",M,6,NA,2024-02-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1368,DI,82,"[74,84)",M,7,NA,2024-02-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1369,DU,85,"[84,Inf)",M,8,64.22254806653905,2024-02-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1370,EZ,43,"[14,44)",F,3,NA,2024-02-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1371,KV,92,"[84,Inf)",M,7,NA,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1372,KV,59,"[44,64)",M,6,NA,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1373,HR,61,"[44,64)",M,4,94.12030744571969,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1374,OX,94,"[84,Inf)",M,7,NA,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1375,OS,77,"[74,84)",M,6,47.30500035084625,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1376,TZ,74,"[74,84)",M,6,NA,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1377,PY,74,"[74,84)",F,7,66.4185729468144,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1378,LR,63,"[44,64)",F,7,NA,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1379,ZE,57,"[44,64)",F,7,NA,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1380,TN,78,"[74,84)",M,8,NA,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1381,SM,86,"[84,Inf)",M,8,53.714205879889384,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1382,HQ,50,"[44,64)",M,4,NA,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1383,QQ,44,"[44,64)",M,3,NA,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1384,EK,54,"[44,64)",F,6,NA,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1385,UJ,55,"[44,64)",F,4,121.08643436305314,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1386,BF,28,"[14,44)",M,2,NA,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1387,UT,93,"[84,Inf)",F,9,81.6599009933753,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1388,OO,71,"[64,74)",M,6,NA,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1389,VQ,93,"[84,Inf)",M,8,NA,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1390,US,64,"[64,74)",F,6,NA,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1391,RV,75,"[74,84)",F,7,NA,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1392,BZ,1,"[1,14)",M,NA,NA,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1393,SO,72,"[64,74)",F,5,NA,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1394,OZ,69,"[64,74)",M,5,NA,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1395,IG,1,"[1,14)",M,NA,NA,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1396,DI,51,"[44,64)",F,5,NA,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1397,NZ,75,"[74,84)",M,7,NA,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1398,HN,72,"[64,74)",F,6,59.14154765419852,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1399,FW,75,"[74,84)",M,7,NA,2024-02-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1400,SD,79,"[74,84)",M,6,NA,2024-02-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1401,FA,85,"[84,Inf)",M,9,NA,2024-02-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1402,UT,62,"[44,64)",M,5,NA,2024-02-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1403,WE,73,"[64,74)",F,6,60.1287395384754,2024-02-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1404,BR,84,"[84,Inf)",F,6,NA,2024-02-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1405,UE,59,"[44,64)",F,7,NA,2024-02-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1406,PV,91,"[84,Inf)",M,7,NA,2024-02-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1407,BN,37,"[14,44)",M,5,NA,2024-02-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1408,ZF,48,"[44,64)",F,5,NA,2024-02-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1409,YB,64,"[64,74)",M,5,NA,2024-02-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1410,ZY,58,"[44,64)",M,6,NA,2024-02-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1411,CR,97,"[84,Inf)",M,8,NA,2024-02-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1412,ER,86,"[84,Inf)",M,9,NA,2024-02-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1413,LK,82,"[74,84)",M,8,NA,2024-02-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1414,DV,78,"[74,84)",M,8,NA,2024-02-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1415,JE,60,"[44,64)",F,4,69.19177443233792,2024-02-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1416,LF,54,"[44,64)",M,5,NA,2024-02-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1417,WK,39,"[14,44)",M,2,NA,2024-02-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1418,AI,92,"[84,Inf)",M,6,NA,2024-02-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1419,TQ,58,"[44,64)",M,7,NA,2024-02-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1420,YZ,49,"[44,64)",F,6,NA,2024-02-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1421,JH,68,"[64,74)",M,6,NA,2024-02-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1422,KC,85,"[84,Inf)",M,8,NA,2024-02-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1423,RD,64,"[64,74)",M,5,NA,2024-02-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1424,QK,89,"[84,Inf)",M,8,65.81972460068286,2024-02-28,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1425,VS,78,"[74,84)",F,7,118.52308472147803,2024-02-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1426,JJ,33,"[14,44)",M,3,97.44842634797043,2024-02-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1427,TZ,60,"[44,64)",M,7,NA,2024-02-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1428,OS,69,"[64,74)",M,4,NA,2024-02-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1429,BI,74,"[74,84)",M,8,NA,2024-02-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1430,OH,92,"[84,Inf)",F,7,NA,2024-02-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1431,FI,46,"[44,64)",M,5,NA,2024-02-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1432,HY,51,"[44,64)",M,6,NA,2024-02-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1433,VA,58,"[44,64)",M,6,NA,2024-02-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1434,DE,48,"[44,64)",F,6,NA,2024-02-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1435,ZH,64,"[64,74)",M,7,65.84432572050541,2024-02-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1436,NU,86,"[84,Inf)",M,9,NA,2024-02-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1437,KX,47,"[44,64)",M,5,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1438,YE,71,"[64,74)",F,5,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1439,OI,94,"[84,Inf)",M,7,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1440,HS,81,"[74,84)",F,8,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1441,EO,48,"[44,64)",M,3,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1442,PM,66,"[64,74)",F,6,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1443,HI,62,"[44,64)",F,4,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1444,EQ,84,"[84,Inf)",M,6,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1445,SO,79,"[74,84)",M,7,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1446,KP,81,"[74,84)",M,8,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1447,FE,49,"[44,64)",F,4,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1448,WF,68,"[64,74)",F,7,81.05652390766151,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1449,OD,82,"[74,84)",M,8,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1450,HM,94,"[84,Inf)",M,9,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1451,FK,71,"[64,74)",M,6,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1452,VY,72,"[64,74)",M,7,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1453,SA,72,"[64,74)",M,5,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1454,SL,33,"[14,44)",F,4,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1455,IB,63,"[44,64)",M,4,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1456,NJ,72,"[64,74)",F,6,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1457,RR,75,"[74,84)",M,7,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1458,CB,93,"[84,Inf)",M,8,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1459,YW,66,"[64,74)",F,6,72.51154463776443,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1460,WF,22,"[14,44)",M,3,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1461,FY,70,"[64,74)",F,4,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1462,QH,57,"[44,64)",M,5,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1463,TZ,78,"[74,84)",M,6,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1464,WM,62,"[44,64)",M,6,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1465,BM,60,"[44,64)",M,5,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1466,TV,73,"[64,74)",M,6,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1467,EO,84,"[84,Inf)",M,7,51.62887887467297,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1468,ZG,41,"[14,44)",F,3,NA,2024-02-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1469,SB,71,"[64,74)",F,8,NA,2024-03-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1470,FM,80,"[74,84)",M,7,47.98500469209774,2024-03-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1471,NW,40,"[14,44)",M,3,NA,2024-03-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1472,AU,83,"[74,84)",M,7,NA,2024-03-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1473,ZZ,89,"[84,Inf)",M,9,NA,2024-03-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1474,CB,21,"[14,44)",M,3,NA,2024-03-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1475,DV,82,"[74,84)",M,8,NA,2024-03-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1476,ZM,73,"[64,74)",M,7,NA,2024-03-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1477,ML,90,"[84,Inf)",M,7,NA,2024-03-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1478,QM,61,"[44,64)",M,5,71.93524443229997,2024-03-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1479,JR,69,"[64,74)",M,5,NA,2024-03-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1480,EC,66,"[64,74)",F,5,NA,2024-03-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1481,HN,55,"[44,64)",F,6,NA,2024-03-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1482,QW,92,"[84,Inf)",M,8,NA,2024-03-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1483,VO,76,"[74,84)",M,6,NA,2024-03-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1484,VL,82,"[74,84)",F,8,NA,2024-03-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1485,KU,91,"[84,Inf)",M,8,NA,2024-03-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1486,NI,79,"[74,84)",F,7,NA,2024-03-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1487,HI,72,"[64,74)",F,7,NA,2024-03-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1488,VO,75,"[74,84)",M,6,NA,2024-03-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1489,NB,92,"[84,Inf)",M,8,37.99614929494098,2024-03-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1490,KE,82,"[74,84)",M,6,NA,2024-03-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1491,DH,50,"[44,64)",F,5,NA,2024-03-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1492,MI,85,"[84,Inf)",M,8,44.34054773051465,2024-03-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1493,UJ,81,"[74,84)",M,9,NA,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1494,GO,77,"[74,84)",F,6,NA,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1495,EE,68,"[64,74)",M,7,NA,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1496,QZ,70,"[64,74)",F,5,NA,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1497,ZQ,65,"[64,74)",F,7,NA,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1498,SU,48,"[44,64)",F,4,107.60247195942952,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1499,DI,84,"[84,Inf)",M,8,NA,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1500,BH,67,"[64,74)",M,6,NA,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1501,WQ,56,"[44,64)",M,5,NA,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1502,VE,95,"[84,Inf)",M,9,NA,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1503,KO,72,"[64,74)",M,6,NA,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1504,NK,0,"[0,1)",M,NA,NA,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1505,NR,74,"[74,84)",M,5,NA,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1506,XD,78,"[74,84)",M,6,NA,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1507,HQ,82,"[74,84)",M,7,NA,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1508,IR,35,"[14,44)",F,1,NA,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1509,IS,77,"[74,84)",F,6,NA,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1510,TE,53,"[44,64)",M,3,NA,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1511,HB,73,"[64,74)",M,7,NA,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1512,VD,58,"[44,64)",M,4,NA,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1513,DE,66,"[64,74)",M,6,NA,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1514,SB,64,"[64,74)",M,4,NA,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1515,PP,64,"[64,74)",M,7,NA,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1516,EO,92,"[84,Inf)",M,8,NA,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1517,NE,81,"[74,84)",M,8,NA,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1518,GO,84,"[84,Inf)",M,8,42.007098131835306,2024-03-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1519,WI,83,"[74,84)",M,6,NA,2024-03-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1520,RZ,81,"[74,84)",M,7,NA,2024-03-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1521,BW,73,"[64,74)",M,6,NA,2024-03-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1522,KM,78,"[74,84)",M,7,53.465924078379835,2024-03-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1523,NL,65,"[64,74)",M,5,NA,2024-03-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1524,EP,89,"[84,Inf)",M,9,NA,2024-03-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1525,KA,0,"[0,1)",F,NA,NA,2024-03-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1526,FW,80,"[74,84)",M,6,NA,2024-03-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1527,KF,83,"[74,84)",M,7,NA,2024-03-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1528,DC,90,"[84,Inf)",M,7,NA,2024-03-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1529,MD,74,"[74,84)",M,8,NA,2024-03-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1530,AQ,91,"[84,Inf)",M,6,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1531,WV,75,"[74,84)",M,5,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1532,HB,89,"[84,Inf)",M,9,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1533,CT,43,"[14,44)",M,7,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1534,OJ,60,"[44,64)",M,3,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1535,PR,54,"[44,64)",M,6,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1536,VG,75,"[74,84)",M,7,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1537,VW,55,"[44,64)",M,4,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1538,SW,71,"[64,74)",M,7,84.59881081686702,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1539,LL,78,"[74,84)",F,7,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1540,ET,91,"[84,Inf)",M,8,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1541,DL,72,"[64,74)",M,6,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1542,IH,87,"[84,Inf)",M,7,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1543,EZ,54,"[44,64)",F,5,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1544,OV,79,"[74,84)",M,8,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1545,LM,66,"[64,74)",M,5,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1546,BO,25,"[14,44)",M,3,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1547,RW,39,"[14,44)",M,4,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1548,HT,56,"[44,64)",M,4,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1549,OR,91,"[84,Inf)",F,9,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1550,QM,96,"[84,Inf)",M,9,52.047061212549224,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1551,JO,54,"[44,64)",M,6,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1552,FE,82,"[74,84)",F,8,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1553,IR,0,"[0,1)",M,NA,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1554,GS,92,"[84,Inf)",M,8,52.89253735823257,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1555,KE,96,"[84,Inf)",M,8,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1556,LH,69,"[64,74)",F,5,87.67428526160464,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1557,ZZ,88,"[84,Inf)",M,8,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1558,BU,64,"[64,74)",M,6,93.62216532885802,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1559,IQ,94,"[84,Inf)",M,8,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1560,YX,88,"[84,Inf)",M,7,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1561,OQ,69,"[64,74)",M,7,80.53395260372758,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1562,HQ,73,"[64,74)",M,7,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1563,EM,51,"[44,64)",M,3,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1564,TJ,75,"[74,84)",F,7,NA,2024-03-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1565,KI,59,"[44,64)",F,5,NA,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1566,AG,82,"[74,84)",F,7,NA,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1567,BE,50,"[44,64)",M,5,NA,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1568,LQ,83,"[74,84)",M,6,42.45325692170725,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1569,CE,81,"[74,84)",M,8,NA,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1570,VE,46,"[44,64)",M,3,155.18588609788637,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1571,LC,40,"[14,44)",M,3,NA,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1572,BH,78,"[74,84)",M,6,NA,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1573,CE,71,"[64,74)",M,7,NA,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1574,WE,93,"[84,Inf)",F,9,52.338853176459054,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1575,NR,0,"[0,1)",M,NA,NA,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1576,HM,81,"[74,84)",F,6,NA,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1577,NL,74,"[74,84)",M,4,NA,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1578,JM,86,"[84,Inf)",M,8,NA,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1579,ZC,65,"[64,74)",F,7,NA,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1580,HC,61,"[44,64)",M,7,76.12967866157075,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1581,FI,59,"[44,64)",F,5,77.27292015113082,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1582,LZ,46,"[44,64)",M,2,NA,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1583,EV,89,"[84,Inf)",F,7,NA,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1584,CM,71,"[64,74)",M,6,NA,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1585,KF,85,"[84,Inf)",M,9,NA,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1586,WQ,1,"[1,14)",F,NA,NA,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1587,VP,63,"[44,64)",F,5,NA,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1588,KH,61,"[44,64)",M,6,92.72709965059371,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1589,OO,72,"[64,74)",M,7,76.8102556892458,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1590,JL,57,"[44,64)",M,6,NA,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1591,WU,91,"[84,Inf)",M,8,NA,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1592,JO,78,"[74,84)",M,8,92.95487302890591,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1593,NG,57,"[44,64)",F,5,NA,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1594,KY,84,"[84,Inf)",M,8,NA,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1595,VN,71,"[64,74)",M,6,NA,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1596,DV,68,"[64,74)",F,6,NA,2024-03-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1597,MW,80,"[74,84)",M,9,NA,2024-03-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1598,XP,66,"[64,74)",F,5,NA,2024-03-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1599,PR,65,"[64,74)",M,7,NA,2024-03-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1600,FC,36,"[14,44)",M,4,NA,2024-03-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1601,ZT,80,"[74,84)",M,8,NA,2024-03-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1602,YD,65,"[64,74)",F,8,51.39783915154197,2024-03-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1603,LC,78,"[74,84)",M,7,NA,2024-03-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1604,ZX,63,"[44,64)",M,6,NA,2024-03-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1605,OV,42,"[14,44)",M,4,NA,2024-03-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1606,QF,44,"[44,64)",M,5,NA,2024-03-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1607,QT,48,"[44,64)",M,3,106.35391513408423,2024-03-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1608,TV,76,"[74,84)",M,6,NA,2024-03-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1609,WN,43,"[14,44)",M,5,NA,2024-03-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1610,RH,67,"[64,74)",F,6,111.33457013166338,2024-03-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1611,JK,42,"[14,44)",F,3,NA,2024-03-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1612,QJ,91,"[84,Inf)",M,9,36.39717585566762,2024-03-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1613,FI,69,"[64,74)",F,6,NA,2024-03-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1614,IA,59,"[44,64)",F,5,81.55827631258585,2024-03-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1615,UX,51,"[44,64)",M,4,NA,2024-03-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1616,AR,86,"[84,Inf)",M,8,NA,2024-03-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1617,EK,74,"[74,84)",F,6,NA,2024-03-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1618,MV,80,"[74,84)",M,8,NA,2024-03-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1619,IR,67,"[64,74)",F,6,NA,2024-03-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1620,NI,66,"[64,74)",M,5,NA,2024-03-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1621,FB,69,"[64,74)",F,6,NA,2024-03-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1622,CG,76,"[74,84)",M,6,NA,2024-03-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1623,NB,0,"[0,1)",M,NA,NA,2024-03-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1624,HH,67,"[64,74)",F,5,NA,2024-03-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1625,MM,73,"[64,74)",F,6,NA,2024-03-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1626,JU,100,"[84,Inf)",F,9,NA,2024-03-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1627,KD,57,"[44,64)",M,5,NA,2024-03-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1628,KS,77,"[74,84)",M,7,NA,2024-03-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1629,HS,89,"[84,Inf)",M,7,NA,2024-03-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1630,FP,71,"[64,74)",F,6,NA,2024-03-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1631,UX,33,"[14,44)",M,3,NA,2024-03-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1632,OW,67,"[64,74)",M,7,101.16441427922894,2024-03-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1633,DX,84,"[84,Inf)",M,7,NA,2024-03-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1634,GF,68,"[64,74)",F,6,NA,2024-03-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1635,PP,72,"[64,74)",M,6,NA,2024-03-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1636,PK,96,"[84,Inf)",M,6,NA,2024-03-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1637,PZ,81,"[74,84)",M,7,39.472594574052096,2024-03-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1638,NA,56,"[44,64)",M,6,NA,2024-03-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1639,ZX,89,"[84,Inf)",F,8,30.378000548863763,2024-03-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1640,JN,75,"[74,84)",M,8,NA,2024-03-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1641,WJ,91,"[84,Inf)",M,9,NA,2024-03-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1642,XA,97,"[84,Inf)",M,8,NA,2024-03-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1643,PY,93,"[84,Inf)",M,9,40.644382675591224,2024-03-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1644,FA,77,"[74,84)",M,9,NA,2024-03-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1645,FA,67,"[64,74)",M,6,102.96683731310006,2024-03-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1646,GY,69,"[64,74)",F,5,NA,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1647,LC,57,"[44,64)",F,5,NA,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1648,CI,73,"[64,74)",M,7,NA,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1649,FR,64,"[64,74)",M,4,NA,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1650,JW,53,"[44,64)",M,6,NA,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1651,BS,63,"[44,64)",M,6,NA,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1652,YJ,79,"[74,84)",F,8,NA,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1653,AC,74,"[74,84)",M,6,NA,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1654,BZ,55,"[44,64)",M,6,NA,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1655,YD,66,"[64,74)",M,5,72.99060549851076,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1656,JD,74,"[74,84)",F,7,NA,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1657,JJ,55,"[44,64)",F,4,74.19882238752433,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1658,SI,96,"[84,Inf)",M,8,75.39250316744045,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1659,WX,94,"[84,Inf)",M,9,NA,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1660,ZR,95,"[84,Inf)",M,8,NA,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1661,JK,78,"[74,84)",M,7,46.43341226039726,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1662,XH,78,"[74,84)",M,7,NA,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1663,MV,31,"[14,44)",M,3,NA,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1664,SQ,81,"[74,84)",M,7,48.359698400756166,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1665,QI,91,"[84,Inf)",M,8,NA,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1666,CJ,60,"[44,64)",M,6,NA,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1667,IK,61,"[44,64)",M,7,NA,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1668,PM,59,"[44,64)",M,5,NA,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1669,PJ,65,"[64,74)",M,6,NA,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1670,FT,79,"[74,84)",M,5,NA,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1671,YW,90,"[84,Inf)",M,9,NA,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1672,CQ,95,"[84,Inf)",M,7,35.70291955296858,2024-03-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1673,VX,70,"[64,74)",M,6,NA,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1674,AC,54,"[44,64)",F,5,NA,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1675,OQ,99,"[84,Inf)",F,8,NA,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1676,NE,44,"[44,64)",M,5,NA,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1677,WC,55,"[44,64)",F,4,NA,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1678,NZ,90,"[84,Inf)",F,8,NA,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1679,CX,82,"[74,84)",M,7,NA,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1680,SN,68,"[64,74)",M,5,NA,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1681,DR,77,"[74,84)",M,6,50.8086085544665,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1682,MQ,78,"[74,84)",M,8,NA,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1683,KW,0,"[0,1)",M,NA,NA,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1684,IC,78,"[74,84)",M,8,NA,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1685,PN,83,"[74,84)",F,8,NA,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1686,ZA,71,"[64,74)",F,6,NA,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1687,QU,0,"[0,1)",F,NA,NA,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1688,PN,64,"[64,74)",F,7,89.84450285604622,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1689,AA,42,"[14,44)",M,4,78.03831242804704,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1690,IV,67,"[64,74)",M,4,NA,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1691,WU,90,"[84,Inf)",M,7,NA,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1692,LL,83,"[74,84)",M,8,74.26719567650433,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1693,SW,74,"[74,84)",M,4,NA,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1694,DW,64,"[64,74)",M,7,NA,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1695,YV,0,"[0,1)",M,NA,NA,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1696,RT,68,"[64,74)",M,5,NA,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1697,VX,59,"[44,64)",F,4,NA,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1698,VO,82,"[74,84)",M,7,NA,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1699,WO,87,"[84,Inf)",M,8,NA,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1700,KN,53,"[44,64)",F,6,NA,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1701,CC,65,"[64,74)",F,4,62.38820662755498,2024-03-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1702,MS,86,"[84,Inf)",M,6,NA,2024-03-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1703,HI,56,"[44,64)",M,5,NA,2024-03-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1704,NN,31,"[14,44)",F,4,NA,2024-03-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1705,MX,88,"[84,Inf)",F,7,NA,2024-03-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1706,FB,44,"[44,64)",M,5,NA,2024-03-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1707,QR,84,"[84,Inf)",M,8,NA,2024-03-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1708,VY,39,"[14,44)",F,2,NA,2024-03-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1709,HR,59,"[44,64)",M,4,NA,2024-03-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1710,TN,61,"[44,64)",F,5,52.57976783936433,2024-03-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1711,XC,75,"[74,84)",F,6,NA,2024-03-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1712,WY,52,"[44,64)",F,6,NA,2024-03-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1713,TY,0,"[0,1)",M,NA,NA,2024-03-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1714,XW,73,"[64,74)",M,4,NA,2024-03-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1715,TK,79,"[74,84)",M,7,NA,2024-03-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1716,ZY,44,"[44,64)",M,5,NA,2024-03-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1717,TJ,56,"[44,64)",F,4,NA,2024-03-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1718,QE,68,"[64,74)",M,5,NA,2024-03-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1719,BB,89,"[84,Inf)",M,9,NA,2024-03-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1720,EU,86,"[84,Inf)",M,8,NA,2024-03-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1721,UU,72,"[64,74)",M,8,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1722,TV,58,"[44,64)",M,6,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1723,YW,74,"[74,84)",F,8,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1724,OQ,75,"[74,84)",F,6,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1725,WA,69,"[64,74)",M,6,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1726,RC,0,"[0,1)",F,NA,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1727,FX,68,"[64,74)",M,9,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1728,DV,89,"[84,Inf)",M,7,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1729,AR,1,"[1,14)",M,NA,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1730,WV,56,"[44,64)",M,5,93.51971178294592,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1731,TQ,76,"[74,84)",M,7,45.384831671571106,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1732,UB,53,"[44,64)",M,5,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1733,XV,82,"[74,84)",M,8,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1734,IL,71,"[64,74)",F,7,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1735,HH,74,"[74,84)",M,7,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1736,BF,84,"[84,Inf)",M,8,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1737,MU,41,"[14,44)",M,4,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1738,CC,89,"[84,Inf)",M,8,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1739,LO,44,"[44,64)",M,4,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1740,IB,51,"[44,64)",F,5,62.97949025928747,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1741,AX,56,"[44,64)",F,7,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1742,LZ,88,"[84,Inf)",F,6,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1743,TC,57,"[44,64)",F,5,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1744,NW,27,"[14,44)",M,3,119.41391976068392,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1745,GW,2,"[1,14)",M,NA,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1746,FP,82,"[74,84)",F,6,50.3018185042777,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1747,GE,94,"[84,Inf)",M,9,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1748,RR,70,"[64,74)",M,6,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1749,GS,55,"[44,64)",M,3,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1750,RP,81,"[74,84)",M,7,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1751,OU,75,"[74,84)",M,6,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1752,EV,82,"[74,84)",F,6,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1753,EI,60,"[44,64)",M,6,NA,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1754,BY,46,"[44,64)",F,4,86.26756124681295,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1755,SW,66,"[64,74)",F,7,51.91042886954064,2024-03-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1756,BS,82,"[74,84)",F,8,45.20568683241024,2024-03-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1757,ZA,75,"[74,84)",M,8,NA,2024-03-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1758,IQ,67,"[64,74)",M,5,71.80945266731877,2024-03-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1759,FU,97,"[84,Inf)",M,9,NA,2024-03-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1760,OF,74,"[74,84)",M,8,NA,2024-03-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1761,XB,94,"[84,Inf)",F,6,NA,2024-03-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1762,RJ,76,"[74,84)",F,6,NA,2024-03-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1763,DA,86,"[84,Inf)",M,7,NA,2024-03-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1764,VF,73,"[64,74)",F,6,NA,2024-03-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1765,EG,64,"[64,74)",M,5,NA,2024-03-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1766,FR,51,"[44,64)",M,5,NA,2024-03-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1767,ZL,83,"[74,84)",F,7,NA,2024-03-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1768,KO,77,"[74,84)",M,8,NA,2024-03-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1769,CO,72,"[64,74)",F,6,NA,2024-03-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1770,PI,81,"[74,84)",F,6,NA,2024-03-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1771,GE,64,"[64,74)",M,6,NA,2024-03-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1772,YT,76,"[74,84)",M,8,54.73140271715655,2024-03-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1773,JG,53,"[44,64)",F,5,NA,2024-03-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1774,JK,80,"[74,84)",M,8,NA,2024-03-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1775,OC,65,"[64,74)",F,6,NA,2024-03-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1776,NF,74,"[74,84)",F,8,NA,2024-03-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1777,EC,69,"[64,74)",F,6,72.90737570358301,2024-03-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1778,QT,57,"[44,64)",F,5,NA,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1779,ID,67,"[64,74)",M,6,NA,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1780,LX,90,"[84,Inf)",M,7,NA,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1781,LQ,51,"[44,64)",M,6,NA,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1782,TF,71,"[64,74)",M,5,NA,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1783,CH,69,"[64,74)",F,7,NA,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1784,TA,79,"[74,84)",M,7,70.87154511615958,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1785,EX,64,"[64,74)",M,6,NA,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1786,JR,68,"[64,74)",F,7,NA,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1787,GP,82,"[74,84)",M,6,NA,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1788,AL,60,"[44,64)",F,5,NA,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1789,BF,97,"[84,Inf)",F,7,NA,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1790,YD,61,"[44,64)",F,6,NA,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1791,KX,69,"[64,74)",F,7,NA,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1792,DX,0,"[0,1)",M,NA,NA,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1793,KW,57,"[44,64)",F,4,NA,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1794,BD,64,"[64,74)",F,6,NA,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1795,WA,76,"[74,84)",F,7,NA,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1796,SV,60,"[44,64)",F,4,NA,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1797,RJ,67,"[64,74)",F,7,77.11537248829285,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1798,ZQ,80,"[74,84)",M,8,35.19114522786344,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1799,DC,55,"[44,64)",F,5,NA,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1800,CN,66,"[64,74)",F,5,NA,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1801,WF,88,"[84,Inf)",F,7,NA,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1802,PE,55,"[44,64)",F,4,NA,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1803,RN,77,"[74,84)",M,7,NA,2024-03-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1804,GX,87,"[84,Inf)",M,7,NA,2024-03-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1805,HR,42,"[14,44)",M,5,NA,2024-03-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1806,DD,76,"[74,84)",M,7,50.47708674851982,2024-03-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1807,UF,69,"[64,74)",F,4,NA,2024-03-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1808,NU,89,"[84,Inf)",M,6,NA,2024-03-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1809,OM,90,"[84,Inf)",M,9,51.753566351668965,2024-03-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1810,ZU,76,"[74,84)",M,7,NA,2024-03-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1811,EZ,67,"[64,74)",F,7,NA,2024-03-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1812,FZ,64,"[64,74)",F,4,NA,2024-03-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1813,FY,89,"[84,Inf)",M,8,NA,2024-03-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1814,NT,77,"[74,84)",F,7,NA,2024-03-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1815,ZN,73,"[64,74)",M,7,NA,2024-03-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1816,DJ,65,"[64,74)",F,7,NA,2024-03-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1817,TG,94,"[84,Inf)",M,9,NA,2024-03-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1818,KF,70,"[64,74)",F,7,NA,2024-03-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1819,EY,71,"[64,74)",M,6,NA,2024-03-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1820,ZW,91,"[84,Inf)",M,8,NA,2024-03-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1821,GU,54,"[44,64)",M,4,72.57521248260785,2024-03-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1822,SO,47,"[44,64)",M,4,NA,2024-03-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1823,GP,51,"[44,64)",M,5,NA,2024-03-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1824,JB,95,"[84,Inf)",M,7,44.424526396467975,2024-03-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1825,OK,1,"[1,14)",M,NA,NA,2024-03-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1826,AU,84,"[84,Inf)",M,8,NA,2024-03-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1827,TI,76,"[74,84)",M,7,51.63479189008219,2024-03-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1828,TX,68,"[64,74)",M,6,NA,2024-03-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1829,WH,0,"[0,1)",F,NA,NA,2024-03-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1830,CE,57,"[44,64)",M,5,NA,2024-03-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1831,DA,49,"[44,64)",M,4,57.28920560835026,2024-03-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1832,JB,90,"[84,Inf)",F,8,NA,2024-03-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1833,PX,81,"[74,84)",M,7,NA,2024-03-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1834,DO,88,"[84,Inf)",M,9,42.37376118165323,2024-03-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1835,DD,88,"[84,Inf)",F,7,NA,2024-03-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1836,NR,68,"[64,74)",M,5,106.12484529113651,2024-03-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1837,FT,71,"[64,74)",M,7,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1838,UJ,67,"[64,74)",M,5,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1839,CF,53,"[44,64)",F,3,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1840,GE,80,"[74,84)",M,7,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1841,BD,78,"[74,84)",M,9,51.5669947107918,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1842,TO,66,"[64,74)",F,6,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1843,BY,1,"[1,14)",M,NA,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1844,ZX,88,"[84,Inf)",F,9,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1845,XG,64,"[64,74)",F,7,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1846,LZ,88,"[84,Inf)",M,8,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1847,NI,90,"[84,Inf)",M,8,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1848,YS,77,"[74,84)",F,8,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1849,RQ,93,"[84,Inf)",M,8,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1850,TR,56,"[44,64)",F,6,101.57170502695023,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1851,GT,81,"[74,84)",M,5,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1852,NB,81,"[74,84)",M,9,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1853,GB,79,"[74,84)",M,7,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1854,KE,94,"[84,Inf)",F,9,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1855,UH,72,"[64,74)",F,7,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1856,SS,52,"[44,64)",M,4,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1857,ZC,26,"[14,44)",M,3,137.52645472882043,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1858,GL,69,"[64,74)",M,5,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1859,ZI,48,"[44,64)",M,4,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1860,AY,88,"[84,Inf)",M,7,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1861,ZB,65,"[64,74)",M,6,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1862,ZF,53,"[44,64)",M,6,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1863,TQ,90,"[84,Inf)",M,8,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1864,YO,53,"[44,64)",M,7,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1865,AH,65,"[64,74)",F,4,57.62159594269454,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1866,PF,96,"[84,Inf)",M,8,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1867,JK,84,"[84,Inf)",M,9,57.489098060862354,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1868,WX,91,"[84,Inf)",M,8,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1869,SA,73,"[64,74)",F,6,133.5142669395767,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1870,IH,89,"[84,Inf)",M,7,NA,2024-03-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1871,QK,0,"[0,1)",M,NA,NA,2024-03-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1872,EB,62,"[44,64)",M,5,NA,2024-03-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1873,NS,82,"[74,84)",F,8,NA,2024-03-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1874,XC,92,"[84,Inf)",M,9,NA,2024-03-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1875,DG,52,"[44,64)",F,6,NA,2024-03-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1876,CX,96,"[84,Inf)",M,7,NA,2024-03-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1877,IZ,48,"[44,64)",F,5,NA,2024-03-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1878,IT,31,"[14,44)",F,3,NA,2024-03-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1879,NO,45,"[44,64)",M,5,81.78083734771718,2024-03-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1880,XY,63,"[44,64)",M,5,NA,2024-03-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1881,EX,84,"[84,Inf)",M,9,NA,2024-03-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1882,HK,49,"[44,64)",M,5,NA,2024-03-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1883,KD,65,"[64,74)",M,6,NA,2024-03-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1884,HA,50,"[44,64)",M,5,NA,2024-03-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1885,IM,69,"[64,74)",F,8,NA,2024-03-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1886,EW,77,"[74,84)",M,6,NA,2024-03-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1887,CL,93,"[84,Inf)",M,9,NA,2024-03-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1888,RN,32,"[14,44)",F,3,137.47556199591105,2024-03-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1889,NZ,65,"[64,74)",F,6,NA,2024-03-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1890,OZ,53,"[44,64)",M,6,NA,2024-03-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1891,RN,97,"[84,Inf)",F,8,NA,2024-03-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1892,UC,38,"[14,44)",M,3,136.32971467336924,2024-03-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1893,FP,55,"[44,64)",M,4,NA,2024-03-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1894,RO,58,"[44,64)",F,5,NA,2024-03-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1895,BZ,69,"[64,74)",F,8,NA,2024-03-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1896,GS,75,"[74,84)",M,7,NA,2024-03-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1897,JT,89,"[84,Inf)",M,7,NA,2024-03-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1898,FU,79,"[74,84)",M,8,75.40057230832832,2024-03-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1899,JN,89,"[84,Inf)",F,7,NA,2024-03-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1900,TN,2,"[1,14)",M,NA,NA,2024-03-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1901,MC,52,"[44,64)",M,5,NA,2024-03-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1902,HM,53,"[44,64)",F,4,NA,2024-03-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1903,CF,49,"[44,64)",F,4,NA,2024-03-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1904,QA,86,"[84,Inf)",F,9,56.13406958637244,2024-03-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1905,GE,59,"[44,64)",M,6,NA,2024-03-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1906,FH,87,"[84,Inf)",M,7,33.76464374432827,2024-03-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1907,ER,92,"[84,Inf)",M,8,NA,2024-03-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1908,CR,55,"[44,64)",M,5,NA,2024-03-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1909,CF,68,"[64,74)",F,7,NA,2024-03-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1910,EH,72,"[64,74)",F,7,NA,2024-03-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1911,VF,86,"[84,Inf)",M,9,NA,2024-03-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1912,FR,84,"[84,Inf)",F,8,NA,2024-03-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1913,LD,87,"[84,Inf)",F,8,NA,2024-03-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1914,ZC,86,"[84,Inf)",M,7,NA,2024-03-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1915,PO,56,"[44,64)",M,5,84.17751294761663,2024-03-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1916,TH,60,"[44,64)",F,5,NA,2024-03-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1917,EQ,86,"[84,Inf)",M,9,NA,2024-03-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1918,NK,81,"[74,84)",M,6,NA,2024-03-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1919,EE,72,"[64,74)",M,5,NA,2024-03-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1920,MQ,86,"[84,Inf)",F,8,58.704064770908765,2024-03-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1921,YM,36,"[14,44)",M,3,103.29909684459076,2024-03-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1922,EU,66,"[64,74)",F,4,91.14882027926141,2024-03-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1923,RF,88,"[84,Inf)",F,8,42.7952346103674,2024-03-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1924,QQ,61,"[44,64)",M,7,NA,2024-03-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1925,YF,57,"[44,64)",F,6,NA,2024-03-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1926,UM,69,"[64,74)",F,5,NA,2024-03-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1927,WE,42,"[14,44)",M,3,NA,2024-03-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1928,YS,49,"[44,64)",M,5,NA,2024-03-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1929,NB,69,"[64,74)",M,5,NA,2024-03-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1930,ZQ,63,"[44,64)",M,5,NA,2024-03-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1931,SL,20,"[14,44)",M,1,NA,2024-03-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1932,ZH,0,"[0,1)",F,NA,NA,2024-03-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1933,DB,62,"[44,64)",M,3,NA,2024-03-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1934,VA,82,"[74,84)",M,7,NA,2024-03-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1935,XH,93,"[84,Inf)",M,8,NA,2024-03-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1936,IN,68,"[64,74)",M,6,NA,2024-03-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1937,ZE,74,"[74,84)",F,8,NA,2024-03-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1938,VN,66,"[64,74)",M,6,NA,2024-03-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1939,KK,95,"[84,Inf)",F,8,NA,2024-03-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1940,DK,71,"[64,74)",F,5,NA,2024-03-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1941,KF,82,"[74,84)",M,8,NA,2024-03-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1942,BC,72,"[64,74)",M,7,NA,2024-03-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1943,CP,97,"[84,Inf)",M,8,NA,2024-03-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1944,MB,87,"[84,Inf)",M,8,NA,2024-03-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1945,VD,78,"[74,84)",M,7,NA,2024-03-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1946,ZS,77,"[74,84)",M,7,NA,2024-03-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1947,GW,74,"[74,84)",M,8,NA,2024-03-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1948,CM,79,"[74,84)",M,7,42.07340481549724,2024-03-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1949,PE,63,"[44,64)",M,5,110.99433985038193,2024-03-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1950,BY,62,"[44,64)",F,6,NA,2024-03-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1951,RQ,96,"[84,Inf)",M,8,NA,2024-03-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1952,FF,0,"[0,1)",M,NA,NA,2024-03-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1953,UM,71,"[64,74)",F,7,NA,2024-03-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1954,FR,89,"[84,Inf)",M,8,NA,2024-03-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1955,DU,77,"[74,84)",F,6,NA,2024-03-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1956,GY,81,"[74,84)",M,7,NA,2024-03-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1957,IX,83,"[74,84)",M,6,NA,2024-03-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1958,SX,43,"[14,44)",F,3,106.93301487967246,2024-03-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1959,NK,59,"[44,64)",M,6,NA,2024-03-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1960,UV,63,"[44,64)",M,6,NA,2024-03-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1961,WO,64,"[64,74)",M,7,NA,2024-03-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1962,TC,74,"[74,84)",F,8,NA,2024-03-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1963,CI,84,"[84,Inf)",F,8,51.79642289291208,2024-03-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1964,BV,66,"[64,74)",F,7,NA,2024-03-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1965,NU,78,"[74,84)",M,7,NA,2024-03-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1966,LT,68,"[64,74)",F,6,NA,2024-03-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1967,EQ,88,"[84,Inf)",F,9,57.541879016304705,2024-03-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1968,CG,81,"[74,84)",F,7,NA,2024-03-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1969,CZ,90,"[84,Inf)",M,9,NA,2024-03-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1970,QG,1,"[1,14)",M,NA,NA,2024-03-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1971,QV,62,"[44,64)",F,5,NA,2024-03-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1972,EE,53,"[44,64)",M,7,NA,2024-03-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1973,LO,71,"[64,74)",M,5,86.92399582704861,2024-03-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1974,EL,82,"[74,84)",M,9,NA,2024-03-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1975,IZ,57,"[44,64)",M,6,NA,2024-03-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1976,ME,59,"[44,64)",M,5,NA,2024-03-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1977,QR,85,"[84,Inf)",M,7,NA,2024-03-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1978,XG,42,"[14,44)",M,4,NA,2024-03-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1979,TE,75,"[74,84)",M,6,NA,2024-03-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1980,ZY,84,"[84,Inf)",M,7,NA,2024-03-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1981,GX,82,"[74,84)",M,8,NA,2024-03-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1982,PG,50,"[44,64)",M,3,NA,2024-03-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1983,LD,60,"[44,64)",M,6,NA,2024-03-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1984,RG,66,"[64,74)",F,6,NA,2024-03-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1985,PH,53,"[44,64)",M,5,NA,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1986,MU,28,"[14,44)",M,5,NA,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1987,HQ,46,"[44,64)",M,5,NA,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1988,KO,0,"[0,1)",F,NA,NA,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1989,UZ,74,"[74,84)",F,6,NA,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1990,UF,77,"[74,84)",M,7,NA,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1991,DJ,71,"[64,74)",M,7,NA,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1992,JL,72,"[64,74)",M,6,NA,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1993,NB,37,"[14,44)",M,4,NA,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1994,BH,21,"[14,44)",M,3,NA,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1995,BN,81,"[74,84)",M,8,NA,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1996,JZ,62,"[44,64)",F,6,NA,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1997,FE,76,"[74,84)",F,7,NA,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1998,FR,82,"[74,84)",M,7,NA,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
1999,VB,41,"[14,44)",M,4,NA,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2000,DI,79,"[74,84)",M,6,NA,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2001,QK,75,"[74,84)",F,7,NA,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2002,MM,87,"[84,Inf)",M,8,NA,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2003,DB,57,"[44,64)",M,5,85.63328831724617,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2004,HJ,51,"[44,64)",F,4,97.64784817741031,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2005,PO,70,"[64,74)",F,6,NA,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2006,LN,98,"[84,Inf)",M,8,NA,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2007,OH,69,"[64,74)",M,8,NA,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2008,BX,90,"[84,Inf)",M,8,NA,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2009,LN,53,"[44,64)",M,5,NA,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2010,JK,79,"[74,84)",F,7,NA,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2011,JX,86,"[84,Inf)",M,7,NA,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2012,JI,81,"[74,84)",M,6,48.00723682962372,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2013,YX,47,"[44,64)",M,2,83.7485966834239,2024-03-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2014,DA,97,"[84,Inf)",M,8,NA,2024-03-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2015,IN,87,"[84,Inf)",F,8,51.32960408711175,2024-03-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2016,AD,63,"[44,64)",M,4,NA,2024-03-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2017,BU,67,"[64,74)",M,4,NA,2024-03-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2018,DF,58,"[44,64)",M,4,NA,2024-03-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2019,JV,84,"[84,Inf)",M,8,NA,2024-03-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2020,CD,82,"[74,84)",M,8,46.44075576028967,2024-03-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2021,UI,94,"[84,Inf)",M,8,39.520407292729175,2024-03-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2022,ER,67,"[64,74)",F,4,NA,2024-03-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2023,HL,92,"[84,Inf)",M,9,NA,2024-03-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2024,OX,0,"[0,1)",F,NA,NA,2024-03-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2025,LJ,92,"[84,Inf)",F,7,35.751551283874036,2024-03-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2026,NL,90,"[84,Inf)",M,9,NA,2024-03-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2027,ZA,75,"[74,84)",M,7,52.32364703223099,2024-03-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2028,AJ,66,"[64,74)",M,6,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2029,NM,96,"[84,Inf)",M,8,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2030,TN,94,"[84,Inf)",M,7,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2031,DL,81,"[74,84)",F,7,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2032,PJ,81,"[74,84)",M,8,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2033,CR,70,"[64,74)",F,6,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2034,TO,71,"[64,74)",M,5,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2035,LA,67,"[64,74)",M,6,75.62648625708815,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2036,FN,90,"[84,Inf)",M,6,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2037,UW,28,"[14,44)",M,4,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2038,GG,84,"[84,Inf)",M,8,63.70884730021072,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2039,KC,91,"[84,Inf)",M,9,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2040,UB,77,"[74,84)",F,7,51.06803769397772,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2041,YY,81,"[74,84)",M,9,52.53981420381587,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2042,SB,78,"[74,84)",M,8,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2043,GD,0,"[0,1)",F,NA,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2044,PO,97,"[84,Inf)",M,9,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2045,SC,51,"[44,64)",M,5,85.9941205890381,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2046,QG,75,"[74,84)",F,7,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2047,XF,61,"[44,64)",F,4,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2048,XO,63,"[44,64)",F,8,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2049,CY,71,"[64,74)",M,7,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2050,DT,62,"[44,64)",F,6,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2051,MX,62,"[44,64)",F,7,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2052,YB,85,"[84,Inf)",F,7,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2053,MR,57,"[44,64)",F,4,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2054,PR,92,"[84,Inf)",F,8,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2055,XH,77,"[74,84)",F,7,36.25781744516932,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2056,YH,80,"[74,84)",M,8,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2057,AC,62,"[44,64)",M,4,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2058,TT,86,"[84,Inf)",M,6,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2059,CK,86,"[84,Inf)",M,8,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2060,SV,83,"[74,84)",F,8,NA,2024-03-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2061,MG,66,"[64,74)",M,6,NA,2024-03-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2062,TC,65,"[64,74)",F,7,NA,2024-03-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2063,IY,89,"[84,Inf)",M,9,NA,2024-03-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2064,AU,87,"[84,Inf)",M,8,NA,2024-03-26,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2065,RC,78,"[74,84)",M,8,NA,2024-03-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2066,LM,97,"[84,Inf)",M,9,NA,2024-03-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2067,ED,87,"[84,Inf)",M,6,NA,2024-03-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2068,PD,61,"[44,64)",M,6,NA,2024-03-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2069,DC,77,"[74,84)",F,7,NA,2024-03-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2070,GG,98,"[84,Inf)",M,9,29.452541868288368,2024-03-26,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2071,QI,48,"[44,64)",M,4,NA,2024-03-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2072,WN,0,"[0,1)",M,NA,NA,2024-03-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2073,LT,86,"[84,Inf)",M,9,NA,2024-03-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2074,VA,61,"[44,64)",F,6,NA,2024-03-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2075,DS,78,"[74,84)",M,7,NA,2024-03-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2076,WI,71,"[64,74)",F,4,NA,2024-03-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2077,OR,97,"[84,Inf)",M,9,NA,2024-03-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2078,AG,76,"[74,84)",F,6,92.25908554630433,2024-03-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2079,QH,89,"[84,Inf)",M,7,NA,2024-03-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2080,HE,85,"[84,Inf)",M,7,NA,2024-03-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2081,IR,76,"[74,84)",F,8,NA,2024-03-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2082,JQ,0,"[0,1)",F,NA,NA,2024-03-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2083,SH,95,"[84,Inf)",M,9,NA,2024-03-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2084,HN,72,"[64,74)",M,7,NA,2024-03-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2085,KG,55,"[44,64)",M,6,NA,2024-03-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2086,XU,53,"[44,64)",M,4,NA,2024-03-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2087,RN,43,"[14,44)",M,4,95.52504351096871,2024-03-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2088,WK,53,"[44,64)",F,5,NA,2024-03-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2089,HX,95,"[84,Inf)",M,7,NA,2024-03-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2090,DJ,68,"[64,74)",F,6,67.40145954469057,2024-03-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2091,OM,1,"[1,14)",M,NA,NA,2024-03-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2092,SW,78,"[74,84)",F,7,75.17137264091669,2024-03-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2093,HX,90,"[84,Inf)",F,9,84.92378117768374,2024-03-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2094,SA,72,"[64,74)",M,4,NA,2024-03-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2095,QY,62,"[44,64)",F,7,NA,2024-03-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2096,MS,83,"[74,84)",F,8,NA,2024-03-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2097,LL,92,"[84,Inf)",M,8,NA,2024-03-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2098,XV,45,"[44,64)",F,3,NA,2024-03-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2099,LD,100,"[84,Inf)",F,6,NA,2024-03-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2100,WO,77,"[74,84)",M,6,NA,2024-03-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2101,CI,46,"[44,64)",M,2,NA,2024-03-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2102,XY,27,"[14,44)",M,1,NA,2024-03-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2103,TL,79,"[74,84)",M,7,NA,2024-03-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2104,XZ,88,"[84,Inf)",F,9,NA,2024-03-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2105,CN,92,"[84,Inf)",M,8,NA,2024-03-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2106,XC,71,"[64,74)",M,5,NA,2024-03-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2107,TB,57,"[44,64)",M,4,NA,2024-03-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2108,XJ,47,"[44,64)",F,4,NA,2024-03-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2109,BH,74,"[74,84)",M,5,NA,2024-03-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2110,KM,49,"[44,64)",M,5,NA,2024-03-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2111,AK,44,"[44,64)",M,4,NA,2024-03-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2112,WR,49,"[44,64)",M,5,94.58653813382712,2024-03-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2113,FZ,44,"[44,64)",M,4,NA,2024-03-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2114,RW,59,"[44,64)",M,5,NA,2024-03-28,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2115,EW,95,"[84,Inf)",M,8,NA,2024-03-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2116,KA,79,"[74,84)",M,7,NA,2024-03-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2117,WH,64,"[64,74)",F,7,NA,2024-03-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2118,HM,65,"[64,74)",M,4,NA,2024-03-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2119,LJ,93,"[84,Inf)",M,8,46.66173269967626,2024-03-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2120,DV,42,"[14,44)",M,3,NA,2024-03-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2121,SK,72,"[64,74)",F,6,107.79968077198183,2024-03-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2122,NX,70,"[64,74)",M,6,NA,2024-03-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2123,QK,86,"[84,Inf)",M,9,NA,2024-03-28,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2124,QZ,82,"[74,84)",M,7,NA,2024-03-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2125,DE,85,"[84,Inf)",F,8,113.96092740614154,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2126,CC,0,"[0,1)",F,NA,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2127,GD,58,"[44,64)",M,6,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2128,HL,69,"[64,74)",M,8,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2129,BR,77,"[74,84)",M,9,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2130,NI,85,"[84,Inf)",F,9,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2131,BN,66,"[64,74)",F,5,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2132,GP,71,"[64,74)",F,8,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2133,DM,19,"[14,44)",M,2,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2134,QB,61,"[44,64)",M,6,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2135,GU,86,"[84,Inf)",M,9,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2136,GV,64,"[64,74)",M,5,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2137,AF,93,"[84,Inf)",M,7,35.06849587972022,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2138,ZZ,43,"[14,44)",M,3,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2139,EP,50,"[44,64)",M,4,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2140,EJ,58,"[44,64)",M,4,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2141,VG,70,"[64,74)",M,6,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2142,CN,37,"[14,44)",F,3,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2143,TN,84,"[84,Inf)",F,6,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2144,CS,67,"[64,74)",M,7,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2145,NT,95,"[84,Inf)",M,9,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2146,VF,88,"[84,Inf)",M,9,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2147,JJ,87,"[84,Inf)",M,8,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2148,CL,76,"[74,84)",F,6,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2149,IO,77,"[74,84)",M,6,59.58454569276221,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2150,ID,65,"[64,74)",M,4,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2151,RD,76,"[74,84)",F,6,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2152,EF,32,"[14,44)",F,2,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2153,MO,66,"[64,74)",F,6,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2154,HT,76,"[74,84)",M,7,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2155,FP,92,"[84,Inf)",M,9,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2156,MM,60,"[44,64)",M,6,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2157,QY,74,"[74,84)",F,6,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2158,YQ,92,"[84,Inf)",M,8,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2159,SP,82,"[74,84)",M,7,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2160,XO,62,"[44,64)",M,5,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2161,EH,78,"[74,84)",M,6,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2162,UZ,79,"[74,84)",M,9,NA,2024-03-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2163,BE,78,"[74,84)",M,7,53.711107892139644,2024-03-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2164,UL,61,"[44,64)",M,5,103.7963750395223,2024-03-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2165,AM,50,"[44,64)",M,5,NA,2024-03-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2166,QE,71,"[64,74)",M,5,NA,2024-03-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2167,ZH,64,"[64,74)",F,7,NA,2024-03-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2168,AZ,91,"[84,Inf)",F,9,NA,2024-03-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2169,LD,73,"[64,74)",M,6,NA,2024-03-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2170,NB,85,"[84,Inf)",M,7,NA,2024-03-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2171,HX,49,"[44,64)",F,7,NA,2024-03-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2172,TN,60,"[44,64)",M,5,103.5013300548043,2024-03-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2173,FA,92,"[84,Inf)",M,9,NA,2024-03-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2174,EZ,0,"[0,1)",M,NA,NA,2024-03-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2175,MV,93,"[84,Inf)",M,7,35.29879323409485,2024-03-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2176,DI,76,"[74,84)",M,8,NA,2024-03-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2177,KW,47,"[44,64)",F,5,93.95553053955008,2024-03-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2178,RX,60,"[44,64)",F,5,NA,2024-03-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2179,EJ,59,"[44,64)",M,7,NA,2024-03-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2180,MN,72,"[64,74)",M,6,NA,2024-03-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2181,DF,64,"[64,74)",F,7,NA,2024-03-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2182,ZN,80,"[74,84)",M,7,NA,2024-03-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2183,KV,76,"[74,84)",M,7,NA,2024-03-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2184,PT,54,"[44,64)",M,6,70.64896458953811,2024-03-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2185,TC,1,"[1,14)",M,NA,NA,2024-03-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2186,OY,55,"[44,64)",M,4,NA,2024-03-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2187,AN,63,"[44,64)",F,7,69.43209618630358,2024-03-31,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2188,PZ,74,"[74,84)",M,7,NA,2024-03-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2189,BA,70,"[64,74)",F,5,NA,2024-03-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2190,NS,79,"[74,84)",M,5,NA,2024-03-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2191,UV,96,"[84,Inf)",M,9,NA,2024-03-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2192,RP,84,"[84,Inf)",M,8,NA,2024-03-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2193,NK,68,"[64,74)",M,5,NA,2024-03-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2194,LH,75,"[74,84)",M,7,NA,2024-03-31,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2195,QW,51,"[44,64)",M,5,NA,2024-03-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2196,MJ,68,"[64,74)",F,6,NA,2024-03-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2197,DJ,89,"[84,Inf)",F,8,NA,2024-03-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2198,QP,88,"[84,Inf)",M,8,NA,2024-03-31,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2199,WZ,67,"[64,74)",F,6,NA,2024-03-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2200,ZX,91,"[84,Inf)",M,7,NA,2024-03-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2201,RS,52,"[44,64)",M,4,NA,2024-03-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2202,TT,62,"[44,64)",M,5,NA,2024-03-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2203,NA,72,"[64,74)",F,6,NA,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2204,IU,54,"[44,64)",M,4,NA,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2205,VF,77,"[74,84)",F,6,70.57649527538761,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2206,QS,63,"[44,64)",M,5,72.08546576006555,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2207,IV,73,"[64,74)",M,5,NA,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2208,UJ,69,"[64,74)",M,7,NA,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2209,ND,47,"[44,64)",M,4,NA,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2210,JS,58,"[44,64)",M,6,NA,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2211,DG,67,"[64,74)",F,4,NA,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2212,HI,95,"[84,Inf)",M,8,NA,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2213,NH,80,"[74,84)",F,8,NA,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2214,OV,77,"[74,84)",M,7,57.81994517697261,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2215,AW,68,"[64,74)",M,7,89.95792117762255,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2216,QG,80,"[74,84)",M,9,NA,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2217,ZS,90,"[84,Inf)",F,9,NA,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2218,YO,76,"[74,84)",M,6,NA,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2219,TG,44,"[44,64)",M,3,NA,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2220,OS,1,"[1,14)",M,NA,NA,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2221,WA,73,"[64,74)",M,8,NA,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2222,JM,69,"[64,74)",F,6,NA,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2223,JV,65,"[64,74)",F,5,NA,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2224,MB,77,"[74,84)",M,8,57.76975115215925,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2225,BE,64,"[64,74)",F,5,NA,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2226,TN,61,"[44,64)",F,5,NA,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2227,WU,76,"[74,84)",M,7,NA,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2228,EI,85,"[84,Inf)",M,7,NA,2024-04-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2229,QB,93,"[84,Inf)",M,7,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2230,UD,69,"[64,74)",F,6,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2231,QF,72,"[64,74)",M,7,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2232,MO,81,"[74,84)",M,6,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2233,QN,64,"[64,74)",M,5,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2234,DV,60,"[44,64)",M,4,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2235,WU,75,"[74,84)",M,6,43.037270013763774,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2236,LE,80,"[74,84)",M,9,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2237,QN,71,"[64,74)",M,6,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2238,XE,77,"[74,84)",M,6,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2239,LF,69,"[64,74)",M,6,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2240,TB,70,"[64,74)",M,6,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2241,EJ,78,"[74,84)",M,8,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2242,ME,89,"[84,Inf)",M,9,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2243,DM,43,"[14,44)",M,2,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2244,XN,81,"[74,84)",F,7,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2245,UB,68,"[64,74)",M,6,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2246,CT,71,"[64,74)",M,7,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2247,HH,60,"[44,64)",M,4,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2248,QZ,71,"[64,74)",F,6,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2249,AR,89,"[84,Inf)",M,7,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2250,PF,94,"[84,Inf)",M,9,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2251,FD,85,"[84,Inf)",M,7,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2252,KP,54,"[44,64)",F,5,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2253,XV,50,"[44,64)",F,3,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2254,YV,43,"[14,44)",F,4,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2255,WS,58,"[44,64)",F,6,NA,2024-04-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2256,XV,85,"[84,Inf)",M,8,NA,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2257,WM,80,"[74,84)",M,8,NA,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2258,HQ,90,"[84,Inf)",M,8,NA,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2259,TI,76,"[74,84)",M,6,43.23855113402014,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2260,IY,62,"[44,64)",F,5,NA,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2261,QA,94,"[84,Inf)",M,9,NA,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2262,HV,75,"[74,84)",M,7,NA,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2263,WF,60,"[44,64)",F,6,NA,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2264,SW,78,"[74,84)",M,6,NA,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2265,QW,91,"[84,Inf)",M,8,NA,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2266,KS,63,"[44,64)",M,5,NA,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2267,ZG,80,"[74,84)",M,7,NA,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2268,OU,63,"[44,64)",F,6,NA,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2269,CB,81,"[74,84)",M,8,NA,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2270,QA,69,"[64,74)",M,4,NA,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2271,BY,50,"[44,64)",M,5,NA,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2272,EJ,90,"[84,Inf)",M,8,52.989105647923715,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2273,JL,60,"[44,64)",F,6,NA,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2274,VG,66,"[64,74)",F,5,NA,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2275,NQ,28,"[14,44)",M,2,102.03895063864815,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2276,AU,59,"[44,64)",F,5,120.94416388730646,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2277,AQ,80,"[74,84)",F,7,34.11784452802174,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2278,AS,53,"[44,64)",M,6,NA,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2279,GA,87,"[84,Inf)",M,7,NA,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2280,HC,81,"[74,84)",F,8,NA,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2281,NA,94,"[84,Inf)",M,8,NA,2024-04-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2282,JT,75,"[74,84)",F,6,NA,2024-04-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2283,AX,67,"[64,74)",M,7,NA,2024-04-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2284,GG,86,"[84,Inf)",M,8,NA,2024-04-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2285,WB,49,"[44,64)",M,4,NA,2024-04-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2286,TI,75,"[74,84)",F,8,NA,2024-04-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2287,YF,72,"[64,74)",F,6,NA,2024-04-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2288,SY,68,"[64,74)",M,8,NA,2024-04-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2289,EZ,86,"[84,Inf)",M,7,NA,2024-04-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2290,ZE,56,"[44,64)",M,3,53.677203494877816,2024-04-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2291,WU,96,"[84,Inf)",M,7,NA,2024-04-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2292,VB,76,"[74,84)",F,7,NA,2024-04-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2293,CM,66,"[64,74)",F,5,NA,2024-04-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2294,QI,69,"[64,74)",F,6,NA,2024-04-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2295,YO,89,"[84,Inf)",M,9,NA,2024-04-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2296,NY,86,"[84,Inf)",M,7,NA,2024-04-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2297,ND,1,"[1,14)",M,NA,NA,2024-04-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2298,US,78,"[74,84)",M,6,NA,2024-04-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2299,WO,53,"[44,64)",M,5,NA,2024-04-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2300,ZY,70,"[64,74)",M,5,NA,2024-04-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2301,YP,42,"[14,44)",F,4,NA,2024-04-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2302,WE,71,"[64,74)",M,4,77.32168325147794,2024-04-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2303,AV,92,"[84,Inf)",M,8,NA,2024-04-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2304,BG,75,"[74,84)",M,6,NA,2024-04-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2305,ZK,79,"[74,84)",M,7,35.76559839748371,2024-04-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2306,WV,98,"[84,Inf)",F,9,NA,2024-04-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2307,QP,75,"[74,84)",F,7,43.280455316807256,2024-04-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2308,CH,30,"[14,44)",M,3,NA,2024-04-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2309,WV,72,"[64,74)",M,8,NA,2024-04-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2310,IT,87,"[84,Inf)",M,8,37.745431036050974,2024-04-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2311,TK,49,"[44,64)",M,3,NA,2024-04-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2312,DG,94,"[84,Inf)",M,9,NA,2024-04-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2313,LI,68,"[64,74)",M,6,NA,2024-04-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2314,NH,56,"[44,64)",M,4,NA,2024-04-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2315,AN,48,"[44,64)",M,4,NA,2024-04-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2316,FC,73,"[64,74)",F,6,NA,2024-04-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2317,RY,80,"[74,84)",M,5,NA,2024-04-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2318,YP,78,"[74,84)",M,8,75.16990615100205,2024-04-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2319,IL,1,"[1,14)",F,NA,NA,2024-04-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2320,TQ,58,"[44,64)",M,5,NA,2024-04-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2321,OW,61,"[44,64)",M,6,NA,2024-04-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2322,TW,88,"[84,Inf)",M,9,NA,2024-04-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2323,ET,48,"[44,64)",F,3,NA,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2324,CT,79,"[74,84)",F,7,90.46889973137124,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2325,GZ,45,"[44,64)",M,5,117.48453996384336,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2326,CV,63,"[44,64)",M,7,NA,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2327,BW,87,"[84,Inf)",M,7,NA,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2328,PZ,82,"[74,84)",F,8,NA,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2329,TD,72,"[64,74)",F,7,NA,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2330,OC,78,"[74,84)",M,7,NA,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2331,CR,69,"[64,74)",M,6,NA,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2332,QC,50,"[44,64)",F,4,NA,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2333,DK,83,"[74,84)",M,7,NA,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2334,RX,69,"[64,74)",M,7,NA,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2335,SV,75,"[74,84)",M,7,46.476037593887725,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2336,QN,84,"[84,Inf)",M,9,NA,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2337,EK,74,"[74,84)",F,6,142.15080789705723,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2338,BW,74,"[74,84)",M,6,NA,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2339,JI,63,"[44,64)",M,5,NA,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2340,ZO,90,"[84,Inf)",F,7,NA,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2341,NK,79,"[74,84)",F,8,NA,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2342,DK,74,"[74,84)",M,7,NA,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2343,CR,50,"[44,64)",F,3,NA,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2344,SG,79,"[74,84)",M,7,74.30414881310612,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2345,MH,61,"[44,64)",F,5,NA,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2346,PP,62,"[44,64)",M,7,NA,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2347,RW,1,"[1,14)",M,NA,NA,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2348,WZ,63,"[44,64)",M,5,NA,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2349,MU,78,"[74,84)",M,8,NA,2024-04-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2350,UU,52,"[44,64)",M,4,NA,2024-04-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2351,EW,40,"[14,44)",M,4,NA,2024-04-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2352,FI,1,"[1,14)",M,NA,NA,2024-04-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2353,FJ,63,"[44,64)",F,7,NA,2024-04-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2354,KB,41,"[14,44)",M,5,NA,2024-04-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2355,QP,89,"[84,Inf)",M,8,NA,2024-04-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2356,EL,54,"[44,64)",M,6,NA,2024-04-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2357,JY,74,"[74,84)",M,7,NA,2024-04-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2358,EA,89,"[84,Inf)",F,8,NA,2024-04-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2359,OE,86,"[84,Inf)",M,9,NA,2024-04-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2360,XD,68,"[64,74)",M,6,NA,2024-04-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2361,VD,89,"[84,Inf)",M,9,51.09196324815017,2024-04-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2362,VX,81,"[74,84)",M,6,NA,2024-04-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2363,NP,56,"[44,64)",M,5,NA,2024-04-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2364,KH,0,"[0,1)",F,NA,NA,2024-04-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2365,UV,92,"[84,Inf)",F,8,NA,2024-04-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2366,IM,87,"[84,Inf)",M,7,NA,2024-04-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2367,RY,90,"[84,Inf)",M,7,NA,2024-04-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2368,AU,54,"[44,64)",M,6,NA,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2369,JL,50,"[44,64)",M,5,NA,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2370,FJ,79,"[74,84)",M,8,53.00776668143755,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2371,AD,95,"[84,Inf)",F,8,27.61542944874039,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2372,RY,68,"[64,74)",M,6,67.50034728674908,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2373,NJ,80,"[74,84)",F,6,44.567881257959,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2374,EL,79,"[74,84)",M,7,NA,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2375,KU,53,"[44,64)",M,5,96.29145284973154,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2376,NF,65,"[64,74)",M,6,NA,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2377,YK,35,"[14,44)",M,2,117.1936626625577,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2378,KY,74,"[74,84)",M,6,NA,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2379,QH,80,"[74,84)",F,9,NA,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2380,QV,89,"[84,Inf)",M,7,NA,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2381,CY,83,"[74,84)",F,6,NA,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2382,GK,69,"[64,74)",M,5,83.47321813184716,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2383,LO,86,"[84,Inf)",M,6,NA,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2384,SC,60,"[44,64)",M,5,80.11130947165549,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2385,LD,69,"[64,74)",F,7,NA,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2386,WG,62,"[44,64)",M,6,NA,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2387,UU,79,"[74,84)",M,7,49.178455271985705,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2388,TO,66,"[64,74)",M,6,77.69246301285887,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2389,VF,72,"[64,74)",F,6,NA,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2390,TN,81,"[74,84)",F,6,NA,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2391,UA,86,"[84,Inf)",F,7,32.28294531150382,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2392,QB,87,"[84,Inf)",M,7,NA,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2393,VQ,51,"[44,64)",M,5,NA,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2394,KN,54,"[44,64)",F,6,NA,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2395,LP,84,"[84,Inf)",F,7,NA,2024-04-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2396,MR,1,"[1,14)",F,NA,NA,2024-04-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2397,EE,66,"[64,74)",M,6,NA,2024-04-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2398,UW,93,"[84,Inf)",M,9,NA,2024-04-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2399,GV,42,"[14,44)",M,3,NA,2024-04-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2400,NW,74,"[74,84)",M,7,NA,2024-04-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2401,MW,45,"[44,64)",M,5,83.04515083789236,2024-04-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2402,DJ,92,"[84,Inf)",F,8,NA,2024-04-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2403,RJ,67,"[64,74)",F,5,NA,2024-04-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2404,VA,48,"[44,64)",F,5,NA,2024-04-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2405,TF,93,"[84,Inf)",M,8,NA,2024-04-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2406,BE,88,"[84,Inf)",M,8,NA,2024-04-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2407,NS,65,"[64,74)",F,5,NA,2024-04-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2408,HW,0,"[0,1)",M,NA,NA,2024-04-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2409,XI,62,"[44,64)",M,6,101.40007274357302,2024-04-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2410,UW,87,"[84,Inf)",M,7,NA,2024-04-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2411,EL,93,"[84,Inf)",M,9,NA,2024-04-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2412,BL,82,"[74,84)",F,8,NA,2024-04-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2413,EO,47,"[44,64)",M,4,104.38418592878149,2024-04-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2414,LB,55,"[44,64)",M,5,NA,2024-04-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2415,QY,66,"[64,74)",M,5,NA,2024-04-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2416,NT,94,"[84,Inf)",M,7,NA,2024-04-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2417,TY,89,"[84,Inf)",M,9,NA,2024-04-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2418,AF,82,"[74,84)",M,6,NA,2024-04-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2419,JP,79,"[74,84)",M,8,NA,2024-04-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2420,LZ,55,"[44,64)",M,5,NA,2024-04-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2421,YU,62,"[44,64)",M,5,148.95565801170824,2024-04-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2422,MW,77,"[74,84)",M,7,40.676793886667966,2024-04-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2423,LE,46,"[44,64)",M,5,NA,2024-04-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2424,BG,44,"[44,64)",M,2,NA,2024-04-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2425,PP,35,"[14,44)",M,5,NA,2024-04-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2426,KY,54,"[44,64)",F,4,78.15530965572592,2024-04-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2427,KH,63,"[44,64)",F,4,88.91194508554943,2024-04-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2428,NA,82,"[74,84)",M,9,NA,2024-04-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2429,KQ,91,"[84,Inf)",F,9,NA,2024-04-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2430,WC,63,"[44,64)",F,8,NA,2024-04-10,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2431,QU,94,"[84,Inf)",M,8,35.131388681141395,2024-04-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2432,YR,0,"[0,1)",M,NA,NA,2024-04-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2433,VZ,25,"[14,44)",F,4,NA,2024-04-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2434,AR,92,"[84,Inf)",M,9,NA,2024-04-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2435,HB,66,"[64,74)",F,6,NA,2024-04-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2436,RT,67,"[64,74)",M,5,NA,2024-04-10,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2437,CZ,59,"[44,64)",M,7,95.5026406511839,2024-04-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2438,DU,85,"[84,Inf)",M,8,NA,2024-04-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2439,AZ,52,"[44,64)",F,6,NA,2024-04-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2440,NP,83,"[74,84)",M,7,NA,2024-04-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2441,RV,85,"[84,Inf)",M,9,NA,2024-04-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2442,MI,70,"[64,74)",M,7,NA,2024-04-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2443,FB,59,"[44,64)",M,7,NA,2024-04-10,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2444,ZX,88,"[84,Inf)",M,8,NA,2024-04-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2445,FQ,94,"[84,Inf)",M,8,NA,2024-04-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2446,QO,71,"[64,74)",M,6,NA,2024-04-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2447,IZ,64,"[64,74)",F,5,NA,2024-04-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2448,YL,53,"[44,64)",F,2,NA,2024-04-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2449,BO,88,"[84,Inf)",F,8,75.57816482978933,2024-04-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2450,CY,67,"[64,74)",M,6,NA,2024-04-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2451,IZ,68,"[64,74)",M,7,NA,2024-04-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2452,GA,90,"[84,Inf)",M,6,NA,2024-04-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2453,CI,62,"[44,64)",M,3,101.81923675866803,2024-04-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2454,VD,65,"[64,74)",M,5,NA,2024-04-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2455,SN,52,"[44,64)",M,4,NA,2024-04-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2456,JY,80,"[74,84)",F,6,NA,2024-04-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2457,HN,68,"[64,74)",F,6,NA,2024-04-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2458,ZZ,68,"[64,74)",F,9,NA,2024-04-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2459,LZ,92,"[84,Inf)",M,7,NA,2024-04-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2460,AU,40,"[14,44)",M,3,101.02275280473106,2024-04-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2461,KR,52,"[44,64)",M,4,NA,2024-04-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2462,VK,87,"[84,Inf)",M,8,NA,2024-04-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2463,NZ,84,"[84,Inf)",F,7,NA,2024-04-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2464,WP,40,"[14,44)",M,4,NA,2024-04-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2465,JJ,66,"[64,74)",M,7,NA,2024-04-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2466,EW,73,"[64,74)",M,8,NA,2024-04-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2467,EB,33,"[14,44)",M,2,100.27060212252952,2024-04-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2468,TT,94,"[84,Inf)",F,7,NA,2024-04-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2469,MK,64,"[64,74)",M,4,NA,2024-04-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2470,FQ,77,"[74,84)",M,7,NA,2024-04-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2471,QM,75,"[74,84)",M,7,NA,2024-04-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2472,CA,47,"[44,64)",F,5,100.77035001594847,2024-04-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2473,GA,49,"[44,64)",M,4,NA,2024-04-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2474,ND,74,"[74,84)",F,6,NA,2024-04-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2475,EK,77,"[74,84)",M,8,NA,2024-04-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2476,SH,74,"[74,84)",M,6,NA,2024-04-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2477,DA,84,"[84,Inf)",M,7,NA,2024-04-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2478,HM,45,"[44,64)",M,4,NA,2024-04-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2479,KM,60,"[44,64)",F,5,NA,2024-04-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2480,OK,34,"[14,44)",M,5,NA,2024-04-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2481,QY,98,"[84,Inf)",F,8,NA,2024-04-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2482,KV,72,"[64,74)",F,6,96.18170117383035,2024-04-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2483,ZK,65,"[64,74)",F,6,106.65694927782289,2024-04-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2484,PQ,64,"[64,74)",M,6,NA,2024-04-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2485,YQ,49,"[44,64)",M,3,NA,2024-04-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2486,OX,0,"[0,1)",M,NA,NA,2024-04-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2487,WK,52,"[44,64)",M,4,NA,2024-04-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2488,BG,82,"[74,84)",M,8,NA,2024-04-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2489,YH,0,"[0,1)",F,NA,NA,2024-04-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2490,QM,67,"[64,74)",M,5,80.74384753689378,2024-04-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2491,VX,51,"[44,64)",M,5,NA,2024-04-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2492,CP,59,"[44,64)",F,4,NA,2024-04-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2493,LK,44,"[44,64)",F,4,130.26436636451993,2024-04-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2494,PZ,52,"[44,64)",M,4,NA,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2495,VQ,42,"[14,44)",M,4,NA,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2496,RY,82,"[74,84)",M,7,NA,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2497,IE,93,"[84,Inf)",M,8,NA,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2498,XA,90,"[84,Inf)",M,8,44.97811451530217,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2499,RB,0,"[0,1)",F,NA,NA,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2500,YE,79,"[74,84)",M,8,NA,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2501,PQ,65,"[64,74)",M,6,NA,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2502,BP,49,"[44,64)",F,3,77.99257911389157,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2503,OT,81,"[74,84)",M,7,NA,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2504,FY,51,"[44,64)",F,4,NA,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2505,YK,67,"[64,74)",M,6,NA,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2506,QV,75,"[74,84)",F,7,NA,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2507,PV,52,"[44,64)",M,5,NA,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2508,JW,61,"[44,64)",M,4,NA,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2509,RV,62,"[44,64)",M,6,NA,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2510,DH,57,"[44,64)",M,4,NA,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2511,MJ,62,"[44,64)",M,6,NA,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2512,HY,85,"[84,Inf)",M,6,NA,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2513,HO,76,"[74,84)",M,8,NA,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2514,UE,51,"[44,64)",F,5,NA,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2515,ZN,74,"[74,84)",F,7,NA,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2516,SI,82,"[74,84)",M,8,55.37703391051709,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2517,HB,1,"[1,14)",M,NA,NA,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2518,BU,64,"[64,74)",F,5,NA,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2519,YE,78,"[74,84)",M,7,NA,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2520,UD,80,"[74,84)",M,7,NA,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2521,WH,74,"[74,84)",M,5,NA,2024-04-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2522,OL,86,"[84,Inf)",M,8,NA,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2523,RU,76,"[74,84)",M,8,NA,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2524,PR,90,"[84,Inf)",M,7,NA,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2525,AO,54,"[44,64)",M,6,NA,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2526,QM,67,"[64,74)",M,6,NA,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2527,KW,49,"[44,64)",M,3,84.32267729447433,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2528,YH,92,"[84,Inf)",M,7,NA,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2529,RT,70,"[64,74)",M,7,NA,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2530,FD,45,"[44,64)",M,3,NA,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2531,TE,56,"[44,64)",M,5,NA,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2532,ET,96,"[84,Inf)",M,9,28.596273016634708,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2533,WD,91,"[84,Inf)",M,9,NA,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2534,EN,59,"[44,64)",M,6,109.0231535777359,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2535,SL,82,"[74,84)",M,7,NA,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2536,YM,73,"[64,74)",M,5,NA,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2537,YE,70,"[64,74)",M,5,NA,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2538,FT,75,"[74,84)",M,6,68.03559280723671,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2539,JP,82,"[74,84)",M,7,NA,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2540,XO,78,"[74,84)",M,5,NA,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2541,CP,82,"[74,84)",M,7,NA,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2542,OO,66,"[64,74)",M,6,NA,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2543,CQ,65,"[64,74)",M,5,NA,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2544,NP,46,"[44,64)",M,4,NA,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2545,JI,80,"[74,84)",M,7,39.367162827219275,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2546,JB,90,"[84,Inf)",F,8,NA,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2547,ZT,66,"[64,74)",M,5,NA,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2548,CI,72,"[64,74)",M,7,66.17711763017869,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2549,TT,96,"[84,Inf)",M,9,NA,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2550,II,67,"[64,74)",F,6,NA,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2551,NH,61,"[44,64)",F,5,NA,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2552,QV,63,"[44,64)",M,5,NA,2024-04-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2553,BJ,64,"[64,74)",M,5,NA,2024-04-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2554,YB,79,"[74,84)",F,8,95.2438300116258,2024-04-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2555,UD,90,"[84,Inf)",M,9,NA,2024-04-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2556,ZC,77,"[74,84)",F,6,NA,2024-04-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2557,WX,77,"[74,84)",F,7,NA,2024-04-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2558,FQ,71,"[64,74)",M,7,NA,2024-04-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2559,UE,47,"[44,64)",M,5,103.7794944171876,2024-04-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2560,RB,37,"[14,44)",M,5,NA,2024-04-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2561,JH,90,"[84,Inf)",F,7,NA,2024-04-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2562,FI,58,"[44,64)",M,4,92.36750862962111,2024-04-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2563,AP,57,"[44,64)",F,5,134.26303447106005,2024-04-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2564,MV,91,"[84,Inf)",F,6,NA,2024-04-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2565,KG,55,"[44,64)",M,6,NA,2024-04-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2566,KG,72,"[64,74)",M,6,NA,2024-04-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2567,DY,79,"[74,84)",M,6,NA,2024-04-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2568,PP,90,"[84,Inf)",M,9,NA,2024-04-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2569,QQ,79,"[74,84)",M,8,50.69395430848834,2024-04-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2570,RR,80,"[74,84)",M,8,NA,2024-04-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2571,SP,71,"[64,74)",F,6,NA,2024-04-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2572,OR,97,"[84,Inf)",M,9,NA,2024-04-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2573,WX,70,"[64,74)",F,7,NA,2024-04-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2574,ZG,75,"[74,84)",M,9,NA,2024-04-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2575,VL,60,"[44,64)",M,7,NA,2024-04-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2576,RE,68,"[64,74)",F,6,NA,2024-04-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2577,EI,47,"[44,64)",M,5,NA,2024-04-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2578,YE,89,"[84,Inf)",M,7,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2579,DA,29,"[14,44)",M,2,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2580,UB,87,"[84,Inf)",M,9,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2581,QW,69,"[64,74)",F,4,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2582,FI,38,"[14,44)",M,2,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2583,AN,95,"[84,Inf)",M,9,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2584,PF,83,"[74,84)",F,8,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2585,AS,70,"[64,74)",M,6,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2586,IG,73,"[64,74)",M,7,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2587,ET,99,"[84,Inf)",F,6,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2588,JR,71,"[64,74)",M,6,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2589,VC,89,"[84,Inf)",F,6,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2590,NC,95,"[84,Inf)",M,7,31.983328717835278,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2591,ZL,75,"[74,84)",M,8,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2592,CB,92,"[84,Inf)",F,9,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2593,ZR,47,"[44,64)",M,5,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2594,DW,96,"[84,Inf)",M,7,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2595,SX,40,"[14,44)",M,4,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2596,JG,76,"[74,84)",M,8,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2597,SI,88,"[84,Inf)",M,8,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2598,VG,83,"[74,84)",M,7,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2599,ZU,84,"[84,Inf)",M,8,67.90682967323987,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2600,BZ,61,"[44,64)",M,5,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2601,DA,84,"[84,Inf)",F,6,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2602,YY,67,"[64,74)",M,6,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2603,CO,3,"[1,14)",M,NA,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2604,YM,71,"[64,74)",F,6,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2605,ZI,68,"[64,74)",M,5,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2606,AV,67,"[64,74)",M,7,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2607,NN,92,"[84,Inf)",M,8,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2608,PZ,78,"[74,84)",F,7,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2609,AR,78,"[74,84)",F,4,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2610,CR,74,"[74,84)",M,7,NA,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2611,KF,42,"[14,44)",M,3,119.92612889154638,2024-04-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2612,QU,93,"[84,Inf)",M,7,NA,2024-04-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2613,SN,80,"[74,84)",F,8,37.17749355277465,2024-04-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2614,GP,70,"[64,74)",M,5,NA,2024-04-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2615,MV,83,"[74,84)",M,9,NA,2024-04-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2616,FD,70,"[64,74)",M,7,NA,2024-04-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2617,ZI,78,"[74,84)",M,7,NA,2024-04-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2618,ZP,75,"[74,84)",M,7,NA,2024-04-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2619,NT,48,"[44,64)",M,6,NA,2024-04-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2620,EN,80,"[74,84)",F,7,NA,2024-04-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2621,DN,48,"[44,64)",M,5,NA,2024-04-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2622,HP,52,"[44,64)",M,5,NA,2024-04-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2623,XQ,83,"[74,84)",F,7,NA,2024-04-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2624,UV,70,"[64,74)",F,4,NA,2024-04-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2625,NZ,66,"[64,74)",F,5,76.9769930692518,2024-04-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2626,CF,60,"[44,64)",F,4,NA,2024-04-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2627,HS,90,"[84,Inf)",F,8,NA,2024-04-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2628,RO,79,"[74,84)",M,5,NA,2024-04-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2629,EX,73,"[64,74)",F,8,77.6919378831217,2024-04-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2630,UE,60,"[44,64)",F,6,NA,2024-04-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2631,OB,47,"[44,64)",F,3,NA,2024-04-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2632,AM,82,"[74,84)",F,7,NA,2024-04-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2633,EC,82,"[74,84)",M,7,NA,2024-04-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2634,LH,74,"[74,84)",M,7,NA,2024-04-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2635,DV,46,"[44,64)",M,5,NA,2024-04-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2636,NA,71,"[64,74)",F,6,NA,2024-04-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2637,JP,92,"[84,Inf)",M,7,NA,2024-04-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2638,US,84,"[84,Inf)",F,7,NA,2024-04-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2639,EB,1,"[1,14)",F,NA,NA,2024-04-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2640,NK,47,"[44,64)",M,4,88.51121818508447,2024-04-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2641,JM,57,"[44,64)",F,4,NA,2024-04-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2642,FC,65,"[64,74)",M,6,NA,2024-04-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2643,NO,60,"[44,64)",M,5,NA,2024-04-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2644,BS,65,"[64,74)",M,6,NA,2024-04-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2645,ZO,54,"[44,64)",F,7,NA,2024-04-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2646,TP,88,"[84,Inf)",M,9,NA,2024-04-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2647,TV,97,"[84,Inf)",F,8,NA,2024-04-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2648,VI,95,"[84,Inf)",M,9,NA,2024-04-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2649,SE,94,"[84,Inf)",M,8,NA,2024-04-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2650,UT,42,"[14,44)",F,5,NA,2024-04-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2651,TC,57,"[44,64)",M,5,NA,2024-04-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2652,SH,39,"[14,44)",F,5,NA,2024-04-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2653,WJ,85,"[84,Inf)",M,7,NA,2024-04-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2654,QT,28,"[14,44)",M,1,NA,2024-04-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2655,KL,84,"[84,Inf)",M,8,NA,2024-04-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2656,DQ,81,"[74,84)",F,8,68.67325357203173,2024-04-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2657,XJ,59,"[44,64)",M,5,NA,2024-04-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2658,VL,66,"[64,74)",M,6,NA,2024-04-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2659,AY,60,"[44,64)",F,4,NA,2024-04-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2660,LR,71,"[64,74)",M,6,61.74316380305386,2024-04-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2661,FN,85,"[84,Inf)",M,8,NA,2024-04-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2662,KD,51,"[44,64)",M,5,NA,2024-04-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2663,XB,66,"[64,74)",F,7,139.48837198004796,2024-04-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2664,WL,84,"[84,Inf)",F,6,NA,2024-04-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2665,CG,94,"[84,Inf)",F,8,NA,2024-04-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2666,SM,80,"[74,84)",M,8,NA,2024-04-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2667,PW,63,"[44,64)",M,6,NA,2024-04-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2668,HS,61,"[44,64)",M,5,NA,2024-04-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2669,IJ,45,"[44,64)",F,5,NA,2024-04-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2670,OE,45,"[44,64)",F,6,85.39411172242998,2024-04-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2671,SU,81,"[74,84)",F,8,NA,2024-04-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2672,XF,45,"[44,64)",M,3,110.77155298879137,2024-04-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2673,MQ,55,"[44,64)",M,4,NA,2024-04-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2674,BJ,85,"[84,Inf)",M,8,35.862875357229974,2024-04-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2675,ZS,70,"[64,74)",M,8,NA,2024-04-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2676,TY,71,"[64,74)",M,8,NA,2024-04-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2677,VZ,59,"[44,64)",M,4,NA,2024-04-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2678,HD,71,"[64,74)",M,5,NA,2024-04-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2679,FU,86,"[84,Inf)",F,8,NA,2024-04-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2680,DB,55,"[44,64)",F,6,NA,2024-04-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2681,MY,74,"[74,84)",M,7,NA,2024-04-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2682,UZ,68,"[64,74)",M,7,87.12139113325244,2024-04-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2683,AV,92,"[84,Inf)",M,8,44.23490340456831,2024-04-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2684,HL,93,"[84,Inf)",M,9,NA,2024-04-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2685,RO,62,"[44,64)",M,4,100.07237256434657,2024-04-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2686,EV,74,"[74,84)",F,7,NA,2024-04-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2687,JO,56,"[44,64)",M,6,102.39808826161648,2024-04-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2688,HZ,68,"[64,74)",F,7,NA,2024-04-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2689,DC,79,"[74,84)",M,8,NA,2024-04-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2690,CO,43,"[14,44)",M,6,95.5622913003006,2024-04-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2691,PS,71,"[64,74)",F,7,89.92333128233152,2024-04-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2692,VJ,66,"[64,74)",F,7,NA,2024-04-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2693,AQ,90,"[84,Inf)",M,7,NA,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2694,VX,52,"[44,64)",M,7,99.82227802599527,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2695,UD,69,"[64,74)",M,8,NA,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2696,GD,78,"[74,84)",M,7,NA,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2697,MO,90,"[84,Inf)",F,9,32.7377575761868,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2698,ZU,50,"[44,64)",M,5,NA,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2699,VM,92,"[84,Inf)",M,8,NA,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2700,YT,75,"[74,84)",M,6,NA,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2701,BJ,77,"[74,84)",F,5,NA,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2702,MZ,82,"[74,84)",F,8,NA,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2703,OG,94,"[84,Inf)",M,7,NA,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2704,VE,71,"[64,74)",M,7,NA,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2705,KY,88,"[84,Inf)",F,6,NA,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2706,PA,62,"[44,64)",M,8,NA,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2707,YU,95,"[84,Inf)",M,8,NA,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2708,QZ,95,"[84,Inf)",M,8,38.22332357213668,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2709,IM,76,"[74,84)",M,8,NA,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2710,WQ,56,"[44,64)",M,5,NA,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2711,YQ,70,"[64,74)",M,7,NA,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2712,BY,82,"[74,84)",F,7,NA,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2713,VN,84,"[84,Inf)",M,8,NA,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2714,QJ,69,"[64,74)",F,5,NA,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2715,AJ,85,"[84,Inf)",F,6,NA,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2716,AM,84,"[84,Inf)",F,8,NA,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2717,JT,85,"[84,Inf)",M,7,32.78702277153118,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2718,XW,61,"[44,64)",M,6,NA,2024-04-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2719,CM,60,"[44,64)",M,4,NA,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2720,OF,64,"[64,74)",F,7,NA,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2721,CO,92,"[84,Inf)",M,9,NA,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2722,MR,79,"[74,84)",M,8,NA,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2723,PO,57,"[44,64)",M,4,NA,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2724,JP,60,"[44,64)",F,6,93.72077573254978,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2725,ZY,89,"[84,Inf)",M,8,NA,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2726,JO,72,"[64,74)",F,6,45.794910118015885,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2727,KH,33,"[14,44)",M,3,NA,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2728,WC,80,"[74,84)",M,6,38.09544183907869,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2729,JG,56,"[44,64)",F,4,61.49737717224314,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2730,KZ,66,"[64,74)",F,7,NA,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2731,HB,86,"[84,Inf)",F,7,NA,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2732,VA,61,"[44,64)",F,4,120.11893163808486,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2733,UW,63,"[44,64)",F,5,NA,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2734,EC,87,"[84,Inf)",M,7,NA,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2735,DG,0,"[0,1)",M,NA,NA,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2736,RW,77,"[74,84)",M,8,NA,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2737,FA,68,"[64,74)",M,3,NA,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2738,NV,52,"[44,64)",M,6,NA,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2739,SD,74,"[74,84)",M,7,65.45068991430533,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2740,XX,42,"[14,44)",F,3,NA,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2741,YZ,68,"[64,74)",M,6,NA,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2742,FD,78,"[74,84)",M,6,NA,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2743,VZ,65,"[64,74)",M,5,NA,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2744,WR,78,"[74,84)",M,6,62.616022542486895,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2745,YB,69,"[64,74)",M,7,NA,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2746,FE,45,"[44,64)",F,5,NA,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2747,JB,97,"[84,Inf)",F,7,NA,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2748,YO,65,"[64,74)",M,5,NA,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2749,NM,81,"[74,84)",M,7,NA,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2750,UW,77,"[74,84)",F,6,NA,2024-04-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2751,TO,64,"[64,74)",F,5,NA,2024-04-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2752,MD,82,"[74,84)",M,7,NA,2024-04-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2753,WD,82,"[74,84)",M,7,61.343213103764825,2024-04-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2754,SZ,59,"[44,64)",F,5,45.963362614747126,2024-04-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2755,RE,55,"[44,64)",F,6,NA,2024-04-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2756,BJ,84,"[84,Inf)",M,6,NA,2024-04-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2757,IM,63,"[44,64)",M,7,NA,2024-04-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2758,OQ,87,"[84,Inf)",M,6,NA,2024-04-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2759,AP,75,"[74,84)",M,6,NA,2024-04-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2760,WV,80,"[74,84)",M,5,39.47889017728938,2024-04-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2761,OL,70,"[64,74)",M,6,NA,2024-04-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2762,GI,63,"[44,64)",M,6,85.08771566778736,2024-04-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2763,WQ,61,"[44,64)",M,6,NA,2024-04-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2764,AO,86,"[84,Inf)",M,8,NA,2024-04-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2765,HO,70,"[64,74)",M,6,NA,2024-04-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2766,DU,66,"[64,74)",M,6,NA,2024-04-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2767,ZD,82,"[74,84)",M,8,NA,2024-04-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2768,FC,45,"[44,64)",M,4,NA,2024-04-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2769,AO,73,"[64,74)",M,8,NA,2024-04-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2770,DV,78,"[74,84)",M,6,NA,2024-04-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2771,LS,86,"[84,Inf)",M,7,NA,2024-04-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2772,OX,53,"[44,64)",M,6,NA,2024-04-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2773,NP,63,"[44,64)",M,6,NA,2024-04-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2774,DK,70,"[64,74)",F,8,87.5937906176732,2024-04-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2775,WO,78,"[74,84)",M,8,NA,2024-04-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2776,RO,60,"[44,64)",M,5,NA,2024-04-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2777,HA,57,"[44,64)",M,5,62.1683272803493,2024-04-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2778,CQ,68,"[64,74)",M,6,NA,2024-04-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2779,JS,79,"[74,84)",M,6,NA,2024-04-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2780,HO,30,"[14,44)",M,2,NA,2024-04-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2781,MJ,75,"[74,84)",M,6,NA,2024-04-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2782,WX,83,"[74,84)",F,6,NA,2024-04-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2783,HD,85,"[84,Inf)",M,8,NA,2024-04-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2784,FE,70,"[64,74)",F,6,NA,2024-04-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2785,QI,88,"[84,Inf)",M,7,NA,2024-04-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2786,CQ,80,"[74,84)",M,7,NA,2024-04-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2787,RE,55,"[44,64)",F,6,NA,2024-04-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2788,FD,87,"[84,Inf)",F,8,NA,2024-04-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2789,OD,83,"[74,84)",F,8,NA,2024-04-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2790,DR,53,"[44,64)",M,4,97.00876401491342,2024-04-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2791,AW,53,"[44,64)",M,5,NA,2024-04-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2792,DE,88,"[84,Inf)",M,7,NA,2024-04-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2793,AY,95,"[84,Inf)",M,9,NA,2024-04-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2794,PP,47,"[44,64)",M,5,NA,2024-04-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2795,WK,65,"[64,74)",F,5,NA,2024-04-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2796,VA,43,"[14,44)",F,3,NA,2024-04-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2797,YM,71,"[64,74)",F,7,NA,2024-04-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2798,NZ,88,"[84,Inf)",M,8,NA,2024-04-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2799,CM,87,"[84,Inf)",M,9,NA,2024-04-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2800,OX,65,"[64,74)",M,6,NA,2024-04-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2801,RS,77,"[74,84)",M,7,NA,2024-04-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2802,SI,57,"[44,64)",M,5,NA,2024-04-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2803,VR,80,"[74,84)",M,5,NA,2024-04-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2804,JP,89,"[84,Inf)",M,8,NA,2024-04-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2805,ME,60,"[44,64)",M,6,NA,2024-04-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2806,QT,89,"[84,Inf)",M,8,NA,2024-04-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2807,KU,91,"[84,Inf)",F,9,NA,2024-04-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2808,HT,78,"[74,84)",M,8,NA,2024-04-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2809,LK,86,"[84,Inf)",M,8,NA,2024-04-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2810,WT,85,"[84,Inf)",M,6,NA,2024-04-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2811,FN,79,"[74,84)",M,8,NA,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2812,LA,50,"[44,64)",M,6,NA,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2813,UX,85,"[84,Inf)",M,7,NA,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2814,YR,74,"[74,84)",M,8,NA,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2815,ZG,76,"[74,84)",M,8,NA,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2816,BU,57,"[44,64)",M,5,NA,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2817,UT,78,"[74,84)",M,8,43.858612806610736,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2818,DL,53,"[44,64)",M,5,NA,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2819,IC,56,"[44,64)",M,5,NA,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2820,XF,76,"[74,84)",M,8,NA,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2821,CQ,78,"[74,84)",F,6,NA,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2822,FG,66,"[64,74)",M,7,NA,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2823,WJ,70,"[64,74)",M,6,NA,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2824,SY,68,"[64,74)",M,5,NA,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2825,PD,83,"[74,84)",M,8,NA,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2826,VT,61,"[44,64)",M,5,122.98881822976463,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2827,QT,54,"[44,64)",M,5,64.82986518273373,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2828,YR,90,"[84,Inf)",M,8,NA,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2829,CS,81,"[74,84)",F,7,NA,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2830,EB,43,"[14,44)",F,5,NA,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2831,KH,75,"[74,84)",F,6,NA,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2832,SP,74,"[74,84)",M,7,NA,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2833,HY,71,"[64,74)",F,7,NA,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2834,KD,70,"[64,74)",M,8,NA,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2835,IC,58,"[44,64)",F,4,89.0801918531833,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2836,RO,84,"[84,Inf)",F,8,NA,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2837,TN,45,"[44,64)",F,4,NA,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2838,TF,77,"[74,84)",M,5,NA,2024-04-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2839,XY,66,"[64,74)",M,7,NA,2024-04-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2840,DU,48,"[44,64)",F,4,NA,2024-04-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2841,HQ,55,"[44,64)",M,4,NA,2024-04-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2842,KN,90,"[84,Inf)",M,8,33.37527363643299,2024-04-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2843,LN,69,"[64,74)",M,7,NA,2024-04-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2844,MU,73,"[64,74)",M,8,NA,2024-04-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2845,FB,75,"[74,84)",M,6,48.87027410986832,2024-04-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2846,PQ,80,"[74,84)",F,7,32.860452753488936,2024-04-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2847,OA,84,"[84,Inf)",M,8,NA,2024-04-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2848,KL,92,"[84,Inf)",F,8,NA,2024-04-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2849,HW,70,"[64,74)",M,5,NA,2024-04-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2850,AE,82,"[74,84)",F,7,NA,2024-04-27,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2851,YM,80,"[74,84)",M,7,NA,2024-04-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2852,IP,94,"[84,Inf)",M,7,NA,2024-04-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2853,DN,52,"[44,64)",F,6,NA,2024-04-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2854,WE,40,"[14,44)",F,4,NA,2024-04-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2855,OL,76,"[74,84)",M,8,NA,2024-04-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2856,VG,76,"[74,84)",F,8,NA,2024-04-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2857,HJ,52,"[44,64)",F,4,NA,2024-04-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2858,NO,67,"[64,74)",M,7,NA,2024-04-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2859,SM,37,"[14,44)",M,3,NA,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2860,JZ,51,"[44,64)",M,4,NA,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2861,TW,58,"[44,64)",M,5,NA,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2862,QF,85,"[84,Inf)",M,6,54.50936091291105,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2863,VS,0,"[0,1)",M,NA,NA,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2864,YN,58,"[44,64)",F,7,NA,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2865,WQ,77,"[74,84)",F,7,NA,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2866,MD,77,"[74,84)",M,8,NA,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2867,UZ,65,"[64,74)",M,6,NA,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2868,VF,48,"[44,64)",M,3,104.09166332519352,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2869,ZO,56,"[44,64)",M,5,NA,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2870,TT,1,"[1,14)",M,NA,NA,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2871,LP,1,"[1,14)",F,NA,NA,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2872,TK,78,"[74,84)",M,7,NA,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2873,EG,49,"[44,64)",M,4,NA,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2874,WL,95,"[84,Inf)",M,8,NA,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2875,QA,77,"[74,84)",M,5,NA,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2876,QH,61,"[44,64)",F,5,NA,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2877,FV,83,"[74,84)",M,7,NA,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2878,NP,76,"[74,84)",M,7,74.39099132111234,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2879,GB,71,"[64,74)",M,5,NA,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2880,HO,58,"[44,64)",F,7,NA,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2881,IR,47,"[44,64)",F,3,NA,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2882,HY,76,"[74,84)",M,7,48.49382282939791,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2883,AZ,82,"[74,84)",M,7,45.52046153791511,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2884,FX,74,"[74,84)",M,6,NA,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2885,TX,38,"[14,44)",M,3,NA,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2886,FB,81,"[74,84)",M,6,NA,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2887,OX,57,"[44,64)",F,5,55.37547352464807,2024-04-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2888,GF,65,"[64,74)",M,7,NA,2024-04-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2889,HX,62,"[44,64)",M,5,NA,2024-04-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2890,WO,0,"[0,1)",M,NA,NA,2024-04-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2891,CQ,65,"[64,74)",F,5,NA,2024-04-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2892,SA,61,"[44,64)",M,7,86.48465162244055,2024-04-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2893,SZ,73,"[64,74)",M,6,NA,2024-04-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2894,VD,50,"[44,64)",M,4,104.39436712246156,2024-04-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2895,VK,86,"[84,Inf)",M,8,NA,2024-04-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2896,JS,86,"[84,Inf)",M,7,NA,2024-04-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2897,QE,69,"[64,74)",F,6,NA,2024-04-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2898,YA,82,"[74,84)",M,7,NA,2024-04-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2899,GA,49,"[44,64)",M,4,NA,2024-04-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2900,GY,77,"[74,84)",F,8,NA,2024-04-29,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2901,JW,66,"[64,74)",M,6,NA,2024-04-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2902,ZR,67,"[64,74)",M,8,NA,2024-04-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2903,TK,88,"[84,Inf)",M,8,NA,2024-04-29,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2904,SY,30,"[14,44)",M,3,NA,2024-04-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2905,RW,0,"[0,1)",M,NA,NA,2024-04-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2906,KJ,92,"[84,Inf)",M,6,NA,2024-04-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2907,EM,44,"[44,64)",M,4,NA,2024-04-29,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2908,VD,55,"[44,64)",F,6,NA,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2909,PS,42,"[14,44)",M,5,NA,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2910,JV,40,"[14,44)",F,4,NA,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2911,II,64,"[64,74)",M,6,89.00945440003534,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2912,JF,70,"[64,74)",M,5,NA,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2913,HB,66,"[64,74)",M,7,80.2274354558692,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2914,WM,48,"[44,64)",F,6,NA,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2915,OZ,65,"[64,74)",M,6,NA,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2916,CY,46,"[44,64)",M,2,NA,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2917,IQ,90,"[84,Inf)",M,9,NA,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2918,UY,73,"[64,74)",M,6,NA,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2919,FR,81,"[74,84)",F,8,NA,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2920,OP,67,"[64,74)",M,8,NA,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2921,PJ,72,"[64,74)",F,5,NA,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2922,DG,81,"[74,84)",M,8,NA,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2923,TF,83,"[74,84)",M,8,NA,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2924,NV,51,"[44,64)",M,4,99.21825299221032,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2925,FU,43,"[14,44)",M,4,NA,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2926,UE,70,"[64,74)",M,6,NA,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2927,FQ,87,"[84,Inf)",M,8,53.696807204633984,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2928,ZF,88,"[84,Inf)",M,9,51.60851907452799,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2929,EE,59,"[44,64)",M,5,NA,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2930,EC,90,"[84,Inf)",F,8,NA,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2931,CS,47,"[44,64)",M,4,NA,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2932,CE,92,"[84,Inf)",F,8,NA,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2933,DZ,58,"[44,64)",F,5,NA,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2934,WF,82,"[74,84)",F,8,44.412843799862884,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2935,AM,69,"[64,74)",F,7,128.3691908110723,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2936,FQ,86,"[84,Inf)",M,7,NA,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2937,FY,53,"[44,64)",M,3,NA,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2938,ZW,69,"[64,74)",F,6,NA,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2939,CS,58,"[44,64)",M,5,NA,2024-04-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2940,VW,71,"[64,74)",F,7,83.27909866506555,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2941,DB,83,"[74,84)",F,7,NA,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2942,IC,80,"[74,84)",M,8,NA,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2943,ZX,48,"[44,64)",M,5,117.85107584279892,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2944,HE,60,"[44,64)",M,5,72.78142837357686,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2945,SI,80,"[74,84)",M,7,NA,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2946,TZ,88,"[84,Inf)",F,7,NA,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2947,LP,76,"[74,84)",M,7,NA,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2948,CP,49,"[44,64)",M,4,NA,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2949,FG,74,"[74,84)",F,7,NA,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2950,NF,86,"[84,Inf)",M,8,NA,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2951,RQ,75,"[74,84)",M,7,59.79071464182656,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2952,DY,76,"[74,84)",M,7,NA,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2953,DD,67,"[64,74)",F,6,112.04918846772051,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2954,HH,76,"[74,84)",M,7,NA,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2955,UI,82,"[74,84)",M,7,NA,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2956,EC,57,"[44,64)",M,5,NA,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2957,EK,58,"[44,64)",M,5,NA,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2958,AV,62,"[44,64)",M,6,NA,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2959,PE,68,"[64,74)",M,6,NA,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2960,QY,55,"[44,64)",M,5,NA,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2961,SI,73,"[64,74)",M,6,NA,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2962,VQ,36,"[14,44)",F,2,NA,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2963,YA,58,"[44,64)",F,5,NA,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2964,WE,75,"[74,84)",M,7,52.136698270403194,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2965,EH,92,"[84,Inf)",M,9,NA,2024-05-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2966,GS,72,"[64,74)",M,7,82.3604497512902,2024-05-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2967,IO,44,"[44,64)",M,6,NA,2024-05-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2968,EZ,66,"[64,74)",M,5,NA,2024-05-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2969,UC,63,"[44,64)",M,8,NA,2024-05-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2970,CP,81,"[74,84)",M,7,NA,2024-05-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2971,FF,58,"[44,64)",M,5,NA,2024-05-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2972,IR,84,"[84,Inf)",M,9,63.63952715676083,2024-05-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2973,OU,67,"[64,74)",M,6,NA,2024-05-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2974,TJ,76,"[74,84)",M,7,NA,2024-05-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2975,GR,72,"[64,74)",M,8,59.84013889632277,2024-05-02,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2976,YW,22,"[14,44)",M,3,NA,2024-05-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2977,YI,83,"[74,84)",F,8,NA,2024-05-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2978,NC,49,"[44,64)",M,5,NA,2024-05-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2979,EA,65,"[64,74)",M,6,NA,2024-05-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2980,ST,80,"[74,84)",M,8,75.93116193416962,2024-05-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2981,SK,77,"[74,84)",M,7,42.26983319136948,2024-05-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2982,ZQ,78,"[74,84)",F,5,NA,2024-05-02,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2983,JO,70,"[64,74)",M,5,NA,2024-05-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2984,GD,82,"[74,84)",M,6,NA,2024-05-02,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2985,AD,1,"[1,14)",M,NA,NA,2024-05-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2986,VC,67,"[64,74)",M,6,NA,2024-05-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2987,LK,53,"[44,64)",F,5,NA,2024-05-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2988,SB,61,"[44,64)",M,5,NA,2024-05-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2989,AK,53,"[44,64)",F,4,NA,2024-05-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2990,ZH,69,"[64,74)",F,7,NA,2024-05-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2991,LL,77,"[74,84)",F,6,NA,2024-05-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2992,UY,77,"[74,84)",M,7,NA,2024-05-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2993,GV,0,"[0,1)",F,NA,NA,2024-05-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2994,EY,51,"[44,64)",M,5,NA,2024-05-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2995,SB,60,"[44,64)",M,7,NA,2024-05-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2996,QD,66,"[64,74)",F,5,NA,2024-05-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2997,OF,81,"[74,84)",M,8,NA,2024-05-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2998,GG,96,"[84,Inf)",F,9,NA,2024-05-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
2999,MJ,52,"[44,64)",F,4,NA,2024-05-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3000,BE,66,"[64,74)",M,6,NA,2024-05-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3001,IO,46,"[44,64)",F,4,NA,2024-05-03,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3002,GG,87,"[84,Inf)",M,8,NA,2024-05-03,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3003,AR,70,"[64,74)",F,7,NA,2024-05-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3004,PD,65,"[64,74)",M,6,NA,2024-05-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3005,FP,75,"[74,84)",M,6,NA,2024-05-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3006,NL,90,"[84,Inf)",M,8,NA,2024-05-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3007,CL,90,"[84,Inf)",F,8,32.50184139525425,2024-05-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3008,KV,73,"[64,74)",M,6,NA,2024-05-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3009,DU,79,"[74,84)",M,6,NA,2024-05-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3010,UL,80,"[74,84)",F,7,27.509724897549706,2024-05-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3011,PQ,68,"[64,74)",F,5,NA,2024-05-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3012,BR,77,"[74,84)",M,6,NA,2024-05-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3013,HT,83,"[74,84)",F,7,NA,2024-05-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3014,FM,81,"[74,84)",M,7,NA,2024-05-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3015,GG,63,"[44,64)",M,5,82.18822098475668,2024-05-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3016,EP,58,"[44,64)",F,4,NA,2024-05-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3017,SI,68,"[64,74)",F,6,NA,2024-05-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3018,BQ,55,"[44,64)",M,4,99.7311077398942,2024-05-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3019,ZU,75,"[74,84)",M,6,51.482209726754036,2024-05-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3020,JF,90,"[84,Inf)",F,8,NA,2024-05-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3021,ER,52,"[44,64)",M,4,NA,2024-05-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3022,SA,78,"[74,84)",M,6,49.07466884393891,2024-05-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3023,UI,78,"[74,84)",M,8,NA,2024-05-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3024,SS,92,"[84,Inf)",M,8,NA,2024-05-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3025,JX,59,"[44,64)",F,6,NA,2024-05-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3026,DC,50,"[44,64)",M,4,NA,2024-05-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3027,XZ,77,"[74,84)",M,8,59.2680206450929,2024-05-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3028,FR,68,"[64,74)",M,7,NA,2024-05-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3029,VN,39,"[14,44)",M,3,NA,2024-05-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3030,NJ,66,"[64,74)",M,8,86.68569193222406,2024-05-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3031,LY,79,"[74,84)",M,7,NA,2024-05-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3032,BP,59,"[44,64)",F,5,NA,2024-05-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3033,EB,60,"[44,64)",F,5,NA,2024-05-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3034,DJ,75,"[74,84)",M,6,NA,2024-05-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3035,XZ,74,"[74,84)",M,5,NA,2024-05-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3036,KX,89,"[84,Inf)",M,8,NA,2024-05-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3037,LP,80,"[74,84)",M,7,NA,2024-05-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3038,DT,83,"[74,84)",F,7,NA,2024-05-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3039,ZQ,83,"[74,84)",M,7,NA,2024-05-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3040,KC,77,"[74,84)",M,6,NA,2024-05-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3041,CF,46,"[44,64)",M,4,NA,2024-05-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3042,HW,51,"[44,64)",M,6,NA,2024-05-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3043,SL,80,"[74,84)",M,7,NA,2024-05-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3044,NC,79,"[74,84)",M,8,NA,2024-05-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3045,WO,75,"[74,84)",M,4,NA,2024-05-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3046,UU,55,"[44,64)",M,5,88.9632792584767,2024-05-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3047,XJ,97,"[84,Inf)",M,9,NA,2024-05-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3048,EF,81,"[74,84)",M,6,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3049,XS,80,"[74,84)",M,7,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3050,PK,93,"[84,Inf)",M,8,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3051,RV,66,"[64,74)",F,6,133.71033581780523,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3052,WY,58,"[44,64)",F,4,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3053,WP,95,"[84,Inf)",M,6,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3054,GL,37,"[14,44)",M,3,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3055,LL,81,"[74,84)",F,9,41.32752670569702,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3056,XL,79,"[74,84)",M,6,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3057,VJ,65,"[64,74)",M,7,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3058,MK,78,"[74,84)",M,6,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3059,XW,84,"[84,Inf)",F,8,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3060,YA,65,"[64,74)",M,8,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3061,PT,0,"[0,1)",M,NA,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3062,XI,78,"[74,84)",F,6,52.39360989210025,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3063,WP,82,"[74,84)",M,9,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3064,KD,66,"[64,74)",M,5,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3065,VV,71,"[64,74)",M,6,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3066,MF,72,"[64,74)",M,6,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3067,RR,45,"[44,64)",M,4,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3068,ZU,31,"[14,44)",F,3,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3069,KS,58,"[44,64)",F,5,76.26108503928353,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3070,KC,81,"[74,84)",M,8,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3071,JO,57,"[44,64)",F,4,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3072,ZQ,64,"[64,74)",F,7,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3073,GC,89,"[84,Inf)",M,7,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3074,KD,80,"[74,84)",F,7,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3075,AR,91,"[84,Inf)",F,8,41.04037127662743,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3076,HO,73,"[64,74)",F,7,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3077,RK,52,"[44,64)",M,3,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3078,JX,84,"[84,Inf)",M,9,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3079,KY,81,"[74,84)",M,8,56.98411682866032,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3080,GL,59,"[44,64)",M,5,110.4529911604574,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3081,XG,82,"[74,84)",M,6,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3082,PF,83,"[74,84)",M,8,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3083,RJ,73,"[64,74)",M,5,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3084,WR,0,"[0,1)",M,NA,NA,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3085,JX,75,"[74,84)",M,8,69.83575924470018,2024-05-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3086,SY,51,"[44,64)",M,4,77.08206845706644,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3087,KB,90,"[84,Inf)",M,9,NA,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3088,GH,80,"[74,84)",M,7,NA,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3089,WB,66,"[64,74)",M,6,NA,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3090,BA,82,"[74,84)",M,7,NA,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3091,MR,72,"[64,74)",M,6,NA,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3092,JS,80,"[74,84)",F,7,NA,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3093,AL,0,"[0,1)",M,NA,NA,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3094,OS,80,"[74,84)",F,6,NA,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3095,XT,80,"[74,84)",M,8,NA,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3096,QI,99,"[84,Inf)",F,9,NA,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3097,TV,58,"[44,64)",M,6,NA,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3098,ME,83,"[74,84)",M,8,45.496012090184315,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3099,HZ,74,"[74,84)",F,7,NA,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3100,CD,47,"[44,64)",M,5,122.93295808662465,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3101,GF,73,"[64,74)",M,6,65.42765869941304,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3102,YV,85,"[84,Inf)",F,6,NA,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3103,BP,88,"[84,Inf)",M,8,NA,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3104,OH,78,"[74,84)",M,7,NA,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3105,ZQ,64,"[64,74)",F,6,NA,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3106,LZ,73,"[64,74)",F,7,NA,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3107,EI,48,"[44,64)",M,5,NA,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3108,NI,58,"[44,64)",F,5,73.9403254890147,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3109,PV,81,"[74,84)",F,8,NA,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3110,MZ,95,"[84,Inf)",M,8,NA,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3111,AQ,54,"[44,64)",M,5,NA,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3112,SA,51,"[44,64)",M,4,NA,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3113,SH,73,"[64,74)",M,6,NA,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3114,KC,65,"[64,74)",F,5,79.7924411873341,2024-05-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3115,FJ,53,"[44,64)",F,3,NA,2024-05-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3116,CB,63,"[44,64)",M,5,NA,2024-05-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3117,RK,91,"[84,Inf)",M,8,40.02072893085593,2024-05-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3118,NJ,78,"[74,84)",M,8,NA,2024-05-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3119,IW,56,"[44,64)",M,4,NA,2024-05-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3120,XU,78,"[74,84)",F,7,NA,2024-05-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3121,HL,59,"[44,64)",M,7,NA,2024-05-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3122,PZ,59,"[44,64)",F,5,NA,2024-05-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3123,MO,41,"[14,44)",F,4,NA,2024-05-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3124,LH,44,"[44,64)",M,4,NA,2024-05-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3125,MU,39,"[14,44)",M,4,NA,2024-05-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3126,TR,97,"[84,Inf)",M,8,37.45295579187577,2024-05-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3127,TZ,65,"[64,74)",F,5,121.64837140667142,2024-05-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3128,TT,77,"[74,84)",M,7,NA,2024-05-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3129,II,73,"[64,74)",M,6,NA,2024-05-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3130,EZ,63,"[44,64)",M,8,NA,2024-05-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3131,YL,58,"[44,64)",F,7,NA,2024-05-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3132,KJ,69,"[64,74)",F,7,NA,2024-05-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3133,YJ,81,"[74,84)",F,6,NA,2024-05-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3134,BI,85,"[84,Inf)",F,9,38.70142083687477,2024-05-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3135,HX,81,"[74,84)",F,8,NA,2024-05-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3136,CV,59,"[44,64)",F,6,NA,2024-05-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3137,LC,93,"[84,Inf)",M,9,NA,2024-05-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3138,XZ,48,"[44,64)",M,3,NA,2024-05-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3139,XQ,38,"[14,44)",F,5,NA,2024-05-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3140,VA,68,"[64,74)",M,5,NA,2024-05-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3141,YI,57,"[44,64)",M,5,80.07571580845851,2024-05-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3142,GM,80,"[74,84)",M,6,38.87517160863983,2024-05-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3143,FE,84,"[84,Inf)",M,6,NA,2024-05-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3144,MM,86,"[84,Inf)",M,8,NA,2024-05-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3145,QS,21,"[14,44)",M,2,NA,2024-05-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3146,MN,35,"[14,44)",M,2,NA,2024-05-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3147,QB,90,"[84,Inf)",M,7,NA,2024-05-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3148,GL,60,"[44,64)",M,6,NA,2024-05-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3149,WT,42,"[14,44)",M,2,96.15391257675373,2024-05-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3150,OM,68,"[64,74)",M,6,NA,2024-05-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3151,KA,91,"[84,Inf)",M,8,35.17609951259774,2024-05-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3152,QB,65,"[64,74)",F,7,133.66283405101197,2024-05-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3153,FP,92,"[84,Inf)",M,7,NA,2024-05-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3154,NS,78,"[74,84)",M,8,44.979350195887015,2024-05-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3155,UW,70,"[64,74)",F,5,NA,2024-05-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3156,XY,48,"[44,64)",M,5,NA,2024-05-10,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3157,HM,71,"[64,74)",M,7,NA,2024-05-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3158,BX,79,"[74,84)",F,6,NA,2024-05-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3159,TF,74,"[74,84)",M,6,NA,2024-05-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3160,PM,86,"[84,Inf)",F,6,NA,2024-05-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3161,ZI,43,"[14,44)",F,3,NA,2024-05-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3162,FP,75,"[74,84)",F,7,NA,2024-05-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3163,TW,51,"[44,64)",M,4,NA,2024-05-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3164,GE,58,"[44,64)",M,6,NA,2024-05-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3165,YU,58,"[44,64)",M,8,NA,2024-05-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3166,YU,79,"[74,84)",M,7,NA,2024-05-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3167,CH,78,"[74,84)",M,7,NA,2024-05-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3168,GO,84,"[84,Inf)",F,7,85.99160414712925,2024-05-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3169,GR,92,"[84,Inf)",M,7,NA,2024-05-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3170,NB,54,"[44,64)",F,5,NA,2024-05-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3171,NQ,69,"[64,74)",M,6,NA,2024-05-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3172,KP,56,"[44,64)",F,5,NA,2024-05-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3173,LQ,46,"[44,64)",M,7,NA,2024-05-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3174,QZ,73,"[64,74)",F,7,NA,2024-05-10,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3175,QC,79,"[74,84)",M,8,NA,2024-05-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3176,QA,40,"[14,44)",M,3,NA,2024-05-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3177,GH,66,"[64,74)",F,6,53.94864292851306,2024-05-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3178,VW,75,"[74,84)",M,7,65.70289843385328,2024-05-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3179,JL,61,"[44,64)",F,5,NA,2024-05-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3180,NG,77,"[74,84)",M,7,NA,2024-05-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3181,JV,53,"[44,64)",F,6,121.51520886502323,2024-05-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3182,UK,94,"[84,Inf)",M,7,NA,2024-05-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3183,DH,1,"[1,14)",F,NA,NA,2024-05-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3184,WL,71,"[64,74)",M,7,NA,2024-05-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3185,VY,46,"[44,64)",F,4,NA,2024-05-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3186,NS,1,"[1,14)",M,NA,NA,2024-05-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3187,NO,79,"[74,84)",M,8,NA,2024-05-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3188,DA,85,"[84,Inf)",M,8,NA,2024-05-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3189,JS,80,"[74,84)",M,8,NA,2024-05-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3190,OI,70,"[64,74)",F,7,NA,2024-05-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3191,KQ,56,"[44,64)",F,4,84.41008631035923,2024-05-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3192,TV,60,"[44,64)",M,6,NA,2024-05-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3193,MX,50,"[44,64)",M,6,NA,2024-05-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3194,RG,76,"[74,84)",M,7,NA,2024-05-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3195,TM,0,"[0,1)",M,NA,NA,2024-05-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3196,MA,69,"[64,74)",F,6,NA,2024-05-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3197,UB,91,"[84,Inf)",M,8,NA,2024-05-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3198,ZI,48,"[44,64)",F,5,69.63436689150858,2024-05-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3199,CK,70,"[64,74)",M,6,51.37242526675538,2024-05-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3200,BW,44,"[44,64)",M,4,NA,2024-05-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3201,NN,67,"[64,74)",M,7,NA,2024-05-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3202,HP,99,"[84,Inf)",F,7,121.79841504226259,2024-05-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3203,QK,72,"[64,74)",M,6,77.29775968380832,2024-05-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3204,TM,0,"[0,1)",M,NA,NA,2024-05-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3205,PE,46,"[44,64)",M,5,78.3580420061252,2024-05-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3206,VC,84,"[84,Inf)",M,7,NA,2024-05-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3207,YU,84,"[84,Inf)",M,8,60.423429896424814,2024-05-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3208,SY,93,"[84,Inf)",M,8,NA,2024-05-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3209,BW,92,"[84,Inf)",M,7,NA,2024-05-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3210,BS,83,"[74,84)",M,8,NA,2024-05-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3211,SX,44,"[44,64)",M,4,NA,2024-05-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3212,TJ,66,"[64,74)",M,6,NA,2024-05-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3213,GP,84,"[84,Inf)",M,8,NA,2024-05-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3214,GR,63,"[44,64)",F,5,NA,2024-05-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3215,TX,68,"[64,74)",M,7,NA,2024-05-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3216,AA,54,"[44,64)",F,5,95.27970706849936,2024-05-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3217,WT,57,"[44,64)",F,4,58.17837025678963,2024-05-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3218,FI,78,"[74,84)",M,6,NA,2024-05-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3219,KS,80,"[74,84)",M,7,NA,2024-05-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3220,HV,63,"[44,64)",M,6,NA,2024-05-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3221,MY,0,"[0,1)",M,NA,NA,2024-05-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3222,BV,91,"[84,Inf)",M,9,NA,2024-05-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3223,ES,1,"[1,14)",M,NA,NA,2024-05-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3224,WG,35,"[14,44)",F,4,NA,2024-05-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3225,LG,83,"[74,84)",F,7,NA,2024-05-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3226,BE,41,"[14,44)",M,1,NA,2024-05-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3227,WZ,62,"[44,64)",M,5,NA,2024-05-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3228,GG,77,"[74,84)",M,8,NA,2024-05-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3229,IZ,66,"[64,74)",M,4,NA,2024-05-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3230,VU,60,"[44,64)",M,3,NA,2024-05-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3231,NY,84,"[84,Inf)",F,8,NA,2024-05-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3232,ED,55,"[44,64)",F,5,103.92377293371668,2024-05-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3233,NH,41,"[14,44)",F,2,NA,2024-05-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3234,LT,86,"[84,Inf)",M,8,NA,2024-05-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3235,PH,93,"[84,Inf)",M,8,NA,2024-05-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3236,DY,92,"[84,Inf)",F,8,NA,2024-05-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3237,VD,81,"[74,84)",M,8,NA,2024-05-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3238,OA,71,"[64,74)",F,6,NA,2024-05-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3239,ON,76,"[74,84)",M,7,NA,2024-05-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3240,LM,70,"[64,74)",M,5,NA,2024-05-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3241,CU,68,"[64,74)",M,5,132.34348391644525,2024-05-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3242,FB,82,"[74,84)",M,7,NA,2024-05-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3243,KE,82,"[74,84)",M,8,NA,2024-05-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3244,BM,80,"[74,84)",M,7,49.297024216252616,2024-05-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3245,ZL,36,"[14,44)",F,3,NA,2024-05-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3246,KV,85,"[84,Inf)",F,8,51.05690303082983,2024-05-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3247,MG,70,"[64,74)",M,4,NA,2024-05-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3248,NC,68,"[64,74)",M,6,NA,2024-05-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3249,KP,81,"[74,84)",F,6,NA,2024-05-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3250,RC,63,"[44,64)",F,5,NA,2024-05-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3251,ZJ,91,"[84,Inf)",M,9,NA,2024-05-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3252,AN,53,"[44,64)",M,3,NA,2024-05-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3253,XW,53,"[44,64)",M,5,106.33045195929026,2024-05-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3254,HT,69,"[64,74)",F,5,89.21284957779874,2024-05-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3255,XT,66,"[64,74)",M,5,87.39565998914887,2024-05-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3256,KS,89,"[84,Inf)",F,7,NA,2024-05-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3257,IV,26,"[14,44)",F,1,NA,2024-05-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3258,PO,62,"[44,64)",M,4,NA,2024-05-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3259,IN,45,"[44,64)",M,4,NA,2024-05-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3260,NC,61,"[44,64)",M,6,NA,2024-05-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3261,KD,89,"[84,Inf)",M,8,NA,2024-05-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3262,VV,63,"[44,64)",F,6,NA,2024-05-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3263,TB,44,"[44,64)",M,3,NA,2024-05-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3264,MN,75,"[74,84)",M,5,NA,2024-05-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3265,KZ,84,"[84,Inf)",M,6,NA,2024-05-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3266,PE,40,"[14,44)",M,5,NA,2024-05-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3267,ZL,62,"[44,64)",M,6,NA,2024-05-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3268,WF,66,"[64,74)",M,6,NA,2024-05-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3269,VQ,64,"[64,74)",M,6,NA,2024-05-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3270,AH,52,"[44,64)",M,4,89.75636159851554,2024-05-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3271,QD,73,"[64,74)",M,8,NA,2024-05-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3272,YM,71,"[64,74)",F,6,NA,2024-05-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3273,QB,63,"[44,64)",M,5,NA,2024-05-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3274,MN,70,"[64,74)",M,6,NA,2024-05-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3275,GN,77,"[74,84)",M,7,NA,2024-05-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3276,DB,55,"[44,64)",F,6,NA,2024-05-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3277,KE,76,"[74,84)",F,6,NA,2024-05-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3278,KS,55,"[44,64)",M,5,NA,2024-05-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3279,GS,94,"[84,Inf)",M,9,NA,2024-05-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3280,HT,65,"[64,74)",F,6,NA,2024-05-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3281,MT,78,"[74,84)",M,8,NA,2024-05-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3282,VO,77,"[74,84)",M,7,NA,2024-05-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3283,LN,92,"[84,Inf)",M,9,NA,2024-05-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3284,YX,91,"[84,Inf)",M,8,NA,2024-05-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3285,DN,93,"[84,Inf)",M,8,NA,2024-05-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3286,TR,96,"[84,Inf)",F,6,NA,2024-05-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3287,KC,77,"[74,84)",M,7,NA,2024-05-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3288,DO,76,"[74,84)",M,6,NA,2024-05-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3289,MU,78,"[74,84)",F,8,NA,2024-05-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3290,RJ,83,"[74,84)",F,9,NA,2024-05-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3291,OX,83,"[74,84)",F,8,NA,2024-05-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3292,TB,73,"[64,74)",M,6,51.776780496303665,2024-05-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3293,NJ,85,"[84,Inf)",M,8,NA,2024-05-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3294,DD,56,"[44,64)",M,7,NA,2024-05-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3295,BJ,84,"[84,Inf)",M,8,NA,2024-05-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3296,DU,91,"[84,Inf)",M,8,32.094884224991304,2024-05-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3297,UN,78,"[74,84)",M,7,44.219152768057086,2024-05-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3298,FZ,59,"[44,64)",M,5,NA,2024-05-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3299,UE,85,"[84,Inf)",M,7,NA,2024-05-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3300,AR,1,"[1,14)",M,NA,NA,2024-05-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3301,ON,58,"[44,64)",M,7,NA,2024-05-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3302,QB,72,"[64,74)",F,7,NA,2024-05-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3303,JR,31,"[14,44)",F,3,NA,2024-05-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3304,BA,70,"[64,74)",F,7,NA,2024-05-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3305,ZW,49,"[44,64)",M,3,NA,2024-05-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3306,BN,79,"[74,84)",M,6,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3307,XT,70,"[64,74)",M,7,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3308,ZD,80,"[74,84)",F,7,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3309,BT,85,"[84,Inf)",F,9,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3310,LS,78,"[74,84)",F,7,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3311,RY,79,"[74,84)",F,8,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3312,FR,51,"[44,64)",M,5,113.48039940781031,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3313,ZJ,2,"[1,14)",M,NA,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3314,HQ,44,"[44,64)",F,3,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3315,AH,84,"[84,Inf)",F,8,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3316,GP,86,"[84,Inf)",M,9,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3317,SN,68,"[64,74)",M,5,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3318,UQ,86,"[84,Inf)",M,8,60.876205960797016,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3319,NP,55,"[44,64)",F,5,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3320,FB,59,"[44,64)",F,5,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3321,BF,74,"[74,84)",F,7,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3322,XS,60,"[44,64)",M,5,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3323,HU,55,"[44,64)",M,4,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3324,XK,66,"[64,74)",M,6,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3325,IR,82,"[74,84)",M,7,45.09115840436472,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3326,RO,97,"[84,Inf)",M,8,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3327,YN,24,"[14,44)",M,1,122.7557638041095,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3328,NB,69,"[64,74)",M,7,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3329,UM,0,"[0,1)",M,NA,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3330,DC,67,"[64,74)",M,7,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3331,YJ,79,"[74,84)",M,7,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3332,WP,82,"[74,84)",F,7,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3333,PP,38,"[14,44)",F,4,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3334,EA,63,"[44,64)",M,5,111.48267318125859,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3335,YF,69,"[64,74)",M,6,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3336,OG,48,"[44,64)",M,6,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3337,AF,62,"[44,64)",M,5,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3338,MP,50,"[44,64)",M,4,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3339,UA,71,"[64,74)",M,6,NA,2024-05-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3340,MG,94,"[84,Inf)",M,7,NA,2024-05-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3341,WV,54,"[44,64)",M,6,NA,2024-05-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3342,MP,57,"[44,64)",M,6,NA,2024-05-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3343,FR,87,"[84,Inf)",F,8,NA,2024-05-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3344,IL,94,"[84,Inf)",M,6,NA,2024-05-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3345,NP,49,"[44,64)",M,5,NA,2024-05-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3346,MT,58,"[44,64)",F,6,NA,2024-05-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3347,JG,71,"[64,74)",F,6,NA,2024-05-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3348,LP,38,"[14,44)",F,3,NA,2024-05-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3349,GM,61,"[44,64)",F,4,NA,2024-05-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3350,RA,78,"[74,84)",M,7,NA,2024-05-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3351,ZQ,84,"[84,Inf)",F,9,NA,2024-05-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3352,OD,57,"[44,64)",F,5,NA,2024-05-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3353,YR,63,"[44,64)",M,7,NA,2024-05-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3354,CG,71,"[64,74)",M,6,NA,2024-05-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3355,XO,87,"[84,Inf)",F,6,78.4548344205489,2024-05-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3356,NP,68,"[64,74)",M,6,NA,2024-05-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3357,QB,0,"[0,1)",M,NA,NA,2024-05-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3358,VG,57,"[44,64)",M,5,96.51489128656928,2024-05-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3359,BU,91,"[84,Inf)",M,7,NA,2024-05-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3360,VU,74,"[74,84)",M,6,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3361,QP,89,"[84,Inf)",F,6,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3362,KS,88,"[84,Inf)",M,8,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3363,SC,50,"[44,64)",M,6,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3364,ME,53,"[44,64)",F,6,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3365,GF,78,"[74,84)",F,5,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3366,JK,66,"[64,74)",F,6,90.20793063633124,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3367,JX,64,"[64,74)",M,6,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3368,OA,82,"[74,84)",M,9,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3369,AF,69,"[64,74)",F,4,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3370,ZG,80,"[74,84)",M,6,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3371,ZO,77,"[74,84)",M,8,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3372,RF,76,"[74,84)",M,6,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3373,PU,71,"[64,74)",F,6,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3374,BG,91,"[84,Inf)",M,8,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3375,NV,87,"[84,Inf)",F,8,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3376,ZM,81,"[74,84)",M,8,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3377,UG,71,"[64,74)",F,8,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3378,AU,65,"[64,74)",M,4,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3379,VA,67,"[64,74)",F,7,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3380,PL,40,"[14,44)",F,3,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3381,JV,62,"[44,64)",M,5,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3382,YG,66,"[64,74)",F,5,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3383,AZ,83,"[74,84)",F,9,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3384,OZ,76,"[74,84)",M,9,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3385,SM,80,"[74,84)",M,7,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3386,QF,77,"[74,84)",M,8,NA,2024-05-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3387,TQ,49,"[44,64)",M,5,NA,2024-05-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3388,BB,56,"[44,64)",F,5,NA,2024-05-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3389,RA,92,"[84,Inf)",M,7,45.83246442176762,2024-05-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3390,DI,74,"[74,84)",M,6,NA,2024-05-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3391,LF,62,"[44,64)",F,6,NA,2024-05-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3392,NN,58,"[44,64)",M,4,NA,2024-05-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3393,KB,59,"[44,64)",M,4,NA,2024-05-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3394,JL,88,"[84,Inf)",M,8,NA,2024-05-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3395,YF,52,"[44,64)",M,5,76.68210410071038,2024-05-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3396,YX,67,"[64,74)",M,7,NA,2024-05-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3397,AS,68,"[64,74)",F,8,NA,2024-05-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3398,HZ,89,"[84,Inf)",M,7,NA,2024-05-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3399,SZ,76,"[74,84)",M,6,NA,2024-05-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3400,SJ,68,"[64,74)",M,4,NA,2024-05-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3401,TK,72,"[64,74)",M,7,NA,2024-05-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3402,CU,48,"[44,64)",F,5,NA,2024-05-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3403,UC,66,"[64,74)",F,6,NA,2024-05-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3404,ZG,86,"[84,Inf)",M,9,NA,2024-05-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3405,IL,61,"[44,64)",M,6,NA,2024-05-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3406,ZZ,94,"[84,Inf)",M,8,NA,2024-05-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3407,AN,73,"[64,74)",M,7,89.16285883380145,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3408,VO,58,"[44,64)",M,6,NA,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3409,XR,99,"[84,Inf)",F,6,NA,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3410,OL,79,"[74,84)",M,8,NA,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3411,OJ,35,"[14,44)",M,6,NA,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3412,FI,28,"[14,44)",M,3,NA,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3413,RM,77,"[74,84)",M,7,NA,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3414,FB,90,"[84,Inf)",M,8,NA,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3415,DW,83,"[74,84)",M,8,36.411481264396805,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3416,NQ,76,"[74,84)",M,7,NA,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3417,PU,70,"[64,74)",M,8,NA,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3418,ZR,74,"[74,84)",M,7,89.24029136215309,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3419,EI,86,"[84,Inf)",M,7,NA,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3420,KG,66,"[64,74)",M,5,NA,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3421,TG,39,"[14,44)",F,4,NA,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3422,CS,75,"[74,84)",F,7,51.38979582070877,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3423,FM,62,"[44,64)",M,6,101.24719071492775,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3424,BS,1,"[1,14)",M,NA,NA,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3425,IO,82,"[74,84)",M,7,NA,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3426,US,81,"[74,84)",M,7,NA,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3427,CG,72,"[64,74)",F,8,93.44937479905226,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3428,AR,75,"[74,84)",M,6,NA,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3429,IG,76,"[74,84)",M,7,NA,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3430,QN,55,"[44,64)",F,6,NA,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3431,XY,64,"[64,74)",M,5,NA,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3432,HA,80,"[74,84)",M,8,NA,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3433,GW,91,"[84,Inf)",M,8,NA,2024-05-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3434,GZ,68,"[64,74)",F,6,NA,2024-05-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3435,HM,66,"[64,74)",M,6,NA,2024-05-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3436,LB,92,"[84,Inf)",F,8,41.026338234499086,2024-05-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3437,ZF,63,"[44,64)",F,5,NA,2024-05-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3438,VS,66,"[64,74)",F,6,NA,2024-05-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3439,CQ,78,"[74,84)",F,8,NA,2024-05-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3440,MD,85,"[84,Inf)",M,6,51.74927373644683,2024-05-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3441,RM,85,"[84,Inf)",F,7,NA,2024-05-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3442,HB,93,"[84,Inf)",M,7,NA,2024-05-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3443,OR,65,"[64,74)",F,6,NA,2024-05-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3444,LV,95,"[84,Inf)",M,9,32.64539376339158,2024-05-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3445,GC,78,"[74,84)",M,6,52.23368083266137,2024-05-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3446,PF,81,"[74,84)",F,7,NA,2024-05-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3447,ID,73,"[64,74)",M,7,103.60633200641128,2024-05-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3448,AK,58,"[44,64)",M,7,NA,2024-05-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3449,JC,78,"[74,84)",M,8,43.62332625242108,2024-05-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3450,RR,73,"[64,74)",M,7,115.82979989667415,2024-05-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3451,BP,57,"[44,64)",M,5,64.67975455299262,2024-05-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3452,ER,96,"[84,Inf)",F,8,26.15683707375309,2024-05-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3453,OX,88,"[84,Inf)",M,7,NA,2024-05-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3454,IC,77,"[74,84)",F,6,NA,2024-05-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3455,GQ,49,"[44,64)",F,4,NA,2024-05-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3456,WH,48,"[44,64)",F,4,NA,2024-05-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3457,GL,70,"[64,74)",F,7,NA,2024-05-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3458,WV,74,"[74,84)",F,8,71.50022996954576,2024-05-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3459,RT,84,"[84,Inf)",M,7,39.51411860902309,2024-05-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3460,IV,53,"[44,64)",F,5,124.69135960764415,2024-05-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3461,FF,83,"[74,84)",M,7,NA,2024-05-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3462,WM,46,"[44,64)",F,4,NA,2024-05-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3463,UE,96,"[84,Inf)",F,7,NA,2024-05-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3464,SH,86,"[84,Inf)",M,7,NA,2024-05-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3465,MX,61,"[44,64)",M,4,NA,2024-05-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3466,PY,62,"[44,64)",F,6,NA,2024-05-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3467,RZ,84,"[84,Inf)",M,8,43.549255884171004,2024-05-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3468,TK,76,"[74,84)",M,7,NA,2024-05-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3469,KC,42,"[14,44)",M,1,NA,2024-05-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3470,PT,39,"[14,44)",M,6,NA,2024-05-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3471,JP,69,"[64,74)",M,6,NA,2024-05-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3472,NP,62,"[44,64)",M,6,NA,2024-05-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3473,IX,53,"[44,64)",M,5,113.88428627583397,2024-05-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3474,EE,90,"[84,Inf)",M,7,45.31442956715204,2024-05-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3475,CC,66,"[64,74)",M,6,NA,2024-05-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3476,YE,82,"[74,84)",F,7,NA,2024-05-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3477,UK,75,"[74,84)",M,6,NA,2024-05-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3478,XM,51,"[44,64)",F,5,NA,2024-05-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3479,VP,63,"[44,64)",M,6,NA,2024-05-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3480,RW,71,"[64,74)",F,6,NA,2024-05-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3481,TK,94,"[84,Inf)",M,8,NA,2024-05-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3482,DC,65,"[64,74)",M,6,NA,2024-05-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3483,ZX,60,"[44,64)",M,4,NA,2024-05-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3484,JO,48,"[44,64)",M,3,NA,2024-05-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3485,UH,80,"[74,84)",F,7,NA,2024-05-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3486,EN,68,"[64,74)",M,4,NA,2024-05-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3487,JB,47,"[44,64)",M,5,NA,2024-05-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3488,SQ,96,"[84,Inf)",M,8,NA,2024-05-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3489,IG,89,"[84,Inf)",M,8,NA,2024-05-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3490,NA,95,"[84,Inf)",M,9,NA,2024-05-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3491,OW,90,"[84,Inf)",F,8,48.324972270936854,2024-05-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3492,IE,29,"[14,44)",F,3,NA,2024-05-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3493,SB,33,"[14,44)",F,2,NA,2024-05-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3494,EW,97,"[84,Inf)",M,6,NA,2024-05-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3495,OL,86,"[84,Inf)",M,8,NA,2024-05-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3496,HU,83,"[74,84)",F,8,NA,2024-05-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3497,SI,96,"[84,Inf)",F,9,26.44063810842028,2024-05-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3498,FB,61,"[44,64)",F,6,NA,2024-05-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3499,RB,54,"[44,64)",M,4,NA,2024-05-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3500,JN,53,"[44,64)",M,5,NA,2024-05-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3501,IU,78,"[74,84)",M,7,NA,2024-05-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3502,ZS,91,"[84,Inf)",M,7,NA,2024-05-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3503,ZT,59,"[44,64)",F,3,NA,2024-05-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3504,YC,82,"[74,84)",M,7,41.31050051597643,2024-05-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3505,MB,81,"[74,84)",M,7,NA,2024-05-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3506,UM,84,"[84,Inf)",M,7,NA,2024-05-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3507,HW,71,"[64,74)",F,8,NA,2024-05-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3508,QR,71,"[64,74)",M,7,NA,2024-05-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3509,ZO,33,"[14,44)",F,3,NA,2024-05-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3510,ZJ,71,"[64,74)",M,6,NA,2024-05-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3511,LG,56,"[44,64)",M,4,NA,2024-05-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3512,SQ,96,"[84,Inf)",M,7,NA,2024-05-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3513,YB,79,"[74,84)",M,7,48.438393752098584,2024-05-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3514,FX,47,"[44,64)",F,5,NA,2024-05-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3515,HZ,75,"[74,84)",M,6,52.95992650660706,2024-05-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3516,QZ,43,"[14,44)",F,3,NA,2024-05-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3517,YK,88,"[84,Inf)",M,8,NA,2024-05-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3518,MH,79,"[74,84)",M,9,NA,2024-05-26,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3519,DX,73,"[64,74)",F,6,NA,2024-05-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3520,ZJ,48,"[44,64)",M,3,NA,2024-05-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3521,SE,65,"[64,74)",M,5,NA,2024-05-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3522,RX,74,"[74,84)",M,7,NA,2024-05-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3523,JQ,55,"[44,64)",M,5,NA,2024-05-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3524,TH,54,"[44,64)",M,7,NA,2024-05-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3525,HR,42,"[14,44)",F,4,NA,2024-05-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3526,JC,87,"[84,Inf)",M,7,NA,2024-05-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3527,LP,77,"[74,84)",M,6,NA,2024-05-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3528,OC,56,"[44,64)",M,3,NA,2024-05-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3529,AS,79,"[74,84)",M,8,NA,2024-05-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3530,LM,61,"[44,64)",M,4,NA,2024-05-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3531,SL,59,"[44,64)",F,5,NA,2024-05-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3532,SH,61,"[44,64)",F,7,99.13881398131701,2024-05-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3533,KE,79,"[74,84)",M,7,NA,2024-05-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3534,RE,1,"[1,14)",M,NA,NA,2024-05-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3535,QA,70,"[64,74)",M,6,NA,2024-05-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3536,FP,74,"[74,84)",M,7,NA,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3537,JO,87,"[84,Inf)",M,8,NA,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3538,ZW,54,"[44,64)",M,5,NA,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3539,GX,79,"[74,84)",M,5,NA,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3540,JN,84,"[84,Inf)",M,5,49.83341808525359,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3541,SJ,46,"[44,64)",M,6,56.91382606929519,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3542,IE,71,"[64,74)",M,6,NA,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3543,AV,68,"[64,74)",M,6,NA,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3544,KS,58,"[44,64)",F,5,60.3051657914885,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3545,LH,73,"[64,74)",M,7,NA,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3546,YV,81,"[74,84)",M,8,43.053448424214935,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3547,BK,53,"[44,64)",M,3,NA,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3548,WM,93,"[84,Inf)",F,8,45.44824301970807,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3549,UD,47,"[44,64)",M,5,NA,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3550,LA,62,"[44,64)",F,7,58.78898607790563,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3551,ZB,88,"[84,Inf)",M,7,NA,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3552,NU,62,"[44,64)",F,6,NA,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3553,KM,51,"[44,64)",F,3,NA,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3554,UE,33,"[14,44)",M,4,116.54441534300108,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3555,AF,65,"[64,74)",F,6,86.70171349834608,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3556,ZQ,71,"[64,74)",F,6,NA,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3557,AQ,82,"[74,84)",M,6,NA,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3558,SP,87,"[84,Inf)",M,5,NA,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3559,VJ,95,"[84,Inf)",M,7,NA,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3560,WB,91,"[84,Inf)",F,8,NA,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3561,ES,85,"[84,Inf)",M,6,NA,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3562,CM,67,"[64,74)",M,7,NA,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3563,SC,87,"[84,Inf)",M,9,NA,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3564,OK,82,"[74,84)",M,8,NA,2024-05-27,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3565,PW,83,"[74,84)",M,8,60.0598289266583,2024-05-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3566,BB,85,"[84,Inf)",M,8,NA,2024-05-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3567,PU,62,"[44,64)",M,5,NA,2024-05-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3568,YS,59,"[44,64)",M,6,NA,2024-05-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3569,MG,72,"[64,74)",F,7,NA,2024-05-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3570,WZ,45,"[44,64)",M,3,96.54679339353504,2024-05-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3571,SX,51,"[44,64)",M,6,NA,2024-05-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3572,QL,82,"[74,84)",M,9,NA,2024-05-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3573,MG,44,"[44,64)",M,3,NA,2024-05-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3574,MO,68,"[64,74)",M,7,NA,2024-05-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3575,BU,73,"[64,74)",M,7,81.9874444137566,2024-05-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3576,EH,39,"[14,44)",M,3,NA,2024-05-28,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3577,TD,79,"[74,84)",M,5,NA,2024-05-28,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3578,YV,60,"[44,64)",M,5,NA,2024-05-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3579,KV,63,"[44,64)",F,6,NA,2024-05-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3580,SZ,72,"[64,74)",M,6,NA,2024-05-28,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3581,PH,70,"[64,74)",F,9,NA,2024-05-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3582,JC,54,"[44,64)",M,5,NA,2024-05-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3583,MA,83,"[74,84)",M,8,NA,2024-05-28,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3584,SO,72,"[64,74)",M,6,NA,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3585,PY,73,"[64,74)",M,9,NA,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3586,MZ,93,"[84,Inf)",F,8,NA,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3587,IW,35,"[14,44)",M,3,NA,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3588,PS,73,"[64,74)",M,5,NA,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3589,XA,50,"[44,64)",M,6,NA,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3590,RF,60,"[44,64)",M,5,72.10566374958846,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3591,LR,59,"[44,64)",M,6,NA,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3592,PQ,54,"[44,64)",M,6,NA,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3593,RE,51,"[44,64)",M,3,130.47411263698726,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3594,LK,73,"[64,74)",M,7,NA,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3595,MP,65,"[64,74)",M,5,60.2622915147256,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3596,AK,81,"[74,84)",F,6,NA,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3597,RO,94,"[84,Inf)",M,8,NA,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3598,XY,75,"[74,84)",M,7,53.12514271750628,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3599,BC,82,"[74,84)",M,6,NA,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3600,OM,35,"[14,44)",M,2,NA,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3601,YR,68,"[64,74)",F,6,NA,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3602,CH,47,"[44,64)",M,5,83.6319613780152,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3603,CW,53,"[44,64)",M,6,91.0105499988294,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3604,HQ,91,"[84,Inf)",M,9,NA,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3605,CV,88,"[84,Inf)",M,8,NA,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3606,PR,73,"[64,74)",F,6,NA,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3607,YS,89,"[84,Inf)",M,7,NA,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3608,ZO,87,"[84,Inf)",M,7,NA,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3609,YW,67,"[64,74)",F,8,NA,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3610,ZX,76,"[74,84)",M,9,NA,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3611,LZ,68,"[64,74)",F,7,NA,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3612,EB,52,"[44,64)",F,8,NA,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3613,PW,77,"[74,84)",M,5,NA,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3614,XT,69,"[64,74)",M,7,NA,2024-05-29,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3615,QL,71,"[64,74)",F,5,NA,2024-05-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3616,WO,77,"[74,84)",M,6,86.60276267121311,2024-05-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3617,QN,84,"[84,Inf)",F,7,NA,2024-05-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3618,IS,55,"[44,64)",M,3,120.828916448727,2024-05-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3619,JF,89,"[84,Inf)",F,9,NA,2024-05-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3620,SN,66,"[64,74)",M,5,NA,2024-05-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3621,SK,0,"[0,1)",M,NA,NA,2024-05-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3622,NF,97,"[84,Inf)",M,7,NA,2024-05-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3623,TG,66,"[64,74)",F,5,NA,2024-05-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3624,DP,34,"[14,44)",M,4,64.46030923541069,2024-05-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3625,BF,77,"[74,84)",M,8,NA,2024-05-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3626,CI,74,"[74,84)",M,8,77.7241590147708,2024-05-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3627,BI,85,"[84,Inf)",F,9,NA,2024-05-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3628,ZH,58,"[44,64)",F,6,NA,2024-05-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3629,MM,67,"[64,74)",F,5,NA,2024-05-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3630,FB,99,"[84,Inf)",F,9,NA,2024-05-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3631,UJ,79,"[74,84)",M,7,NA,2024-05-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3632,MX,48,"[44,64)",M,2,NA,2024-05-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3633,FT,46,"[44,64)",M,5,NA,2024-05-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3634,BX,66,"[64,74)",M,7,NA,2024-05-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3635,FG,64,"[64,74)",M,6,NA,2024-05-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3636,TF,94,"[84,Inf)",M,7,86.61319161715569,2024-05-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3637,AE,71,"[64,74)",M,7,NA,2024-05-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3638,NE,81,"[74,84)",M,7,NA,2024-05-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3639,HU,83,"[74,84)",M,5,NA,2024-05-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3640,YO,41,"[14,44)",F,4,NA,2024-05-31,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3641,YB,71,"[64,74)",M,6,NA,2024-05-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3642,HX,89,"[84,Inf)",F,9,NA,2024-05-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3643,NO,61,"[44,64)",M,5,84.53863156005019,2024-05-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3644,DM,25,"[14,44)",M,2,NA,2024-05-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3645,PW,89,"[84,Inf)",M,6,NA,2024-05-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3646,KP,72,"[64,74)",F,5,NA,2024-05-31,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3647,PM,91,"[84,Inf)",M,8,NA,2024-05-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3648,SI,36,"[14,44)",M,3,NA,2024-05-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3649,KP,70,"[64,74)",M,6,NA,2024-05-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3650,OP,53,"[44,64)",M,5,114.542999609897,2024-05-31,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3651,MR,70,"[64,74)",M,5,60.598536167911824,2024-05-31,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3652,SF,32,"[14,44)",M,3,NA,2024-05-31,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3653,YP,78,"[74,84)",F,9,NA,2024-05-31,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3654,UJ,42,"[14,44)",M,4,NA,2024-06-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3655,RR,34,"[14,44)",M,4,NA,2024-06-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3656,YJ,66,"[64,74)",M,5,NA,2024-06-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3657,XP,76,"[74,84)",M,5,NA,2024-06-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3658,QL,45,"[44,64)",F,3,NA,2024-06-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3659,YL,37,"[14,44)",F,2,NA,2024-06-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3660,NX,75,"[74,84)",M,7,104.44912198879678,2024-06-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3661,ST,39,"[14,44)",M,3,NA,2024-06-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3662,UK,44,"[44,64)",M,6,NA,2024-06-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3663,NT,43,"[14,44)",M,4,NA,2024-06-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3664,KV,48,"[44,64)",F,6,88.82381303872039,2024-06-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3665,BJ,53,"[44,64)",F,5,NA,2024-06-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3666,TW,66,"[64,74)",M,8,NA,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3667,SB,32,"[14,44)",M,3,NA,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3668,KR,51,"[44,64)",M,5,NA,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3669,IF,59,"[44,64)",F,6,NA,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3670,LW,89,"[84,Inf)",M,7,41.16297306799785,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3671,LE,94,"[84,Inf)",M,8,NA,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3672,VI,0,"[0,1)",M,NA,NA,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3673,EU,66,"[64,74)",F,6,NA,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3674,YV,50,"[44,64)",M,5,NA,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3675,CG,74,"[74,84)",M,7,70.77189433169697,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3676,ZW,74,"[74,84)",M,8,NA,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3677,CK,75,"[74,84)",M,7,NA,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3678,SC,89,"[84,Inf)",M,8,NA,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3679,QN,66,"[64,74)",M,6,NA,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3680,XP,73,"[64,74)",M,6,NA,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3681,QA,71,"[64,74)",M,7,NA,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3682,AH,35,"[14,44)",M,3,89.19292157225989,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3683,LA,56,"[44,64)",M,7,NA,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3684,MH,85,"[84,Inf)",M,8,NA,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3685,MS,84,"[84,Inf)",M,8,NA,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3686,IZ,81,"[74,84)",M,6,NA,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3687,PT,69,"[64,74)",F,7,NA,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3688,FY,83,"[74,84)",M,8,NA,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3689,AB,55,"[44,64)",F,5,NA,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3690,AI,86,"[84,Inf)",M,8,NA,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3691,ZD,68,"[64,74)",M,7,NA,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3692,BF,80,"[74,84)",F,7,NA,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3693,ZZ,85,"[84,Inf)",M,8,NA,2024-06-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3694,DT,78,"[74,84)",M,8,NA,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3695,LV,60,"[44,64)",M,6,NA,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3696,AN,57,"[44,64)",F,6,NA,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3697,PQ,55,"[44,64)",M,5,86.79525991132952,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3698,AZ,51,"[44,64)",F,6,NA,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3699,HA,40,"[14,44)",M,6,NA,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3700,NE,85,"[84,Inf)",M,5,NA,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3701,NS,65,"[64,74)",M,8,NA,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3702,BM,82,"[74,84)",M,8,NA,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3703,EX,68,"[64,74)",M,6,63.35685543268373,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3704,OW,73,"[64,74)",F,7,NA,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3705,VV,67,"[64,74)",M,8,93.44011017997512,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3706,FP,1,"[1,14)",M,NA,NA,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3707,BC,65,"[64,74)",M,6,69.30556969612432,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3708,MD,78,"[74,84)",M,7,89.60632997739317,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3709,MT,83,"[74,84)",M,8,52.03530163339701,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3710,JB,44,"[44,64)",M,2,NA,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3711,FC,26,"[14,44)",M,2,NA,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3712,RB,73,"[64,74)",M,5,92.4955862026143,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3713,FH,70,"[64,74)",F,6,NA,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3714,GT,93,"[84,Inf)",M,8,NA,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3715,NR,55,"[44,64)",F,6,NA,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3716,RE,56,"[44,64)",M,4,NA,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3717,QO,83,"[74,84)",M,7,NA,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3718,JU,72,"[64,74)",M,6,NA,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3719,IS,56,"[44,64)",M,4,NA,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3720,XS,74,"[74,84)",F,8,NA,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3721,JX,41,"[14,44)",M,3,NA,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3722,KP,45,"[44,64)",F,4,NA,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3723,FX,90,"[84,Inf)",M,7,NA,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3724,IJ,43,"[14,44)",M,2,NA,2024-06-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3725,PR,98,"[84,Inf)",F,9,23.67490282403564,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3726,BZ,53,"[44,64)",M,3,NA,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3727,KQ,94,"[84,Inf)",M,8,NA,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3728,PT,65,"[64,74)",F,6,NA,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3729,UZ,80,"[74,84)",M,7,NA,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3730,AE,95,"[84,Inf)",M,7,NA,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3731,MX,95,"[84,Inf)",M,8,NA,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3732,ZO,83,"[74,84)",M,8,50.16073391425521,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3733,SL,79,"[74,84)",F,6,NA,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3734,JD,29,"[14,44)",M,3,NA,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3735,ZC,52,"[44,64)",F,5,60.736274720838544,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3736,CR,55,"[44,64)",F,5,NA,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3737,PY,71,"[64,74)",F,7,NA,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3738,NS,69,"[64,74)",M,5,NA,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3739,RW,61,"[44,64)",F,6,NA,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3740,SB,89,"[84,Inf)",M,8,39.3321658291671,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3741,EP,22,"[14,44)",M,2,NA,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3742,CI,66,"[64,74)",F,6,NA,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3743,IL,73,"[64,74)",M,7,84.90774342804704,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3744,GV,77,"[74,84)",M,7,NA,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3745,NZ,66,"[64,74)",F,4,NA,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3746,KN,47,"[44,64)",F,3,NA,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3747,RH,66,"[64,74)",F,7,113.04846728821333,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3748,EH,68,"[64,74)",F,6,NA,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3749,QF,52,"[44,64)",M,4,NA,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3750,OC,78,"[74,84)",M,8,NA,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3751,LO,82,"[74,84)",M,7,NA,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3752,QQ,69,"[64,74)",M,4,NA,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3753,FK,67,"[64,74)",M,4,NA,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3754,IO,49,"[44,64)",M,3,104.29643707387984,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3755,CE,80,"[74,84)",M,7,NA,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3756,BT,48,"[44,64)",M,4,98.17850294903019,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3757,OX,81,"[74,84)",F,5,NA,2024-06-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3758,ES,80,"[74,84)",F,7,NA,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3759,DM,68,"[64,74)",M,7,125.02158049167372,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3760,AF,69,"[64,74)",M,7,NA,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3761,CL,83,"[74,84)",M,8,NA,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3762,BA,69,"[64,74)",F,8,111.97070003532502,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3763,LZ,56,"[44,64)",F,4,152.49025344048235,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3764,FQ,72,"[64,74)",M,4,NA,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3765,FP,44,"[44,64)",M,4,NA,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3766,TE,40,"[14,44)",M,5,NA,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3767,QD,65,"[64,74)",F,6,82.24573754176129,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3768,PB,46,"[44,64)",M,4,NA,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3769,MR,60,"[44,64)",F,6,NA,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3770,IO,3,"[1,14)",M,NA,NA,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3771,QN,82,"[74,84)",M,8,NA,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3772,EM,68,"[64,74)",M,8,NA,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3773,RN,69,"[64,74)",F,6,NA,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3774,FG,84,"[84,Inf)",M,7,NA,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3775,AI,46,"[44,64)",M,5,101.61268685503369,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3776,GP,91,"[84,Inf)",F,9,NA,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3777,TT,80,"[74,84)",M,8,NA,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3778,NJ,68,"[64,74)",M,6,66.45002588369474,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3779,KF,95,"[84,Inf)",F,9,NA,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3780,BT,74,"[74,84)",M,7,NA,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3781,PC,61,"[44,64)",M,6,NA,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3782,HB,43,"[14,44)",M,4,NA,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3783,OK,93,"[84,Inf)",M,9,NA,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3784,CL,58,"[44,64)",M,6,NA,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3785,VJ,75,"[74,84)",M,8,NA,2024-06-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3786,XW,86,"[84,Inf)",M,8,54.80803478603963,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3787,IF,69,"[64,74)",M,7,NA,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3788,HQ,79,"[74,84)",F,7,NA,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3789,HE,67,"[64,74)",M,5,NA,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3790,EN,48,"[44,64)",M,4,88.45162611056418,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3791,JG,74,"[74,84)",F,7,NA,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3792,JZ,93,"[84,Inf)",F,9,NA,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3793,QZ,78,"[74,84)",M,7,NA,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3794,BT,82,"[74,84)",M,7,NA,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3795,HS,63,"[44,64)",M,4,NA,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3796,BN,57,"[44,64)",M,5,NA,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3797,FH,71,"[64,74)",M,7,NA,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3798,LM,85,"[84,Inf)",M,6,NA,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3799,HV,57,"[44,64)",F,5,NA,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3800,NR,72,"[64,74)",F,5,NA,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3801,BD,85,"[84,Inf)",F,7,NA,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3802,TH,80,"[74,84)",F,8,NA,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3803,AN,80,"[74,84)",M,7,NA,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3804,ZU,62,"[44,64)",M,6,NA,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3805,AN,79,"[74,84)",M,7,NA,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3806,ZW,69,"[64,74)",F,7,NA,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3807,NM,66,"[64,74)",M,7,NA,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3808,OK,62,"[44,64)",F,5,NA,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3809,AK,75,"[74,84)",F,8,NA,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3810,EM,73,"[64,74)",F,7,NA,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3811,ZR,64,"[64,74)",M,5,NA,2024-06-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3812,PR,72,"[64,74)",F,8,NA,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3813,JD,79,"[74,84)",F,6,NA,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3814,XB,77,"[74,84)",M,5,NA,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3815,PD,86,"[84,Inf)",M,8,NA,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3816,FE,68,"[64,74)",M,8,NA,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3817,CQ,93,"[84,Inf)",M,9,NA,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3818,TB,0,"[0,1)",F,NA,NA,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3819,EF,83,"[74,84)",M,8,NA,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3820,XN,70,"[64,74)",M,7,NA,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3821,VD,96,"[84,Inf)",F,9,112.99808311013035,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3822,FO,81,"[74,84)",F,8,NA,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3823,CX,88,"[84,Inf)",M,8,63.296314842769426,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3824,FK,63,"[44,64)",F,6,NA,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3825,GD,91,"[84,Inf)",M,8,NA,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3826,OQ,76,"[74,84)",M,7,NA,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3827,CX,57,"[44,64)",M,6,NA,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3828,SZ,81,"[74,84)",M,7,55.0003151153259,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3829,LV,59,"[44,64)",M,7,NA,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3830,NT,73,"[64,74)",M,7,NA,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3831,TP,71,"[64,74)",F,6,NA,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3832,CE,78,"[74,84)",M,8,NA,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3833,WU,72,"[64,74)",M,6,NA,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3834,OI,96,"[84,Inf)",M,9,32.3757545131339,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3835,QZ,83,"[74,84)",M,7,NA,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3836,QM,75,"[74,84)",M,6,NA,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3837,QY,79,"[74,84)",M,8,NA,2024-06-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3838,PG,59,"[44,64)",M,4,NA,2024-06-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3839,DH,86,"[84,Inf)",M,8,NA,2024-06-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3840,BQ,69,"[64,74)",M,5,NA,2024-06-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3841,WV,66,"[64,74)",F,6,76.43220937050643,2024-06-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3842,WA,64,"[64,74)",M,5,59.90994209566755,2024-06-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3843,IY,66,"[64,74)",F,7,67.36905236356658,2024-06-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3844,AP,60,"[44,64)",F,7,NA,2024-06-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3845,IE,54,"[44,64)",M,4,NA,2024-06-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3846,HX,49,"[44,64)",M,5,NA,2024-06-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3847,PE,61,"[44,64)",F,4,NA,2024-06-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3848,IV,78,"[74,84)",M,6,NA,2024-06-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3849,RN,61,"[44,64)",F,8,NA,2024-06-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3850,AJ,92,"[84,Inf)",M,9,NA,2024-06-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3851,RV,82,"[74,84)",M,8,NA,2024-06-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3852,UF,83,"[74,84)",M,6,NA,2024-06-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3853,TG,71,"[64,74)",F,6,98.12793495359651,2024-06-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3854,HC,61,"[44,64)",M,5,NA,2024-06-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3855,FA,70,"[64,74)",F,4,NA,2024-06-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3856,QZ,92,"[84,Inf)",M,8,NA,2024-06-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3857,ZB,66,"[64,74)",M,7,NA,2024-06-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3858,DO,50,"[44,64)",F,5,NA,2024-06-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3859,EA,42,"[14,44)",M,4,NA,2024-06-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3860,CT,74,"[74,84)",F,6,NA,2024-06-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3861,ND,90,"[84,Inf)",M,6,NA,2024-06-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3862,YU,77,"[74,84)",M,6,NA,2024-06-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3863,ZH,22,"[14,44)",M,1,NA,2024-06-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3864,LS,86,"[84,Inf)",M,7,NA,2024-06-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3865,WO,63,"[44,64)",M,4,NA,2024-06-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3866,ZU,61,"[44,64)",M,6,83.24010451265694,2024-06-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3867,MK,73,"[64,74)",F,7,81.45769104850021,2024-06-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3868,HU,81,"[74,84)",M,8,NA,2024-06-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3869,ZA,30,"[14,44)",M,4,NA,2024-06-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3870,VM,60,"[44,64)",M,6,NA,2024-06-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3871,IG,60,"[44,64)",F,5,NA,2024-06-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3872,BE,60,"[44,64)",F,5,NA,2024-06-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3873,XG,79,"[74,84)",F,7,NA,2024-06-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3874,TF,84,"[84,Inf)",M,8,NA,2024-06-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3875,UY,55,"[44,64)",M,4,NA,2024-06-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3876,BD,64,"[64,74)",M,6,NA,2024-06-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3877,DD,91,"[84,Inf)",M,8,31.86652216509548,2024-06-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3878,HI,0,"[0,1)",M,NA,NA,2024-06-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3879,VU,80,"[74,84)",M,7,NA,2024-06-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3880,YA,62,"[44,64)",F,5,NA,2024-06-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3881,VY,88,"[84,Inf)",M,8,NA,2024-06-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3882,PM,86,"[84,Inf)",F,8,NA,2024-06-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3883,EC,91,"[84,Inf)",F,8,NA,2024-06-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3884,RP,66,"[64,74)",M,7,NA,2024-06-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3885,RM,80,"[74,84)",M,8,NA,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3886,JI,27,"[14,44)",M,2,NA,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3887,DK,67,"[64,74)",M,6,NA,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3888,GQ,82,"[74,84)",M,8,NA,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3889,PR,76,"[74,84)",F,5,NA,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3890,LY,23,"[14,44)",M,3,NA,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3891,IY,69,"[64,74)",M,5,NA,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3892,UC,60,"[44,64)",F,4,69.71646713865728,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3893,DN,66,"[64,74)",M,8,NA,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3894,CH,80,"[74,84)",F,9,NA,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3895,HP,52,"[44,64)",F,6,116.57622178003014,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3896,TV,68,"[64,74)",M,7,NA,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3897,BY,54,"[44,64)",M,6,NA,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3898,IJ,93,"[84,Inf)",M,9,NA,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3899,UX,92,"[84,Inf)",M,8,32.048504497288214,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3900,QO,29,"[14,44)",M,2,NA,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3901,IA,60,"[44,64)",F,5,131.7904086891558,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3902,XR,57,"[44,64)",M,6,NA,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3903,VX,49,"[44,64)",F,4,NA,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3904,SN,75,"[74,84)",M,8,NA,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3905,ET,61,"[44,64)",F,5,NA,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3906,DS,90,"[84,Inf)",M,8,NA,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3907,FJ,72,"[64,74)",M,7,NA,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3908,WV,86,"[84,Inf)",F,9,NA,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3909,GA,67,"[64,74)",M,5,NA,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3910,BN,66,"[64,74)",F,7,NA,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3911,AO,84,"[84,Inf)",M,8,NA,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3912,WY,69,"[64,74)",F,7,NA,2024-06-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3913,JR,2,"[1,14)",F,NA,NA,2024-06-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3914,ZF,74,"[74,84)",M,6,72.48089989493766,2024-06-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3915,IC,73,"[64,74)",F,7,51.27136443719736,2024-06-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3916,ML,83,"[74,84)",M,6,NA,2024-06-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3917,QK,78,"[74,84)",M,7,NA,2024-06-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3918,CL,60,"[44,64)",M,5,NA,2024-06-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3919,DW,74,"[74,84)",F,6,NA,2024-06-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3920,KE,86,"[84,Inf)",F,7,NA,2024-06-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3921,LW,90,"[84,Inf)",F,7,NA,2024-06-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3922,WT,54,"[44,64)",F,6,NA,2024-06-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3923,KK,42,"[14,44)",M,5,NA,2024-06-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3924,YX,71,"[64,74)",F,7,137.52819179930157,2024-06-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3925,EY,88,"[84,Inf)",M,8,NA,2024-06-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3926,WF,1,"[1,14)",F,NA,NA,2024-06-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3927,SJ,57,"[44,64)",F,6,NA,2024-06-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3928,GU,85,"[84,Inf)",M,8,NA,2024-06-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3929,CK,86,"[84,Inf)",F,8,29.044211771140127,2024-06-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3930,RR,48,"[44,64)",F,4,NA,2024-06-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3931,TU,76,"[74,84)",M,7,NA,2024-06-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3932,XJ,73,"[64,74)",M,5,NA,2024-06-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3933,JS,61,"[44,64)",M,6,NA,2024-06-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3934,CY,55,"[44,64)",M,4,NA,2024-06-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3935,LN,60,"[44,64)",M,5,NA,2024-06-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3936,ZL,71,"[64,74)",M,5,52.990662917022895,2024-06-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3937,WD,38,"[14,44)",M,6,NA,2024-06-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3938,AZ,54,"[44,64)",M,6,73.25872329938991,2024-06-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3939,XQ,2,"[1,14)",M,NA,NA,2024-06-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3940,LC,52,"[44,64)",M,4,86.02556059504744,2024-06-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3941,RD,96,"[84,Inf)",F,9,NA,2024-06-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3942,NQ,84,"[84,Inf)",M,6,NA,2024-06-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3943,FD,87,"[84,Inf)",M,6,NA,2024-06-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3944,XF,75,"[74,84)",M,6,NA,2024-06-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3945,DU,58,"[44,64)",F,6,NA,2024-06-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3946,NS,83,"[74,84)",M,7,NA,2024-06-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3947,YL,63,"[44,64)",F,5,50.56669406175838,2024-06-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3948,AM,61,"[44,64)",M,5,NA,2024-06-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3949,TA,42,"[14,44)",M,4,NA,2024-06-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3950,ZI,57,"[44,64)",M,5,NA,2024-06-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3951,DA,49,"[44,64)",M,5,118.17251806020118,2024-06-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3952,XY,88,"[84,Inf)",F,8,NA,2024-06-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3953,GB,72,"[64,74)",M,5,NA,2024-06-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3954,MN,84,"[84,Inf)",M,8,NA,2024-06-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3955,EU,50,"[44,64)",M,4,87.28650384555267,2024-06-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3956,SN,86,"[84,Inf)",F,7,NA,2024-06-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3957,NF,60,"[44,64)",M,5,87.51284861077185,2024-06-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3958,SB,87,"[84,Inf)",M,8,39.473176003406536,2024-06-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3959,AB,56,"[44,64)",F,4,NA,2024-06-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3960,ZQ,75,"[74,84)",M,7,NA,2024-06-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3961,EQ,86,"[84,Inf)",M,7,NA,2024-06-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3962,UF,70,"[64,74)",F,7,119.36661005304632,2024-06-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3963,IK,73,"[64,74)",M,7,74.28480345745999,2024-06-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3964,UV,68,"[64,74)",M,7,NA,2024-06-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3965,EW,59,"[44,64)",M,7,NA,2024-06-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3966,HO,58,"[44,64)",M,6,94.1931719530325,2024-06-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3967,KG,95,"[84,Inf)",M,8,NA,2024-06-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3968,NO,90,"[84,Inf)",M,8,NA,2024-06-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3969,SV,80,"[74,84)",F,7,NA,2024-06-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3970,PA,57,"[44,64)",M,4,NA,2024-06-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3971,CI,56,"[44,64)",F,6,NA,2024-06-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3972,RL,93,"[84,Inf)",M,8,NA,2024-06-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3973,IR,89,"[84,Inf)",M,9,NA,2024-06-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3974,TN,72,"[64,74)",F,5,85.83873104957571,2024-06-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3975,HA,74,"[74,84)",F,5,NA,2024-06-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3976,OO,26,"[14,44)",M,2,NA,2024-06-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3977,VK,88,"[84,Inf)",M,9,NA,2024-06-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3978,YR,80,"[74,84)",M,7,NA,2024-06-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3979,LG,81,"[74,84)",F,8,NA,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3980,OV,81,"[74,84)",F,8,NA,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3981,KC,96,"[84,Inf)",M,8,NA,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3982,BX,91,"[84,Inf)",M,8,NA,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3983,RJ,29,"[14,44)",M,1,NA,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3984,LF,73,"[64,74)",M,7,NA,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3985,XG,29,"[14,44)",M,2,NA,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3986,OT,69,"[64,74)",M,6,119.26394368011904,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3987,YA,58,"[44,64)",M,6,112.19420818081177,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3988,MM,76,"[74,84)",M,7,NA,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3989,AZ,53,"[44,64)",F,6,NA,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3990,HX,68,"[64,74)",M,4,NA,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3991,XI,56,"[44,64)",M,5,NA,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3992,TJ,76,"[74,84)",M,7,NA,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3993,BL,95,"[84,Inf)",M,7,NA,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3994,MA,65,"[64,74)",M,7,91.33364127925746,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3995,KW,90,"[84,Inf)",M,8,NA,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3996,GX,84,"[84,Inf)",M,8,NA,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3997,QH,87,"[84,Inf)",M,8,NA,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3998,JM,68,"[64,74)",M,5,NA,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
3999,XR,78,"[74,84)",F,7,NA,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4000,BI,70,"[64,74)",M,6,51.42927756957363,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4001,HT,40,"[14,44)",M,3,NA,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4002,XZ,92,"[84,Inf)",M,8,NA,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4003,MM,73,"[64,74)",M,7,NA,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4004,BM,72,"[64,74)",M,5,NA,2024-06-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4005,BD,1,"[1,14)",M,NA,NA,2024-06-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4006,NG,59,"[44,64)",M,6,NA,2024-06-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4007,RE,41,"[14,44)",M,4,84.27518115838978,2024-06-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4008,VG,77,"[74,84)",M,6,NA,2024-06-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4009,ZF,57,"[44,64)",M,5,NA,2024-06-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4010,UM,86,"[84,Inf)",M,8,NA,2024-06-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4011,BT,51,"[44,64)",F,3,NA,2024-06-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4012,LS,35,"[14,44)",M,3,NA,2024-06-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4013,IM,3,"[1,14)",M,NA,NA,2024-06-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4014,JO,86,"[84,Inf)",M,6,NA,2024-06-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4015,KA,85,"[84,Inf)",M,8,NA,2024-06-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4016,ZF,48,"[44,64)",M,4,NA,2024-06-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4017,NB,69,"[64,74)",M,8,NA,2024-06-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4018,GP,83,"[74,84)",M,8,NA,2024-06-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4019,QQ,72,"[64,74)",M,7,NA,2024-06-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4020,UN,76,"[74,84)",M,7,NA,2024-06-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4021,LU,47,"[44,64)",M,5,NA,2024-06-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4022,EF,67,"[64,74)",M,5,NA,2024-06-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4023,ZI,67,"[64,74)",M,7,NA,2024-06-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4024,QT,88,"[84,Inf)",F,9,NA,2024-06-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4025,GX,58,"[44,64)",M,4,NA,2024-06-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4026,WR,93,"[84,Inf)",F,9,NA,2024-06-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4027,BV,75,"[74,84)",M,6,NA,2024-06-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4028,GX,43,"[14,44)",F,4,NA,2024-06-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4029,JK,72,"[64,74)",F,7,NA,2024-06-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4030,EG,67,"[64,74)",M,5,NA,2024-06-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4031,WP,77,"[74,84)",M,7,NA,2024-06-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4032,HI,59,"[44,64)",F,5,52.764601499817196,2024-06-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4033,OZ,85,"[84,Inf)",M,8,NA,2024-06-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4034,AY,90,"[84,Inf)",M,9,NA,2024-06-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4035,QO,78,"[74,84)",F,8,NA,2024-06-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4036,YT,75,"[74,84)",M,7,49.46946757472799,2024-06-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4037,FC,88,"[84,Inf)",F,7,46.4845241335302,2024-06-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4038,XA,72,"[64,74)",M,7,NA,2024-06-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4039,QK,55,"[44,64)",M,5,73.37571409253941,2024-06-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4040,HC,55,"[44,64)",M,6,70.59064491505998,2024-06-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4041,XY,51,"[44,64)",M,3,NA,2024-06-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4042,UK,59,"[44,64)",F,7,NA,2024-06-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4043,SD,88,"[84,Inf)",M,8,NA,2024-06-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4044,NP,0,"[0,1)",M,NA,NA,2024-06-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4045,TR,48,"[44,64)",M,5,82.68937938369744,2024-06-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4046,KX,82,"[74,84)",F,7,NA,2024-06-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4047,TX,97,"[84,Inf)",M,8,NA,2024-06-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4048,RI,68,"[64,74)",F,7,NA,2024-06-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4049,XS,78,"[74,84)",F,7,NA,2024-06-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4050,WX,69,"[64,74)",M,5,NA,2024-06-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4051,NX,70,"[64,74)",F,6,NA,2024-06-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4052,YE,45,"[44,64)",M,4,NA,2024-06-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4053,NX,61,"[44,64)",M,4,NA,2024-06-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4054,KK,70,"[64,74)",F,7,NA,2024-06-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4055,MR,75,"[74,84)",M,8,NA,2024-06-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4056,PA,79,"[74,84)",M,8,61.15044754606195,2024-06-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4057,RA,61,"[44,64)",M,6,NA,2024-06-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4058,JV,61,"[44,64)",F,5,80.40363698083891,2024-06-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4059,KS,91,"[84,Inf)",M,9,NA,2024-06-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4060,WY,75,"[74,84)",F,8,NA,2024-06-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4061,PM,55,"[44,64)",F,6,62.976402047112515,2024-06-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4062,SG,66,"[64,74)",M,6,NA,2024-06-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4063,EI,86,"[84,Inf)",M,7,NA,2024-06-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4064,SA,85,"[84,Inf)",M,9,NA,2024-06-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4065,SA,40,"[14,44)",F,4,127.2913629137522,2024-06-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4066,GL,57,"[44,64)",M,6,NA,2024-06-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4067,VJ,74,"[74,84)",M,7,101.20505976749091,2024-06-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4068,TC,69,"[64,74)",M,5,62.90856378517828,2024-06-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4069,XX,44,"[44,64)",M,3,NA,2024-06-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4070,UB,92,"[84,Inf)",M,8,NA,2024-06-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4071,CJ,38,"[14,44)",M,3,NA,2024-06-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4072,KZ,88,"[84,Inf)",M,7,NA,2024-06-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4073,AQ,76,"[74,84)",M,5,NA,2024-06-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4074,FO,58,"[44,64)",M,5,70.528052171766,2024-06-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4075,KH,93,"[84,Inf)",F,9,NA,2024-06-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4076,CY,58,"[44,64)",F,6,NA,2024-06-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4077,VJ,89,"[84,Inf)",M,8,NA,2024-06-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4078,BN,73,"[64,74)",F,6,NA,2024-06-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4079,WU,93,"[84,Inf)",M,7,NA,2024-06-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4080,PR,94,"[84,Inf)",M,8,47.095019409073885,2024-06-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4081,WD,96,"[84,Inf)",M,9,29.65992477798255,2024-06-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4082,AL,97,"[84,Inf)",F,9,NA,2024-06-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4083,QD,83,"[74,84)",M,8,NA,2024-06-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4084,IU,60,"[44,64)",M,5,NA,2024-06-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4085,FU,64,"[64,74)",F,6,NA,2024-06-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4086,BR,84,"[84,Inf)",M,7,NA,2024-06-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4087,HF,52,"[44,64)",M,5,NA,2024-06-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4088,QQ,50,"[44,64)",M,4,NA,2024-06-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4089,BI,94,"[84,Inf)",M,8,NA,2024-06-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4090,MR,68,"[64,74)",F,6,NA,2024-06-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4091,RR,97,"[84,Inf)",M,9,NA,2024-06-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4092,SR,60,"[44,64)",F,6,NA,2024-06-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4093,HC,62,"[44,64)",M,5,NA,2024-06-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4094,XM,57,"[44,64)",F,5,NA,2024-06-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4095,VY,66,"[64,74)",F,6,NA,2024-06-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4096,FA,74,"[74,84)",F,7,NA,2024-06-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4097,RO,74,"[74,84)",M,7,58.66592150221627,2024-06-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4098,SF,87,"[84,Inf)",F,7,NA,2024-06-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4099,YN,51,"[44,64)",F,4,82.21054643986774,2024-06-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4100,HT,67,"[64,74)",F,8,79.14936791672137,2024-06-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4101,JA,71,"[64,74)",M,6,NA,2024-06-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4102,QE,55,"[44,64)",F,7,105.70774162458184,2024-06-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4103,FE,74,"[74,84)",M,7,NA,2024-06-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4104,QI,47,"[44,64)",M,5,NA,2024-06-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4105,CV,66,"[64,74)",F,5,NA,2024-06-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4106,GD,84,"[84,Inf)",M,6,46.051476005082336,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4107,XJ,71,"[64,74)",M,4,NA,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4108,RB,73,"[64,74)",F,6,NA,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4109,KF,48,"[44,64)",F,3,NA,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4110,HE,28,"[14,44)",M,2,NA,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4111,BY,72,"[64,74)",M,8,NA,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4112,LR,46,"[44,64)",F,5,NA,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4113,HS,84,"[84,Inf)",M,9,NA,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4114,PT,85,"[84,Inf)",M,7,49.72688410484157,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4115,DC,71,"[64,74)",M,7,NA,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4116,MF,86,"[84,Inf)",F,9,NA,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4117,ZC,67,"[64,74)",M,6,NA,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4118,OH,2,"[1,14)",M,NA,NA,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4119,AF,81,"[74,84)",M,9,NA,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4120,KS,56,"[44,64)",M,7,NA,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4121,UB,85,"[84,Inf)",M,7,52.15643501895146,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4122,NW,68,"[64,74)",M,6,NA,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4123,OV,47,"[44,64)",F,4,NA,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4124,KV,70,"[64,74)",F,6,NA,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4125,OR,74,"[74,84)",M,7,58.47015139347521,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4126,ND,42,"[14,44)",M,3,NA,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4127,RT,65,"[64,74)",M,6,NA,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4128,MO,70,"[64,74)",F,9,139.25501594566623,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4129,AD,82,"[74,84)",M,7,NA,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4130,ZO,41,"[14,44)",M,2,NA,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4131,FE,82,"[74,84)",M,8,37.25253625129858,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4132,ZP,67,"[64,74)",F,5,NA,2024-06-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4133,JW,96,"[84,Inf)",M,9,NA,2024-06-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4134,BF,40,"[14,44)",M,4,NA,2024-06-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4135,WU,73,"[64,74)",M,6,85.76171620425792,2024-06-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4136,XO,83,"[74,84)",F,8,NA,2024-06-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4137,MD,50,"[44,64)",M,4,NA,2024-06-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4138,SS,61,"[44,64)",F,5,NA,2024-06-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4139,QZ,46,"[44,64)",M,6,NA,2024-06-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4140,WC,74,"[74,84)",F,7,NA,2024-06-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4141,FK,67,"[64,74)",F,5,92.7406621348083,2024-06-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4142,YB,98,"[84,Inf)",M,9,50.04460992672751,2024-06-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4143,HM,51,"[44,64)",M,4,NA,2024-06-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4144,TY,70,"[64,74)",M,8,NA,2024-06-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4145,AC,66,"[64,74)",M,6,77.67357357994568,2024-06-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4146,KA,65,"[64,74)",F,6,NA,2024-06-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4147,QS,0,"[0,1)",M,NA,NA,2024-06-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4148,VC,77,"[74,84)",M,6,NA,2024-06-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4149,QK,66,"[64,74)",M,7,NA,2024-06-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4150,WW,71,"[64,74)",F,6,NA,2024-06-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4151,RT,42,"[14,44)",M,4,NA,2024-06-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4152,NO,77,"[74,84)",M,6,NA,2024-06-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4153,VX,67,"[64,74)",M,6,101.90694796855804,2024-06-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4154,FL,89,"[84,Inf)",M,7,NA,2024-06-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4155,SO,62,"[44,64)",F,5,120.80077303725817,2024-06-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4156,XP,58,"[44,64)",M,7,NA,2024-06-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4157,NC,70,"[64,74)",M,5,NA,2024-06-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4158,RN,89,"[84,Inf)",M,8,NA,2024-06-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4159,WV,77,"[74,84)",M,7,NA,2024-06-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4160,ZB,22,"[14,44)",M,1,NA,2024-06-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4161,AC,59,"[44,64)",M,6,NA,2024-06-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4162,EO,61,"[44,64)",M,6,63.92408935598935,2024-06-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4163,HE,55,"[44,64)",M,3,NA,2024-06-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4164,ZT,72,"[64,74)",F,6,NA,2024-06-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4165,NK,43,"[14,44)",M,4,NA,2024-06-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4166,LD,92,"[84,Inf)",M,7,NA,2024-06-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4167,MP,68,"[64,74)",M,7,NA,2024-06-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4168,KH,82,"[74,84)",M,8,NA,2024-06-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4169,GS,69,"[64,74)",M,7,NA,2024-06-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4170,LN,91,"[84,Inf)",M,9,NA,2024-06-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4171,ZI,86,"[84,Inf)",F,8,NA,2024-06-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4172,YP,74,"[74,84)",F,7,NA,2024-06-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4173,ZR,76,"[74,84)",F,7,NA,2024-06-23,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4174,RP,75,"[74,84)",M,6,70.87725684267794,2024-06-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4175,PC,69,"[64,74)",F,8,NA,2024-06-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4176,EL,51,"[44,64)",M,5,NA,2024-06-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4177,DZ,90,"[84,Inf)",M,8,NA,2024-06-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4178,WK,72,"[64,74)",F,7,NA,2024-06-23,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4179,PI,92,"[84,Inf)",F,7,NA,2024-06-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4180,XM,70,"[64,74)",M,9,81.70623500830331,2024-06-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4181,FS,87,"[84,Inf)",F,6,51.903669238775635,2024-06-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4182,AZ,84,"[84,Inf)",M,7,49.0349987010332,2024-06-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4183,LF,67,"[64,74)",M,5,NA,2024-06-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4184,JJ,90,"[84,Inf)",M,7,30.51066725183248,2024-06-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4185,CQ,67,"[64,74)",M,7,87.62777421634995,2024-06-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4186,ZE,82,"[74,84)",M,9,NA,2024-06-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4187,TS,75,"[74,84)",F,6,NA,2024-06-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4188,AQ,71,"[64,74)",M,6,NA,2024-06-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4189,HC,71,"[64,74)",F,4,NA,2024-06-23,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4190,NF,66,"[64,74)",M,6,NA,2024-06-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4191,NE,77,"[74,84)",M,6,NA,2024-06-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4192,PZ,48,"[44,64)",M,4,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4193,KM,50,"[44,64)",M,4,90.57956503399183,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4194,IB,76,"[74,84)",M,8,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4195,WK,90,"[84,Inf)",F,9,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4196,HN,82,"[74,84)",F,9,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4197,UN,63,"[44,64)",F,6,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4198,RR,86,"[84,Inf)",M,9,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4199,NQ,32,"[14,44)",M,3,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4200,NR,82,"[74,84)",M,6,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4201,EG,63,"[44,64)",F,7,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4202,WU,77,"[74,84)",M,8,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4203,AI,83,"[74,84)",F,6,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4204,RI,76,"[74,84)",F,9,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4205,KS,90,"[84,Inf)",M,9,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4206,JT,80,"[74,84)",M,7,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4207,CJ,85,"[84,Inf)",M,7,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4208,WS,53,"[44,64)",M,5,86.25173397635261,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4209,SS,79,"[74,84)",M,6,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4210,GO,87,"[84,Inf)",M,8,47.3398777001191,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4211,QR,33,"[14,44)",M,3,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4212,AB,89,"[84,Inf)",M,9,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4213,RY,70,"[64,74)",F,6,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4214,PM,86,"[84,Inf)",M,7,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4215,DL,84,"[84,Inf)",M,5,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4216,IE,79,"[74,84)",F,7,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4217,PE,74,"[74,84)",F,5,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4218,UJ,47,"[44,64)",M,3,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4219,TS,99,"[84,Inf)",F,8,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4220,FW,71,"[64,74)",F,7,NA,2024-06-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4221,WL,77,"[74,84)",F,6,NA,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4222,PT,61,"[44,64)",F,7,97.34274492041843,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4223,PS,54,"[44,64)",F,6,NA,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4224,UO,63,"[44,64)",M,5,NA,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4225,EW,0,"[0,1)",M,NA,NA,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4226,JK,59,"[44,64)",M,5,NA,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4227,FU,79,"[74,84)",M,6,NA,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4228,QU,70,"[64,74)",M,5,NA,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4229,UA,34,"[14,44)",M,4,NA,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4230,VD,34,"[14,44)",F,3,NA,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4231,QU,99,"[84,Inf)",F,9,NA,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4232,YR,70,"[64,74)",M,7,NA,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4233,ND,73,"[64,74)",M,7,NA,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4234,ON,49,"[44,64)",F,3,NA,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4235,MD,88,"[84,Inf)",F,9,NA,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4236,VJ,93,"[84,Inf)",M,9,NA,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4237,FS,34,"[14,44)",M,4,NA,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4238,JJ,78,"[74,84)",M,6,51.398867490914526,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4239,MQ,82,"[74,84)",M,8,NA,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4240,TD,67,"[64,74)",F,5,NA,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4241,SR,46,"[44,64)",M,4,NA,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4242,WN,65,"[64,74)",M,4,92.82583528734804,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4243,TE,58,"[44,64)",M,6,NA,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4244,MO,62,"[44,64)",F,3,NA,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4245,JT,67,"[64,74)",M,7,NA,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4246,FX,65,"[64,74)",F,7,NA,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4247,GY,78,"[74,84)",M,8,NA,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4248,IE,86,"[84,Inf)",F,7,76.36229679016087,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4249,KS,51,"[44,64)",M,5,NA,2024-06-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4250,ZA,81,"[74,84)",M,5,NA,2024-06-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4251,HD,95,"[84,Inf)",M,8,31.498335718670905,2024-06-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4252,AT,1,"[1,14)",M,NA,NA,2024-06-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4253,QQ,61,"[44,64)",M,6,80.4270728361519,2024-06-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4254,TH,84,"[84,Inf)",M,8,NA,2024-06-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4255,NG,72,"[64,74)",F,6,90.32396241194343,2024-06-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4256,MA,55,"[44,64)",F,5,119.3613323283754,2024-06-26,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4257,WI,74,"[74,84)",M,6,NA,2024-06-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4258,TB,70,"[64,74)",M,7,NA,2024-06-26,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4259,RU,77,"[74,84)",F,7,NA,2024-06-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4260,TD,48,"[44,64)",M,5,NA,2024-06-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4261,HV,90,"[84,Inf)",M,8,NA,2024-06-26,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4262,DU,66,"[64,74)",M,5,73.03855746261914,2024-06-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4263,ZE,63,"[44,64)",F,7,NA,2024-06-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4264,DL,43,"[14,44)",M,4,NA,2024-06-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4265,HJ,64,"[64,74)",F,6,NA,2024-06-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4266,QH,70,"[64,74)",F,5,NA,2024-06-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4267,IY,61,"[44,64)",F,6,NA,2024-06-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4268,DV,66,"[64,74)",F,7,101.00775324214855,2024-06-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4269,CF,23,"[14,44)",M,2,147.56381327722872,2024-06-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4270,IC,86,"[84,Inf)",M,9,NA,2024-06-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4271,YW,83,"[74,84)",F,7,NA,2024-06-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4272,TL,70,"[64,74)",M,8,NA,2024-06-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4273,RU,67,"[64,74)",F,6,NA,2024-06-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4274,GM,91,"[84,Inf)",M,9,NA,2024-06-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4275,GM,73,"[64,74)",M,7,NA,2024-06-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4276,VW,67,"[64,74)",M,6,NA,2024-06-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4277,LQ,68,"[64,74)",M,7,NA,2024-06-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4278,ZF,79,"[74,84)",M,8,NA,2024-06-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4279,YP,72,"[64,74)",M,7,72.51816502688435,2024-06-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4280,HT,71,"[64,74)",M,6,NA,2024-06-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4281,PM,60,"[44,64)",M,5,80.30004962234602,2024-06-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4282,CR,82,"[74,84)",M,8,NA,2024-06-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4283,HJ,92,"[84,Inf)",M,8,49.727309934382056,2024-06-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4284,OA,67,"[64,74)",M,5,NA,2024-06-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4285,JB,69,"[64,74)",F,5,68.73320000636578,2024-06-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4286,LB,68,"[64,74)",M,7,NA,2024-06-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4287,RM,86,"[84,Inf)",M,8,NA,2024-06-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4288,CX,85,"[84,Inf)",M,8,44.66218667645479,2024-06-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4289,UB,67,"[64,74)",F,7,59.063788650214484,2024-06-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4290,YH,74,"[74,84)",F,6,NA,2024-06-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4291,EA,68,"[64,74)",M,7,NA,2024-06-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4292,YB,58,"[44,64)",F,6,NA,2024-06-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4293,QD,74,"[74,84)",M,6,NA,2024-06-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4294,SO,32,"[14,44)",M,2,NA,2024-06-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4295,ZW,53,"[44,64)",F,5,NA,2024-06-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4296,RZ,79,"[74,84)",M,7,NA,2024-06-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4297,CH,68,"[64,74)",M,6,NA,2024-06-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4298,EJ,84,"[84,Inf)",F,9,32.43407065146496,2024-06-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4299,CN,75,"[74,84)",F,6,NA,2024-06-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4300,UU,89,"[84,Inf)",M,8,NA,2024-06-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4301,QB,51,"[44,64)",M,4,NA,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4302,AS,70,"[64,74)",M,6,NA,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4303,KG,50,"[44,64)",F,5,NA,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4304,SS,91,"[84,Inf)",M,8,NA,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4305,AV,43,"[14,44)",F,5,NA,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4306,KP,82,"[74,84)",M,7,NA,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4307,VU,77,"[74,84)",M,8,82.06149806799668,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4308,EE,2,"[1,14)",M,NA,NA,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4309,MH,86,"[84,Inf)",M,8,NA,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4310,YG,64,"[64,74)",M,7,NA,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4311,VI,85,"[84,Inf)",F,7,NA,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4312,VB,67,"[64,74)",M,6,NA,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4313,LJ,75,"[74,84)",M,7,NA,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4314,DA,60,"[44,64)",M,5,82.64608009383375,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4315,KK,69,"[64,74)",F,5,NA,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4316,YE,32,"[14,44)",M,2,107.64974471623474,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4317,HW,93,"[84,Inf)",F,9,NA,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4318,LQ,55,"[44,64)",M,5,NA,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4319,OR,65,"[64,74)",M,5,NA,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4320,RW,77,"[74,84)",M,8,NA,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4321,UW,70,"[64,74)",M,7,NA,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4322,EV,92,"[84,Inf)",M,6,NA,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4323,YV,77,"[74,84)",F,7,49.186491628536125,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4324,OJ,50,"[44,64)",M,3,NA,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4325,CQ,59,"[44,64)",M,6,126.12318754320589,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4326,SP,86,"[84,Inf)",M,7,NA,2024-06-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4327,WN,84,"[84,Inf)",F,8,NA,2024-06-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4328,FR,71,"[64,74)",M,6,NA,2024-06-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4329,VB,90,"[84,Inf)",F,7,NA,2024-06-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4330,EE,75,"[74,84)",M,7,56.25138516919025,2024-06-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4331,LJ,78,"[74,84)",M,7,NA,2024-06-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4332,AC,68,"[64,74)",M,5,NA,2024-06-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4333,PU,57,"[44,64)",M,6,NA,2024-06-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4334,KX,64,"[64,74)",F,6,64.29284434793033,2024-06-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4335,VQ,92,"[84,Inf)",M,9,NA,2024-06-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4336,YF,87,"[84,Inf)",M,9,35.79001693672549,2024-06-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4337,IN,67,"[64,74)",M,5,NA,2024-06-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4338,DN,56,"[44,64)",F,5,71.68161166336753,2024-06-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4339,OP,81,"[74,84)",F,7,NA,2024-06-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4340,DK,80,"[74,84)",F,5,NA,2024-06-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4341,EU,74,"[74,84)",F,5,NA,2024-06-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4342,BB,76,"[74,84)",M,7,NA,2024-06-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4343,TY,81,"[74,84)",M,8,NA,2024-06-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4344,XP,57,"[44,64)",F,4,68.11804398787201,2024-06-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4345,IV,81,"[74,84)",F,8,NA,2024-06-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4346,IR,80,"[74,84)",M,9,NA,2024-06-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4347,JD,63,"[44,64)",M,7,NA,2024-06-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4348,JJ,39,"[14,44)",M,2,NA,2024-06-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4349,TO,95,"[84,Inf)",M,9,NA,2024-06-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4350,KG,76,"[74,84)",F,7,50.40892748021106,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4351,NC,59,"[44,64)",M,6,63.1870750190347,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4352,DY,77,"[74,84)",M,7,NA,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4353,UE,87,"[84,Inf)",F,8,NA,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4354,GI,97,"[84,Inf)",F,7,NA,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4355,DS,56,"[44,64)",M,6,NA,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4356,SV,77,"[74,84)",M,8,NA,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4357,NU,1,"[1,14)",M,NA,NA,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4358,ZE,93,"[84,Inf)",M,9,NA,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4359,OO,74,"[74,84)",M,6,NA,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4360,QQ,72,"[64,74)",F,5,NA,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4361,MM,94,"[84,Inf)",M,7,NA,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4362,XW,66,"[64,74)",F,6,81.40830553935065,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4363,XS,83,"[74,84)",M,7,NA,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4364,OO,72,"[64,74)",F,8,NA,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4365,HY,58,"[44,64)",M,7,NA,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4366,SF,66,"[64,74)",M,6,NA,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4367,QP,78,"[74,84)",M,8,NA,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4368,YT,68,"[64,74)",M,5,66.40545036762467,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4369,NB,77,"[74,84)",M,6,NA,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4370,WJ,73,"[64,74)",M,7,NA,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4371,FA,86,"[84,Inf)",F,7,NA,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4372,VV,50,"[44,64)",M,5,NA,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4373,ZZ,90,"[84,Inf)",F,9,36.328732233483976,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4374,XK,64,"[64,74)",M,6,NA,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4375,IV,95,"[84,Inf)",M,9,NA,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4376,NW,77,"[74,84)",M,6,65.28482490028954,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4377,FX,69,"[64,74)",F,6,NA,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4378,DX,77,"[74,84)",M,7,NA,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4379,DP,65,"[64,74)",M,6,NA,2024-07-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4380,EF,90,"[84,Inf)",M,8,NA,2024-07-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4381,UJ,53,"[44,64)",F,6,NA,2024-07-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4382,SI,55,"[44,64)",M,5,NA,2024-07-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4383,JO,53,"[44,64)",M,5,NA,2024-07-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4384,NZ,70,"[64,74)",M,7,NA,2024-07-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4385,YH,74,"[74,84)",M,6,NA,2024-07-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4386,DO,90,"[84,Inf)",M,8,NA,2024-07-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4387,FY,78,"[74,84)",M,8,NA,2024-07-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4388,ES,79,"[74,84)",F,8,NA,2024-07-02,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4389,BM,80,"[74,84)",M,8,NA,2024-07-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4390,ZM,37,"[14,44)",M,3,NA,2024-07-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4391,BT,53,"[44,64)",M,5,NA,2024-07-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4392,GE,83,"[74,84)",F,8,NA,2024-07-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4393,MO,85,"[84,Inf)",M,8,NA,2024-07-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4394,PH,63,"[44,64)",M,6,NA,2024-07-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4395,HD,60,"[44,64)",M,7,NA,2024-07-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4396,JN,63,"[44,64)",M,7,NA,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4397,XT,77,"[74,84)",F,7,NA,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4398,OP,79,"[74,84)",F,7,NA,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4399,OQ,80,"[74,84)",M,6,65.7593819957014,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4400,GU,92,"[84,Inf)",M,9,NA,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4401,JA,69,"[64,74)",M,7,NA,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4402,RQ,77,"[74,84)",M,7,NA,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4403,RZ,88,"[84,Inf)",M,7,NA,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4404,ZE,62,"[44,64)",F,6,NA,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4405,PW,74,"[74,84)",M,5,NA,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4406,DL,66,"[64,74)",M,4,NA,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4407,LG,77,"[74,84)",F,7,55.97754702866563,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4408,VE,73,"[64,74)",M,7,NA,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4409,VT,85,"[84,Inf)",M,8,NA,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4410,AV,75,"[74,84)",M,6,NA,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4411,WK,96,"[84,Inf)",M,8,30.492344755180245,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4412,XP,68,"[64,74)",F,5,NA,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4413,IJ,90,"[84,Inf)",M,8,NA,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4414,EL,74,"[74,84)",F,6,NA,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4415,FN,80,"[74,84)",M,7,NA,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4416,EX,1,"[1,14)",M,NA,NA,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4417,ZP,69,"[64,74)",F,5,95.08045040244069,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4418,OF,90,"[84,Inf)",M,7,NA,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4419,XV,97,"[84,Inf)",M,8,NA,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4420,DY,76,"[74,84)",F,8,NA,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4421,YT,61,"[44,64)",M,5,74.66178017916484,2024-07-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4422,GO,89,"[84,Inf)",F,8,NA,2024-07-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4423,NC,91,"[84,Inf)",M,9,NA,2024-07-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4424,OE,91,"[84,Inf)",F,9,NA,2024-07-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4425,SI,95,"[84,Inf)",F,9,NA,2024-07-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4426,AP,67,"[64,74)",M,8,NA,2024-07-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4427,MH,39,"[14,44)",M,4,NA,2024-07-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4428,MB,79,"[74,84)",M,7,73.98638926473242,2024-07-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4429,NE,92,"[84,Inf)",M,8,NA,2024-07-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4430,WE,63,"[44,64)",F,6,NA,2024-07-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4431,GD,77,"[74,84)",M,8,45.35143972748178,2024-07-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4432,YQ,81,"[74,84)",M,7,NA,2024-07-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4433,GY,74,"[74,84)",F,8,NA,2024-07-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4434,AP,86,"[84,Inf)",F,9,NA,2024-07-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4435,VH,87,"[84,Inf)",M,9,38.10656353932691,2024-07-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4436,NX,84,"[84,Inf)",F,9,NA,2024-07-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4437,UZ,58,"[44,64)",F,5,NA,2024-07-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4438,WI,68,"[64,74)",M,7,NA,2024-07-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4439,MJ,83,"[74,84)",M,8,NA,2024-07-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4440,SP,70,"[64,74)",M,7,NA,2024-07-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4441,YM,41,"[14,44)",M,4,NA,2024-07-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4442,KT,48,"[44,64)",F,4,NA,2024-07-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4443,SU,2,"[1,14)",F,NA,NA,2024-07-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4444,AE,60,"[44,64)",M,4,98.74479047411963,2024-07-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4445,BT,66,"[64,74)",M,7,NA,2024-07-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4446,MR,68,"[64,74)",M,6,NA,2024-07-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4447,ZU,51,"[44,64)",M,3,93.66495171233758,2024-07-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4448,NB,75,"[74,84)",M,6,NA,2024-07-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4449,KN,59,"[44,64)",M,3,NA,2024-07-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4450,ZN,84,"[84,Inf)",M,8,NA,2024-07-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4451,SJ,75,"[74,84)",F,7,NA,2024-07-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4452,MC,62,"[44,64)",F,7,NA,2024-07-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4453,GQ,98,"[84,Inf)",F,9,NA,2024-07-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4454,EH,83,"[74,84)",M,8,40.73688839816046,2024-07-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4455,KB,67,"[64,74)",F,6,NA,2024-07-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4456,AM,82,"[74,84)",M,7,NA,2024-07-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4457,ZU,46,"[44,64)",M,3,NA,2024-07-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4458,ST,45,"[44,64)",M,3,NA,2024-07-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4459,QW,63,"[44,64)",M,5,NA,2024-07-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4460,YC,48,"[44,64)",M,6,NA,2024-07-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4461,AN,75,"[74,84)",M,7,NA,2024-07-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4462,TX,82,"[74,84)",M,7,48.15370907871788,2024-07-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4463,GQ,65,"[64,74)",M,7,NA,2024-07-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4464,ZZ,34,"[14,44)",M,4,77.97410247895765,2024-07-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4465,VZ,69,"[64,74)",M,6,NA,2024-07-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4466,QY,61,"[44,64)",M,4,NA,2024-07-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4467,FR,87,"[84,Inf)",M,9,50.398508535325604,2024-07-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4468,XZ,82,"[74,84)",M,7,NA,2024-07-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4469,AH,90,"[84,Inf)",M,9,34.58790302451068,2024-07-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4470,TX,73,"[64,74)",M,6,NA,2024-07-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4471,LZ,72,"[64,74)",M,7,NA,2024-07-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4472,SS,71,"[64,74)",M,6,NA,2024-07-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4473,WG,86,"[84,Inf)",F,7,NA,2024-07-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4474,YX,64,"[64,74)",F,5,NA,2024-07-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4475,PM,72,"[64,74)",M,7,NA,2024-07-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4476,XF,95,"[84,Inf)",F,8,NA,2024-07-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4477,BS,33,"[14,44)",F,4,NA,2024-07-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4478,AL,72,"[64,74)",F,7,NA,2024-07-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4479,JZ,60,"[44,64)",F,3,NA,2024-07-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4480,SO,58,"[44,64)",M,3,NA,2024-07-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4481,TH,58,"[44,64)",F,4,NA,2024-07-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4482,RA,49,"[44,64)",F,4,73.56126570885694,2024-07-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4483,NL,65,"[64,74)",F,6,96.33197364772498,2024-07-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4484,PA,49,"[44,64)",F,5,NA,2024-07-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4485,BP,38,"[14,44)",M,4,NA,2024-07-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4486,UF,34,"[14,44)",M,3,NA,2024-07-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4487,WX,83,"[74,84)",F,6,NA,2024-07-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4488,KJ,40,"[14,44)",M,5,NA,2024-07-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4489,HO,70,"[64,74)",M,6,NA,2024-07-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4490,NF,50,"[44,64)",M,4,67.6740954932591,2024-07-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4491,UB,95,"[84,Inf)",M,8,NA,2024-07-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4492,LJ,79,"[74,84)",M,5,NA,2024-07-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4493,WA,87,"[84,Inf)",M,8,NA,2024-07-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4494,KS,80,"[74,84)",M,7,NA,2024-07-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4495,IB,77,"[74,84)",M,7,NA,2024-07-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4496,PD,71,"[64,74)",M,5,93.62173178751327,2024-07-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4497,MN,73,"[64,74)",M,8,NA,2024-07-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4498,UT,91,"[84,Inf)",F,8,NA,2024-07-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4499,ST,76,"[74,84)",M,6,NA,2024-07-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4500,LL,0,"[0,1)",F,NA,NA,2024-07-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4501,XY,67,"[64,74)",M,5,NA,2024-07-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4502,VP,84,"[84,Inf)",M,9,NA,2024-07-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4503,WQ,90,"[84,Inf)",M,8,NA,2024-07-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4504,RR,72,"[64,74)",F,6,NA,2024-07-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4505,HA,83,"[74,84)",M,8,47.58255060238046,2024-07-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4506,GI,73,"[64,74)",F,7,115.34834708814218,2024-07-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4507,OO,51,"[44,64)",F,4,NA,2024-07-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4508,ET,67,"[64,74)",M,7,NA,2024-07-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4509,NK,84,"[84,Inf)",M,6,48.91808496293648,2024-07-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4510,JN,83,"[74,84)",F,7,NA,2024-07-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4511,DL,74,"[74,84)",M,8,NA,2024-07-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4512,UW,67,"[64,74)",F,4,NA,2024-07-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4513,DJ,84,"[84,Inf)",M,8,NA,2024-07-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4514,JK,60,"[44,64)",M,5,NA,2024-07-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4515,FA,61,"[44,64)",F,5,NA,2024-07-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4516,TH,81,"[74,84)",M,7,53.20509635157305,2024-07-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4517,KA,87,"[84,Inf)",M,9,NA,2024-07-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4518,DD,89,"[84,Inf)",M,6,NA,2024-07-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4519,ET,73,"[64,74)",F,7,NA,2024-07-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4520,KG,87,"[84,Inf)",F,6,NA,2024-07-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4521,QB,83,"[74,84)",M,7,NA,2024-07-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4522,GW,85,"[84,Inf)",M,8,NA,2024-07-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4523,RE,64,"[64,74)",M,5,NA,2024-07-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4524,BX,73,"[64,74)",M,7,NA,2024-07-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4525,TJ,1,"[1,14)",M,NA,NA,2024-07-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4526,HI,71,"[64,74)",M,7,NA,2024-07-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4527,TP,71,"[64,74)",M,9,NA,2024-07-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4528,OD,86,"[84,Inf)",M,6,NA,2024-07-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4529,HT,57,"[44,64)",F,3,NA,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4530,ZW,83,"[74,84)",F,8,113.8924426623365,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4531,MT,63,"[44,64)",M,5,NA,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4532,IS,70,"[64,74)",M,7,NA,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4533,QK,93,"[84,Inf)",M,8,47.73862645089471,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4534,TY,93,"[84,Inf)",M,8,NA,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4535,HN,90,"[84,Inf)",M,7,NA,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4536,HA,59,"[44,64)",F,4,NA,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4537,OT,62,"[44,64)",F,7,NA,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4538,YE,76,"[74,84)",F,6,48.63185282413123,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4539,OD,67,"[64,74)",F,5,NA,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4540,AS,62,"[44,64)",M,7,NA,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4541,KW,0,"[0,1)",M,NA,NA,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4542,RW,87,"[84,Inf)",M,8,48.68815460892904,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4543,SD,65,"[64,74)",M,6,NA,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4544,LU,61,"[44,64)",M,5,NA,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4545,LT,77,"[74,84)",F,6,NA,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4546,NB,82,"[74,84)",M,8,NA,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4547,FU,75,"[74,84)",F,6,NA,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4548,LB,2,"[1,14)",M,NA,NA,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4549,RK,40,"[14,44)",M,5,NA,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4550,NZ,91,"[84,Inf)",M,9,NA,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4551,YD,39,"[14,44)",M,3,116.44509400737812,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4552,NE,69,"[64,74)",M,5,NA,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4553,LD,71,"[64,74)",F,5,NA,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4554,AH,60,"[44,64)",M,5,NA,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4555,NS,68,"[64,74)",F,5,NA,2024-07-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4556,TX,68,"[64,74)",M,7,NA,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4557,VV,61,"[44,64)",M,7,NA,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4558,BF,85,"[84,Inf)",M,9,NA,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4559,OP,74,"[74,84)",M,7,NA,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4560,FF,61,"[44,64)",M,5,NA,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4561,ZJ,44,"[44,64)",F,4,69.51294175975201,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4562,SE,50,"[44,64)",F,4,NA,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4563,BG,31,"[14,44)",M,3,NA,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4564,NJ,86,"[84,Inf)",M,8,NA,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4565,ZR,59,"[44,64)",M,6,NA,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4566,LX,62,"[44,64)",M,6,NA,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4567,ON,79,"[74,84)",M,6,66.25177620520567,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4568,PB,33,"[14,44)",M,1,NA,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4569,QA,37,"[14,44)",M,3,NA,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4570,CD,54,"[44,64)",F,6,NA,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4571,LL,47,"[44,64)",M,5,NA,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4572,ZO,90,"[84,Inf)",M,8,NA,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4573,EZ,93,"[84,Inf)",F,8,NA,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4574,KF,89,"[84,Inf)",M,7,49.834857344659675,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4575,KP,59,"[44,64)",F,5,NA,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4576,JJ,59,"[44,64)",M,4,NA,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4577,UB,85,"[84,Inf)",M,7,NA,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4578,PH,58,"[44,64)",M,5,NA,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4579,BQ,41,"[14,44)",M,3,NA,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4580,II,56,"[44,64)",M,5,NA,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4581,GW,81,"[74,84)",M,9,58.218303491802004,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4582,QX,59,"[44,64)",M,5,NA,2024-07-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4583,NW,56,"[44,64)",M,7,NA,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4584,WS,50,"[44,64)",M,4,NA,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4585,MY,74,"[74,84)",M,7,NA,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4586,AQ,32,"[14,44)",M,5,NA,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4587,MQ,86,"[84,Inf)",F,8,NA,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4588,ET,81,"[74,84)",M,6,NA,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4589,UY,92,"[84,Inf)",M,9,NA,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4590,RK,63,"[44,64)",M,5,NA,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4591,YS,54,"[44,64)",M,5,76.34891880991134,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4592,XH,66,"[64,74)",F,5,NA,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4593,KG,86,"[84,Inf)",F,8,NA,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4594,TI,82,"[74,84)",M,8,NA,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4595,UH,70,"[64,74)",M,8,NA,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4596,JA,70,"[64,74)",M,6,NA,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4597,JV,62,"[44,64)",F,6,154.4008102284583,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4598,AV,61,"[44,64)",M,6,NA,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4599,TT,74,"[74,84)",M,8,NA,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4600,XM,70,"[64,74)",M,6,NA,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4601,OD,34,"[14,44)",M,5,NA,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4602,IJ,87,"[84,Inf)",M,7,NA,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4603,RR,94,"[84,Inf)",M,7,NA,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4604,IP,79,"[74,84)",M,7,NA,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4605,DD,87,"[84,Inf)",M,7,NA,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4606,DJ,78,"[74,84)",M,6,NA,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4607,VM,48,"[44,64)",M,3,NA,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4608,TT,83,"[74,84)",F,7,NA,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4609,NU,48,"[44,64)",F,3,NA,2024-07-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4610,GZ,59,"[44,64)",F,5,NA,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4611,LH,88,"[84,Inf)",M,9,NA,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4612,PC,66,"[64,74)",F,8,NA,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4613,LY,76,"[74,84)",F,5,NA,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4614,PN,97,"[84,Inf)",M,9,NA,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4615,UZ,71,"[64,74)",F,6,NA,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4616,NH,81,"[74,84)",M,7,NA,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4617,ME,79,"[74,84)",M,8,NA,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4618,UR,53,"[44,64)",M,6,NA,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4619,DB,73,"[64,74)",M,5,NA,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4620,DV,45,"[44,64)",M,3,NA,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4621,RO,92,"[84,Inf)",F,7,NA,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4622,SB,65,"[64,74)",M,6,90.41645715780115,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4623,HI,64,"[64,74)",F,6,NA,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4624,DW,59,"[44,64)",M,5,NA,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4625,YK,0,"[0,1)",F,NA,NA,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4626,OC,88,"[84,Inf)",M,8,NA,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4627,IL,75,"[74,84)",F,5,NA,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4628,EK,37,"[14,44)",M,5,NA,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4629,KF,65,"[64,74)",M,5,NA,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4630,HD,76,"[74,84)",M,7,48.36467242608331,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4631,AE,98,"[84,Inf)",M,8,NA,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4632,BW,67,"[64,74)",M,5,78.18781518354494,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4633,YF,55,"[44,64)",M,5,NA,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4634,DJ,80,"[74,84)",F,7,35.8408013666058,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4635,SZ,87,"[84,Inf)",M,7,51.48089323422301,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4636,AS,73,"[64,74)",M,8,84.84297994610186,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4637,JE,82,"[74,84)",F,8,NA,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4638,PX,36,"[14,44)",F,3,NA,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4639,RV,72,"[64,74)",M,6,NA,2024-07-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4640,UI,47,"[44,64)",F,5,NA,2024-07-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4641,TJ,80,"[74,84)",M,8,NA,2024-07-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4642,QN,67,"[64,74)",F,7,NA,2024-07-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4643,LU,0,"[0,1)",M,NA,NA,2024-07-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4644,NU,70,"[64,74)",M,8,NA,2024-07-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4645,XL,58,"[44,64)",M,6,NA,2024-07-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4646,BA,74,"[74,84)",M,7,95.15744365965486,2024-07-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4647,RB,65,"[64,74)",M,7,NA,2024-07-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4648,GR,22,"[14,44)",M,2,NA,2024-07-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4649,RX,70,"[64,74)",M,7,83.99788881152378,2024-07-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4650,KO,42,"[14,44)",M,4,NA,2024-07-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4651,VO,68,"[64,74)",M,5,89.23399965566561,2024-07-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4652,QP,85,"[84,Inf)",M,8,NA,2024-07-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4653,CJ,71,"[64,74)",F,6,NA,2024-07-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4654,JV,37,"[14,44)",M,4,NA,2024-07-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4655,GL,24,"[14,44)",F,2,NA,2024-07-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4656,BI,54,"[44,64)",F,6,NA,2024-07-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4657,XS,47,"[44,64)",M,3,86.51701021573494,2024-07-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4658,NU,36,"[14,44)",F,3,100.76837996213527,2024-07-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4659,DU,66,"[64,74)",M,6,NA,2024-07-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4660,NT,60,"[44,64)",M,4,NA,2024-07-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4661,TZ,81,"[74,84)",M,8,47.19626108435776,2024-07-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4662,OD,47,"[44,64)",M,4,NA,2024-07-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4663,YO,72,"[64,74)",M,5,NA,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4664,SV,55,"[44,64)",F,6,118.86731087619431,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4665,CQ,66,"[64,74)",M,6,NA,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4666,VB,77,"[74,84)",M,9,NA,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4667,SS,63,"[44,64)",F,7,117.15292571554419,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4668,HY,52,"[44,64)",M,4,NA,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4669,YO,67,"[64,74)",F,6,NA,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4670,OP,37,"[14,44)",F,2,NA,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4671,ZT,90,"[84,Inf)",F,9,29.551697116442785,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4672,QN,75,"[74,84)",F,6,NA,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4673,VD,70,"[64,74)",F,8,NA,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4674,VU,64,"[64,74)",F,6,NA,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4675,PP,58,"[44,64)",F,5,NA,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4676,QF,72,"[64,74)",M,6,NA,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4677,XB,52,"[44,64)",F,4,NA,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4678,XO,73,"[64,74)",M,7,NA,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4679,YX,57,"[44,64)",F,4,77.87281845024688,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4680,ZW,79,"[74,84)",F,7,NA,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4681,WZ,84,"[84,Inf)",M,7,NA,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4682,FT,85,"[84,Inf)",M,7,47.50842102490783,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4683,BN,93,"[84,Inf)",F,8,NA,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4684,UK,57,"[44,64)",M,6,NA,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4685,BF,69,"[64,74)",F,7,NA,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4686,XZ,59,"[44,64)",M,6,60.93643240621699,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4687,KT,2,"[1,14)",M,NA,NA,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4688,EB,98,"[84,Inf)",M,7,32.114952471439125,2024-07-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4689,YA,58,"[44,64)",F,6,NA,2024-07-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4690,PJ,60,"[44,64)",M,6,NA,2024-07-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4691,ZM,51,"[44,64)",M,4,NA,2024-07-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4692,TE,86,"[84,Inf)",M,7,NA,2024-07-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4693,GP,74,"[74,84)",M,8,75.82083261113962,2024-07-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4694,YE,64,"[64,74)",M,7,75.72023912798936,2024-07-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4695,TJ,32,"[14,44)",M,3,145.63155459756447,2024-07-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4696,TD,85,"[84,Inf)",M,8,NA,2024-07-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4697,WI,57,"[44,64)",F,6,NA,2024-07-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4698,HP,77,"[74,84)",M,9,NA,2024-07-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4699,KO,58,"[44,64)",M,5,102.47087280220398,2024-07-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4700,TQ,62,"[44,64)",M,5,NA,2024-07-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4701,XD,84,"[84,Inf)",F,8,80.67209087497771,2024-07-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4702,GB,71,"[64,74)",M,7,NA,2024-07-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4703,JD,56,"[44,64)",M,5,NA,2024-07-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4704,YM,81,"[74,84)",F,6,NA,2024-07-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4705,LV,45,"[44,64)",F,4,NA,2024-07-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4706,CL,59,"[44,64)",F,3,82.71635810331689,2024-07-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4707,OX,72,"[64,74)",M,7,58.53512276281974,2024-07-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4708,GM,45,"[44,64)",M,3,NA,2024-07-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4709,WW,63,"[44,64)",F,6,NA,2024-07-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4710,DZ,79,"[74,84)",F,8,41.355009101895725,2024-07-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4711,QD,85,"[84,Inf)",M,7,NA,2024-07-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4712,UV,69,"[64,74)",M,6,61.88963831525635,2024-07-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4713,QW,60,"[44,64)",M,3,NA,2024-07-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4714,CX,2,"[1,14)",M,NA,NA,2024-07-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4715,RX,70,"[64,74)",M,8,72.307059166867,2024-07-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4716,GG,71,"[64,74)",M,6,NA,2024-07-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4717,WP,78,"[74,84)",M,7,NA,2024-07-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4718,ED,88,"[84,Inf)",M,9,51.0861524157938,2024-07-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4719,LX,43,"[14,44)",F,4,NA,2024-07-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4720,VA,80,"[74,84)",M,7,NA,2024-07-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4721,UI,68,"[64,74)",F,6,82.68303703958719,2024-07-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4722,EM,88,"[84,Inf)",F,8,NA,2024-07-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4723,BN,93,"[84,Inf)",M,9,NA,2024-07-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4724,DH,80,"[74,84)",M,8,NA,2024-07-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4725,CG,77,"[74,84)",F,6,NA,2024-07-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4726,RP,68,"[64,74)",F,7,NA,2024-07-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4727,JA,93,"[84,Inf)",F,7,NA,2024-07-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4728,BL,87,"[84,Inf)",M,8,NA,2024-07-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4729,YZ,0,"[0,1)",F,NA,NA,2024-07-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4730,SF,70,"[64,74)",M,6,67.94560759140622,2024-07-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4731,ZN,63,"[44,64)",F,6,NA,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4732,TO,30,"[14,44)",M,2,NA,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4733,ZU,79,"[74,84)",F,7,NA,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4734,BD,74,"[74,84)",M,7,NA,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4735,OK,63,"[44,64)",F,5,NA,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4736,DG,81,"[74,84)",M,8,NA,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4737,AG,56,"[44,64)",M,6,NA,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4738,PS,76,"[74,84)",M,6,NA,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4739,HA,60,"[44,64)",F,6,NA,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4740,JP,52,"[44,64)",F,3,87.8112235627006,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4741,KV,98,"[84,Inf)",M,9,NA,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4742,EJ,76,"[74,84)",M,8,65.76636885414572,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4743,PK,53,"[44,64)",M,5,NA,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4744,US,57,"[44,64)",F,4,NA,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4745,CA,65,"[64,74)",M,6,NA,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4746,ME,68,"[64,74)",M,6,NA,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4747,WH,70,"[64,74)",F,7,NA,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4748,HF,83,"[74,84)",F,6,NA,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4749,FT,57,"[44,64)",M,5,NA,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4750,EX,76,"[74,84)",M,7,NA,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4751,DI,62,"[44,64)",F,4,NA,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4752,TI,85,"[84,Inf)",F,8,NA,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4753,WO,1,"[1,14)",M,NA,NA,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4754,XC,79,"[74,84)",F,8,NA,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4755,BY,93,"[84,Inf)",M,8,NA,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4756,SX,57,"[44,64)",F,5,64.47932609037926,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4757,HJ,80,"[74,84)",F,6,NA,2024-07-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4758,KH,92,"[84,Inf)",M,9,NA,2024-07-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4759,FY,48,"[44,64)",M,3,89.75903815221716,2024-07-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4760,UR,25,"[14,44)",M,3,NA,2024-07-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4761,EX,71,"[64,74)",M,6,NA,2024-07-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4762,IC,84,"[84,Inf)",F,8,NA,2024-07-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4763,DM,46,"[44,64)",M,4,NA,2024-07-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4764,EP,64,"[64,74)",M,6,NA,2024-07-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4765,EP,93,"[84,Inf)",M,9,NA,2024-07-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4766,AO,64,"[64,74)",M,4,62.59920787416551,2024-07-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4767,IY,40,"[14,44)",M,6,NA,2024-07-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4768,QD,0,"[0,1)",M,NA,NA,2024-07-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4769,LO,69,"[64,74)",M,6,NA,2024-07-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4770,FD,80,"[74,84)",M,8,50.53602666568791,2024-07-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4771,KA,80,"[74,84)",M,8,NA,2024-07-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4772,CZ,62,"[44,64)",M,4,NA,2024-07-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4773,GZ,98,"[84,Inf)",M,8,NA,2024-07-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4774,LU,99,"[84,Inf)",F,9,77.53706195305271,2024-07-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4775,MB,65,"[64,74)",F,6,NA,2024-07-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4776,CH,70,"[64,74)",M,7,NA,2024-07-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4777,DZ,57,"[44,64)",M,5,NA,2024-07-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4778,SJ,78,"[74,84)",M,7,57.30963014422471,2024-07-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4779,AW,84,"[84,Inf)",F,7,NA,2024-07-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4780,SH,71,"[64,74)",F,6,NA,2024-07-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4781,XS,87,"[84,Inf)",M,9,NA,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4782,YR,87,"[84,Inf)",F,7,NA,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4783,EO,57,"[44,64)",M,4,71.88362182874978,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4784,YL,75,"[74,84)",F,8,75.94113995144413,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4785,MH,74,"[74,84)",M,6,NA,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4786,VV,62,"[44,64)",F,7,44.32791684338946,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4787,AK,81,"[74,84)",M,7,NA,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4788,SR,87,"[84,Inf)",M,8,53.706033390607104,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4789,PX,85,"[84,Inf)",F,9,NA,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4790,DG,45,"[44,64)",F,4,NA,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4791,KS,0,"[0,1)",M,NA,NA,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4792,HU,80,"[74,84)",M,9,NA,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4793,KA,73,"[64,74)",F,7,33.21963493149512,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4794,BN,40,"[14,44)",F,2,108.69245361954316,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4795,EI,71,"[64,74)",F,8,49.249035923152434,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4796,YA,72,"[64,74)",M,7,NA,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4797,RY,55,"[44,64)",M,7,NA,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4798,FT,79,"[74,84)",M,7,NA,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4799,RT,59,"[44,64)",M,4,NA,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4800,FZ,66,"[64,74)",M,7,NA,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4801,RF,51,"[44,64)",M,3,NA,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4802,ZY,85,"[84,Inf)",M,7,41.77542399371329,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4803,MJ,81,"[74,84)",M,8,NA,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4804,CF,73,"[64,74)",M,7,NA,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4805,DG,55,"[44,64)",M,6,NA,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4806,ME,87,"[84,Inf)",F,8,NA,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4807,NP,68,"[64,74)",M,5,78.69646132144467,2024-07-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4808,CU,57,"[44,64)",M,6,NA,2024-07-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4809,LY,85,"[84,Inf)",M,9,NA,2024-07-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4810,TO,73,"[64,74)",F,6,NA,2024-07-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4811,DF,68,"[64,74)",M,5,NA,2024-07-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4812,TE,47,"[44,64)",M,3,NA,2024-07-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4813,FR,84,"[84,Inf)",M,7,NA,2024-07-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4814,AS,56,"[44,64)",M,3,NA,2024-07-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4815,WC,76,"[74,84)",M,5,NA,2024-07-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4816,UG,63,"[44,64)",F,5,NA,2024-07-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4817,FU,59,"[44,64)",M,4,NA,2024-07-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4818,CD,87,"[84,Inf)",F,7,NA,2024-07-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4819,LU,80,"[74,84)",M,6,48.04151651250025,2024-07-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4820,SI,48,"[44,64)",F,5,NA,2024-07-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4821,NL,66,"[64,74)",M,6,NA,2024-07-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4822,XP,63,"[44,64)",M,7,NA,2024-07-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4823,NT,52,"[44,64)",M,4,NA,2024-07-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4824,TC,71,"[64,74)",M,9,73.84713017862195,2024-07-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4825,HI,57,"[44,64)",M,5,NA,2024-07-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4826,OI,71,"[64,74)",M,7,NA,2024-07-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4827,NT,95,"[84,Inf)",M,9,NA,2024-07-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4828,FZ,70,"[64,74)",F,6,NA,2024-07-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4829,PN,65,"[64,74)",F,5,NA,2024-07-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4830,EZ,84,"[84,Inf)",M,7,NA,2024-07-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4831,FX,61,"[44,64)",F,6,NA,2024-07-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4832,KH,78,"[74,84)",M,8,44.411007649842496,2024-07-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4833,ED,87,"[84,Inf)",M,7,NA,2024-07-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4834,DX,98,"[84,Inf)",M,6,36.85441854707659,2024-07-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4835,XE,57,"[44,64)",M,6,NA,2024-07-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4836,KU,84,"[84,Inf)",M,7,NA,2024-07-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4837,KX,83,"[74,84)",M,5,46.00927152635813,2024-07-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4838,RI,58,"[44,64)",M,6,104.08411079793396,2024-07-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4839,OQ,67,"[64,74)",F,6,NA,2024-07-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4840,UA,73,"[64,74)",M,7,NA,2024-07-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4841,JD,91,"[84,Inf)",M,9,NA,2024-07-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4842,KW,86,"[84,Inf)",M,8,48.41592222018295,2024-07-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4843,DS,84,"[84,Inf)",M,7,NA,2024-07-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4844,VP,57,"[44,64)",F,4,NA,2024-07-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4845,JU,62,"[44,64)",F,5,NA,2024-07-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4846,XF,89,"[84,Inf)",F,7,NA,2024-07-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4847,YG,39,"[14,44)",F,2,71.42704936758159,2024-07-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4848,UK,81,"[74,84)",F,8,35.68755915128353,2024-07-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4849,TZ,89,"[84,Inf)",M,8,NA,2024-07-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4850,TY,67,"[64,74)",F,6,NA,2024-07-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4851,MV,66,"[64,74)",F,6,NA,2024-07-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4852,FH,68,"[64,74)",M,6,NA,2024-07-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4853,CE,95,"[84,Inf)",M,8,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4854,LT,88,"[84,Inf)",F,8,28.135414506822745,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4855,JD,53,"[44,64)",M,4,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4856,LY,66,"[64,74)",M,5,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4857,ZX,96,"[84,Inf)",M,9,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4858,ZZ,75,"[74,84)",M,8,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4859,SS,92,"[84,Inf)",M,9,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4860,TF,80,"[74,84)",M,7,41.948643841372764,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4861,HF,74,"[74,84)",M,6,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4862,RI,55,"[44,64)",M,5,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4863,DG,59,"[44,64)",M,6,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4864,DK,46,"[44,64)",F,5,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4865,XF,53,"[44,64)",F,5,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4866,HT,70,"[64,74)",M,8,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4867,FW,78,"[74,84)",M,7,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4868,US,63,"[44,64)",F,5,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4869,PZ,91,"[84,Inf)",M,8,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4870,MU,68,"[64,74)",M,7,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4871,ST,49,"[44,64)",F,4,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4872,VZ,57,"[44,64)",F,5,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4873,RB,60,"[44,64)",F,7,108.40945611064033,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4874,GY,58,"[44,64)",F,6,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4875,ZH,52,"[44,64)",F,5,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4876,ED,73,"[64,74)",M,7,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4877,NP,70,"[64,74)",F,7,76.1480969741979,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4878,ZH,77,"[74,84)",M,6,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4879,AG,79,"[74,84)",M,7,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4880,LH,85,"[84,Inf)",M,9,39.31762311326167,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4881,BE,75,"[74,84)",M,8,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4882,YP,64,"[64,74)",M,5,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4883,VU,70,"[64,74)",M,5,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4884,KS,80,"[74,84)",F,7,NA,2024-07-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4885,BF,52,"[44,64)",M,5,NA,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4886,HH,44,"[44,64)",F,3,NA,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4887,QG,62,"[44,64)",F,7,62.071736976237446,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4888,LW,67,"[64,74)",M,6,NA,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4889,XY,1,"[1,14)",M,NA,NA,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4890,LW,69,"[64,74)",M,8,NA,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4891,KW,87,"[84,Inf)",M,7,NA,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4892,WP,69,"[64,74)",M,7,NA,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4893,SS,55,"[44,64)",M,4,NA,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4894,BG,94,"[84,Inf)",M,9,46.14145558831167,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4895,VN,71,"[64,74)",F,7,NA,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4896,UY,76,"[74,84)",M,6,NA,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4897,KU,59,"[44,64)",M,5,77.32089155701995,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4898,MU,55,"[44,64)",F,5,122.74864444279024,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4899,IB,56,"[44,64)",M,5,NA,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4900,RI,67,"[64,74)",M,5,NA,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4901,BG,68,"[64,74)",M,6,64.08478043619874,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4902,EF,69,"[64,74)",F,6,NA,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4903,ZQ,71,"[64,74)",F,8,NA,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4904,LT,53,"[44,64)",M,5,NA,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4905,DN,56,"[44,64)",M,5,NA,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4906,BH,90,"[84,Inf)",M,7,NA,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4907,TW,56,"[44,64)",M,6,NA,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4908,FY,54,"[44,64)",F,3,58.51902445156107,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4909,EA,68,"[64,74)",F,5,NA,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4910,TT,92,"[84,Inf)",M,8,NA,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4911,VF,78,"[74,84)",F,6,NA,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4912,NW,81,"[74,84)",M,8,NA,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4913,NL,92,"[84,Inf)",F,9,NA,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4914,PW,47,"[44,64)",M,5,126.71684870038172,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4915,IJ,55,"[44,64)",M,4,66.99328224758767,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4916,DL,67,"[64,74)",F,6,NA,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4917,NO,71,"[64,74)",M,6,NA,2024-07-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4918,BM,96,"[84,Inf)",M,9,NA,2024-07-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4919,QP,45,"[44,64)",M,5,NA,2024-07-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4920,VL,76,"[74,84)",F,8,NA,2024-07-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4921,DU,71,"[64,74)",M,6,NA,2024-07-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4922,FG,78,"[74,84)",M,6,NA,2024-07-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4923,YW,68,"[64,74)",F,4,NA,2024-07-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4924,RR,53,"[44,64)",M,5,NA,2024-07-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4925,BX,99,"[84,Inf)",F,9,NA,2024-07-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4926,NN,74,"[74,84)",F,7,NA,2024-07-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4927,NJ,74,"[74,84)",M,4,NA,2024-07-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4928,LK,74,"[74,84)",M,7,NA,2024-07-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4929,TD,71,"[64,74)",F,4,NA,2024-07-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4930,OL,71,"[64,74)",F,7,NA,2024-07-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4931,TC,75,"[74,84)",M,8,NA,2024-07-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4932,LO,51,"[44,64)",F,4,NA,2024-07-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4933,EZ,47,"[44,64)",M,3,NA,2024-07-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4934,PT,67,"[64,74)",M,7,NA,2024-07-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4935,YB,68,"[64,74)",F,5,NA,2024-07-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4936,TU,97,"[84,Inf)",F,9,NA,2024-07-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4937,AS,88,"[84,Inf)",M,7,NA,2024-07-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4938,MI,79,"[74,84)",M,8,NA,2024-07-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4939,QF,64,"[64,74)",M,7,61.293139416147326,2024-07-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4940,SK,74,"[74,84)",M,7,NA,2024-07-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4941,DZ,94,"[84,Inf)",M,8,NA,2024-07-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4942,DP,75,"[74,84)",M,6,NA,2024-07-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4943,RQ,93,"[84,Inf)",M,8,NA,2024-07-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4944,HT,81,"[74,84)",M,7,NA,2024-07-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4945,SW,88,"[84,Inf)",M,8,NA,2024-07-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4946,IK,68,"[64,74)",M,5,NA,2024-07-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4947,ON,84,"[84,Inf)",M,8,NA,2024-07-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4948,TZ,77,"[74,84)",F,8,NA,2024-07-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4949,ST,77,"[74,84)",M,7,NA,2024-07-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4950,IL,77,"[74,84)",M,7,NA,2024-07-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4951,CD,68,"[64,74)",M,7,64.01206944348975,2024-07-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4952,PL,73,"[64,74)",M,6,NA,2024-07-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4953,VW,69,"[64,74)",M,5,NA,2024-07-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4954,RS,40,"[14,44)",M,3,NA,2024-07-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4955,DU,55,"[44,64)",M,5,NA,2024-07-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4956,QH,45,"[44,64)",F,5,NA,2024-07-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4957,UG,60,"[44,64)",F,6,NA,2024-07-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4958,SW,84,"[84,Inf)",M,8,50.59328858685556,2024-07-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4959,GL,70,"[64,74)",M,7,NA,2024-07-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4960,FL,88,"[84,Inf)",M,8,NA,2024-07-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4961,YV,72,"[64,74)",M,6,NA,2024-07-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4962,KU,79,"[74,84)",M,6,106.70868003034279,2024-07-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4963,QJ,71,"[64,74)",M,7,NA,2024-07-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4964,FI,37,"[14,44)",M,3,NA,2024-07-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4965,UG,84,"[84,Inf)",M,7,NA,2024-07-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4966,GW,66,"[64,74)",M,7,76.45018987011063,2024-07-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4967,AV,57,"[44,64)",M,5,NA,2024-07-26,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4968,TK,70,"[64,74)",M,5,NA,2024-07-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4969,UO,88,"[84,Inf)",M,8,NA,2024-07-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4970,YB,81,"[74,84)",M,9,NA,2024-07-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4971,EK,60,"[44,64)",M,4,NA,2024-07-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4972,WN,73,"[64,74)",M,7,NA,2024-07-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4973,MD,1,"[1,14)",M,NA,NA,2024-07-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4974,QU,84,"[84,Inf)",M,7,NA,2024-07-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4975,BY,60,"[44,64)",M,4,NA,2024-07-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4976,DF,78,"[74,84)",M,8,NA,2024-07-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4977,JP,53,"[44,64)",M,4,NA,2024-07-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4978,PG,70,"[64,74)",M,6,NA,2024-07-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4979,UB,40,"[14,44)",F,3,116.33962338026194,2024-07-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4980,HW,79,"[74,84)",M,6,NA,2024-07-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4981,LM,35,"[14,44)",M,1,NA,2024-07-26,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4982,AC,73,"[64,74)",F,7,87.15933568835224,2024-07-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4983,AL,54,"[44,64)",F,6,NA,2024-07-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4984,FM,44,"[44,64)",M,4,NA,2024-07-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4985,ZV,93,"[84,Inf)",F,7,75.8903827902642,2024-07-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4986,GS,53,"[44,64)",F,6,NA,2024-07-27,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4987,SS,62,"[44,64)",M,5,88.68768655031651,2024-07-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4988,AM,80,"[74,84)",M,8,NA,2024-07-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4989,RJ,76,"[74,84)",M,8,47.12654931255627,2024-07-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4990,JW,76,"[74,84)",F,8,NA,2024-07-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4991,OM,56,"[44,64)",F,4,NA,2024-07-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4992,XB,49,"[44,64)",M,6,NA,2024-07-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4993,XT,64,"[64,74)",M,5,NA,2024-07-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4994,FJ,95,"[84,Inf)",M,7,NA,2024-07-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4995,BF,63,"[44,64)",F,5,NA,2024-07-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4996,YL,91,"[84,Inf)",F,8,NA,2024-07-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4997,VC,73,"[64,74)",F,6,NA,2024-07-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4998,NC,57,"[44,64)",M,6,NA,2024-07-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
4999,TW,80,"[74,84)",M,7,43.52627914727444,2024-07-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5000,VJ,76,"[74,84)",M,7,NA,2024-07-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5001,RL,46,"[44,64)",M,4,NA,2024-07-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5002,NP,72,"[64,74)",M,6,82.08758771821371,2024-07-27,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5003,KQ,50,"[44,64)",M,5,NA,2024-07-27,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5004,GA,67,"[64,74)",M,5,NA,2024-07-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5005,TH,1,"[1,14)",M,NA,NA,2024-07-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5006,PT,55,"[44,64)",M,6,NA,2024-07-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5007,XX,77,"[74,84)",M,6,NA,2024-07-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5008,QC,52,"[44,64)",M,7,NA,2024-07-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5009,NS,73,"[64,74)",M,6,NA,2024-07-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5010,YV,65,"[64,74)",F,4,NA,2024-07-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5011,TN,87,"[84,Inf)",F,6,30.006841486221088,2024-07-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5012,JK,83,"[74,84)",M,8,NA,2024-07-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5013,BZ,76,"[74,84)",M,6,NA,2024-07-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5014,FC,64,"[64,74)",M,6,NA,2024-07-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5015,BD,42,"[14,44)",M,3,NA,2024-07-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5016,II,72,"[64,74)",F,8,NA,2024-07-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5017,YT,86,"[84,Inf)",M,7,53.615622431112904,2024-07-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5018,JB,89,"[84,Inf)",M,6,42.5274032281224,2024-07-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5019,MD,74,"[74,84)",M,7,NA,2024-07-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5020,LN,74,"[74,84)",M,6,NA,2024-07-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5021,VT,88,"[84,Inf)",M,7,NA,2024-07-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5022,WK,89,"[84,Inf)",M,7,NA,2024-07-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5023,AT,78,"[74,84)",M,7,NA,2024-07-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5024,UX,64,"[64,74)",F,7,NA,2024-07-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5025,EZ,79,"[74,84)",F,8,NA,2024-07-28,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5026,XF,68,"[64,74)",F,7,NA,2024-07-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5027,WA,75,"[74,84)",F,8,NA,2024-07-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5028,RX,96,"[84,Inf)",F,7,NA,2024-07-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5029,BU,51,"[44,64)",M,4,NA,2024-07-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5030,BZ,87,"[84,Inf)",M,6,NA,2024-07-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5031,RQ,85,"[84,Inf)",M,8,NA,2024-07-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5032,SX,87,"[84,Inf)",F,8,NA,2024-07-29,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5033,LW,50,"[44,64)",M,4,104.67275092732875,2024-07-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5034,BL,1,"[1,14)",M,NA,NA,2024-07-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5035,EP,77,"[74,84)",F,7,NA,2024-07-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5036,YS,83,"[74,84)",M,7,NA,2024-07-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5037,UD,45,"[44,64)",M,5,117.48457950740752,2024-07-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5038,YJ,75,"[74,84)",F,6,NA,2024-07-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5039,NF,72,"[64,74)",F,7,134.47260589403066,2024-07-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5040,OV,86,"[84,Inf)",F,9,NA,2024-07-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5041,NE,83,"[74,84)",F,7,NA,2024-07-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5042,GS,69,"[64,74)",M,6,NA,2024-07-29,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5043,GF,73,"[64,74)",M,6,NA,2024-07-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5044,KD,73,"[64,74)",M,7,NA,2024-07-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5045,SG,82,"[74,84)",F,7,NA,2024-07-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5046,JJ,82,"[74,84)",M,6,NA,2024-07-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5047,BJ,77,"[74,84)",F,8,NA,2024-07-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5048,XC,77,"[74,84)",M,9,NA,2024-07-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5049,JE,61,"[44,64)",M,5,NA,2024-07-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5050,GW,76,"[74,84)",M,7,NA,2024-07-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5051,OO,72,"[64,74)",M,6,87.00626914165292,2024-07-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5052,IG,86,"[84,Inf)",F,8,NA,2024-07-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5053,NE,45,"[44,64)",M,5,NA,2024-07-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5054,JK,77,"[74,84)",M,7,NA,2024-07-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5055,NY,51,"[44,64)",M,5,NA,2024-07-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5056,BR,59,"[44,64)",F,5,NA,2024-07-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5057,AS,91,"[84,Inf)",M,8,50.41435158897801,2024-07-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5058,YB,78,"[74,84)",F,6,76.07497197414028,2024-07-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5059,WI,62,"[44,64)",M,5,NA,2024-07-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5060,BO,62,"[44,64)",F,5,NA,2024-07-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5061,KA,84,"[84,Inf)",M,7,NA,2024-07-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5062,OG,95,"[84,Inf)",M,8,NA,2024-07-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5063,ZE,68,"[64,74)",M,4,NA,2024-07-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5064,CM,38,"[14,44)",M,2,NA,2024-07-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5065,BY,63,"[44,64)",M,7,79.35382517871243,2024-07-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5066,VU,59,"[44,64)",M,4,95.75745802412591,2024-07-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5067,CX,78,"[74,84)",M,7,NA,2024-07-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5068,EK,80,"[74,84)",M,8,NA,2024-07-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5069,PJ,81,"[74,84)",M,8,NA,2024-07-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5070,EZ,77,"[74,84)",M,7,NA,2024-07-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5071,ER,73,"[64,74)",M,7,78.90219355886515,2024-07-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5072,GY,72,"[64,74)",M,6,NA,2024-07-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5073,OG,69,"[64,74)",M,6,NA,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5074,CF,85,"[84,Inf)",F,8,NA,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5075,UX,38,"[14,44)",M,3,118.60194473997073,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5076,BC,65,"[64,74)",M,6,NA,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5077,WW,64,"[64,74)",M,7,NA,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5078,IM,93,"[84,Inf)",F,9,NA,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5079,OG,59,"[44,64)",M,5,NA,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5080,AO,78,"[74,84)",F,5,NA,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5081,NR,30,"[14,44)",M,5,NA,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5082,OU,80,"[74,84)",F,8,43.778220181997355,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5083,GB,72,"[64,74)",M,6,NA,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5084,FE,71,"[64,74)",M,6,NA,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5085,BC,82,"[74,84)",F,7,NA,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5086,LM,69,"[64,74)",M,6,100.53162305743014,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5087,SO,73,"[64,74)",M,6,NA,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5088,JD,49,"[44,64)",M,5,NA,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5089,IY,47,"[44,64)",F,4,67.55958317298268,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5090,NV,72,"[64,74)",F,8,NA,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5091,FX,49,"[44,64)",M,5,NA,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5092,XV,81,"[74,84)",F,8,NA,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5093,CZ,62,"[44,64)",M,6,NA,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5094,KG,85,"[84,Inf)",M,8,44.66899664855046,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5095,PC,65,"[64,74)",F,5,NA,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5096,UU,71,"[64,74)",F,7,55.759512355821776,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5097,AY,64,"[64,74)",F,7,NA,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5098,DL,60,"[44,64)",F,6,NA,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5099,MT,69,"[64,74)",M,6,NA,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5100,HX,77,"[74,84)",M,8,NA,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5101,XN,64,"[64,74)",M,5,NA,2024-07-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5102,CC,49,"[44,64)",M,7,NA,2024-08-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5103,OK,82,"[74,84)",M,8,NA,2024-08-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5104,WU,67,"[64,74)",M,6,NA,2024-08-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5105,JJ,59,"[44,64)",M,5,NA,2024-08-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5106,OD,60,"[44,64)",F,6,NA,2024-08-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5107,OX,71,"[64,74)",M,5,NA,2024-08-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5108,GU,100,"[84,Inf)",F,9,NA,2024-08-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5109,WQ,57,"[44,64)",F,4,57.18106077013883,2024-08-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5110,HI,61,"[44,64)",M,7,NA,2024-08-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5111,CD,72,"[64,74)",F,6,NA,2024-08-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5112,ZS,56,"[44,64)",M,3,NA,2024-08-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5113,TU,63,"[44,64)",M,6,NA,2024-08-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5114,IE,92,"[84,Inf)",M,9,NA,2024-08-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5115,DR,75,"[74,84)",F,7,NA,2024-08-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5116,PH,81,"[74,84)",M,7,NA,2024-08-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5117,YU,67,"[64,74)",M,7,NA,2024-08-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5118,RS,75,"[74,84)",F,7,NA,2024-08-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5119,RG,91,"[84,Inf)",M,8,NA,2024-08-02,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5120,RR,52,"[44,64)",M,4,92.58505468480861,2024-08-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5121,RH,77,"[74,84)",M,7,NA,2024-08-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5122,KX,90,"[84,Inf)",M,9,39.9512921304541,2024-08-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5123,ZH,90,"[84,Inf)",M,9,NA,2024-08-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5124,NK,85,"[84,Inf)",M,7,43.809825263446115,2024-08-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5125,AZ,73,"[64,74)",F,5,NA,2024-08-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5126,AB,69,"[64,74)",M,6,NA,2024-08-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5127,MT,88,"[84,Inf)",F,8,NA,2024-08-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5128,QK,85,"[84,Inf)",M,9,NA,2024-08-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5129,ZA,56,"[44,64)",M,6,NA,2024-08-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5130,EH,32,"[14,44)",M,1,NA,2024-08-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5131,AF,57,"[44,64)",M,6,86.75293947687891,2024-08-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5132,OK,97,"[84,Inf)",M,7,NA,2024-08-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5133,IR,74,"[74,84)",M,7,NA,2024-08-03,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5134,QW,59,"[44,64)",M,6,NA,2024-08-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5135,XP,87,"[84,Inf)",M,5,38.30271430831186,2024-08-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5136,RL,86,"[84,Inf)",M,9,NA,2024-08-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5137,MD,82,"[74,84)",M,7,NA,2024-08-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5138,MK,53,"[44,64)",M,6,NA,2024-08-03,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5139,YX,61,"[44,64)",M,5,85.73255590031498,2024-08-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5140,UG,67,"[64,74)",F,6,82.58592165139105,2024-08-03,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5141,SU,84,"[84,Inf)",F,7,NA,2024-08-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5142,SX,83,"[74,84)",M,7,NA,2024-08-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5143,WA,75,"[74,84)",M,7,NA,2024-08-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5144,SE,76,"[74,84)",F,8,NA,2024-08-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5145,XV,94,"[84,Inf)",M,9,NA,2024-08-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5146,OG,94,"[84,Inf)",M,8,NA,2024-08-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5147,SP,79,"[74,84)",M,6,NA,2024-08-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5148,UI,79,"[74,84)",M,8,41.938464363998335,2024-08-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5149,XM,77,"[74,84)",M,6,NA,2024-08-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5150,GT,63,"[44,64)",M,4,NA,2024-08-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5151,KO,39,"[14,44)",M,4,NA,2024-08-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5152,YY,59,"[44,64)",M,5,100.8843659645039,2024-08-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5153,CT,74,"[74,84)",F,6,NA,2024-08-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5154,PY,72,"[64,74)",F,7,NA,2024-08-03,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5155,WU,80,"[74,84)",M,8,NA,2024-08-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5156,PI,89,"[84,Inf)",M,8,NA,2024-08-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5157,WY,69,"[64,74)",F,7,79.65009487250687,2024-08-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5158,BB,57,"[44,64)",M,5,NA,2024-08-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5159,DM,68,"[64,74)",F,7,NA,2024-08-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5160,QR,65,"[64,74)",F,6,NA,2024-08-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5161,QB,63,"[44,64)",F,6,102.21850123369705,2024-08-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5162,HL,74,"[74,84)",F,6,NA,2024-08-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5163,JR,48,"[44,64)",M,4,NA,2024-08-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5164,BG,85,"[84,Inf)",M,7,NA,2024-08-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5165,WN,82,"[74,84)",M,6,NA,2024-08-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5166,GQ,53,"[44,64)",M,4,NA,2024-08-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5167,DN,2,"[1,14)",M,NA,NA,2024-08-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5168,EV,89,"[84,Inf)",M,8,NA,2024-08-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5169,OA,63,"[44,64)",M,8,69.1133088122189,2024-08-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5170,OO,80,"[74,84)",F,7,55.7239095909651,2024-08-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5171,OV,89,"[84,Inf)",M,9,NA,2024-08-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5172,XA,62,"[44,64)",M,6,NA,2024-08-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5173,GI,66,"[64,74)",F,6,80.77805270694076,2024-08-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5174,UX,91,"[84,Inf)",F,9,NA,2024-08-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5175,GE,80,"[74,84)",M,6,NA,2024-08-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5176,BD,60,"[44,64)",M,6,NA,2024-08-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5177,LC,31,"[14,44)",M,2,NA,2024-08-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5178,AR,71,"[64,74)",F,7,125.1237347634152,2024-08-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5179,YO,96,"[84,Inf)",M,8,32.160980820880795,2024-08-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5180,TM,83,"[74,84)",M,7,NA,2024-08-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5181,EK,79,"[74,84)",M,7,NA,2024-08-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5182,BA,65,"[64,74)",M,7,NA,2024-08-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5183,FD,74,"[74,84)",F,5,NA,2024-08-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5184,UZ,84,"[84,Inf)",M,7,NA,2024-08-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5185,EK,73,"[64,74)",F,8,NA,2024-08-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5186,WF,75,"[74,84)",M,7,81.85222448281482,2024-08-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5187,VN,89,"[84,Inf)",F,8,34.73858499974282,2024-08-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5188,XE,47,"[44,64)",F,4,88.14283829739335,2024-08-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5189,UM,68,"[64,74)",F,6,NA,2024-08-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5190,ZC,65,"[64,74)",F,4,NA,2024-08-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5191,TZ,68,"[64,74)",M,7,NA,2024-08-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5192,TH,62,"[44,64)",M,5,115.99015127687693,2024-08-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5193,MQ,45,"[44,64)",M,4,NA,2024-08-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5194,ZX,83,"[74,84)",F,9,NA,2024-08-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5195,CC,80,"[74,84)",F,6,NA,2024-08-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5196,RI,75,"[74,84)",M,7,NA,2024-08-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5197,DJ,91,"[84,Inf)",M,7,NA,2024-08-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5198,OS,33,"[14,44)",M,3,NA,2024-08-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5199,LL,75,"[74,84)",F,6,60.77181113603145,2024-08-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5200,OF,79,"[74,84)",M,8,NA,2024-08-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5201,BA,55,"[44,64)",M,5,NA,2024-08-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5202,NG,93,"[84,Inf)",M,8,NA,2024-08-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5203,WG,56,"[44,64)",M,3,NA,2024-08-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5204,TD,92,"[84,Inf)",M,9,NA,2024-08-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5205,XA,95,"[84,Inf)",F,8,NA,2024-08-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5206,JK,78,"[74,84)",M,7,NA,2024-08-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5207,YS,76,"[74,84)",M,7,49.28131814959195,2024-08-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5208,OQ,61,"[44,64)",M,5,153.0331789448311,2024-08-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5209,LI,89,"[84,Inf)",M,8,30.849956514782644,2024-08-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5210,YD,67,"[64,74)",M,6,NA,2024-08-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5211,LG,96,"[84,Inf)",M,7,NA,2024-08-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5212,YY,55,"[44,64)",F,7,NA,2024-08-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5213,VA,96,"[84,Inf)",F,9,47.777490263717496,2024-08-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5214,YC,50,"[44,64)",F,3,NA,2024-08-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5215,YK,45,"[44,64)",M,4,NA,2024-08-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5216,JP,87,"[84,Inf)",M,8,37.20537913288114,2024-08-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5217,TR,94,"[84,Inf)",M,6,NA,2024-08-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5218,UO,77,"[74,84)",F,7,NA,2024-08-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5219,DU,69,"[64,74)",M,6,62.790742080292304,2024-08-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5220,XL,97,"[84,Inf)",M,7,NA,2024-08-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5221,WE,68,"[64,74)",M,6,NA,2024-08-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5222,PI,41,"[14,44)",M,3,NA,2024-08-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5223,DS,67,"[64,74)",M,6,NA,2024-08-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5224,WO,71,"[64,74)",M,7,NA,2024-08-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5225,PT,87,"[84,Inf)",M,8,37.35206297586636,2024-08-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5226,PO,90,"[84,Inf)",M,6,NA,2024-08-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5227,YQ,55,"[44,64)",M,6,115.84396912034106,2024-08-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5228,FM,46,"[44,64)",M,6,98.66190186839177,2024-08-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5229,XV,80,"[74,84)",F,8,NA,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5230,OH,41,"[14,44)",M,4,NA,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5231,LI,45,"[44,64)",M,4,NA,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5232,FM,75,"[74,84)",M,7,NA,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5233,OU,77,"[74,84)",M,7,NA,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5234,TG,69,"[64,74)",M,5,NA,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5235,PT,62,"[44,64)",M,5,NA,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5236,AK,78,"[74,84)",M,8,NA,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5237,YB,67,"[64,74)",M,5,NA,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5238,UB,76,"[74,84)",F,9,NA,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5239,OF,76,"[74,84)",M,7,NA,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5240,GI,77,"[74,84)",M,7,NA,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5241,KR,75,"[74,84)",M,8,61.969138118328736,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5242,UT,71,"[64,74)",M,5,NA,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5243,EE,81,"[74,84)",F,7,NA,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5244,OB,72,"[64,74)",M,7,NA,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5245,PB,54,"[44,64)",F,4,127.98167930737077,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5246,VC,63,"[44,64)",M,5,77.72995506614632,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5247,SY,80,"[74,84)",M,8,NA,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5248,QE,72,"[64,74)",F,7,NA,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5249,HI,79,"[74,84)",F,7,126.19251701052868,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5250,GR,78,"[74,84)",M,7,NA,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5251,CT,39,"[14,44)",F,3,NA,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5252,FY,86,"[84,Inf)",M,8,81.9842480407382,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5253,LT,68,"[64,74)",F,7,NA,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5254,WW,62,"[44,64)",F,6,NA,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5255,OY,58,"[44,64)",M,6,NA,2024-08-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5256,OZ,73,"[64,74)",M,6,NA,2024-08-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5257,XI,45,"[44,64)",M,3,NA,2024-08-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5258,JW,34,"[14,44)",F,3,NA,2024-08-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5259,SH,63,"[44,64)",M,6,70.91218418269162,2024-08-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5260,HA,90,"[84,Inf)",F,9,NA,2024-08-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5261,BR,71,"[64,74)",F,7,NA,2024-08-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5262,UG,62,"[44,64)",M,6,78.92957583882658,2024-08-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5263,VQ,81,"[74,84)",M,6,NA,2024-08-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5264,KL,57,"[44,64)",F,6,NA,2024-08-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5265,MY,73,"[64,74)",F,6,71.00847742091918,2024-08-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5266,WA,73,"[64,74)",F,6,NA,2024-08-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5267,AO,65,"[64,74)",F,6,NA,2024-08-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5268,GT,80,"[74,84)",F,7,NA,2024-08-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5269,PG,57,"[44,64)",M,5,86.59009050725307,2024-08-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5270,HL,53,"[44,64)",M,5,NA,2024-08-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5271,BP,78,"[74,84)",M,7,55.95762334400037,2024-08-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5272,YE,48,"[44,64)",M,3,NA,2024-08-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5273,ZJ,86,"[84,Inf)",M,7,NA,2024-08-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5274,PH,36,"[14,44)",M,2,NA,2024-08-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5275,DM,77,"[74,84)",M,6,NA,2024-08-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5276,CA,55,"[44,64)",M,5,NA,2024-08-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5277,AR,83,"[74,84)",F,9,38.376141377011564,2024-08-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5278,RJ,68,"[64,74)",F,7,NA,2024-08-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5279,CY,79,"[74,84)",F,7,NA,2024-08-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5280,KL,60,"[44,64)",M,5,NA,2024-08-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5281,RM,81,"[74,84)",M,7,NA,2024-08-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5282,HV,92,"[84,Inf)",M,7,NA,2024-08-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5283,ZG,45,"[44,64)",F,6,NA,2024-08-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5284,TJ,89,"[84,Inf)",F,7,NA,2024-08-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5285,NI,96,"[84,Inf)",M,8,NA,2024-08-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5286,DJ,1,"[1,14)",F,NA,NA,2024-08-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5287,XB,78,"[74,84)",M,7,105.76571255528077,2024-08-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5288,HO,45,"[44,64)",M,4,NA,2024-08-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5289,MI,55,"[44,64)",M,5,NA,2024-08-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5290,PZ,78,"[74,84)",M,5,NA,2024-08-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5291,RY,83,"[74,84)",M,7,44.37529985918484,2024-08-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5292,RU,51,"[44,64)",M,5,NA,2024-08-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5293,QC,64,"[64,74)",M,7,70.10655961992903,2024-08-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5294,CZ,90,"[84,Inf)",M,9,NA,2024-08-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5295,AN,97,"[84,Inf)",M,8,NA,2024-08-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5296,VJ,50,"[44,64)",M,3,NA,2024-08-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5297,RG,81,"[74,84)",F,8,NA,2024-08-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5298,MU,68,"[64,74)",M,6,NA,2024-08-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5299,HJ,89,"[84,Inf)",M,9,NA,2024-08-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5300,PQ,74,"[74,84)",M,6,NA,2024-08-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5301,HA,74,"[74,84)",M,6,NA,2024-08-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5302,ZQ,68,"[64,74)",M,6,NA,2024-08-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5303,RO,76,"[74,84)",F,8,NA,2024-08-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5304,DT,66,"[64,74)",F,6,NA,2024-08-10,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5305,JH,68,"[64,74)",M,6,NA,2024-08-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5306,WT,92,"[84,Inf)",M,8,NA,2024-08-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5307,OY,89,"[84,Inf)",F,8,NA,2024-08-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5308,SY,35,"[14,44)",M,3,NA,2024-08-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5309,YH,72,"[64,74)",M,7,NA,2024-08-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5310,MZ,81,"[74,84)",M,8,NA,2024-08-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5311,JI,82,"[74,84)",M,8,NA,2024-08-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5312,OB,75,"[74,84)",F,6,44.804827465091236,2024-08-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5313,KN,64,"[64,74)",F,5,NA,2024-08-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5314,GA,36,"[14,44)",F,4,NA,2024-08-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5315,NU,94,"[84,Inf)",F,9,NA,2024-08-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5316,MR,90,"[84,Inf)",M,9,NA,2024-08-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5317,ZS,79,"[74,84)",M,8,59.88343031847309,2024-08-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5318,BY,68,"[64,74)",F,7,NA,2024-08-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5319,OM,69,"[64,74)",F,7,NA,2024-08-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5320,OB,68,"[64,74)",M,6,NA,2024-08-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5321,CQ,71,"[64,74)",M,5,NA,2024-08-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5322,RS,84,"[84,Inf)",M,8,NA,2024-08-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5323,XP,49,"[44,64)",F,4,NA,2024-08-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5324,UZ,77,"[74,84)",M,8,NA,2024-08-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5325,ZZ,80,"[74,84)",M,7,NA,2024-08-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5326,UI,77,"[74,84)",M,8,NA,2024-08-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5327,QK,67,"[64,74)",M,6,73.54672440420616,2024-08-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5328,ZY,74,"[74,84)",M,7,NA,2024-08-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5329,DM,49,"[44,64)",F,4,NA,2024-08-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5330,XM,79,"[74,84)",M,7,NA,2024-08-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5331,KA,73,"[64,74)",M,8,NA,2024-08-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5332,DK,61,"[44,64)",M,8,83.55337310045276,2024-08-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5333,RD,65,"[64,74)",M,5,88.97630760416355,2024-08-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5334,DE,68,"[64,74)",M,6,NA,2024-08-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5335,UC,39,"[14,44)",M,3,NA,2024-08-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5336,WJ,70,"[64,74)",F,6,NA,2024-08-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5337,WU,64,"[64,74)",M,7,NA,2024-08-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5338,LE,75,"[74,84)",M,7,NA,2024-08-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5339,CH,84,"[84,Inf)",F,8,NA,2024-08-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5340,YU,70,"[64,74)",F,5,NA,2024-08-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5341,ZY,89,"[84,Inf)",M,8,36.90936189946071,2024-08-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5342,XM,77,"[74,84)",M,6,NA,2024-08-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5343,NS,36,"[14,44)",M,5,86.50242508346557,2024-08-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5344,XV,55,"[44,64)",M,4,NA,2024-08-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5345,AX,41,"[14,44)",F,2,NA,2024-08-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5346,VS,62,"[44,64)",M,4,NA,2024-08-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5347,KZ,79,"[74,84)",M,8,NA,2024-08-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5348,MY,60,"[44,64)",M,4,NA,2024-08-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5349,XY,62,"[44,64)",M,6,NA,2024-08-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5350,DG,96,"[84,Inf)",M,7,NA,2024-08-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5351,YD,89,"[84,Inf)",M,9,NA,2024-08-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5352,KU,98,"[84,Inf)",M,9,NA,2024-08-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5353,XH,54,"[44,64)",M,4,NA,2024-08-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5354,ZA,89,"[84,Inf)",M,9,NA,2024-08-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5355,BZ,82,"[74,84)",M,7,NA,2024-08-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5356,NG,82,"[74,84)",M,7,43.45396066780312,2024-08-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5357,IX,79,"[74,84)",M,7,NA,2024-08-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5358,PY,75,"[74,84)",F,6,NA,2024-08-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5359,BS,68,"[64,74)",F,5,NA,2024-08-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5360,QP,62,"[44,64)",M,5,NA,2024-08-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5361,ZN,52,"[44,64)",M,5,66.10711169258349,2024-08-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5362,ZO,63,"[44,64)",F,6,47.410790531593236,2024-08-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5363,ZQ,59,"[44,64)",M,5,NA,2024-08-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5364,DT,80,"[74,84)",M,7,NA,2024-08-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5365,XI,86,"[84,Inf)",F,8,NA,2024-08-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5366,ID,58,"[44,64)",F,5,NA,2024-08-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5367,YI,83,"[74,84)",M,7,NA,2024-08-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5368,JA,90,"[84,Inf)",F,9,NA,2024-08-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5369,MP,69,"[64,74)",F,6,NA,2024-08-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5370,OH,72,"[64,74)",F,6,NA,2024-08-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5371,EN,91,"[84,Inf)",M,8,NA,2024-08-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5372,NY,74,"[74,84)",M,7,NA,2024-08-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5373,UV,74,"[74,84)",F,6,NA,2024-08-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5374,BR,21,"[14,44)",M,4,NA,2024-08-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5375,OO,23,"[14,44)",M,3,NA,2024-08-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5376,MM,79,"[74,84)",M,7,NA,2024-08-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5377,RT,58,"[44,64)",M,5,NA,2024-08-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5378,VX,0,"[0,1)",M,NA,NA,2024-08-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5379,UW,85,"[84,Inf)",F,8,38.913428582653914,2024-08-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5380,CC,87,"[84,Inf)",M,8,NA,2024-08-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5381,OP,85,"[84,Inf)",M,7,NA,2024-08-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5382,MP,52,"[44,64)",F,5,NA,2024-08-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5383,IG,74,"[74,84)",M,8,95.77385309550063,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5384,EI,80,"[74,84)",M,6,NA,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5385,LE,89,"[84,Inf)",M,7,61.220474432623234,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5386,PJ,77,"[74,84)",F,8,NA,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5387,HL,53,"[44,64)",M,4,NA,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5388,RI,67,"[64,74)",F,7,NA,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5389,IA,73,"[64,74)",F,6,NA,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5390,HK,77,"[74,84)",F,7,42.78481552879622,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5391,WS,86,"[84,Inf)",M,7,NA,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5392,MJ,72,"[64,74)",M,7,65.55639307178704,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5393,IL,61,"[44,64)",M,5,NA,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5394,IH,67,"[64,74)",M,7,NA,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5395,YC,59,"[44,64)",F,6,64.04091871695387,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5396,JM,87,"[84,Inf)",M,8,33.38859557805869,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5397,UJ,97,"[84,Inf)",M,9,NA,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5398,HZ,62,"[44,64)",F,5,NA,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5399,HG,70,"[64,74)",M,5,NA,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5400,ZZ,48,"[44,64)",F,5,NA,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5401,XT,79,"[74,84)",M,6,NA,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5402,OG,85,"[84,Inf)",F,7,NA,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5403,KQ,97,"[84,Inf)",M,8,NA,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5404,WB,80,"[74,84)",F,8,NA,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5405,XC,56,"[44,64)",M,6,NA,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5406,WG,67,"[64,74)",F,7,NA,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5407,IY,56,"[44,64)",M,5,NA,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5408,EB,66,"[64,74)",M,7,NA,2024-08-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5409,KI,80,"[74,84)",F,8,NA,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5410,BV,76,"[74,84)",M,7,NA,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5411,EX,78,"[74,84)",M,6,58.56349704823496,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5412,VQ,73,"[64,74)",M,6,NA,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5413,OG,98,"[84,Inf)",M,9,NA,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5414,GZ,68,"[64,74)",M,6,155.57126487461971,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5415,SX,91,"[84,Inf)",M,9,NA,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5416,GZ,84,"[84,Inf)",M,8,NA,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5417,SP,62,"[44,64)",M,6,91.96645151954547,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5418,SF,74,"[74,84)",M,6,NA,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5419,OQ,81,"[74,84)",M,8,NA,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5420,MS,88,"[84,Inf)",M,9,NA,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5421,WC,32,"[14,44)",M,3,NA,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5422,JF,87,"[84,Inf)",F,8,NA,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5423,ZV,58,"[44,64)",M,4,NA,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5424,RK,86,"[84,Inf)",M,8,NA,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5425,KT,65,"[64,74)",M,4,NA,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5426,BR,40,"[14,44)",M,4,NA,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5427,TH,60,"[44,64)",M,4,NA,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5428,JW,68,"[64,74)",F,7,NA,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5429,UG,82,"[74,84)",M,7,NA,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5430,WT,60,"[44,64)",M,7,NA,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5431,FM,38,"[14,44)",M,4,NA,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5432,WY,81,"[74,84)",M,8,50.489080866465166,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5433,MP,56,"[44,64)",F,6,NA,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5434,KX,63,"[44,64)",M,6,58.3997253467097,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5435,UW,72,"[64,74)",M,6,NA,2024-08-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5436,HN,60,"[44,64)",M,6,NA,2024-08-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5437,YE,73,"[64,74)",M,7,86.119342845296,2024-08-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5438,ZC,85,"[84,Inf)",M,8,NA,2024-08-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5439,SY,59,"[44,64)",M,5,NA,2024-08-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5440,GQ,68,"[64,74)",F,6,NA,2024-08-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5441,YZ,79,"[74,84)",F,9,NA,2024-08-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5442,HN,88,"[84,Inf)",F,8,NA,2024-08-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5443,RU,85,"[84,Inf)",F,7,NA,2024-08-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5444,RZ,65,"[64,74)",F,6,77.01073431004403,2024-08-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5445,AX,66,"[64,74)",F,6,NA,2024-08-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5446,CY,65,"[64,74)",M,5,NA,2024-08-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5447,WP,60,"[44,64)",M,4,NA,2024-08-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5448,FL,78,"[74,84)",M,6,38.367520957284,2024-08-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5449,XQ,47,"[44,64)",M,4,117.86463682895327,2024-08-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5450,SK,95,"[84,Inf)",M,8,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5451,ES,38,"[14,44)",M,4,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5452,TH,61,"[44,64)",F,6,78.3307134951783,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5453,GJ,75,"[74,84)",M,7,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5454,AW,63,"[44,64)",M,6,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5455,FA,46,"[44,64)",F,4,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5456,WJ,67,"[64,74)",M,7,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5457,JH,58,"[44,64)",M,4,91.79369873224327,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5458,BH,51,"[44,64)",M,3,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5459,RU,49,"[44,64)",F,3,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5460,UG,50,"[44,64)",M,4,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5461,KE,60,"[44,64)",F,5,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5462,FQ,82,"[74,84)",M,6,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5463,WM,57,"[44,64)",F,4,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5464,FG,72,"[64,74)",M,7,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5465,IP,61,"[44,64)",M,5,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5466,XJ,56,"[44,64)",F,5,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5467,GO,69,"[64,74)",M,7,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5468,BQ,51,"[44,64)",M,4,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5469,WW,92,"[84,Inf)",M,8,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5470,IV,77,"[74,84)",M,8,40.56424786973233,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5471,RP,59,"[44,64)",F,4,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5472,HN,68,"[64,74)",M,3,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5473,WE,80,"[74,84)",M,6,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5474,CJ,54,"[44,64)",M,5,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5475,HL,51,"[44,64)",F,5,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5476,OW,77,"[74,84)",M,6,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5477,GN,78,"[74,84)",M,8,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5478,VK,53,"[44,64)",F,6,72.03260708752792,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5479,IC,86,"[84,Inf)",M,7,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5480,WY,22,"[14,44)",M,3,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5481,KL,67,"[64,74)",M,6,NA,2024-08-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5482,WJ,84,"[84,Inf)",M,7,NA,2024-08-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5483,JK,84,"[84,Inf)",M,7,NA,2024-08-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5484,LC,50,"[44,64)",F,2,NA,2024-08-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5485,UD,57,"[44,64)",M,6,NA,2024-08-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5486,UL,87,"[84,Inf)",M,7,34.98344722938123,2024-08-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5487,EB,1,"[1,14)",M,NA,NA,2024-08-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5488,JS,82,"[74,84)",M,8,NA,2024-08-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5489,CE,77,"[74,84)",M,7,NA,2024-08-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5490,LQ,87,"[84,Inf)",F,8,NA,2024-08-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5491,BC,81,"[74,84)",M,7,NA,2024-08-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5492,AL,73,"[64,74)",M,7,NA,2024-08-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5493,YH,62,"[44,64)",M,5,NA,2024-08-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5494,GQ,66,"[64,74)",M,6,NA,2024-08-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5495,VD,73,"[64,74)",M,6,NA,2024-08-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5496,TU,0,"[0,1)",F,NA,NA,2024-08-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5497,QO,49,"[44,64)",F,5,NA,2024-08-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5498,RU,94,"[84,Inf)",M,8,45.46430188449276,2024-08-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5499,YS,93,"[84,Inf)",M,8,NA,2024-08-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5500,FA,82,"[74,84)",M,8,54.08917019890518,2024-08-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5501,NC,86,"[84,Inf)",M,8,NA,2024-08-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5502,YC,64,"[64,74)",F,5,NA,2024-08-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5503,TI,61,"[44,64)",F,5,NA,2024-08-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5504,SN,80,"[74,84)",F,5,98.44189269174338,2024-08-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5505,IY,77,"[74,84)",M,7,NA,2024-08-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5506,UJ,1,"[1,14)",F,NA,NA,2024-08-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5507,QP,70,"[64,74)",M,5,NA,2024-08-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5508,IG,68,"[64,74)",F,7,NA,2024-08-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5509,TG,88,"[84,Inf)",M,7,NA,2024-08-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5510,NE,65,"[64,74)",M,7,NA,2024-08-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5511,DS,56,"[44,64)",M,6,NA,2024-08-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5512,VX,79,"[74,84)",M,8,NA,2024-08-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5513,RR,81,"[74,84)",M,8,NA,2024-08-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5514,GA,80,"[74,84)",F,8,NA,2024-08-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5515,ZV,74,"[74,84)",M,8,NA,2024-08-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5516,WA,60,"[44,64)",M,4,95.46341638755484,2024-08-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5517,EK,76,"[74,84)",M,8,NA,2024-08-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5518,GQ,75,"[74,84)",M,7,NA,2024-08-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5519,HR,58,"[44,64)",M,6,NA,2024-08-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5520,JZ,53,"[44,64)",M,4,NA,2024-08-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5521,PY,93,"[84,Inf)",M,8,NA,2024-08-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5522,YQ,79,"[74,84)",M,7,NA,2024-08-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5523,TY,82,"[74,84)",M,6,56.37016329328639,2024-08-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5524,EA,1,"[1,14)",M,NA,NA,2024-08-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5525,CX,85,"[84,Inf)",M,8,NA,2024-08-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5526,ES,54,"[44,64)",M,5,NA,2024-08-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5527,KL,96,"[84,Inf)",M,9,NA,2024-08-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5528,GD,55,"[44,64)",M,5,NA,2024-08-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5529,LK,67,"[64,74)",M,6,NA,2024-08-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5530,HX,52,"[44,64)",F,4,NA,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5531,LM,73,"[64,74)",M,4,NA,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5532,DQ,67,"[64,74)",M,5,NA,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5533,MJ,95,"[84,Inf)",M,9,NA,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5534,XM,66,"[64,74)",F,6,90.51523040841103,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5535,JG,56,"[44,64)",M,5,NA,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5536,LO,74,"[74,84)",M,7,NA,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5537,VR,66,"[64,74)",F,6,NA,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5538,HT,2,"[1,14)",M,NA,NA,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5539,QT,77,"[74,84)",F,8,69.71598837250944,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5540,MH,0,"[0,1)",M,NA,NA,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5541,ZX,85,"[84,Inf)",F,7,NA,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5542,AN,3,"[1,14)",M,NA,NA,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5543,OU,72,"[64,74)",F,7,NA,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5544,VW,67,"[64,74)",F,7,58.382568644150446,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5545,PR,88,"[84,Inf)",M,7,41.52329443051879,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5546,XA,97,"[84,Inf)",M,9,NA,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5547,IW,76,"[74,84)",M,7,NA,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5548,TA,49,"[44,64)",M,3,NA,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5549,WB,53,"[44,64)",M,5,NA,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5550,KQ,38,"[14,44)",M,3,NA,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5551,EM,68,"[64,74)",F,7,NA,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5552,UE,50,"[44,64)",F,7,NA,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5553,KT,66,"[64,74)",M,5,NA,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5554,AM,47,"[44,64)",F,5,NA,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5555,GT,50,"[44,64)",M,3,84.90764280760864,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5556,LX,57,"[44,64)",M,5,56.836568194898696,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5557,LB,59,"[44,64)",M,5,NA,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5558,XY,52,"[44,64)",F,4,NA,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5559,ZK,2,"[1,14)",F,NA,NA,2024-08-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5560,PP,60,"[44,64)",F,6,NA,2024-08-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5561,KM,88,"[84,Inf)",M,8,NA,2024-08-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5562,AG,81,"[74,84)",F,6,NA,2024-08-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5563,VX,88,"[84,Inf)",M,8,NA,2024-08-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5564,HI,66,"[64,74)",F,7,NA,2024-08-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5565,MJ,54,"[44,64)",M,2,122.30841153631503,2024-08-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5566,DZ,64,"[64,74)",F,6,NA,2024-08-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5567,AU,86,"[84,Inf)",M,8,49.11553103260702,2024-08-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5568,OK,55,"[44,64)",M,6,113.02028958527863,2024-08-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5569,JP,84,"[84,Inf)",M,7,NA,2024-08-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5570,IS,28,"[14,44)",M,4,NA,2024-08-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5571,UH,50,"[44,64)",M,5,NA,2024-08-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5572,EM,81,"[74,84)",F,9,27.300730563378426,2024-08-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5573,JC,44,"[44,64)",M,5,NA,2024-08-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5574,QA,57,"[44,64)",F,5,81.29026820842793,2024-08-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5575,YO,72,"[64,74)",M,7,NA,2024-08-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5576,ET,54,"[44,64)",M,4,NA,2024-08-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5577,RO,64,"[64,74)",F,5,NA,2024-08-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5578,VB,90,"[84,Inf)",M,8,52.10894477785523,2024-08-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5579,XA,68,"[64,74)",M,5,70.4529340363672,2024-08-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5580,JD,96,"[84,Inf)",M,8,30.278200244752675,2024-08-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5581,QC,65,"[64,74)",F,7,NA,2024-08-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5582,LX,81,"[74,84)",M,9,NA,2024-08-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5583,TT,96,"[84,Inf)",M,7,NA,2024-08-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5584,PC,38,"[14,44)",M,2,NA,2024-08-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5585,FI,60,"[44,64)",F,5,NA,2024-08-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5586,DD,70,"[64,74)",M,5,112.24164556297417,2024-08-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5587,FX,87,"[84,Inf)",M,8,NA,2024-08-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5588,HB,74,"[74,84)",M,7,NA,2024-08-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5589,OU,71,"[64,74)",M,5,NA,2024-08-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5590,SX,93,"[84,Inf)",M,8,NA,2024-08-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5591,CA,97,"[84,Inf)",M,8,NA,2024-08-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5592,QA,79,"[74,84)",F,9,NA,2024-08-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5593,XQ,56,"[44,64)",F,6,NA,2024-08-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5594,EI,64,"[64,74)",F,5,103.06335008865837,2024-08-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5595,DL,86,"[84,Inf)",M,8,NA,2024-08-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5596,VN,43,"[14,44)",F,5,NA,2024-08-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5597,FX,47,"[44,64)",M,6,NA,2024-08-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5598,KG,81,"[74,84)",F,8,39.39854104552697,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5599,ZR,79,"[74,84)",F,6,NA,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5600,UO,65,"[64,74)",F,7,152.4517880349952,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5601,IP,78,"[74,84)",F,8,NA,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5602,GL,91,"[84,Inf)",F,7,NA,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5603,YR,82,"[74,84)",M,7,52.783898201788816,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5604,PT,71,"[64,74)",M,7,NA,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5605,VM,0,"[0,1)",F,NA,NA,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5606,MA,78,"[74,84)",M,7,NA,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5607,MI,56,"[44,64)",M,4,NA,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5608,UL,65,"[64,74)",F,6,NA,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5609,OT,96,"[84,Inf)",M,7,NA,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5610,SY,58,"[44,64)",M,7,77.58046005899216,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5611,YY,64,"[64,74)",M,7,NA,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5612,HH,93,"[84,Inf)",M,8,NA,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5613,HO,80,"[74,84)",M,8,43.73216686433075,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5614,GQ,75,"[74,84)",M,7,102.29230855896694,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5615,QY,0,"[0,1)",M,NA,NA,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5616,JE,60,"[44,64)",M,6,NA,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5617,JU,93,"[84,Inf)",M,9,NA,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5618,XM,70,"[64,74)",F,8,NA,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5619,BA,68,"[64,74)",M,5,108.74656578162434,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5620,MV,54,"[44,64)",F,6,NA,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5621,DE,74,"[74,84)",M,8,NA,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5622,IS,87,"[84,Inf)",M,8,NA,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5623,ES,93,"[84,Inf)",M,9,NA,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5624,KM,58,"[44,64)",M,6,NA,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5625,RC,74,"[74,84)",M,7,58.890694350406996,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5626,KK,74,"[74,84)",M,6,NA,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5627,NH,68,"[64,74)",M,5,NA,2024-08-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5628,WR,61,"[44,64)",M,4,NA,2024-08-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5629,FZ,78,"[74,84)",M,6,NA,2024-08-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5630,PQ,77,"[74,84)",F,7,116.90079047227863,2024-08-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5631,LE,85,"[84,Inf)",M,9,NA,2024-08-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5632,HS,82,"[74,84)",M,8,NA,2024-08-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5633,TQ,71,"[64,74)",F,6,NA,2024-08-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5634,LZ,72,"[64,74)",M,6,NA,2024-08-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5635,KZ,82,"[74,84)",M,7,NA,2024-08-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5636,SI,77,"[74,84)",M,7,NA,2024-08-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5637,XD,76,"[74,84)",F,7,NA,2024-08-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5638,QL,62,"[44,64)",M,5,NA,2024-08-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5639,OS,57,"[44,64)",M,6,NA,2024-08-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5640,TI,88,"[84,Inf)",M,8,NA,2024-08-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5641,FU,73,"[64,74)",M,6,NA,2024-08-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5642,HO,1,"[1,14)",M,NA,NA,2024-08-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5643,QX,0,"[0,1)",M,NA,NA,2024-08-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5644,BM,100,"[84,Inf)",F,9,NA,2024-08-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5645,HK,66,"[64,74)",F,5,NA,2024-08-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5646,OF,76,"[74,84)",M,8,NA,2024-08-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5647,XA,61,"[44,64)",M,5,NA,2024-08-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5648,AT,61,"[44,64)",F,4,105.27575135408583,2024-08-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5649,HO,43,"[14,44)",M,4,NA,2024-08-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5650,ZA,40,"[14,44)",F,4,NA,2024-08-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5651,FF,69,"[64,74)",M,7,77.68517691777193,2024-08-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5652,RQ,71,"[64,74)",M,7,NA,2024-08-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5653,EU,71,"[64,74)",M,5,NA,2024-08-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5654,ES,92,"[84,Inf)",M,7,38.846381204701025,2024-08-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5655,CN,40,"[14,44)",M,3,NA,2024-08-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5656,ZU,95,"[84,Inf)",M,9,NA,2024-08-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5657,XA,97,"[84,Inf)",M,8,NA,2024-08-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5658,KP,96,"[84,Inf)",M,9,NA,2024-08-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5659,LI,78,"[74,84)",M,7,NA,2024-08-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5660,OG,91,"[84,Inf)",M,9,NA,2024-08-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5661,PH,73,"[64,74)",F,7,47.346481691608886,2024-08-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5662,HJ,67,"[64,74)",F,8,NA,2024-08-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5663,UD,68,"[64,74)",M,6,NA,2024-08-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5664,ZP,90,"[84,Inf)",F,8,NA,2024-08-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5665,TS,84,"[84,Inf)",M,8,NA,2024-08-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5666,YJ,79,"[74,84)",F,8,NA,2024-08-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5667,XQ,47,"[44,64)",M,5,NA,2024-08-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5668,CT,64,"[64,74)",M,6,95.12339946742769,2024-08-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5669,JG,73,"[64,74)",F,7,NA,2024-08-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5670,RH,60,"[44,64)",M,7,NA,2024-08-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5671,WS,53,"[44,64)",M,4,NA,2024-08-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5672,RO,80,"[74,84)",F,6,NA,2024-08-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5673,JB,74,"[74,84)",M,7,NA,2024-08-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5674,KQ,72,"[64,74)",F,7,NA,2024-08-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5675,CY,66,"[64,74)",M,6,NA,2024-08-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5676,LZ,49,"[44,64)",M,5,NA,2024-08-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5677,RC,50,"[44,64)",M,4,69.23465332741605,2024-08-26,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5678,KS,64,"[64,74)",F,6,NA,2024-08-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5679,XB,70,"[64,74)",M,7,61.33249624546322,2024-08-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5680,YL,73,"[64,74)",M,7,NA,2024-08-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5681,BA,52,"[44,64)",M,4,NA,2024-08-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5682,DL,71,"[64,74)",M,6,80.48536128897953,2024-08-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5683,CZ,85,"[84,Inf)",M,8,52.60549211581953,2024-08-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5684,ZA,38,"[14,44)",M,3,NA,2024-08-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5685,AT,84,"[84,Inf)",M,7,45.40006954926472,2024-08-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5686,CA,76,"[74,84)",F,8,NA,2024-08-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5687,PW,73,"[64,74)",F,6,NA,2024-08-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5688,KW,68,"[64,74)",M,6,NA,2024-08-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5689,ZI,89,"[84,Inf)",M,8,NA,2024-08-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5690,MI,60,"[44,64)",M,4,NA,2024-08-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5691,FR,63,"[44,64)",M,6,NA,2024-08-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5692,TB,59,"[44,64)",F,6,NA,2024-08-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5693,CF,66,"[64,74)",F,6,NA,2024-08-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5694,KS,68,"[64,74)",M,5,NA,2024-08-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5695,VU,63,"[44,64)",F,4,NA,2024-08-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5696,KX,67,"[64,74)",M,5,NA,2024-08-27,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5697,NP,66,"[64,74)",M,6,82.00815776219024,2024-08-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5698,TR,67,"[64,74)",M,7,NA,2024-08-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5699,PL,86,"[84,Inf)",M,8,NA,2024-08-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5700,RM,75,"[74,84)",M,9,NA,2024-08-27,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5701,WS,60,"[44,64)",M,6,106.02316192417408,2024-08-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5702,NS,53,"[44,64)",M,5,NA,2024-08-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5703,TF,29,"[14,44)",M,3,NA,2024-08-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5704,CD,89,"[84,Inf)",M,7,NA,2024-08-27,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5705,JP,57,"[44,64)",M,5,102.59108919966322,2024-08-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5706,QW,55,"[44,64)",F,6,NA,2024-08-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5707,YD,83,"[74,84)",M,7,NA,2024-08-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5708,XP,90,"[84,Inf)",F,8,28.85010070831248,2024-08-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5709,IJ,54,"[44,64)",F,4,NA,2024-08-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5710,FN,62,"[44,64)",M,5,NA,2024-08-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5711,AU,81,"[74,84)",M,6,NA,2024-08-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5712,VN,69,"[64,74)",M,7,NA,2024-08-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5713,JS,57,"[44,64)",M,6,NA,2024-08-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5714,WH,87,"[84,Inf)",M,9,NA,2024-08-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5715,OL,85,"[84,Inf)",F,8,28.961983898378406,2024-08-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5716,PR,82,"[74,84)",M,7,NA,2024-08-28,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5717,WT,74,"[74,84)",M,6,NA,2024-08-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5718,BB,68,"[64,74)",M,6,NA,2024-08-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5719,GL,52,"[44,64)",M,3,NA,2024-08-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5720,NT,65,"[64,74)",M,5,NA,2024-08-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5721,EV,66,"[64,74)",M,5,NA,2024-08-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5722,KD,61,"[44,64)",M,6,112.50165389435978,2024-08-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5723,PU,78,"[74,84)",M,6,47.91490818827426,2024-08-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5724,PJ,64,"[64,74)",F,5,67.03673936354167,2024-08-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5725,MH,1,"[1,14)",M,NA,NA,2024-08-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5726,ZJ,71,"[64,74)",M,7,107.34908801371103,2024-08-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5727,JP,70,"[64,74)",F,7,NA,2024-08-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5728,FU,91,"[84,Inf)",M,9,NA,2024-08-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5729,JN,84,"[84,Inf)",M,8,46.408366461824855,2024-08-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5730,TU,74,"[74,84)",M,7,62.14098426182674,2024-08-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5731,QB,83,"[74,84)",M,6,NA,2024-08-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5732,TX,86,"[84,Inf)",M,7,NA,2024-08-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5733,XW,71,"[64,74)",M,3,NA,2024-08-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5734,HF,69,"[64,74)",F,6,NA,2024-08-29,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5735,NX,54,"[44,64)",M,4,NA,2024-08-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5736,GO,98,"[84,Inf)",M,9,NA,2024-08-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5737,AZ,58,"[44,64)",M,5,104.0533881475321,2024-08-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5738,CR,63,"[44,64)",M,4,NA,2024-08-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5739,RJ,92,"[84,Inf)",M,9,NA,2024-08-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5740,OO,54,"[44,64)",M,5,NA,2024-08-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5741,BL,78,"[74,84)",M,7,NA,2024-08-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5742,XJ,2,"[1,14)",M,NA,NA,2024-08-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5743,PV,84,"[84,Inf)",F,7,NA,2024-08-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5744,XN,89,"[84,Inf)",M,8,42.43073956669387,2024-08-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5745,DY,92,"[84,Inf)",M,9,NA,2024-08-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5746,CH,67,"[64,74)",F,6,68.8612040276825,2024-08-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5747,ZV,55,"[44,64)",M,5,NA,2024-08-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5748,XM,90,"[84,Inf)",F,7,NA,2024-08-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5749,RG,53,"[44,64)",M,5,NA,2024-08-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5750,ZY,82,"[74,84)",M,7,NA,2024-08-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5751,WZ,43,"[14,44)",F,2,78.31204843657753,2024-08-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5752,YT,50,"[44,64)",M,4,NA,2024-08-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5753,AE,70,"[64,74)",M,6,NA,2024-08-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5754,VC,83,"[74,84)",M,7,NA,2024-08-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5755,GY,75,"[74,84)",M,7,NA,2024-08-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5756,MK,69,"[64,74)",F,5,65.33647915382875,2024-08-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5757,VW,95,"[84,Inf)",M,7,NA,2024-08-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5758,MP,53,"[44,64)",M,6,NA,2024-08-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5759,UX,62,"[44,64)",M,6,NA,2024-08-31,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5760,CH,91,"[84,Inf)",M,8,51.05811076811396,2024-08-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5761,AD,45,"[44,64)",F,3,NA,2024-08-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5762,VN,59,"[44,64)",F,5,NA,2024-08-31,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5763,TJ,70,"[64,74)",M,6,NA,2024-08-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5764,HR,72,"[64,74)",M,6,NA,2024-08-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5765,EV,31,"[14,44)",M,5,NA,2024-08-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5766,PZ,96,"[84,Inf)",M,8,NA,2024-08-31,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5767,PQ,68,"[64,74)",M,5,NA,2024-08-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5768,AE,74,"[74,84)",F,7,NA,2024-08-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5769,TR,91,"[84,Inf)",M,9,NA,2024-08-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5770,BB,63,"[44,64)",M,7,NA,2024-08-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5771,KO,68,"[64,74)",M,6,NA,2024-08-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5772,KO,91,"[84,Inf)",M,8,NA,2024-08-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5773,HW,39,"[14,44)",M,1,NA,2024-08-31,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5774,LI,72,"[64,74)",M,8,NA,2024-08-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5775,SS,50,"[44,64)",M,4,NA,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5776,PO,38,"[14,44)",F,3,99.52844688502708,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5777,GO,67,"[64,74)",F,6,NA,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5778,JJ,61,"[44,64)",M,5,63.83565708533013,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5779,XL,81,"[74,84)",M,8,NA,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5780,CT,87,"[84,Inf)",M,7,NA,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5781,LE,53,"[44,64)",M,6,NA,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5782,IQ,85,"[84,Inf)",M,6,NA,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5783,DI,57,"[44,64)",F,5,NA,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5784,HU,93,"[84,Inf)",M,7,49.63784097559029,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5785,XQ,77,"[74,84)",M,7,NA,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5786,XA,91,"[84,Inf)",M,7,NA,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5787,SH,83,"[74,84)",F,7,NA,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5788,FW,63,"[44,64)",M,6,NA,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5789,XI,65,"[64,74)",M,6,NA,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5790,AJ,51,"[44,64)",M,5,84.4052882877977,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5791,HP,83,"[74,84)",M,7,NA,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5792,NI,77,"[74,84)",F,6,NA,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5793,DC,81,"[74,84)",M,7,NA,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5794,IR,76,"[74,84)",M,7,NA,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5795,FE,84,"[84,Inf)",M,8,53.89659635985066,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5796,HK,49,"[44,64)",F,4,92.81525670709516,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5797,SB,88,"[84,Inf)",M,7,46.24204783155313,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5798,DP,79,"[74,84)",M,8,NA,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5799,KL,87,"[84,Inf)",M,8,57.638297287661665,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5800,LF,73,"[64,74)",M,6,NA,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5801,UB,83,"[74,84)",M,7,NA,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5802,SG,55,"[44,64)",M,6,NA,2024-09-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5803,QP,91,"[84,Inf)",M,8,NA,2024-09-02,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5804,YJ,81,"[74,84)",M,7,NA,2024-09-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5805,KH,62,"[44,64)",F,5,70.54934059817414,2024-09-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5806,MA,69,"[64,74)",M,5,NA,2024-09-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5807,LQ,55,"[44,64)",M,5,NA,2024-09-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5808,YY,86,"[84,Inf)",M,8,NA,2024-09-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5809,YV,69,"[64,74)",F,5,NA,2024-09-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5810,QD,71,"[64,74)",M,6,NA,2024-09-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5811,AK,86,"[84,Inf)",M,7,NA,2024-09-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5812,QT,95,"[84,Inf)",M,9,NA,2024-09-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5813,AI,39,"[14,44)",F,4,NA,2024-09-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5814,WD,86,"[84,Inf)",M,7,NA,2024-09-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5815,WH,79,"[74,84)",F,7,NA,2024-09-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5816,HA,76,"[74,84)",F,6,NA,2024-09-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5817,UL,95,"[84,Inf)",F,8,NA,2024-09-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5818,MP,43,"[14,44)",M,2,106.06550247023387,2024-09-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5819,QQ,57,"[44,64)",M,5,NA,2024-09-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5820,AR,55,"[44,64)",M,5,NA,2024-09-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5821,XI,66,"[64,74)",F,6,114.9367710031786,2024-09-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5822,NX,70,"[64,74)",F,6,NA,2024-09-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5823,CA,68,"[64,74)",F,7,NA,2024-09-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5824,EQ,86,"[84,Inf)",M,8,NA,2024-09-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5825,KV,77,"[74,84)",M,9,NA,2024-09-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5826,JE,65,"[64,74)",M,7,NA,2024-09-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5827,EA,60,"[44,64)",M,7,NA,2024-09-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5828,XB,53,"[44,64)",M,5,NA,2024-09-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5829,KQ,66,"[64,74)",F,7,NA,2024-09-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5830,NY,57,"[44,64)",M,4,NA,2024-09-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5831,RT,39,"[14,44)",M,3,NA,2024-09-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5832,ZZ,55,"[44,64)",M,4,NA,2024-09-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5833,MZ,26,"[14,44)",F,3,NA,2024-09-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5834,HZ,74,"[74,84)",M,5,NA,2024-09-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5835,PI,67,"[64,74)",M,6,NA,2024-09-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5836,RH,67,"[64,74)",M,7,NA,2024-09-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5837,WX,54,"[44,64)",M,4,NA,2024-09-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5838,XR,77,"[74,84)",M,9,NA,2024-09-03,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5839,QO,55,"[44,64)",M,5,NA,2024-09-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5840,QD,55,"[44,64)",M,6,84.98081181760031,2024-09-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5841,QG,69,"[64,74)",M,7,NA,2024-09-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5842,TD,95,"[84,Inf)",M,9,NA,2024-09-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5843,WX,71,"[64,74)",M,8,NA,2024-09-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5844,JM,48,"[44,64)",M,5,105.87472110989735,2024-09-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5845,HH,74,"[74,84)",M,6,NA,2024-09-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5846,XQ,1,"[1,14)",M,NA,NA,2024-09-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5847,UA,86,"[84,Inf)",F,6,NA,2024-09-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5848,WA,59,"[44,64)",F,5,NA,2024-09-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5849,YA,46,"[44,64)",M,3,NA,2024-09-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5850,VP,56,"[44,64)",M,5,NA,2024-09-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5851,ZA,98,"[84,Inf)",M,9,NA,2024-09-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5852,WI,94,"[84,Inf)",M,8,NA,2024-09-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5853,XM,31,"[14,44)",M,2,NA,2024-09-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5854,JD,95,"[84,Inf)",F,8,26.649075915755795,2024-09-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5855,HK,56,"[44,64)",F,6,NA,2024-09-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5856,BY,59,"[44,64)",M,6,94.92148250731292,2024-09-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5857,EE,54,"[44,64)",M,5,NA,2024-09-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5858,HX,57,"[44,64)",M,6,NA,2024-09-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5859,NN,92,"[84,Inf)",M,9,NA,2024-09-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5860,TS,71,"[64,74)",M,7,NA,2024-09-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5861,AH,83,"[74,84)",M,9,NA,2024-09-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5862,OE,78,"[74,84)",M,6,NA,2024-09-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5863,KH,71,"[64,74)",F,7,NA,2024-09-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5864,NQ,89,"[84,Inf)",M,8,NA,2024-09-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5865,RM,69,"[64,74)",M,7,NA,2024-09-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5866,JZ,80,"[74,84)",M,7,NA,2024-09-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5867,UY,78,"[74,84)",F,7,44.211795862355764,2024-09-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5868,BA,91,"[84,Inf)",M,8,NA,2024-09-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5869,NZ,78,"[74,84)",F,7,NA,2024-09-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5870,FV,85,"[84,Inf)",M,8,NA,2024-09-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5871,OM,61,"[44,64)",M,5,NA,2024-09-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5872,UM,76,"[74,84)",F,7,NA,2024-09-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5873,NP,55,"[44,64)",M,5,NA,2024-09-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5874,EY,1,"[1,14)",M,NA,NA,2024-09-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5875,XW,70,"[64,74)",M,5,NA,2024-09-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5876,WW,47,"[44,64)",M,4,NA,2024-09-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5877,FF,85,"[84,Inf)",F,8,NA,2024-09-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5878,VT,76,"[74,84)",M,7,NA,2024-09-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5879,MQ,70,"[64,74)",M,7,NA,2024-09-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5880,JO,63,"[44,64)",F,5,104.7018633810441,2024-09-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5881,IF,82,"[74,84)",M,6,NA,2024-09-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5882,MR,62,"[44,64)",M,6,NA,2024-09-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5883,LO,94,"[84,Inf)",M,8,NA,2024-09-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5884,MH,83,"[74,84)",F,7,NA,2024-09-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5885,CU,79,"[74,84)",M,6,NA,2024-09-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5886,GS,91,"[84,Inf)",M,7,NA,2024-09-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5887,BG,96,"[84,Inf)",F,7,NA,2024-09-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5888,JG,85,"[84,Inf)",M,8,NA,2024-09-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5889,HF,89,"[84,Inf)",M,9,47.38638923777289,2024-09-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5890,RQ,84,"[84,Inf)",F,9,NA,2024-09-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5891,SZ,0,"[0,1)",F,NA,NA,2024-09-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5892,MY,77,"[74,84)",M,7,57.8981453800265,2024-09-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5893,IT,55,"[44,64)",M,4,NA,2024-09-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5894,UF,0,"[0,1)",M,NA,NA,2024-09-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5895,TC,51,"[44,64)",M,5,NA,2024-09-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5896,IJ,54,"[44,64)",M,5,NA,2024-09-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5897,FT,69,"[64,74)",M,7,NA,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5898,SD,70,"[64,74)",M,7,NA,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5899,YM,96,"[84,Inf)",M,8,NA,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5900,IR,66,"[64,74)",M,7,NA,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5901,KH,79,"[74,84)",M,8,NA,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5902,SG,53,"[44,64)",F,6,NA,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5903,RA,62,"[44,64)",M,4,NA,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5904,HZ,60,"[44,64)",F,6,89.68862537695098,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5905,WP,67,"[64,74)",M,7,NA,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5906,EX,50,"[44,64)",M,5,NA,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5907,TH,48,"[44,64)",F,3,NA,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5908,WG,78,"[74,84)",M,8,NA,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5909,AV,52,"[44,64)",M,4,NA,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5910,NV,66,"[64,74)",F,7,69.57699758112986,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5911,SH,0,"[0,1)",M,NA,NA,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5912,XO,81,"[74,84)",M,8,NA,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5913,BG,0,"[0,1)",M,NA,NA,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5914,YC,63,"[44,64)",M,6,96.16369597523433,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5915,TA,62,"[44,64)",M,5,88.09069779176711,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5916,IY,68,"[64,74)",M,5,93.35380639381015,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5917,ME,92,"[84,Inf)",M,8,NA,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5918,VK,42,"[14,44)",M,4,NA,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5919,OF,62,"[44,64)",M,5,NA,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5920,ON,78,"[74,84)",F,8,NA,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5921,QB,62,"[44,64)",F,5,96.56985083922945,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5922,GQ,66,"[64,74)",M,6,NA,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5923,NB,77,"[74,84)",M,6,NA,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5924,XV,71,"[64,74)",M,5,NA,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5925,OB,60,"[44,64)",M,6,89.65764605058747,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5926,ZB,61,"[44,64)",F,6,60.62083869450625,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5927,CF,81,"[74,84)",F,7,NA,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5928,YF,87,"[84,Inf)",M,8,NA,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5929,ZC,47,"[44,64)",M,5,88.91811424557163,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5930,JU,85,"[84,Inf)",M,8,NA,2024-09-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5931,BA,75,"[74,84)",M,8,NA,2024-09-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5932,SB,62,"[44,64)",M,6,97.49306794653687,2024-09-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5933,HE,71,"[64,74)",M,7,89.87491723049956,2024-09-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5934,PE,59,"[44,64)",F,6,NA,2024-09-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5935,AX,51,"[44,64)",M,4,NA,2024-09-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5936,UT,83,"[74,84)",M,8,NA,2024-09-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5937,SS,41,"[14,44)",F,2,NA,2024-09-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5938,QR,88,"[84,Inf)",M,6,NA,2024-09-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5939,WF,53,"[44,64)",M,4,NA,2024-09-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5940,IP,75,"[74,84)",M,6,NA,2024-09-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5941,QS,74,"[74,84)",M,7,NA,2024-09-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5942,RS,94,"[84,Inf)",M,9,NA,2024-09-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5943,FC,68,"[64,74)",M,3,NA,2024-09-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5944,XT,74,"[74,84)",M,8,NA,2024-09-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5945,MO,58,"[44,64)",M,6,NA,2024-09-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5946,TH,73,"[64,74)",M,6,96.35702102186079,2024-09-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5947,FL,77,"[74,84)",M,6,NA,2024-09-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5948,LN,59,"[44,64)",M,6,88.51788649434064,2024-09-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5949,LS,89,"[84,Inf)",M,8,NA,2024-09-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5950,VB,79,"[74,84)",M,7,NA,2024-09-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5951,DD,75,"[74,84)",F,7,46.954414129181494,2024-09-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5952,HJ,75,"[74,84)",F,5,NA,2024-09-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5953,DH,75,"[74,84)",M,6,NA,2024-09-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5954,VB,64,"[64,74)",M,8,NA,2024-09-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5955,YC,41,"[14,44)",M,3,NA,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5956,ON,59,"[44,64)",M,6,NA,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5957,HB,35,"[14,44)",M,3,NA,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5958,MC,70,"[64,74)",F,6,73.66699311286604,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5959,OT,93,"[84,Inf)",F,7,28.900172121797233,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5960,SR,78,"[74,84)",M,8,NA,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5961,FB,92,"[84,Inf)",F,8,NA,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5962,NN,48,"[44,64)",M,5,NA,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5963,ID,35,"[14,44)",M,2,77.59356075530387,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5964,IS,68,"[64,74)",F,7,NA,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5965,GU,47,"[44,64)",M,4,NA,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5966,QK,68,"[64,74)",M,7,NA,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5967,EE,86,"[84,Inf)",F,9,NA,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5968,GZ,82,"[74,84)",M,8,NA,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5969,XK,60,"[44,64)",F,5,NA,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5970,AF,81,"[74,84)",F,8,26.7783719433802,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5971,LU,60,"[44,64)",M,6,NA,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5972,ED,47,"[44,64)",M,4,124.60235735887369,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5973,ET,65,"[64,74)",M,5,NA,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5974,RW,70,"[64,74)",M,8,NA,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5975,YX,83,"[74,84)",F,8,NA,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5976,UU,63,"[44,64)",M,5,NA,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5977,OU,74,"[74,84)",M,6,NA,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5978,XC,82,"[74,84)",M,8,NA,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5979,SE,59,"[44,64)",M,6,NA,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5980,GG,61,"[44,64)",M,7,NA,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5981,QH,91,"[84,Inf)",M,7,NA,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5982,SG,73,"[64,74)",M,6,75.314274547373,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5983,MB,61,"[44,64)",M,5,NA,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5984,NM,63,"[44,64)",M,3,NA,2024-09-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5985,JD,31,"[14,44)",M,2,NA,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5986,BF,62,"[44,64)",F,6,NA,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5987,EZ,49,"[44,64)",M,5,NA,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5988,DN,91,"[84,Inf)",M,7,NA,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5989,XU,88,"[84,Inf)",M,8,34.54038516037481,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5990,VT,100,"[84,Inf)",F,7,NA,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5991,MM,44,"[44,64)",F,5,NA,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5992,DQ,88,"[84,Inf)",M,7,NA,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5993,DZ,67,"[64,74)",M,8,NA,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5994,UH,69,"[64,74)",F,6,NA,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5995,MB,86,"[84,Inf)",M,9,NA,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5996,MQ,53,"[44,64)",M,7,NA,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5997,EB,38,"[14,44)",M,4,NA,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5998,FE,55,"[44,64)",F,4,NA,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
5999,IJ,34,"[14,44)",M,3,NA,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6000,AH,85,"[84,Inf)",M,6,NA,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6001,IA,43,"[14,44)",M,4,NA,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6002,PC,60,"[44,64)",M,2,NA,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6003,AZ,44,"[44,64)",M,4,NA,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6004,DC,81,"[74,84)",F,6,NA,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6005,LQ,71,"[64,74)",F,6,NA,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6006,YG,89,"[84,Inf)",M,8,NA,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6007,SQ,87,"[84,Inf)",M,9,55.17124249684565,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6008,ZE,87,"[84,Inf)",F,7,NA,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6009,LX,59,"[44,64)",M,5,NA,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6010,CO,74,"[74,84)",F,7,NA,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6011,LU,64,"[64,74)",M,6,79.4268716750473,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6012,TS,91,"[84,Inf)",M,7,NA,2024-09-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6013,EU,73,"[64,74)",F,7,74.64464969766932,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6014,VO,64,"[64,74)",M,6,NA,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6015,XK,80,"[74,84)",F,6,NA,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6016,XK,62,"[44,64)",M,6,NA,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6017,AB,0,"[0,1)",M,NA,NA,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6018,ZD,97,"[84,Inf)",F,8,28.83526611604238,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6019,FG,63,"[44,64)",M,5,NA,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6020,FU,0,"[0,1)",M,NA,NA,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6021,QQ,72,"[64,74)",F,7,87.92273139380569,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6022,WO,53,"[44,64)",F,5,NA,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6023,CB,63,"[44,64)",M,5,NA,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6024,TB,51,"[44,64)",M,5,NA,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6025,WO,90,"[84,Inf)",M,8,46.73004513474037,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6026,ZZ,0,"[0,1)",F,NA,NA,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6027,RH,80,"[74,84)",F,6,NA,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6028,RK,70,"[64,74)",M,7,69.12030239862052,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6029,YE,80,"[74,84)",M,9,48.00886127713175,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6030,DX,66,"[64,74)",M,5,NA,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6031,HY,57,"[44,64)",M,3,NA,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6032,OG,67,"[64,74)",M,5,NA,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6033,TQ,75,"[74,84)",M,6,NA,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6034,KU,82,"[74,84)",M,7,NA,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6035,WR,65,"[64,74)",F,7,NA,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6036,GR,82,"[74,84)",F,8,NA,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6037,XT,1,"[1,14)",F,NA,NA,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6038,LU,63,"[44,64)",M,6,NA,2024-09-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6039,LN,88,"[84,Inf)",M,7,NA,2024-09-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6040,PA,66,"[64,74)",M,7,95.55582593225998,2024-09-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6041,XJ,84,"[84,Inf)",M,6,NA,2024-09-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6042,UO,93,"[84,Inf)",M,8,NA,2024-09-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6043,KS,75,"[74,84)",M,6,NA,2024-09-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6044,EL,88,"[84,Inf)",M,7,NA,2024-09-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6045,TW,85,"[84,Inf)",M,7,NA,2024-09-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6046,QB,73,"[64,74)",F,8,NA,2024-09-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6047,LR,77,"[74,84)",F,5,NA,2024-09-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6048,UP,69,"[64,74)",F,4,NA,2024-09-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6049,GO,87,"[84,Inf)",M,7,25.794613640474704,2024-09-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6050,TP,86,"[84,Inf)",F,7,NA,2024-09-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6051,LL,53,"[44,64)",M,4,NA,2024-09-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6052,IY,72,"[64,74)",F,6,84.69596600620348,2024-09-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6053,JK,74,"[74,84)",M,7,NA,2024-09-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6054,RW,90,"[84,Inf)",M,8,NA,2024-09-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6055,LJ,48,"[44,64)",M,5,NA,2024-09-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6056,SI,53,"[44,64)",M,5,84.42415930395977,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6057,HC,37,"[14,44)",M,5,NA,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6058,YJ,63,"[44,64)",M,5,94.44929547140106,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6059,FE,94,"[84,Inf)",M,9,47.918197809417116,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6060,KM,62,"[44,64)",F,7,NA,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6061,WS,58,"[44,64)",M,6,NA,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6062,YL,92,"[84,Inf)",M,9,NA,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6063,QU,89,"[84,Inf)",M,8,NA,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6064,ME,93,"[84,Inf)",F,8,38.0786209596846,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6065,WK,87,"[84,Inf)",M,8,41.43456098135518,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6066,DV,55,"[44,64)",M,6,142.1054238906925,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6067,QE,58,"[44,64)",M,6,100.97842459266298,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6068,BO,74,"[74,84)",F,5,NA,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6069,OX,62,"[44,64)",F,5,57.12920124935571,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6070,ZZ,48,"[44,64)",M,5,NA,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6071,SI,85,"[84,Inf)",M,7,NA,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6072,RC,28,"[14,44)",M,2,NA,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6073,TU,75,"[74,84)",M,8,NA,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6074,SD,63,"[44,64)",F,6,NA,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6075,LQ,80,"[74,84)",M,7,NA,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6076,TD,88,"[84,Inf)",F,8,NA,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6077,OB,63,"[44,64)",F,7,NA,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6078,LV,52,"[44,64)",F,5,NA,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6079,AC,52,"[44,64)",M,5,NA,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6080,YE,90,"[84,Inf)",M,8,NA,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6081,RK,42,"[14,44)",M,5,NA,2024-09-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6082,JQ,56,"[44,64)",F,6,NA,2024-09-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6083,MI,74,"[74,84)",M,7,69.92648342029105,2024-09-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6084,RG,80,"[74,84)",M,8,NA,2024-09-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6085,FY,73,"[64,74)",M,4,NA,2024-09-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6086,SD,82,"[74,84)",M,7,NA,2024-09-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6087,YF,75,"[74,84)",M,7,NA,2024-09-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6088,FN,35,"[14,44)",M,3,93.15004004476431,2024-09-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6089,EX,75,"[74,84)",M,8,NA,2024-09-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6090,JH,33,"[14,44)",M,2,NA,2024-09-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6091,XP,62,"[44,64)",M,6,NA,2024-09-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6092,IX,47,"[44,64)",F,5,NA,2024-09-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6093,XI,58,"[44,64)",M,5,NA,2024-09-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6094,PQ,88,"[84,Inf)",M,7,NA,2024-09-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6095,XH,68,"[64,74)",M,7,NA,2024-09-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6096,ZS,67,"[64,74)",M,5,71.64851245212239,2024-09-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6097,AL,67,"[64,74)",F,6,130.78735671236936,2024-09-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6098,VB,60,"[44,64)",F,5,NA,2024-09-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6099,NJ,53,"[44,64)",F,6,NA,2024-09-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6100,VG,60,"[44,64)",M,5,NA,2024-09-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6101,FM,56,"[44,64)",F,6,NA,2024-09-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6102,QD,64,"[64,74)",F,7,51.539458829599496,2024-09-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6103,HW,82,"[74,84)",M,7,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6104,VG,83,"[74,84)",M,8,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6105,LU,61,"[44,64)",M,5,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6106,KP,68,"[64,74)",F,6,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6107,BQ,85,"[84,Inf)",F,8,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6108,YZ,57,"[44,64)",F,5,78.65537171715323,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6109,KF,36,"[14,44)",M,3,91.29233277928874,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6110,AF,47,"[44,64)",M,3,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6111,ZJ,75,"[74,84)",M,7,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6112,YS,48,"[44,64)",M,4,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6113,JX,72,"[64,74)",M,8,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6114,KU,90,"[84,Inf)",M,7,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6115,AZ,61,"[44,64)",F,6,67.94347003002098,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6116,IP,79,"[74,84)",M,7,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6117,AV,87,"[84,Inf)",M,7,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6118,RS,62,"[44,64)",F,5,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6119,IR,65,"[64,74)",M,5,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6120,AF,29,"[14,44)",M,3,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6121,MI,79,"[74,84)",M,7,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6122,GT,68,"[64,74)",M,7,72.4396910293908,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6123,RO,75,"[74,84)",M,6,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6124,AI,75,"[74,84)",F,7,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6125,MR,75,"[74,84)",M,7,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6126,LK,84,"[84,Inf)",F,9,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6127,AG,79,"[74,84)",M,7,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6128,KY,97,"[84,Inf)",F,8,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6129,AJ,75,"[74,84)",M,8,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6130,QR,85,"[84,Inf)",M,7,42.42159052670163,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6131,BV,88,"[84,Inf)",M,7,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6132,HN,53,"[44,64)",M,4,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6133,HH,91,"[84,Inf)",M,7,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6134,WL,74,"[74,84)",F,6,NA,2024-09-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6135,II,77,"[74,84)",F,7,60.61803710456361,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6136,VK,88,"[84,Inf)",M,7,NA,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6137,LI,49,"[44,64)",M,4,132.72222109002558,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6138,MC,90,"[84,Inf)",M,7,NA,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6139,MH,80,"[74,84)",M,7,NA,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6140,YY,51,"[44,64)",F,5,NA,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6141,UD,69,"[64,74)",F,6,100.28493781138525,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6142,UQ,73,"[64,74)",F,5,66.97365190425978,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6143,JK,78,"[74,84)",M,6,NA,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6144,PP,84,"[84,Inf)",M,9,NA,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6145,IL,65,"[64,74)",M,4,NA,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6146,UF,52,"[44,64)",M,6,NA,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6147,YK,59,"[44,64)",F,5,NA,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6148,GE,65,"[64,74)",F,5,NA,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6149,EI,40,"[14,44)",M,1,NA,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6150,PE,89,"[84,Inf)",M,8,48.40821452034904,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6151,GJ,87,"[84,Inf)",M,9,NA,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6152,VS,36,"[14,44)",M,4,NA,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6153,HX,84,"[84,Inf)",M,6,NA,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6154,BV,50,"[44,64)",F,4,NA,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6155,PK,79,"[74,84)",F,5,NA,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6156,CR,39,"[14,44)",M,4,NA,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6157,MS,61,"[44,64)",F,4,65.85874232848292,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6158,ZK,59,"[44,64)",M,4,NA,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6159,WM,0,"[0,1)",M,NA,NA,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6160,IP,56,"[44,64)",M,4,NA,2024-09-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6161,OI,31,"[14,44)",M,4,NA,2024-09-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6162,TE,83,"[74,84)",M,7,53.29269113170705,2024-09-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6163,SP,46,"[44,64)",M,3,97.15941031168812,2024-09-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6164,EZ,76,"[74,84)",M,7,45.47602065109677,2024-09-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6165,PR,77,"[74,84)",M,7,NA,2024-09-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6166,JN,82,"[74,84)",F,8,63.234832362754716,2024-09-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6167,VU,84,"[84,Inf)",M,8,NA,2024-09-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6168,XS,86,"[84,Inf)",M,7,NA,2024-09-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6169,EQ,51,"[44,64)",M,4,NA,2024-09-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6170,LI,87,"[84,Inf)",M,8,46.25283983318579,2024-09-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6171,YW,65,"[64,74)",F,5,NA,2024-09-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6172,PX,1,"[1,14)",F,NA,NA,2024-09-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6173,LD,48,"[44,64)",M,5,NA,2024-09-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6174,IH,64,"[64,74)",M,6,NA,2024-09-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6175,VK,34,"[14,44)",F,3,NA,2024-09-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6176,XP,68,"[64,74)",F,5,NA,2024-09-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6177,WU,73,"[64,74)",M,7,NA,2024-09-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6178,ZC,58,"[44,64)",F,6,NA,2024-09-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6179,FY,83,"[74,84)",M,8,NA,2024-09-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6180,DL,51,"[44,64)",F,2,83.46750753027385,2024-09-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6181,GS,59,"[44,64)",F,5,NA,2024-09-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6182,EH,72,"[64,74)",F,7,49.62086124117727,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6183,DT,73,"[64,74)",M,7,NA,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6184,GB,46,"[44,64)",M,3,NA,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6185,JG,72,"[64,74)",M,6,NA,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6186,HS,74,"[74,84)",F,6,NA,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6187,DI,39,"[14,44)",F,2,NA,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6188,LD,58,"[44,64)",M,5,NA,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6189,HT,47,"[44,64)",F,5,NA,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6190,EV,63,"[44,64)",M,5,NA,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6191,ZZ,78,"[74,84)",M,6,51.1347993994491,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6192,GS,71,"[64,74)",F,4,NA,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6193,SN,59,"[44,64)",F,4,NA,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6194,RC,57,"[44,64)",F,4,NA,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6195,DL,85,"[84,Inf)",M,6,47.14957621827039,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6196,YS,61,"[44,64)",M,4,NA,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6197,ZA,82,"[74,84)",M,8,NA,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6198,JT,72,"[64,74)",M,7,NA,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6199,PE,80,"[74,84)",M,8,46.385255386320004,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6200,WR,58,"[44,64)",M,4,NA,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6201,ME,77,"[74,84)",M,9,NA,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6202,QT,29,"[14,44)",M,3,NA,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6203,DI,58,"[44,64)",M,5,NA,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6204,ES,77,"[74,84)",M,6,NA,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6205,XL,74,"[74,84)",F,7,NA,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6206,KK,88,"[84,Inf)",M,8,NA,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6207,OU,60,"[44,64)",F,6,NA,2024-09-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6208,VV,46,"[44,64)",F,4,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6209,SQ,86,"[84,Inf)",F,9,41.79475041495586,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6210,BY,79,"[74,84)",M,5,63.27667367761182,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6211,FN,74,"[74,84)",M,7,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6212,FJ,91,"[84,Inf)",M,8,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6213,UR,79,"[74,84)",F,8,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6214,NQ,61,"[44,64)",M,6,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6215,VE,70,"[64,74)",F,6,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6216,XD,75,"[74,84)",M,6,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6217,HK,68,"[64,74)",M,7,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6218,BV,73,"[64,74)",M,6,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6219,IA,70,"[64,74)",M,7,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6220,MO,77,"[74,84)",M,6,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6221,WW,65,"[64,74)",M,6,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6222,IS,72,"[64,74)",F,5,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6223,SM,78,"[74,84)",M,8,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6224,UQ,89,"[84,Inf)",M,8,30.412122804450977,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6225,PC,74,"[74,84)",F,7,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6226,KG,67,"[64,74)",F,5,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6227,CJ,81,"[74,84)",M,8,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6228,VB,81,"[74,84)",F,8,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6229,RP,74,"[74,84)",M,6,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6230,MF,1,"[1,14)",M,NA,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6231,NZ,81,"[74,84)",M,7,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6232,NO,86,"[84,Inf)",M,7,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6233,XT,75,"[74,84)",M,7,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6234,JG,42,"[14,44)",M,5,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6235,TV,86,"[84,Inf)",M,8,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6236,WQ,24,"[14,44)",M,4,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6237,RI,86,"[84,Inf)",F,9,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6238,JX,70,"[64,74)",F,6,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6239,TS,75,"[74,84)",M,8,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6240,YO,65,"[64,74)",F,6,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6241,DG,24,"[14,44)",M,3,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6242,QP,91,"[84,Inf)",M,9,NA,2024-09-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6243,WU,59,"[44,64)",M,6,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6244,GE,75,"[74,84)",F,8,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6245,UY,38,"[14,44)",M,2,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6246,CC,96,"[84,Inf)",M,9,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6247,QZ,72,"[64,74)",M,6,65.76448375319879,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6248,UZ,66,"[64,74)",M,7,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6249,OG,100,"[84,Inf)",F,9,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6250,RH,63,"[44,64)",F,5,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6251,CY,77,"[74,84)",F,7,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6252,LA,63,"[44,64)",M,4,76.81153087475049,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6253,KZ,43,"[14,44)",M,3,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6254,LP,65,"[64,74)",M,4,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6255,QF,82,"[74,84)",M,7,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6256,OB,78,"[74,84)",M,8,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6257,MT,59,"[44,64)",M,4,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6258,GI,43,"[14,44)",F,5,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6259,LB,1,"[1,14)",F,NA,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6260,TO,66,"[64,74)",F,6,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6261,DX,54,"[44,64)",F,6,112.14312353519352,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6262,EI,69,"[64,74)",F,6,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6263,SP,63,"[44,64)",F,7,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6264,VX,75,"[74,84)",M,7,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6265,NX,71,"[64,74)",F,6,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6266,SF,95,"[84,Inf)",M,8,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6267,UL,37,"[14,44)",M,4,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6268,CC,54,"[44,64)",M,5,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6269,RY,69,"[64,74)",M,6,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6270,BQ,59,"[44,64)",M,6,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6271,DK,49,"[44,64)",F,4,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6272,BZ,87,"[84,Inf)",F,7,NA,2024-09-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6273,JS,77,"[74,84)",M,7,78.11075002579707,2024-09-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6274,SM,90,"[84,Inf)",M,9,NA,2024-09-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6275,NP,84,"[84,Inf)",M,7,NA,2024-09-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6276,NW,86,"[84,Inf)",M,7,NA,2024-09-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6277,BJ,83,"[74,84)",M,7,NA,2024-09-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6278,LY,75,"[74,84)",F,8,48.978778957193484,2024-09-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6279,RB,89,"[84,Inf)",M,9,39.72171058050984,2024-09-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6280,XG,76,"[74,84)",F,8,NA,2024-09-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6281,MH,63,"[44,64)",M,6,NA,2024-09-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6282,PD,90,"[84,Inf)",M,7,NA,2024-09-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6283,FX,79,"[74,84)",M,7,NA,2024-09-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6284,IM,68,"[64,74)",M,7,NA,2024-09-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6285,NE,79,"[74,84)",M,9,NA,2024-09-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6286,JM,80,"[74,84)",M,8,NA,2024-09-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6287,FT,89,"[84,Inf)",F,8,NA,2024-09-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6288,ML,30,"[14,44)",M,2,NA,2024-09-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6289,TB,69,"[64,74)",M,6,66.65293723543829,2024-09-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6290,IS,72,"[64,74)",M,7,NA,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6291,XB,67,"[64,74)",M,8,73.72994486495082,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6292,CM,71,"[64,74)",M,8,NA,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6293,YI,88,"[84,Inf)",M,8,NA,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6294,RZ,71,"[64,74)",M,5,96.38200282224123,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6295,CM,74,"[74,84)",F,6,NA,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6296,CS,88,"[84,Inf)",M,8,NA,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6297,LB,70,"[64,74)",M,7,NA,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6298,JC,66,"[64,74)",F,6,89.24254339486258,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6299,PH,88,"[84,Inf)",F,9,NA,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6300,SI,58,"[44,64)",M,7,NA,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6301,RP,38,"[14,44)",M,2,NA,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6302,SS,0,"[0,1)",F,NA,NA,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6303,QQ,75,"[74,84)",M,6,NA,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6304,LT,80,"[74,84)",F,7,NA,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6305,UE,61,"[44,64)",M,7,NA,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6306,JP,60,"[44,64)",M,6,72.52933073652676,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6307,QE,74,"[74,84)",F,7,NA,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6308,IA,78,"[74,84)",F,9,NA,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6309,HC,83,"[74,84)",F,7,NA,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6310,PO,67,"[64,74)",M,5,NA,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6311,EB,90,"[84,Inf)",F,9,NA,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6312,HT,70,"[64,74)",F,6,123.72026358224805,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6313,IB,65,"[64,74)",M,4,NA,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6314,ID,64,"[64,74)",M,7,65.56933179264331,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6315,IA,74,"[74,84)",F,7,NA,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6316,AA,41,"[14,44)",M,2,NA,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6317,ZH,76,"[74,84)",M,6,NA,2024-09-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6318,AF,66,"[64,74)",F,5,50.79885731648532,2024-09-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6319,XS,84,"[84,Inf)",M,8,67.8243521575878,2024-09-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6320,GF,73,"[64,74)",M,6,NA,2024-09-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6321,YQ,85,"[84,Inf)",M,9,NA,2024-09-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6322,FC,65,"[64,74)",F,7,NA,2024-09-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6323,ZX,73,"[64,74)",F,8,NA,2024-09-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6324,BC,69,"[64,74)",M,5,NA,2024-09-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6325,VX,76,"[74,84)",M,7,NA,2024-09-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6326,LD,70,"[64,74)",F,8,NA,2024-09-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6327,OK,76,"[74,84)",M,7,61.12816684636464,2024-09-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6328,XA,2,"[1,14)",M,NA,NA,2024-09-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6329,HP,72,"[64,74)",M,5,NA,2024-09-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6330,EB,91,"[84,Inf)",M,9,NA,2024-09-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6331,QX,86,"[84,Inf)",M,6,NA,2024-09-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6332,IU,61,"[44,64)",M,6,80.11923545466145,2024-09-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6333,LS,57,"[44,64)",M,4,NA,2024-09-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6334,IS,66,"[64,74)",M,5,NA,2024-09-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6335,DK,86,"[84,Inf)",M,7,NA,2024-09-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6336,KS,87,"[84,Inf)",M,9,NA,2024-09-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6337,LZ,68,"[64,74)",F,7,NA,2024-09-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6338,UR,76,"[74,84)",M,7,NA,2024-09-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6339,AZ,61,"[44,64)",F,7,NA,2024-09-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6340,DW,70,"[64,74)",M,7,NA,2024-09-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6341,MI,56,"[44,64)",F,6,144.92046191954623,2024-09-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6342,LK,52,"[44,64)",M,4,NA,2024-09-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6343,IU,38,"[14,44)",M,3,93.02063759950964,2024-09-23,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6344,TH,64,"[64,74)",M,6,NA,2024-09-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6345,NZ,68,"[64,74)",M,5,NA,2024-09-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6346,XA,46,"[44,64)",F,4,NA,2024-09-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6347,BL,81,"[74,84)",M,8,NA,2024-09-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6348,QH,88,"[84,Inf)",F,8,NA,2024-09-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6349,SA,62,"[44,64)",F,5,NA,2024-09-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6350,ST,86,"[84,Inf)",M,6,62.01098934206386,2024-09-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6351,VV,64,"[64,74)",F,6,NA,2024-09-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6352,QW,52,"[44,64)",M,7,NA,2024-09-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6353,DB,76,"[74,84)",M,6,62.18365495498872,2024-09-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6354,ZB,91,"[84,Inf)",M,9,NA,2024-09-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6355,FV,50,"[44,64)",M,4,NA,2024-09-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6356,JZ,79,"[74,84)",M,6,44.74098393109232,2024-09-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6357,BD,86,"[84,Inf)",M,6,NA,2024-09-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6358,AR,80,"[74,84)",F,4,41.66021490220215,2024-09-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6359,LM,66,"[64,74)",M,7,NA,2024-09-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6360,PV,32,"[14,44)",M,2,NA,2024-09-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6361,GA,71,"[64,74)",M,6,93.06440994649182,2024-09-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6362,QI,70,"[64,74)",M,8,NA,2024-09-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6363,JD,53,"[44,64)",M,5,NA,2024-09-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6364,YL,77,"[74,84)",F,8,NA,2024-09-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6365,EJ,63,"[44,64)",M,6,NA,2024-09-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6366,FD,56,"[44,64)",M,7,105.69724356281972,2024-09-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6367,FH,0,"[0,1)",M,NA,NA,2024-09-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6368,OE,77,"[74,84)",M,8,NA,2024-09-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6369,FG,45,"[44,64)",M,4,NA,2024-09-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6370,PL,69,"[64,74)",M,8,NA,2024-09-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6371,IX,51,"[44,64)",M,4,NA,2024-09-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6372,XU,76,"[74,84)",F,6,NA,2024-09-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6373,EC,75,"[74,84)",M,6,NA,2024-09-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6374,MI,70,"[64,74)",F,6,NA,2024-09-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6375,GE,61,"[44,64)",F,6,NA,2024-09-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6376,UK,87,"[84,Inf)",M,8,NA,2024-09-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6377,UK,77,"[74,84)",F,8,NA,2024-09-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6378,CB,62,"[44,64)",M,7,NA,2024-09-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6379,QS,86,"[84,Inf)",M,7,NA,2024-09-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6380,QO,68,"[64,74)",M,5,69.71626964430662,2024-09-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6381,OZ,74,"[74,84)",M,5,NA,2024-09-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6382,AZ,89,"[84,Inf)",M,7,NA,2024-09-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6383,LA,46,"[44,64)",F,6,NA,2024-09-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6384,AX,47,"[44,64)",M,5,114.6184799154181,2024-09-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6385,BI,71,"[64,74)",F,7,NA,2024-09-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6386,WZ,51,"[44,64)",F,6,77.28038667767395,2024-09-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6387,HA,77,"[74,84)",M,6,NA,2024-09-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6388,RF,84,"[84,Inf)",M,8,NA,2024-09-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6389,TQ,88,"[84,Inf)",F,9,NA,2024-09-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6390,VD,88,"[84,Inf)",F,9,NA,2024-09-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6391,SS,78,"[74,84)",M,6,38.947976274973456,2024-09-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6392,QI,72,"[64,74)",F,6,NA,2024-09-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6393,KB,74,"[74,84)",F,8,NA,2024-09-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6394,BB,65,"[64,74)",F,6,79.35075685774743,2024-09-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6395,GQ,84,"[84,Inf)",M,7,50.82955995964882,2024-09-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6396,OY,82,"[74,84)",M,8,NA,2024-09-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6397,UC,84,"[84,Inf)",M,8,NA,2024-09-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6398,WR,57,"[44,64)",F,4,NA,2024-09-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6399,DL,73,"[64,74)",M,8,99.05438219118172,2024-09-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6400,UT,76,"[74,84)",M,5,NA,2024-09-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6401,HL,60,"[44,64)",F,4,NA,2024-09-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6402,GG,88,"[84,Inf)",M,7,NA,2024-09-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6403,SK,76,"[74,84)",F,6,NA,2024-09-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6404,EV,75,"[74,84)",M,7,NA,2024-09-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6405,KJ,74,"[74,84)",M,6,NA,2024-09-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6406,PH,43,"[14,44)",F,3,NA,2024-09-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6407,OM,59,"[44,64)",F,5,NA,2024-09-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6408,BT,95,"[84,Inf)",M,9,NA,2024-09-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6409,GY,76,"[74,84)",M,8,52.907546479833414,2024-09-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6410,AG,60,"[44,64)",M,6,NA,2024-09-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6411,GG,89,"[84,Inf)",M,8,NA,2024-09-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6412,IU,82,"[74,84)",M,8,NA,2024-09-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6413,UT,88,"[84,Inf)",M,8,NA,2024-09-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6414,TN,56,"[44,64)",M,4,NA,2024-09-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6415,BL,71,"[64,74)",M,5,NA,2024-09-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6416,TQ,69,"[64,74)",M,6,79.43658317273727,2024-09-26,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6417,GS,59,"[44,64)",M,7,NA,2024-09-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6418,NG,0,"[0,1)",F,NA,NA,2024-09-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6419,UN,94,"[84,Inf)",M,8,NA,2024-09-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6420,SZ,61,"[44,64)",M,5,NA,2024-09-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6421,XA,74,"[74,84)",M,5,65.27229669547175,2024-09-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6422,PK,58,"[44,64)",M,6,NA,2024-09-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6423,RS,75,"[74,84)",M,7,43.874406046106316,2024-09-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6424,RU,92,"[84,Inf)",M,9,43.096345182242395,2024-09-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6425,LQ,69,"[64,74)",M,8,112.66098029821794,2024-09-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6426,KB,50,"[44,64)",M,4,NA,2024-09-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6427,SW,65,"[64,74)",M,6,NA,2024-09-26,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6428,DW,0,"[0,1)",F,NA,NA,2024-09-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6429,IF,72,"[64,74)",M,6,NA,2024-09-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6430,UX,2,"[1,14)",M,NA,NA,2024-09-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6431,SM,88,"[84,Inf)",M,8,NA,2024-09-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6432,SB,68,"[64,74)",F,7,NA,2024-09-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6433,ZX,83,"[74,84)",M,7,NA,2024-09-27,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6434,NS,68,"[64,74)",M,6,88.97646176850645,2024-09-27,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6435,FE,36,"[14,44)",F,1,NA,2024-09-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6436,YA,76,"[74,84)",M,6,NA,2024-09-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6437,PE,63,"[44,64)",M,5,NA,2024-09-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6438,HR,58,"[44,64)",F,5,NA,2024-09-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6439,HX,77,"[74,84)",M,5,NA,2024-09-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6440,GP,45,"[44,64)",F,4,NA,2024-09-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6441,MT,41,"[14,44)",M,5,NA,2024-09-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6442,FS,70,"[64,74)",M,6,NA,2024-09-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6443,EP,0,"[0,1)",M,NA,NA,2024-09-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6444,HI,0,"[0,1)",M,NA,NA,2024-09-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6445,JB,88,"[84,Inf)",M,8,NA,2024-09-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6446,IR,73,"[64,74)",M,7,NA,2024-09-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6447,VP,1,"[1,14)",F,NA,NA,2024-09-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6448,ZY,75,"[74,84)",M,6,83.12976517143646,2024-09-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6449,KJ,82,"[74,84)",F,7,NA,2024-09-27,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6450,LU,40,"[14,44)",M,4,NA,2024-09-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6451,VQ,95,"[84,Inf)",M,8,NA,2024-09-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6452,OO,82,"[74,84)",F,8,NA,2024-09-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6453,MD,46,"[44,64)",M,2,NA,2024-09-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6454,BN,82,"[74,84)",M,6,NA,2024-09-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6455,QC,86,"[84,Inf)",M,7,NA,2024-09-28,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6456,MA,0,"[0,1)",F,NA,NA,2024-09-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6457,JM,72,"[64,74)",M,6,NA,2024-09-28,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6458,KU,79,"[74,84)",M,7,NA,2024-09-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6459,YQ,63,"[44,64)",F,5,85.87569942104828,2024-09-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6460,GR,76,"[74,84)",M,8,NA,2024-09-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6461,VL,51,"[44,64)",M,4,NA,2024-09-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6462,IZ,36,"[14,44)",M,2,NA,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6463,AX,48,"[44,64)",M,3,NA,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6464,KX,71,"[64,74)",M,6,51.64536553253391,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6465,WT,85,"[84,Inf)",M,6,40.86234148532093,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6466,BU,87,"[84,Inf)",M,7,NA,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6467,XP,79,"[74,84)",F,6,125.0025899070996,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6468,PA,58,"[44,64)",M,6,NA,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6469,LR,39,"[14,44)",M,3,NA,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6470,VQ,74,"[74,84)",M,6,NA,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6471,UK,74,"[74,84)",F,6,NA,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6472,UT,91,"[84,Inf)",M,6,NA,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6473,ZA,96,"[84,Inf)",M,8,34.06346477740392,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6474,WG,76,"[74,84)",M,6,49.24588036066356,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6475,VS,70,"[64,74)",M,6,83.46695946009504,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6476,YN,56,"[44,64)",F,6,NA,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6477,EM,53,"[44,64)",M,6,NA,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6478,VH,71,"[64,74)",F,5,89.42270312344772,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6479,IG,1,"[1,14)",F,NA,NA,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6480,WU,83,"[74,84)",F,7,40.761004541636765,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6481,GI,78,"[74,84)",M,7,59.489846339910116,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6482,EN,50,"[44,64)",F,6,NA,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6483,KF,64,"[64,74)",M,6,NA,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6484,IH,58,"[44,64)",F,5,142.04150098057556,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6485,JF,78,"[74,84)",M,8,NA,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6486,BN,44,"[44,64)",M,3,NA,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6487,LS,0,"[0,1)",M,NA,NA,2024-09-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6488,JU,89,"[84,Inf)",M,8,48.83622509015794,2024-09-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6489,LH,60,"[44,64)",F,5,NA,2024-09-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6490,YA,35,"[14,44)",M,4,NA,2024-09-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6491,RF,63,"[44,64)",F,6,NA,2024-09-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6492,DW,55,"[44,64)",M,5,NA,2024-09-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6493,XK,91,"[84,Inf)",F,7,NA,2024-09-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6494,VQ,78,"[74,84)",M,7,NA,2024-09-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6495,ZV,72,"[64,74)",M,8,NA,2024-09-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6496,HT,59,"[44,64)",M,5,NA,2024-09-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6497,ZV,68,"[64,74)",F,5,NA,2024-09-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6498,HS,66,"[64,74)",F,7,NA,2024-09-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6499,YJ,75,"[74,84)",M,6,NA,2024-09-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6500,SK,94,"[84,Inf)",M,8,34.723122694356555,2024-09-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6501,PV,83,"[74,84)",M,9,NA,2024-09-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6502,ZZ,77,"[74,84)",M,7,NA,2024-09-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6503,IX,88,"[84,Inf)",F,8,NA,2024-09-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6504,PY,78,"[74,84)",M,7,NA,2024-09-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6505,RP,69,"[64,74)",M,5,79.62931252451203,2024-09-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6506,VN,71,"[64,74)",F,5,NA,2024-09-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6507,GV,95,"[84,Inf)",M,9,NA,2024-09-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6508,AP,52,"[44,64)",F,5,76.22237019036854,2024-09-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6509,PK,80,"[74,84)",M,8,NA,2024-09-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6510,RA,80,"[74,84)",M,6,NA,2024-09-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6511,UX,86,"[84,Inf)",M,8,NA,2024-09-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6512,OE,61,"[44,64)",F,4,NA,2024-09-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6513,SE,54,"[44,64)",M,4,105.91919939749377,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6514,UI,43,"[14,44)",M,4,NA,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6515,AX,72,"[64,74)",M,8,NA,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6516,XR,95,"[84,Inf)",M,9,NA,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6517,CO,69,"[64,74)",F,6,NA,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6518,WH,89,"[84,Inf)",F,7,NA,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6519,TI,19,"[14,44)",M,1,101.60402210380477,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6520,QI,70,"[64,74)",M,6,79.10533266351153,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6521,VZ,72,"[64,74)",M,6,NA,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6522,GG,56,"[44,64)",F,3,140.59916550441665,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6523,SO,59,"[44,64)",M,6,NA,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6524,LL,57,"[44,64)",M,5,NA,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6525,VE,67,"[64,74)",F,5,67.69861301970374,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6526,LR,48,"[44,64)",F,4,NA,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6527,HX,88,"[84,Inf)",M,7,46.772021439035704,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6528,ZD,73,"[64,74)",M,6,84.41864407948911,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6529,TG,86,"[84,Inf)",M,8,35.80954668091617,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6530,GI,47,"[44,64)",M,4,NA,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6531,PS,45,"[44,64)",F,3,116.15197023660937,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6532,CW,81,"[74,84)",M,8,NA,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6533,KK,67,"[64,74)",F,6,NA,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6534,YO,81,"[74,84)",M,7,NA,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6535,JQ,80,"[74,84)",M,8,NA,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6536,GV,89,"[84,Inf)",M,7,NA,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6537,SW,69,"[64,74)",M,6,NA,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6538,UG,37,"[14,44)",M,3,NA,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6539,QW,66,"[64,74)",M,6,NA,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6540,WB,67,"[64,74)",M,6,NA,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6541,WB,63,"[44,64)",F,5,NA,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6542,AZ,65,"[64,74)",M,7,NA,2024-10-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6543,UW,57,"[44,64)",M,5,NA,2024-10-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6544,BL,61,"[44,64)",F,5,NA,2024-10-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6545,HC,76,"[74,84)",M,8,79.64487014787963,2024-10-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6546,RU,74,"[74,84)",M,7,NA,2024-10-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6547,ED,50,"[44,64)",M,2,NA,2024-10-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6548,OM,33,"[14,44)",M,3,81.78176269889937,2024-10-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6549,OI,82,"[74,84)",M,7,42.849489582812836,2024-10-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6550,SO,83,"[74,84)",M,6,NA,2024-10-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6551,FE,76,"[74,84)",M,7,NA,2024-10-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6552,IV,45,"[44,64)",M,4,NA,2024-10-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6553,WY,1,"[1,14)",F,NA,NA,2024-10-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6554,GR,85,"[84,Inf)",M,7,NA,2024-10-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6555,GP,65,"[64,74)",M,6,NA,2024-10-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6556,NM,77,"[74,84)",M,8,NA,2024-10-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6557,ZU,96,"[84,Inf)",M,9,NA,2024-10-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6558,FD,82,"[74,84)",M,7,60.341475097098225,2024-10-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6559,RG,51,"[44,64)",F,5,NA,2024-10-02,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6560,HE,0,"[0,1)",F,NA,NA,2024-10-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6561,CA,94,"[84,Inf)",M,7,NA,2024-10-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6562,TW,0,"[0,1)",M,NA,NA,2024-10-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6563,ZW,61,"[44,64)",F,6,90.55355296848484,2024-10-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6564,FD,67,"[64,74)",F,7,NA,2024-10-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6565,LQ,66,"[64,74)",M,6,NA,2024-10-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6566,KQ,83,"[74,84)",M,9,NA,2024-10-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6567,BI,97,"[84,Inf)",M,8,NA,2024-10-03,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6568,TF,47,"[44,64)",M,4,83.6608079748431,2024-10-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6569,KN,39,"[14,44)",M,3,NA,2024-10-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6570,XP,0,"[0,1)",M,NA,NA,2024-10-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6571,HB,79,"[74,84)",F,7,NA,2024-10-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6572,SQ,46,"[44,64)",M,4,NA,2024-10-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6573,QA,84,"[84,Inf)",M,7,42.83527424773006,2024-10-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6574,JU,64,"[64,74)",F,5,NA,2024-10-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6575,DX,75,"[74,84)",F,6,NA,2024-10-03,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6576,TO,51,"[44,64)",M,3,NA,2024-10-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6577,PR,63,"[44,64)",M,6,NA,2024-10-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6578,QQ,84,"[84,Inf)",F,8,NA,2024-10-03,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6579,DS,88,"[84,Inf)",M,8,38.36545034664143,2024-10-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6580,NN,65,"[64,74)",F,5,NA,2024-10-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6581,NI,65,"[64,74)",M,6,105.17762339143148,2024-10-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6582,IS,91,"[84,Inf)",M,7,NA,2024-10-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6583,BA,39,"[14,44)",M,5,NA,2024-10-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6584,OD,80,"[74,84)",M,7,51.94435736052735,2024-10-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6585,PC,94,"[84,Inf)",M,7,NA,2024-10-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6586,AF,0,"[0,1)",F,NA,NA,2024-10-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6587,UI,87,"[84,Inf)",M,8,NA,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6588,YZ,90,"[84,Inf)",M,8,NA,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6589,FP,45,"[44,64)",M,5,NA,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6590,OE,64,"[64,74)",F,7,NA,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6591,SA,44,"[44,64)",F,3,NA,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6592,PZ,77,"[74,84)",M,8,NA,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6593,YS,79,"[74,84)",M,7,NA,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6594,YU,57,"[44,64)",M,5,NA,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6595,XX,88,"[84,Inf)",M,8,NA,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6596,FB,86,"[84,Inf)",F,7,43.936927333455955,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6597,SO,77,"[74,84)",M,7,59.67917200151052,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6598,MJ,72,"[64,74)",M,7,NA,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6599,RH,56,"[44,64)",M,5,NA,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6600,OL,58,"[44,64)",F,6,NA,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6601,AW,86,"[84,Inf)",M,7,54.05368986698981,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6602,EX,65,"[64,74)",M,6,NA,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6603,AL,79,"[74,84)",M,8,NA,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6604,DX,82,"[74,84)",F,6,NA,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6605,WU,93,"[84,Inf)",F,8,28.78937251595831,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6606,GV,80,"[74,84)",M,6,NA,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6607,NM,76,"[74,84)",M,8,NA,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6608,QL,88,"[84,Inf)",M,8,NA,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6609,YT,79,"[74,84)",M,8,NA,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6610,VP,39,"[14,44)",F,4,56.16094354902789,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6611,CJ,65,"[64,74)",F,5,NA,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6612,XU,87,"[84,Inf)",M,7,40.44267096293129,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6613,ND,79,"[74,84)",M,9,NA,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6614,BG,66,"[64,74)",M,6,NA,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6615,AF,70,"[64,74)",F,5,NA,2024-10-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6616,KA,92,"[84,Inf)",M,8,43.275168231968905,2024-10-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6617,XX,50,"[44,64)",F,5,NA,2024-10-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6618,BB,70,"[64,74)",M,6,85.27687527607101,2024-10-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6619,GG,40,"[14,44)",M,3,NA,2024-10-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6620,BT,47,"[44,64)",F,4,NA,2024-10-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6621,RA,42,"[14,44)",F,4,NA,2024-10-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6622,KW,65,"[64,74)",F,6,NA,2024-10-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6623,TV,63,"[44,64)",M,3,NA,2024-10-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6624,YI,79,"[74,84)",M,8,46.7574269763411,2024-10-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6625,MF,74,"[74,84)",M,7,NA,2024-10-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6626,RY,90,"[84,Inf)",M,8,45.93873550379628,2024-10-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6627,SP,81,"[74,84)",M,7,NA,2024-10-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6628,LJ,79,"[74,84)",F,8,65.12440916965657,2024-10-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6629,FK,1,"[1,14)",M,NA,NA,2024-10-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6630,PY,63,"[44,64)",M,6,NA,2024-10-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6631,RF,74,"[74,84)",M,7,NA,2024-10-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6632,XK,87,"[84,Inf)",M,9,NA,2024-10-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6633,KB,66,"[64,74)",M,5,NA,2024-10-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6634,HU,35,"[14,44)",F,2,NA,2024-10-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6635,LS,70,"[64,74)",F,6,NA,2024-10-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6636,OT,79,"[74,84)",M,7,NA,2024-10-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6637,YC,52,"[44,64)",M,4,NA,2024-10-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6638,GS,80,"[74,84)",F,8,35.01268193933921,2024-10-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6639,SS,61,"[44,64)",M,6,NA,2024-10-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6640,JA,39,"[14,44)",M,3,NA,2024-10-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6641,CZ,68,"[64,74)",F,6,NA,2024-10-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6642,CH,95,"[84,Inf)",F,9,NA,2024-10-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6643,RM,63,"[44,64)",M,5,NA,2024-10-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6644,SJ,55,"[44,64)",M,5,NA,2024-10-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6645,EW,16,"[14,44)",M,NA,NA,2024-10-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6646,PP,81,"[74,84)",M,7,NA,2024-10-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6647,QC,96,"[84,Inf)",F,9,NA,2024-10-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6648,YQ,91,"[84,Inf)",M,7,65.07319487451555,2024-10-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6649,ML,79,"[74,84)",F,7,NA,2024-10-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6650,LN,59,"[44,64)",M,5,NA,2024-10-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6651,PO,87,"[84,Inf)",M,7,NA,2024-10-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6652,WF,47,"[44,64)",M,6,NA,2024-10-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6653,JA,59,"[44,64)",F,5,NA,2024-10-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6654,JP,37,"[14,44)",M,3,NA,2024-10-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6655,KS,59,"[44,64)",M,5,NA,2024-10-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6656,WU,26,"[14,44)",M,3,131.521069575987,2024-10-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6657,WR,55,"[44,64)",M,7,NA,2024-10-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6658,CY,62,"[44,64)",M,6,NA,2024-10-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6659,QH,66,"[64,74)",M,8,NA,2024-10-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6660,IG,85,"[84,Inf)",M,7,NA,2024-10-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6661,DA,80,"[74,84)",M,8,NA,2024-10-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6662,PV,87,"[84,Inf)",M,9,55.40875722808208,2024-10-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6663,CZ,76,"[74,84)",F,7,NA,2024-10-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6664,KB,75,"[74,84)",M,7,49.897649557607615,2024-10-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6665,CF,73,"[64,74)",F,6,NA,2024-10-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6666,LW,21,"[14,44)",M,3,NA,2024-10-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6667,CI,1,"[1,14)",F,NA,NA,2024-10-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6668,DS,65,"[64,74)",M,8,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6669,CC,78,"[74,84)",M,8,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6670,DX,79,"[74,84)",M,7,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6671,VW,82,"[74,84)",M,7,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6672,HD,70,"[64,74)",M,6,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6673,ZV,66,"[64,74)",M,4,113.78864965985093,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6674,MQ,66,"[64,74)",M,6,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6675,YW,89,"[84,Inf)",M,8,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6676,MQ,76,"[74,84)",M,7,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6677,HC,76,"[74,84)",M,7,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6678,WS,70,"[64,74)",F,6,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6679,PR,58,"[44,64)",M,7,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6680,WO,84,"[84,Inf)",M,9,75.40302670330236,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6681,MK,42,"[14,44)",F,3,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6682,DD,76,"[74,84)",M,7,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6683,VF,39,"[14,44)",M,3,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6684,UW,80,"[74,84)",F,7,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6685,KY,76,"[74,84)",M,7,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6686,LK,54,"[44,64)",F,4,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6687,EX,70,"[64,74)",M,7,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6688,ND,55,"[44,64)",M,6,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6689,KQ,49,"[44,64)",F,5,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6690,SD,59,"[44,64)",F,4,107.12176560499705,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6691,VV,77,"[74,84)",M,7,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6692,DL,81,"[74,84)",M,7,54.03677894048669,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6693,GJ,0,"[0,1)",F,NA,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6694,OX,90,"[84,Inf)",M,8,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6695,ID,63,"[44,64)",M,6,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6696,GN,65,"[64,74)",M,7,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6697,YJ,86,"[84,Inf)",M,7,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6698,SA,83,"[74,84)",F,8,48.899293817539714,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6699,AL,69,"[64,74)",F,7,49.83961138584983,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6700,ID,85,"[84,Inf)",M,8,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6701,GK,58,"[44,64)",M,6,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6702,HB,68,"[64,74)",M,8,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6703,LK,53,"[44,64)",F,3,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6704,KL,60,"[44,64)",M,5,NA,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6705,EX,42,"[14,44)",M,3,92.95147365005451,2024-10-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6706,AV,64,"[64,74)",M,7,NA,2024-10-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6707,GT,85,"[84,Inf)",F,7,NA,2024-10-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6708,JW,80,"[74,84)",M,8,NA,2024-10-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6709,ZB,90,"[84,Inf)",M,8,NA,2024-10-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6710,HV,84,"[84,Inf)",M,8,NA,2024-10-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6711,MD,92,"[84,Inf)",M,8,44.420254349307605,2024-10-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6712,VY,76,"[74,84)",M,7,67.68763020598065,2024-10-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6713,EH,58,"[44,64)",M,5,NA,2024-10-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6714,EU,87,"[84,Inf)",M,9,NA,2024-10-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6715,CW,60,"[44,64)",M,6,NA,2024-10-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6716,GU,84,"[84,Inf)",M,7,68.0682808886629,2024-10-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6717,OJ,71,"[64,74)",M,6,87.68619864002832,2024-10-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6718,VT,84,"[84,Inf)",M,8,42.74322732040621,2024-10-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6719,WO,82,"[74,84)",F,8,NA,2024-10-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6720,GN,99,"[84,Inf)",F,7,NA,2024-10-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6721,LN,76,"[74,84)",M,8,NA,2024-10-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6722,SX,67,"[64,74)",F,6,NA,2024-10-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6723,PT,63,"[44,64)",F,6,NA,2024-10-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6724,SE,56,"[44,64)",M,5,NA,2024-10-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6725,EW,21,"[14,44)",M,2,NA,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6726,MD,80,"[74,84)",M,9,NA,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6727,DQ,63,"[44,64)",F,7,NA,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6728,EN,69,"[64,74)",F,4,NA,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6729,CW,69,"[64,74)",M,6,NA,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6730,JS,74,"[74,84)",M,8,NA,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6731,TF,49,"[44,64)",M,3,NA,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6732,TH,43,"[14,44)",M,3,NA,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6733,TJ,95,"[84,Inf)",M,6,NA,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6734,ZH,83,"[74,84)",F,7,NA,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6735,CG,79,"[74,84)",F,7,NA,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6736,ZN,90,"[84,Inf)",M,7,44.510972133998614,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6737,QM,49,"[44,64)",F,6,94.3724981076166,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6738,EP,50,"[44,64)",M,4,NA,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6739,JI,83,"[74,84)",M,7,NA,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6740,TE,87,"[84,Inf)",M,9,52.077406117054316,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6741,RY,77,"[74,84)",M,6,NA,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6742,FP,0,"[0,1)",M,NA,NA,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6743,AS,63,"[44,64)",F,6,NA,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6744,AX,91,"[84,Inf)",M,7,NA,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6745,PL,63,"[44,64)",F,6,NA,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6746,RQ,36,"[14,44)",M,4,NA,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6747,TW,69,"[64,74)",M,6,NA,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6748,AG,58,"[44,64)",M,7,NA,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6749,XA,78,"[74,84)",M,8,55.6066296906392,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6750,ED,98,"[84,Inf)",M,8,47.01940131199428,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6751,UR,47,"[44,64)",M,6,NA,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6752,RX,86,"[84,Inf)",M,8,56.71408610652403,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6753,ZW,93,"[84,Inf)",M,8,NA,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6754,GS,77,"[74,84)",M,7,NA,2024-10-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6755,AW,63,"[44,64)",F,6,NA,2024-10-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6756,TC,72,"[64,74)",M,6,78.09287668141518,2024-10-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6757,PK,68,"[64,74)",F,6,NA,2024-10-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6758,TP,96,"[84,Inf)",M,9,30.903961529136673,2024-10-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6759,NV,55,"[44,64)",F,6,NA,2024-10-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6760,FV,52,"[44,64)",M,4,NA,2024-10-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6761,XU,53,"[44,64)",M,6,NA,2024-10-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6762,DN,68,"[64,74)",F,6,NA,2024-10-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6763,TM,54,"[44,64)",M,4,NA,2024-10-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6764,BQ,86,"[84,Inf)",F,7,47.968047267478475,2024-10-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6765,VU,78,"[74,84)",M,6,54.900302146533164,2024-10-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6766,CH,71,"[64,74)",F,5,NA,2024-10-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6767,RZ,84,"[84,Inf)",M,8,NA,2024-10-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6768,RP,74,"[74,84)",M,6,NA,2024-10-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6769,GN,43,"[14,44)",F,4,NA,2024-10-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6770,RE,89,"[84,Inf)",M,6,NA,2024-10-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6771,VQ,71,"[64,74)",M,6,NA,2024-10-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6772,PO,54,"[44,64)",M,4,NA,2024-10-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6773,SO,0,"[0,1)",M,NA,NA,2024-10-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6774,DQ,79,"[74,84)",M,7,NA,2024-10-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6775,KU,65,"[64,74)",F,6,NA,2024-10-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6776,UP,74,"[74,84)",F,6,NA,2024-10-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6777,BC,72,"[64,74)",M,5,NA,2024-10-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6778,JT,94,"[84,Inf)",M,7,NA,2024-10-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6779,PA,80,"[74,84)",F,6,NA,2024-10-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6780,PX,64,"[64,74)",F,5,NA,2024-10-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6781,LK,88,"[84,Inf)",F,9,NA,2024-10-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6782,FT,72,"[64,74)",F,7,NA,2024-10-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6783,VV,57,"[44,64)",M,3,NA,2024-10-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6784,XV,68,"[64,74)",M,7,NA,2024-10-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6785,PF,82,"[74,84)",F,6,NA,2024-10-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6786,AN,54,"[44,64)",M,4,NA,2024-10-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6787,PX,62,"[44,64)",F,5,NA,2024-10-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6788,PV,93,"[84,Inf)",M,8,46.83973999870063,2024-10-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6789,RC,65,"[64,74)",M,6,NA,2024-10-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6790,GG,82,"[74,84)",F,8,NA,2024-10-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6791,CD,83,"[74,84)",M,9,NA,2024-10-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6792,GW,68,"[64,74)",M,5,NA,2024-10-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6793,DZ,64,"[64,74)",F,8,125.06725284162587,2024-10-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6794,NU,0,"[0,1)",M,NA,NA,2024-10-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6795,CZ,82,"[74,84)",F,7,40.12913593585755,2024-10-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6796,BR,83,"[74,84)",M,5,NA,2024-10-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6797,OC,66,"[64,74)",M,7,NA,2024-10-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6798,RM,67,"[64,74)",M,5,NA,2024-10-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6799,XE,74,"[74,84)",M,6,NA,2024-10-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6800,BF,65,"[64,74)",M,5,NA,2024-10-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6801,HI,79,"[74,84)",F,8,32.04165408968757,2024-10-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6802,LN,51,"[44,64)",M,4,90.38567831920615,2024-10-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6803,WQ,58,"[44,64)",M,4,NA,2024-10-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6804,RF,68,"[64,74)",M,7,NA,2024-10-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6805,MJ,68,"[64,74)",M,6,NA,2024-10-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6806,AD,91,"[84,Inf)",M,8,NA,2024-10-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6807,AD,47,"[44,64)",M,6,87.61568873951678,2024-10-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6808,VT,88,"[84,Inf)",M,7,NA,2024-10-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6809,HD,91,"[84,Inf)",M,7,NA,2024-10-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6810,SB,70,"[64,74)",M,6,NA,2024-10-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6811,KX,83,"[74,84)",M,8,NA,2024-10-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6812,MR,72,"[64,74)",M,5,NA,2024-10-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6813,HX,62,"[44,64)",F,7,NA,2024-10-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6814,RL,34,"[14,44)",M,2,NA,2024-10-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6815,WH,71,"[64,74)",F,5,71.87937994689749,2024-10-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6816,CI,92,"[84,Inf)",M,8,NA,2024-10-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6817,ND,55,"[44,64)",F,6,NA,2024-10-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6818,VK,58,"[44,64)",M,4,90.91331538243209,2024-10-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6819,RH,94,"[84,Inf)",M,7,45.8309400089128,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6820,EC,90,"[84,Inf)",F,6,NA,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6821,DN,75,"[74,84)",F,6,39.924740075014086,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6822,YC,74,"[74,84)",M,8,46.15094003650767,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6823,BF,89,"[84,Inf)",F,6,NA,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6824,XJ,45,"[44,64)",M,4,NA,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6825,VH,83,"[74,84)",M,7,NA,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6826,WE,57,"[44,64)",F,6,125.89839660405735,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6827,KJ,83,"[74,84)",M,9,52.102552083715906,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6828,AD,73,"[64,74)",F,6,NA,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6829,MK,80,"[74,84)",M,7,60.843410617892275,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6830,HD,84,"[84,Inf)",M,9,NA,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6831,SB,75,"[74,84)",F,7,NA,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6832,TQ,73,"[64,74)",F,7,NA,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6833,GJ,1,"[1,14)",M,NA,NA,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6834,FX,62,"[44,64)",F,5,NA,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6835,XZ,92,"[84,Inf)",M,8,NA,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6836,SX,58,"[44,64)",F,6,NA,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6837,FT,61,"[44,64)",F,4,NA,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6838,OU,87,"[84,Inf)",F,8,NA,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6839,LI,51,"[44,64)",M,3,NA,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6840,AT,56,"[44,64)",M,4,NA,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6841,WI,74,"[74,84)",F,6,NA,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6842,LB,0,"[0,1)",M,NA,NA,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6843,YZ,80,"[74,84)",M,7,NA,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6844,DL,61,"[44,64)",F,4,NA,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6845,XM,87,"[84,Inf)",M,9,NA,2024-10-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6846,FI,67,"[64,74)",M,6,NA,2024-10-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6847,CR,76,"[74,84)",F,7,NA,2024-10-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6848,XD,74,"[74,84)",M,6,74.82153427576957,2024-10-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6849,HC,76,"[74,84)",M,6,NA,2024-10-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6850,DU,78,"[74,84)",M,9,62.131833442970596,2024-10-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6851,EQ,92,"[84,Inf)",M,8,NA,2024-10-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6852,MH,79,"[74,84)",F,7,NA,2024-10-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6853,GK,73,"[64,74)",M,7,NA,2024-10-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6854,AT,44,"[44,64)",F,4,NA,2024-10-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6855,MR,35,"[14,44)",M,3,NA,2024-10-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6856,GJ,71,"[64,74)",M,5,NA,2024-10-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6857,NR,68,"[64,74)",M,6,NA,2024-10-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6858,UH,81,"[74,84)",M,7,NA,2024-10-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6859,UD,54,"[44,64)",M,4,NA,2024-10-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6860,YC,70,"[64,74)",M,8,NA,2024-10-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6861,AS,75,"[74,84)",F,7,NA,2024-10-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6862,OX,46,"[44,64)",M,3,NA,2024-10-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6863,YT,48,"[44,64)",F,5,105.0448176809531,2024-10-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6864,TP,66,"[64,74)",F,6,NA,2024-10-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6865,WL,73,"[64,74)",F,5,NA,2024-10-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6866,KE,63,"[44,64)",M,6,84.87339061953676,2024-10-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6867,OM,60,"[44,64)",M,5,NA,2024-10-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6868,ZP,0,"[0,1)",M,NA,NA,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6869,NW,94,"[84,Inf)",M,8,36.551087209069415,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6870,NA,47,"[44,64)",M,4,NA,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6871,JR,88,"[84,Inf)",M,7,68.71944605327668,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6872,IW,58,"[44,64)",F,5,NA,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6873,JW,83,"[74,84)",F,8,NA,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6874,MA,88,"[84,Inf)",M,8,NA,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6875,QD,76,"[74,84)",M,8,NA,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6876,GB,77,"[74,84)",M,6,NA,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6877,HC,71,"[64,74)",M,6,NA,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6878,HG,55,"[44,64)",M,6,NA,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6879,FU,57,"[44,64)",F,5,NA,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6880,HG,45,"[44,64)",M,3,NA,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6881,TX,93,"[84,Inf)",M,7,NA,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6882,ZZ,62,"[44,64)",F,6,NA,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6883,ET,70,"[64,74)",M,7,NA,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6884,MS,66,"[64,74)",M,5,NA,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6885,TL,83,"[74,84)",M,8,NA,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6886,CS,88,"[84,Inf)",M,8,NA,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6887,HF,48,"[44,64)",M,5,NA,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6888,VJ,88,"[84,Inf)",M,8,NA,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6889,GL,57,"[44,64)",F,4,NA,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6890,ZP,71,"[64,74)",M,8,NA,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6891,XX,75,"[74,84)",M,7,NA,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6892,MB,88,"[84,Inf)",M,8,51.804646440072666,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6893,MX,35,"[14,44)",F,1,NA,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6894,UG,63,"[44,64)",M,5,NA,2024-10-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6895,BD,72,"[64,74)",F,7,NA,2024-10-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6896,HK,48,"[44,64)",F,4,NA,2024-10-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6897,KY,78,"[74,84)",M,7,57.95123771357096,2024-10-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6898,PI,79,"[74,84)",M,6,67.08596179367785,2024-10-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6899,AX,81,"[74,84)",F,8,NA,2024-10-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6900,NM,71,"[64,74)",M,7,NA,2024-10-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6901,IC,77,"[74,84)",F,7,127.86198063067614,2024-10-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6902,YK,72,"[64,74)",M,7,NA,2024-10-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6903,ZH,56,"[44,64)",F,5,NA,2024-10-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6904,FV,0,"[0,1)",M,NA,NA,2024-10-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6905,ZJ,59,"[44,64)",M,7,NA,2024-10-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6906,BM,72,"[64,74)",M,6,NA,2024-10-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6907,OP,57,"[44,64)",F,6,NA,2024-10-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6908,NI,85,"[84,Inf)",M,6,50.240614225100245,2024-10-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6909,WB,77,"[74,84)",F,8,NA,2024-10-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6910,CS,62,"[44,64)",M,7,NA,2024-10-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6911,DZ,89,"[84,Inf)",M,8,NA,2024-10-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6912,AI,73,"[64,74)",F,7,NA,2024-10-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6913,BM,85,"[84,Inf)",F,9,NA,2024-10-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6914,SH,64,"[64,74)",M,7,NA,2024-10-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6915,DG,66,"[64,74)",M,6,NA,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6916,BU,56,"[44,64)",F,6,NA,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6917,HA,77,"[74,84)",M,8,NA,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6918,UH,90,"[84,Inf)",M,9,NA,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6919,DL,51,"[44,64)",M,4,NA,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6920,MX,82,"[74,84)",F,8,NA,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6921,QL,85,"[84,Inf)",F,7,NA,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6922,GO,56,"[44,64)",F,5,133.87305003754838,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6923,EZ,73,"[64,74)",F,6,NA,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6924,QR,67,"[64,74)",F,7,NA,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6925,CD,91,"[84,Inf)",M,8,64.62692558271375,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6926,PW,80,"[74,84)",M,6,NA,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6927,PZ,62,"[44,64)",F,6,NA,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6928,JW,50,"[44,64)",M,5,109.85437329126749,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6929,PB,94,"[84,Inf)",M,8,NA,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6930,FF,71,"[64,74)",M,6,NA,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6931,IO,28,"[14,44)",M,2,104.47094380406931,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6932,MR,24,"[14,44)",M,3,NA,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6933,JK,53,"[44,64)",M,5,NA,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6934,NU,87,"[84,Inf)",M,8,NA,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6935,AZ,95,"[84,Inf)",M,7,NA,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6936,KP,87,"[84,Inf)",M,9,NA,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6937,HG,81,"[74,84)",F,8,NA,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6938,UO,77,"[74,84)",M,6,NA,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6939,XW,68,"[64,74)",F,6,64.20138233582968,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6940,ZC,50,"[44,64)",F,2,NA,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6941,QG,68,"[64,74)",F,8,118.7299665040379,2024-10-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6942,PV,77,"[74,84)",M,7,NA,2024-10-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6943,DH,77,"[74,84)",M,7,NA,2024-10-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6944,BV,72,"[64,74)",F,6,NA,2024-10-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6945,KD,63,"[44,64)",F,8,NA,2024-10-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6946,PV,76,"[74,84)",M,7,NA,2024-10-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6947,ZB,69,"[64,74)",F,6,NA,2024-10-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6948,WK,85,"[84,Inf)",M,6,NA,2024-10-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6949,WT,74,"[74,84)",M,7,NA,2024-10-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6950,RT,68,"[64,74)",M,7,NA,2024-10-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6951,AM,82,"[74,84)",M,6,NA,2024-10-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6952,GW,75,"[74,84)",M,6,NA,2024-10-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6953,LU,60,"[44,64)",F,6,NA,2024-10-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6954,IO,92,"[84,Inf)",M,9,30.67019613626826,2024-10-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6955,DF,33,"[14,44)",M,2,138.27827048516494,2024-10-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6956,BN,52,"[44,64)",F,5,NA,2024-10-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6957,XA,56,"[44,64)",M,7,NA,2024-10-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6958,FJ,77,"[74,84)",M,7,NA,2024-10-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6959,BP,76,"[74,84)",M,7,NA,2024-10-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6960,DV,44,"[44,64)",M,5,NA,2024-10-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6961,KT,63,"[44,64)",M,6,67.13273864751773,2024-10-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6962,DR,72,"[64,74)",M,7,63.23642570540749,2024-10-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6963,CT,79,"[74,84)",M,7,83.55421030373496,2024-10-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6964,DF,78,"[74,84)",F,6,NA,2024-10-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6965,PS,77,"[74,84)",M,5,96.86506120178885,2024-10-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6966,XS,76,"[74,84)",M,5,42.44418409774063,2024-10-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6967,NF,79,"[74,84)",M,8,NA,2024-10-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6968,EM,66,"[64,74)",M,6,NA,2024-10-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6969,JQ,89,"[84,Inf)",M,6,NA,2024-10-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6970,OH,66,"[64,74)",M,6,47.9004753554558,2024-10-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6971,AT,71,"[64,74)",M,8,NA,2024-10-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6972,XN,64,"[64,74)",M,6,NA,2024-10-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6973,ED,91,"[84,Inf)",M,7,NA,2024-10-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6974,TB,59,"[44,64)",F,7,NA,2024-10-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6975,ZD,30,"[14,44)",M,2,NA,2024-10-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6976,JI,58,"[44,64)",M,8,NA,2024-10-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6977,FN,0,"[0,1)",F,NA,NA,2024-10-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6978,KY,59,"[44,64)",M,7,NA,2024-10-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6979,NS,84,"[84,Inf)",F,6,47.197913877854205,2024-10-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6980,TR,84,"[84,Inf)",M,8,NA,2024-10-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6981,AL,96,"[84,Inf)",M,7,NA,2024-10-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6982,OG,94,"[84,Inf)",M,8,NA,2024-10-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6983,CP,37,"[14,44)",M,3,NA,2024-10-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6984,FD,63,"[44,64)",M,6,NA,2024-10-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6985,JE,61,"[44,64)",M,5,NA,2024-10-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6986,WO,50,"[44,64)",M,5,NA,2024-10-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6987,MA,78,"[74,84)",M,6,NA,2024-10-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6988,XG,42,"[14,44)",M,3,NA,2024-10-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6989,WM,67,"[64,74)",F,5,NA,2024-10-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6990,MI,64,"[64,74)",F,6,NA,2024-10-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6991,CE,82,"[74,84)",M,6,NA,2024-10-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6992,AX,70,"[64,74)",M,6,NA,2024-10-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6993,MZ,71,"[64,74)",M,7,NA,2024-10-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6994,NC,53,"[44,64)",M,4,97.44904754063737,2024-10-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6995,TJ,88,"[84,Inf)",M,8,NA,2024-10-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6996,CH,69,"[64,74)",F,6,NA,2024-10-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6997,WW,50,"[44,64)",F,6,78.11084690352592,2024-10-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6998,JS,0,"[0,1)",M,NA,NA,2024-10-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
6999,FV,98,"[84,Inf)",M,9,NA,2024-10-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7000,OR,75,"[74,84)",M,7,50.104482528139364,2024-10-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7001,NR,71,"[64,74)",M,6,NA,2024-10-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7002,VJ,84,"[84,Inf)",F,8,NA,2024-10-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7003,SN,62,"[44,64)",M,5,NA,2024-10-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7004,OB,62,"[44,64)",M,6,NA,2024-10-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7005,MB,60,"[44,64)",F,6,NA,2024-10-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7006,HH,94,"[84,Inf)",M,8,NA,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7007,MN,93,"[84,Inf)",F,9,NA,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7008,PJ,76,"[74,84)",F,7,118.63632276615557,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7009,YE,84,"[84,Inf)",M,9,NA,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7010,MW,59,"[44,64)",M,6,NA,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7011,CX,67,"[64,74)",M,4,NA,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7012,HT,82,"[74,84)",M,6,54.721774580232214,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7013,TF,71,"[64,74)",F,7,NA,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7014,JH,63,"[44,64)",M,7,NA,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7015,SD,76,"[74,84)",M,7,NA,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7016,GU,87,"[84,Inf)",F,7,NA,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7017,MP,80,"[74,84)",F,6,NA,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7018,YN,83,"[74,84)",M,7,NA,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7019,LV,37,"[14,44)",M,5,NA,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7020,XY,75,"[74,84)",M,6,NA,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7021,ZJ,26,"[14,44)",M,2,NA,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7022,CN,79,"[74,84)",M,8,70.27874305964586,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7023,XL,54,"[44,64)",M,5,NA,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7024,BE,69,"[64,74)",F,5,NA,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7025,ID,83,"[74,84)",M,6,NA,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7026,CD,90,"[84,Inf)",F,7,26.152792301939943,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7027,KT,63,"[44,64)",M,6,NA,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7028,OA,1,"[1,14)",M,NA,NA,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7029,OA,83,"[74,84)",F,7,NA,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7030,WA,87,"[84,Inf)",M,7,NA,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7031,GO,84,"[84,Inf)",M,7,NA,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7032,MT,75,"[74,84)",M,7,NA,2024-10-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7033,BH,55,"[44,64)",M,4,NA,2024-10-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7034,VC,58,"[44,64)",M,5,112.41866110189405,2024-10-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7035,OH,66,"[64,74)",F,6,147.67482824842213,2024-10-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7036,AT,89,"[84,Inf)",M,8,NA,2024-10-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7037,IN,83,"[74,84)",M,6,NA,2024-10-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7038,YJ,35,"[14,44)",F,5,NA,2024-10-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7039,FB,70,"[64,74)",M,7,NA,2024-10-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7040,BP,80,"[74,84)",M,7,NA,2024-10-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7041,LA,89,"[84,Inf)",F,6,NA,2024-10-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7042,FG,71,"[64,74)",M,6,NA,2024-10-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7043,MO,89,"[84,Inf)",M,9,NA,2024-10-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7044,FE,59,"[44,64)",M,5,NA,2024-10-23,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7045,UL,72,"[64,74)",M,9,NA,2024-10-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7046,IO,50,"[44,64)",F,4,NA,2024-10-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7047,XY,68,"[64,74)",M,5,65.00451113935586,2024-10-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7048,UU,83,"[74,84)",M,8,82.68722163187473,2024-10-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7049,MQ,65,"[64,74)",M,5,NA,2024-10-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7050,RH,73,"[64,74)",F,7,NA,2024-10-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7051,VX,82,"[74,84)",M,7,NA,2024-10-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7052,WJ,83,"[74,84)",M,9,NA,2024-10-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7053,UL,78,"[74,84)",M,7,NA,2024-10-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7054,BC,56,"[44,64)",M,5,NA,2024-10-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7055,QP,75,"[74,84)",M,6,79.17552446013784,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7056,MS,57,"[44,64)",M,5,NA,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7057,CL,0,"[0,1)",F,NA,NA,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7058,ZC,81,"[74,84)",M,9,52.836881517340714,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7059,IZ,81,"[74,84)",M,9,NA,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7060,YK,72,"[64,74)",M,7,NA,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7061,QA,72,"[64,74)",F,6,NA,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7062,BD,89,"[84,Inf)",M,8,NA,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7063,PG,63,"[44,64)",M,6,NA,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7064,TJ,72,"[64,74)",M,5,NA,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7065,UL,32,"[14,44)",F,5,NA,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7066,OY,62,"[44,64)",M,6,NA,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7067,XV,91,"[84,Inf)",M,9,41.505060795207065,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7068,ST,80,"[74,84)",M,6,NA,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7069,CZ,59,"[44,64)",F,5,NA,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7070,MT,71,"[64,74)",M,5,NA,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7071,BZ,59,"[44,64)",F,7,NA,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7072,FH,44,"[44,64)",M,3,NA,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7073,FY,71,"[64,74)",M,6,NA,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7074,GK,93,"[84,Inf)",M,8,NA,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7075,EN,86,"[84,Inf)",M,7,NA,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7076,DV,76,"[74,84)",M,6,48.90080601125125,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7077,AG,46,"[44,64)",M,6,89.46393838169186,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7078,IW,79,"[74,84)",M,6,NA,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7079,DJ,79,"[74,84)",M,7,NA,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7080,VK,54,"[44,64)",M,4,NA,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7081,VA,83,"[74,84)",M,9,NA,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7082,MH,81,"[74,84)",M,7,NA,2024-10-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7083,XB,69,"[64,74)",F,6,NA,2024-10-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7084,IA,76,"[74,84)",F,7,77.36395919130639,2024-10-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7085,KH,75,"[74,84)",M,5,NA,2024-10-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7086,QF,51,"[44,64)",M,3,NA,2024-10-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7087,DL,60,"[44,64)",M,4,NA,2024-10-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7088,NU,85,"[84,Inf)",M,8,NA,2024-10-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7089,EN,24,"[14,44)",F,3,NA,2024-10-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7090,OR,57,"[44,64)",F,5,NA,2024-10-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7091,HU,75,"[74,84)",F,6,NA,2024-10-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7092,PL,87,"[84,Inf)",M,8,NA,2024-10-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7093,WZ,30,"[14,44)",M,2,NA,2024-10-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7094,QR,62,"[44,64)",M,5,NA,2024-10-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7095,XG,75,"[74,84)",M,8,NA,2024-10-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7096,RE,53,"[44,64)",M,4,NA,2024-10-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7097,HH,70,"[64,74)",M,6,72.81340797382906,2024-10-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7098,RA,72,"[64,74)",M,7,NA,2024-10-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7099,XZ,62,"[44,64)",M,5,94.78430343413739,2024-10-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7100,OO,70,"[64,74)",M,6,NA,2024-10-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7101,EX,78,"[74,84)",M,8,NA,2024-10-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7102,WT,74,"[74,84)",M,8,NA,2024-10-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7103,NR,70,"[64,74)",F,8,NA,2024-10-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7104,EG,51,"[44,64)",M,5,NA,2024-10-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7105,JA,89,"[84,Inf)",M,7,40.8413883928461,2024-10-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7106,GC,86,"[84,Inf)",M,9,NA,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7107,EM,78,"[74,84)",M,7,NA,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7108,YS,84,"[84,Inf)",F,7,NA,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7109,QN,75,"[74,84)",F,4,NA,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7110,ZX,65,"[64,74)",F,6,NA,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7111,JN,77,"[74,84)",F,8,NA,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7112,LS,82,"[74,84)",M,7,NA,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7113,KU,79,"[74,84)",M,7,NA,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7114,KW,86,"[84,Inf)",M,8,61.35932129253521,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7115,ZN,77,"[74,84)",M,7,NA,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7116,NP,71,"[64,74)",M,7,NA,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7117,TR,47,"[44,64)",M,4,NA,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7118,IQ,89,"[84,Inf)",M,8,37.91996993680462,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7119,IP,77,"[74,84)",F,8,NA,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7120,XN,74,"[74,84)",M,9,NA,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7121,QV,72,"[64,74)",M,6,NA,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7122,AH,92,"[84,Inf)",M,9,NA,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7123,JE,76,"[74,84)",M,6,50.92435961959107,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7124,ZZ,80,"[74,84)",M,9,NA,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7125,PL,58,"[44,64)",M,6,NA,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7126,OV,42,"[14,44)",M,4,NA,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7127,VL,83,"[74,84)",M,7,NA,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7128,SV,93,"[84,Inf)",M,8,NA,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7129,UR,86,"[84,Inf)",M,9,NA,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7130,RT,67,"[64,74)",M,6,NA,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7131,KT,60,"[44,64)",F,5,NA,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7132,NZ,42,"[14,44)",F,3,NA,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7133,BF,57,"[44,64)",F,5,NA,2024-10-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7134,IB,81,"[74,84)",F,7,NA,2024-10-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7135,EA,99,"[84,Inf)",F,9,NA,2024-10-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7136,OT,68,"[64,74)",M,8,NA,2024-10-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7137,RL,44,"[44,64)",M,4,NA,2024-10-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7138,XW,59,"[44,64)",M,8,NA,2024-10-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7139,DW,75,"[74,84)",M,7,NA,2024-10-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7140,TM,80,"[74,84)",M,6,NA,2024-10-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7141,UC,83,"[74,84)",F,8,NA,2024-10-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7142,NC,62,"[44,64)",M,7,NA,2024-10-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7143,HA,64,"[64,74)",M,5,NA,2024-10-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7144,UO,68,"[64,74)",F,6,NA,2024-10-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7145,YV,83,"[74,84)",F,6,NA,2024-10-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7146,DM,89,"[84,Inf)",M,9,NA,2024-10-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7147,JG,74,"[74,84)",M,7,73.3247112056546,2024-10-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7148,QN,64,"[64,74)",M,7,NA,2024-10-27,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7149,QU,42,"[14,44)",M,4,75.17320589185684,2024-10-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7150,RJ,66,"[64,74)",M,7,NA,2024-10-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7151,EQ,64,"[64,74)",M,6,NA,2024-10-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7152,PD,65,"[64,74)",M,5,NA,2024-10-27,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7153,NN,84,"[84,Inf)",M,7,NA,2024-10-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7154,VF,94,"[84,Inf)",M,7,NA,2024-10-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7155,WQ,59,"[44,64)",F,6,NA,2024-10-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7156,XX,0,"[0,1)",M,NA,NA,2024-10-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7157,UV,66,"[64,74)",F,6,NA,2024-10-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7158,XH,86,"[84,Inf)",M,8,39.4388358618894,2024-10-28,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7159,TL,57,"[44,64)",M,7,NA,2024-10-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7160,HQ,61,"[44,64)",M,6,NA,2024-10-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7161,HP,87,"[84,Inf)",M,7,NA,2024-10-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7162,LA,66,"[64,74)",M,7,NA,2024-10-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7163,PZ,64,"[64,74)",F,6,NA,2024-10-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7164,KK,86,"[84,Inf)",M,8,NA,2024-10-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7165,DG,84,"[84,Inf)",M,9,NA,2024-10-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7166,PN,58,"[44,64)",F,4,NA,2024-10-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7167,UK,76,"[74,84)",M,5,NA,2024-10-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7168,YI,80,"[74,84)",F,6,NA,2024-10-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7169,PJ,56,"[44,64)",M,4,71.07178574149026,2024-10-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7170,DH,92,"[84,Inf)",M,9,NA,2024-10-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7171,JA,83,"[74,84)",M,5,53.8344010697789,2024-10-28,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7172,HZ,90,"[84,Inf)",M,8,NA,2024-10-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7173,ZE,56,"[44,64)",F,5,NA,2024-10-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7174,QA,72,"[64,74)",M,8,NA,2024-10-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7175,RD,79,"[74,84)",M,7,NA,2024-10-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7176,BZ,59,"[44,64)",M,5,NA,2024-10-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7177,CW,85,"[84,Inf)",F,6,NA,2024-10-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7178,BN,58,"[44,64)",M,6,64.40261775501398,2024-10-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7179,ZC,81,"[74,84)",M,8,NA,2024-10-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7180,SJ,54,"[44,64)",F,5,82.04533957131581,2024-10-29,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7181,VX,61,"[44,64)",M,5,NA,2024-10-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7182,ZY,80,"[74,84)",M,9,NA,2024-10-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7183,GD,58,"[44,64)",M,6,NA,2024-10-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7184,LQ,93,"[84,Inf)",M,7,NA,2024-10-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7185,TI,81,"[74,84)",M,7,NA,2024-10-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7186,LJ,80,"[74,84)",F,7,NA,2024-10-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7187,NF,0,"[0,1)",M,NA,NA,2024-10-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7188,KS,87,"[84,Inf)",M,9,NA,2024-10-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7189,WZ,65,"[64,74)",M,5,NA,2024-10-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7190,PZ,83,"[74,84)",F,9,NA,2024-10-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7191,UF,80,"[74,84)",M,8,69.63980766158892,2024-10-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7192,CC,86,"[84,Inf)",M,9,NA,2024-10-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7193,ZW,94,"[84,Inf)",M,8,NA,2024-10-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7194,DE,86,"[84,Inf)",M,5,NA,2024-10-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7195,VK,61,"[44,64)",M,5,NA,2024-10-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7196,OV,72,"[64,74)",M,7,NA,2024-10-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7197,IS,73,"[64,74)",M,7,NA,2024-10-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7198,QR,40,"[14,44)",M,3,NA,2024-10-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7199,DX,62,"[44,64)",F,5,87.77597343207606,2024-10-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7200,IB,51,"[44,64)",F,4,NA,2024-10-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7201,RZ,65,"[64,74)",F,6,NA,2024-10-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7202,CL,76,"[74,84)",M,8,NA,2024-10-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7203,XO,75,"[74,84)",M,6,NA,2024-10-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7204,IY,65,"[64,74)",F,6,76.71262362701736,2024-10-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7205,TA,56,"[44,64)",M,6,NA,2024-10-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7206,PN,90,"[84,Inf)",M,7,41.00201419957511,2024-10-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7207,AX,63,"[44,64)",M,6,NA,2024-10-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7208,XM,62,"[44,64)",F,4,NA,2024-10-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7209,YE,74,"[74,84)",M,7,NA,2024-10-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7210,FH,89,"[84,Inf)",M,7,NA,2024-10-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7211,YF,72,"[64,74)",M,8,NA,2024-10-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7212,YI,85,"[84,Inf)",M,7,NA,2024-10-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7213,SQ,85,"[84,Inf)",M,7,NA,2024-10-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7214,BX,68,"[64,74)",M,5,NA,2024-10-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7215,VR,59,"[44,64)",F,6,NA,2024-10-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7216,CV,81,"[74,84)",M,8,NA,2024-10-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7217,DW,48,"[44,64)",M,4,NA,2024-10-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7218,WZ,94,"[84,Inf)",M,9,NA,2024-10-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7219,SO,60,"[44,64)",M,5,100.02911750084718,2024-10-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7220,JM,71,"[64,74)",M,6,NA,2024-10-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7221,NU,74,"[74,84)",F,6,NA,2024-10-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7222,MS,70,"[64,74)",F,6,54.28112912850027,2024-10-31,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7223,PM,0,"[0,1)",F,NA,NA,2024-10-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7224,YP,89,"[84,Inf)",M,8,NA,2024-10-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7225,EM,1,"[1,14)",M,NA,NA,2024-10-31,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7226,AB,73,"[64,74)",M,7,NA,2024-10-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7227,BP,79,"[74,84)",M,9,NA,2024-10-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7228,OG,53,"[44,64)",M,5,NA,2024-10-31,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7229,CI,64,"[64,74)",M,5,NA,2024-10-31,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7230,YM,88,"[84,Inf)",M,9,NA,2024-10-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7231,UZ,61,"[44,64)",F,5,NA,2024-10-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7232,BX,58,"[44,64)",M,7,NA,2024-10-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7233,JB,75,"[74,84)",F,9,127.81585200071126,2024-10-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7234,OC,72,"[64,74)",M,7,NA,2024-10-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7235,RL,71,"[64,74)",M,6,NA,2024-10-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7236,VA,82,"[74,84)",F,7,32.49312560457402,2024-10-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7237,RQ,37,"[14,44)",M,3,NA,2024-10-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7238,IG,59,"[44,64)",F,6,NA,2024-10-31,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7239,KK,66,"[64,74)",F,5,NA,2024-10-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7240,RM,92,"[84,Inf)",M,7,NA,2024-10-31,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7241,ED,91,"[84,Inf)",M,8,32.62866098530543,2024-10-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7242,BH,81,"[74,84)",M,7,NA,2024-10-31,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7243,HG,81,"[74,84)",M,6,NA,2024-10-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7244,PY,83,"[74,84)",F,7,34.29400172946077,2024-10-31,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7245,VA,59,"[44,64)",M,3,NA,2024-10-31,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7246,XS,67,"[64,74)",M,7,NA,2024-11-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7247,PP,75,"[74,84)",F,7,NA,2024-11-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7248,KU,63,"[44,64)",M,6,NA,2024-11-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7249,QX,83,"[74,84)",M,7,NA,2024-11-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7250,RZ,87,"[84,Inf)",M,8,42.38766227224149,2024-11-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7251,GI,91,"[84,Inf)",M,9,33.96645531667535,2024-11-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7252,XJ,72,"[64,74)",F,6,NA,2024-11-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7253,BQ,85,"[84,Inf)",F,6,39.718332639768825,2024-11-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7254,BQ,76,"[74,84)",M,7,NA,2024-11-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7255,FL,78,"[74,84)",M,6,42.14754218061738,2024-11-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7256,NT,73,"[64,74)",F,7,NA,2024-11-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7257,WY,70,"[64,74)",M,7,NA,2024-11-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7258,TT,79,"[74,84)",M,6,NA,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7259,QU,90,"[84,Inf)",M,7,NA,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7260,PS,73,"[64,74)",M,7,62.58115722512926,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7261,WN,79,"[74,84)",M,7,45.88834194604549,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7262,NN,60,"[44,64)",M,7,NA,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7263,SN,87,"[84,Inf)",M,8,NA,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7264,BI,93,"[84,Inf)",M,9,NA,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7265,YF,88,"[84,Inf)",M,7,NA,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7266,RJ,77,"[74,84)",F,6,NA,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7267,UC,66,"[64,74)",M,6,NA,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7268,HY,58,"[44,64)",M,5,NA,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7269,TY,69,"[64,74)",F,7,41.07759723715284,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7270,UF,89,"[84,Inf)",M,9,NA,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7271,RW,67,"[64,74)",F,6,NA,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7272,QA,56,"[44,64)",M,2,NA,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7273,SB,85,"[84,Inf)",M,8,48.34322958750364,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7274,DX,73,"[64,74)",F,7,NA,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7275,ZW,87,"[84,Inf)",M,9,NA,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7276,DO,53,"[44,64)",F,6,NA,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7277,TQ,69,"[64,74)",M,5,61.15232023620683,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7278,UO,63,"[44,64)",F,7,NA,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7279,VY,64,"[64,74)",M,6,NA,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7280,UQ,63,"[44,64)",M,6,NA,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7281,GF,75,"[74,84)",M,6,47.38063251908619,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7282,NL,77,"[74,84)",M,7,NA,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7283,OA,73,"[64,74)",F,6,111.95541436897753,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7284,DV,74,"[74,84)",M,7,NA,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7285,WC,46,"[44,64)",M,4,NA,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7286,EZ,30,"[14,44)",F,3,NA,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7287,KQ,0,"[0,1)",F,NA,NA,2024-11-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7288,TC,72,"[64,74)",M,6,NA,2024-11-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7289,LE,71,"[64,74)",M,7,NA,2024-11-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7290,FX,76,"[74,84)",M,9,NA,2024-11-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7291,DS,85,"[84,Inf)",M,6,NA,2024-11-03,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7292,LA,60,"[44,64)",F,5,123.53897553410174,2024-11-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7293,DX,91,"[84,Inf)",F,7,NA,2024-11-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7294,JL,55,"[44,64)",F,4,NA,2024-11-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7295,CH,54,"[44,64)",F,5,88.72304508914496,2024-11-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7296,TE,63,"[44,64)",M,6,NA,2024-11-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7297,VR,70,"[64,74)",M,6,NA,2024-11-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7298,RK,67,"[64,74)",M,6,NA,2024-11-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7299,ES,11,"[1,14)",M,NA,NA,2024-11-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7300,UZ,59,"[44,64)",F,5,NA,2024-11-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7301,XA,69,"[64,74)",M,7,NA,2024-11-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7302,UA,82,"[74,84)",M,6,NA,2024-11-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7303,XC,70,"[64,74)",M,7,NA,2024-11-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7304,SV,58,"[44,64)",F,5,NA,2024-11-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7305,SJ,59,"[44,64)",M,6,NA,2024-11-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7306,FS,91,"[84,Inf)",M,8,33.35075743665099,2024-11-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7307,ZE,91,"[84,Inf)",M,7,38.269404938107165,2024-11-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7308,VA,69,"[64,74)",M,7,NA,2024-11-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7309,VL,64,"[64,74)",M,6,NA,2024-11-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7310,NK,70,"[64,74)",M,6,116.06972062926448,2024-11-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7311,GU,88,"[84,Inf)",M,9,NA,2024-11-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7312,IC,85,"[84,Inf)",F,8,55.39895242598781,2024-11-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7313,KX,78,"[74,84)",F,6,NA,2024-11-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7314,CW,66,"[64,74)",F,8,NA,2024-11-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7315,XM,87,"[84,Inf)",M,8,NA,2024-11-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7316,RG,55,"[44,64)",M,2,NA,2024-11-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7317,NU,87,"[84,Inf)",M,8,NA,2024-11-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7318,EA,90,"[84,Inf)",M,7,41.88185572543936,2024-11-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7319,ND,35,"[14,44)",M,3,NA,2024-11-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7320,XI,71,"[64,74)",M,7,NA,2024-11-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7321,XG,14,"[14,44)",M,NA,NA,2024-11-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7322,MY,77,"[74,84)",M,7,53.60257568778483,2024-11-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7323,IL,87,"[84,Inf)",M,8,NA,2024-11-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7324,WY,80,"[74,84)",M,8,NA,2024-11-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7325,TH,47,"[44,64)",M,3,95.73965340028468,2024-11-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7326,UW,1,"[1,14)",M,NA,NA,2024-11-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7327,PO,82,"[74,84)",F,8,NA,2024-11-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7328,SG,47,"[44,64)",M,5,NA,2024-11-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7329,IZ,75,"[74,84)",M,7,NA,2024-11-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7330,DA,49,"[44,64)",M,5,NA,2024-11-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7331,VB,85,"[84,Inf)",M,8,35.96208303276712,2024-11-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7332,OY,56,"[44,64)",F,5,NA,2024-11-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7333,OX,92,"[84,Inf)",F,8,NA,2024-11-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7334,HW,72,"[64,74)",F,7,NA,2024-11-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7335,TT,31,"[14,44)",M,2,NA,2024-11-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7336,BA,52,"[44,64)",M,3,NA,2024-11-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7337,GZ,76,"[74,84)",M,7,NA,2024-11-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7338,CD,61,"[44,64)",M,7,NA,2024-11-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7339,GB,67,"[64,74)",M,7,NA,2024-11-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7340,DQ,84,"[84,Inf)",M,8,NA,2024-11-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7341,AZ,60,"[44,64)",M,5,NA,2024-11-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7342,WF,89,"[84,Inf)",M,8,NA,2024-11-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7343,MB,91,"[84,Inf)",M,8,NA,2024-11-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7344,XW,58,"[44,64)",M,5,NA,2024-11-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7345,RI,95,"[84,Inf)",F,8,NA,2024-11-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7346,VF,62,"[44,64)",F,6,136.38640820926148,2024-11-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7347,KL,68,"[64,74)",M,6,78.45195266299376,2024-11-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7348,AU,74,"[74,84)",F,6,NA,2024-11-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7349,QQ,44,"[44,64)",M,4,NA,2024-11-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7350,WY,0,"[0,1)",M,NA,NA,2024-11-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7351,XJ,63,"[44,64)",F,7,NA,2024-11-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7352,NB,72,"[64,74)",M,6,NA,2024-11-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7353,WX,67,"[64,74)",F,6,NA,2024-11-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7354,FM,1,"[1,14)",M,NA,NA,2024-11-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7355,WY,70,"[64,74)",M,6,NA,2024-11-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7356,ZM,85,"[84,Inf)",M,8,NA,2024-11-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7357,XR,87,"[84,Inf)",M,8,NA,2024-11-06,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7358,FG,58,"[44,64)",M,6,NA,2024-11-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7359,KC,54,"[44,64)",M,5,NA,2024-11-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7360,JF,45,"[44,64)",F,3,NA,2024-11-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7361,LK,79,"[74,84)",M,8,NA,2024-11-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7362,IL,57,"[44,64)",M,5,NA,2024-11-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7363,NJ,77,"[74,84)",M,7,NA,2024-11-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7364,EH,87,"[84,Inf)",F,8,NA,2024-11-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7365,PK,78,"[74,84)",M,6,NA,2024-11-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7366,KW,68,"[64,74)",F,7,NA,2024-11-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7367,UG,49,"[44,64)",M,5,NA,2024-11-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7368,OT,59,"[44,64)",M,5,NA,2024-11-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7369,JO,65,"[64,74)",F,6,NA,2024-11-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7370,EC,55,"[44,64)",F,6,NA,2024-11-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7371,HV,69,"[64,74)",F,7,NA,2024-11-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7372,NF,69,"[64,74)",M,5,77.13148225615954,2024-11-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7373,QM,88,"[84,Inf)",M,9,NA,2024-11-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7374,GK,71,"[64,74)",M,6,79.32963003984226,2024-11-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7375,BC,84,"[84,Inf)",M,7,NA,2024-11-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7376,CW,52,"[44,64)",M,4,NA,2024-11-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7377,KU,63,"[44,64)",M,6,NA,2024-11-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7378,VC,42,"[14,44)",M,4,NA,2024-11-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7379,ZX,60,"[44,64)",M,6,78.93264037904139,2024-11-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7380,GP,0,"[0,1)",M,NA,NA,2024-11-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7381,CE,65,"[64,74)",F,5,NA,2024-11-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7382,JX,59,"[44,64)",M,6,NA,2024-11-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7383,FA,80,"[74,84)",M,6,45.65011536005111,2024-11-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7384,YF,97,"[84,Inf)",M,9,NA,2024-11-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7385,XQ,57,"[44,64)",F,5,NA,2024-11-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7386,BE,85,"[84,Inf)",M,6,49.31122853004928,2024-11-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7387,KZ,92,"[84,Inf)",M,8,NA,2024-11-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7388,LN,66,"[64,74)",F,7,96.66598050233277,2024-11-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7389,LW,70,"[64,74)",F,7,NA,2024-11-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7390,HR,54,"[44,64)",M,5,NA,2024-11-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7391,TG,80,"[74,84)",F,5,NA,2024-11-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7392,ZD,80,"[74,84)",M,6,NA,2024-11-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7393,BU,68,"[64,74)",M,6,NA,2024-11-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7394,EL,59,"[44,64)",M,4,NA,2024-11-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7395,SX,89,"[84,Inf)",F,9,52.56177380284458,2024-11-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7396,AV,64,"[64,74)",M,5,80.98293134772118,2024-11-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7397,CE,73,"[64,74)",F,6,NA,2024-11-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7398,IX,67,"[64,74)",F,5,NA,2024-11-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7399,HF,64,"[64,74)",F,7,NA,2024-11-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7400,SD,76,"[74,84)",F,8,NA,2024-11-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7401,KH,61,"[44,64)",M,4,NA,2024-11-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7402,BD,51,"[44,64)",M,5,NA,2024-11-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7403,RG,93,"[84,Inf)",M,7,NA,2024-11-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7404,VJ,61,"[44,64)",M,5,NA,2024-11-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7405,EW,79,"[74,84)",F,7,NA,2024-11-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7406,KO,47,"[44,64)",M,3,NA,2024-11-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7407,OQ,78,"[74,84)",F,7,77.94097878318665,2024-11-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7408,LH,71,"[64,74)",M,6,NA,2024-11-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7409,WK,36,"[14,44)",F,4,NA,2024-11-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7410,PE,80,"[74,84)",M,8,57.572152242814006,2024-11-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7411,NQ,81,"[74,84)",M,8,NA,2024-11-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7412,KQ,86,"[84,Inf)",F,7,46.95779345171262,2024-11-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7413,NO,45,"[44,64)",M,4,89.36399221999366,2024-11-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7414,SM,82,"[74,84)",F,6,NA,2024-11-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7415,AO,59,"[44,64)",M,6,NA,2024-11-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7416,AM,64,"[64,74)",M,6,NA,2024-11-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7417,XH,84,"[84,Inf)",M,8,NA,2024-11-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7418,AL,95,"[84,Inf)",M,7,NA,2024-11-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7419,HE,88,"[84,Inf)",M,9,NA,2024-11-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7420,MY,79,"[74,84)",M,6,NA,2024-11-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7421,PH,82,"[74,84)",M,7,NA,2024-11-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7422,WT,68,"[64,74)",M,7,NA,2024-11-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7423,YC,71,"[64,74)",F,7,NA,2024-11-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7424,CC,61,"[44,64)",F,6,NA,2024-11-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7425,MG,79,"[74,84)",M,7,NA,2024-11-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7426,KZ,84,"[84,Inf)",M,8,NA,2024-11-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7427,HL,57,"[44,64)",M,4,NA,2024-11-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7428,FM,97,"[84,Inf)",M,9,NA,2024-11-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7429,NU,69,"[64,74)",M,7,NA,2024-11-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7430,IU,3,"[1,14)",M,NA,NA,2024-11-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7431,FD,66,"[64,74)",M,5,NA,2024-11-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7432,UU,62,"[44,64)",F,7,NA,2024-11-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7433,QJ,65,"[64,74)",M,5,NA,2024-11-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7434,BB,88,"[84,Inf)",M,7,NA,2024-11-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7435,KP,65,"[64,74)",F,4,47.5366181368485,2024-11-10,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7436,WI,57,"[44,64)",M,4,110.22802749738496,2024-11-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7437,PF,87,"[84,Inf)",F,9,45.594613029185545,2024-11-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7438,PF,85,"[84,Inf)",M,6,NA,2024-11-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7439,BP,72,"[64,74)",F,5,NA,2024-11-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7440,US,1,"[1,14)",M,NA,NA,2024-11-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7441,LJ,51,"[44,64)",M,5,NA,2024-11-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7442,LU,63,"[44,64)",F,7,NA,2024-11-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7443,EE,86,"[84,Inf)",M,9,60.45087550225088,2024-11-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7444,IK,75,"[74,84)",F,7,NA,2024-11-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7445,BI,52,"[44,64)",M,4,NA,2024-11-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7446,IU,55,"[44,64)",F,5,NA,2024-11-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7447,WX,77,"[74,84)",F,7,92.88992681300002,2024-11-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7448,XR,84,"[84,Inf)",M,8,41.37097523370151,2024-11-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7449,UB,76,"[74,84)",F,6,NA,2024-11-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7450,PB,91,"[84,Inf)",M,9,NA,2024-11-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7451,NG,89,"[84,Inf)",F,9,NA,2024-11-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7452,SH,55,"[44,64)",M,3,NA,2024-11-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7453,WM,84,"[84,Inf)",F,8,47.12291009908044,2024-11-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7454,XC,100,"[84,Inf)",F,8,21.94442315654168,2024-11-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7455,RK,0,"[0,1)",M,NA,NA,2024-11-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7456,IW,61,"[44,64)",M,6,NA,2024-11-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7457,HO,64,"[64,74)",F,6,NA,2024-11-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7458,HO,50,"[44,64)",M,4,NA,2024-11-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7459,UT,76,"[74,84)",F,7,NA,2024-11-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7460,NN,75,"[74,84)",F,7,66.07583290246865,2024-11-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7461,OP,72,"[64,74)",M,7,NA,2024-11-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7462,FI,84,"[84,Inf)",M,9,NA,2024-11-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7463,PS,30,"[14,44)",M,2,NA,2024-11-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7464,CJ,83,"[74,84)",M,7,NA,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7465,SP,89,"[84,Inf)",M,8,38.87799717641508,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7466,TD,66,"[64,74)",F,7,NA,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7467,FM,88,"[84,Inf)",M,8,NA,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7468,JP,76,"[74,84)",M,7,NA,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7469,LJ,47,"[44,64)",F,4,NA,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7470,WI,63,"[44,64)",F,5,NA,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7471,EO,89,"[84,Inf)",M,7,NA,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7472,TJ,82,"[74,84)",M,7,NA,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7473,KE,62,"[44,64)",F,6,NA,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7474,EI,95,"[84,Inf)",M,8,NA,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7475,DG,83,"[74,84)",M,8,NA,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7476,OA,78,"[74,84)",M,7,NA,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7477,ZE,55,"[44,64)",M,5,83.80852009691799,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7478,EM,60,"[44,64)",F,7,NA,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7479,ST,71,"[64,74)",F,7,NA,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7480,KP,76,"[74,84)",M,5,48.66859690310349,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7481,VI,62,"[44,64)",M,5,NA,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7482,BH,91,"[84,Inf)",F,8,NA,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7483,YQ,73,"[64,74)",F,7,NA,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7484,JR,53,"[44,64)",M,6,NA,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7485,SQ,67,"[64,74)",M,7,79.14860826064911,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7486,KS,68,"[64,74)",F,5,NA,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7487,GT,53,"[44,64)",M,3,NA,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7488,EW,76,"[74,84)",M,6,NA,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7489,WU,73,"[64,74)",M,6,NA,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7490,UI,81,"[74,84)",M,8,NA,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7491,YV,69,"[64,74)",M,6,NA,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7492,OT,61,"[44,64)",M,5,NA,2024-11-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7493,AH,82,"[74,84)",M,8,NA,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7494,NB,72,"[64,74)",F,7,78.14678871792387,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7495,TA,83,"[74,84)",F,7,58.99005661041717,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7496,VT,58,"[44,64)",M,5,NA,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7497,MK,91,"[84,Inf)",M,9,NA,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7498,YX,31,"[14,44)",M,4,NA,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7499,VR,47,"[44,64)",M,4,NA,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7500,AL,67,"[64,74)",M,6,NA,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7501,HP,22,"[14,44)",M,1,NA,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7502,PZ,86,"[84,Inf)",M,8,NA,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7503,SL,92,"[84,Inf)",M,7,NA,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7504,RS,26,"[14,44)",M,2,NA,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7505,TU,0,"[0,1)",M,NA,NA,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7506,EM,86,"[84,Inf)",M,9,NA,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7507,PC,64,"[64,74)",M,7,NA,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7508,GB,72,"[64,74)",F,7,NA,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7509,ZF,93,"[84,Inf)",M,8,38.34110720815668,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7510,UN,62,"[44,64)",F,5,NA,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7511,YV,61,"[44,64)",M,6,NA,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7512,QQ,76,"[74,84)",F,7,NA,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7513,LA,42,"[14,44)",F,2,NA,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7514,FM,78,"[74,84)",M,7,NA,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7515,KZ,66,"[64,74)",M,7,NA,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7516,CA,94,"[84,Inf)",M,8,NA,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7517,WN,63,"[44,64)",F,6,NA,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7518,HG,81,"[74,84)",M,8,NA,2024-11-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7519,EW,66,"[64,74)",M,5,NA,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7520,YZ,83,"[74,84)",M,7,NA,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7521,OH,82,"[74,84)",M,8,NA,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7522,KY,60,"[44,64)",F,6,NA,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7523,VH,46,"[44,64)",M,4,NA,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7524,SA,72,"[64,74)",M,7,NA,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7525,VU,92,"[84,Inf)",M,7,47.95605895860441,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7526,YR,83,"[74,84)",F,7,NA,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7527,VU,77,"[74,84)",M,6,NA,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7528,DV,80,"[74,84)",M,6,NA,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7529,HF,86,"[84,Inf)",F,7,NA,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7530,OP,69,"[64,74)",M,7,NA,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7531,RN,96,"[84,Inf)",M,8,NA,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7532,QZ,51,"[44,64)",M,5,NA,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7533,KU,95,"[84,Inf)",M,8,NA,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7534,KD,52,"[44,64)",M,5,NA,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7535,KZ,95,"[84,Inf)",M,7,NA,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7536,LK,85,"[84,Inf)",M,6,NA,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7537,KL,58,"[44,64)",M,5,NA,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7538,YN,63,"[44,64)",M,8,NA,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7539,DE,50,"[44,64)",M,5,NA,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7540,OK,88,"[84,Inf)",M,9,NA,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7541,CM,87,"[84,Inf)",M,7,NA,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7542,GG,77,"[74,84)",F,7,NA,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7543,MD,84,"[84,Inf)",F,7,NA,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7544,XS,90,"[84,Inf)",M,8,NA,2024-11-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7545,OX,61,"[44,64)",F,6,78.58419968630912,2024-11-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7546,ZD,58,"[44,64)",M,6,NA,2024-11-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7547,AN,83,"[74,84)",F,8,NA,2024-11-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7548,GD,46,"[44,64)",M,3,NA,2024-11-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7549,MK,65,"[64,74)",F,5,73.06564981147923,2024-11-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7550,KL,84,"[84,Inf)",F,7,NA,2024-11-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7551,NU,60,"[44,64)",M,6,NA,2024-11-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7552,XP,56,"[44,64)",M,3,NA,2024-11-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7553,BX,97,"[84,Inf)",M,9,25.88961332868497,2024-11-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7554,AQ,1,"[1,14)",F,NA,NA,2024-11-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7555,KL,94,"[84,Inf)",M,9,NA,2024-11-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7556,PP,59,"[44,64)",F,5,NA,2024-11-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7557,SU,82,"[74,84)",M,7,49.46956954441338,2024-11-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7558,ER,49,"[44,64)",F,6,NA,2024-11-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7559,OC,74,"[74,84)",M,8,87.91285942593717,2024-11-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7560,LH,87,"[84,Inf)",F,8,NA,2024-11-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7561,IY,89,"[84,Inf)",M,7,NA,2024-11-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7562,MY,86,"[84,Inf)",F,5,NA,2024-11-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7563,OF,0,"[0,1)",M,NA,NA,2024-11-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7564,QU,85,"[84,Inf)",F,8,53.523182828094974,2024-11-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7565,QC,68,"[64,74)",M,7,NA,2024-11-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7566,OV,51,"[44,64)",M,4,NA,2024-11-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7567,CD,63,"[44,64)",M,6,NA,2024-11-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7568,MO,41,"[14,44)",F,4,NA,2024-11-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7569,XK,78,"[74,84)",F,8,NA,2024-11-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7570,FQ,80,"[74,84)",M,6,NA,2024-11-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7571,UX,56,"[44,64)",M,5,NA,2024-11-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7572,NO,51,"[44,64)",M,4,NA,2024-11-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7573,VV,79,"[74,84)",F,7,114.20392970343805,2024-11-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7574,BN,78,"[74,84)",M,6,NA,2024-11-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7575,FB,83,"[74,84)",M,8,NA,2024-11-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7576,ZF,59,"[44,64)",M,5,75.59782414521032,2024-11-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7577,MX,99,"[84,Inf)",F,9,38.95788884632519,2024-11-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7578,RF,58,"[44,64)",M,5,NA,2024-11-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7579,CC,65,"[64,74)",M,5,NA,2024-11-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7580,DV,74,"[74,84)",F,7,NA,2024-11-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7581,PR,94,"[84,Inf)",F,8,NA,2024-11-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7582,ED,53,"[44,64)",M,3,NA,2024-11-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7583,YK,40,"[14,44)",F,5,NA,2024-11-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7584,VA,76,"[74,84)",F,7,NA,2024-11-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7585,XZ,74,"[74,84)",M,7,NA,2024-11-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7586,XK,60,"[44,64)",F,5,NA,2024-11-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7587,JJ,42,"[14,44)",M,6,NA,2024-11-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7588,CC,85,"[84,Inf)",M,8,62.58945147170225,2024-11-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7589,KJ,50,"[44,64)",M,5,NA,2024-11-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7590,PR,85,"[84,Inf)",M,7,NA,2024-11-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7591,CL,44,"[44,64)",F,3,NA,2024-11-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7592,EL,0,"[0,1)",M,NA,NA,2024-11-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7593,UW,73,"[64,74)",F,6,NA,2024-11-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7594,NX,72,"[64,74)",M,7,NA,2024-11-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7595,WF,83,"[74,84)",M,8,NA,2024-11-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7596,AP,58,"[44,64)",M,6,NA,2024-11-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7597,SR,78,"[74,84)",M,7,NA,2024-11-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7598,SS,93,"[84,Inf)",M,8,36.21886935277749,2024-11-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7599,MX,59,"[44,64)",M,6,NA,2024-11-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7600,LR,60,"[44,64)",F,5,NA,2024-11-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7601,IL,36,"[14,44)",M,3,NA,2024-11-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7602,BF,98,"[84,Inf)",F,9,NA,2024-11-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7603,DL,42,"[14,44)",M,2,136.65955566051497,2024-11-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7604,YS,55,"[44,64)",F,6,NA,2024-11-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7605,LJ,36,"[14,44)",M,3,NA,2024-11-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7606,BK,76,"[74,84)",F,5,NA,2024-11-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7607,CJ,53,"[44,64)",M,7,83.77990301499784,2024-11-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7608,MC,55,"[44,64)",F,5,NA,2024-11-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7609,DK,76,"[74,84)",M,6,NA,2024-11-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7610,WC,42,"[14,44)",M,4,NA,2024-11-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7611,TZ,48,"[44,64)",M,2,NA,2024-11-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7612,VD,45,"[44,64)",F,4,NA,2024-11-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7613,XV,67,"[64,74)",F,6,115.79616613618292,2024-11-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7614,LK,49,"[44,64)",M,4,75.15084527236468,2024-11-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7615,IL,25,"[14,44)",M,1,NA,2024-11-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7616,IR,56,"[44,64)",M,4,NA,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7617,CI,85,"[84,Inf)",M,8,NA,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7618,VX,0,"[0,1)",M,NA,NA,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7619,DK,33,"[14,44)",F,3,NA,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7620,LQ,79,"[74,84)",M,8,NA,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7621,NH,78,"[74,84)",M,7,NA,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7622,MN,65,"[64,74)",M,6,NA,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7623,IL,67,"[64,74)",M,8,NA,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7624,WG,49,"[44,64)",F,5,NA,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7625,LY,87,"[84,Inf)",M,8,59.60564742364358,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7626,KO,91,"[84,Inf)",M,9,31.76923899891452,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7627,AJ,69,"[64,74)",F,7,NA,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7628,UC,86,"[84,Inf)",M,7,NA,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7629,GS,92,"[84,Inf)",F,9,NA,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7630,NA,91,"[84,Inf)",M,7,NA,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7631,WS,58,"[44,64)",M,5,NA,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7632,TB,71,"[64,74)",M,6,NA,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7633,GA,61,"[44,64)",M,5,NA,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7634,GV,71,"[64,74)",M,7,NA,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7635,LL,65,"[64,74)",M,6,NA,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7636,IL,82,"[74,84)",M,8,56.98297496069895,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7637,PD,77,"[74,84)",M,6,NA,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7638,CH,68,"[64,74)",M,7,NA,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7639,BJ,48,"[44,64)",F,5,NA,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7640,MR,50,"[44,64)",M,5,NA,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7641,JW,57,"[44,64)",M,4,NA,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7642,VP,78,"[74,84)",M,7,NA,2024-11-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7643,FW,86,"[84,Inf)",M,8,56.02715217045376,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7644,EP,90,"[84,Inf)",M,8,NA,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7645,QS,0,"[0,1)",M,NA,NA,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7646,NO,63,"[44,64)",M,4,84.02924143903951,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7647,GH,91,"[84,Inf)",M,8,50.80145503539192,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7648,QI,84,"[84,Inf)",F,6,NA,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7649,SW,47,"[44,64)",F,3,NA,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7650,MQ,61,"[44,64)",M,6,NA,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7651,EH,83,"[74,84)",M,7,48.19113138010363,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7652,UP,55,"[44,64)",M,4,93.13931297936877,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7653,WF,67,"[64,74)",M,8,NA,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7654,FW,66,"[64,74)",M,5,105.33772940225316,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7655,CQ,79,"[74,84)",M,7,48.306477531754,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7656,EQ,78,"[74,84)",M,7,NA,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7657,IG,82,"[74,84)",M,7,NA,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7658,RC,42,"[14,44)",M,4,NA,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7659,FI,82,"[74,84)",M,8,70.88704026492518,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7660,FZ,0,"[0,1)",F,NA,NA,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7661,WT,97,"[84,Inf)",M,7,NA,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7662,QO,43,"[14,44)",M,3,78.9398158409687,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7663,VN,89,"[84,Inf)",M,6,NA,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7664,RC,35,"[14,44)",M,3,NA,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7665,PK,79,"[74,84)",M,7,NA,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7666,LI,66,"[64,74)",M,6,77.19904413823568,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7667,WX,38,"[14,44)",M,3,NA,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7668,GV,31,"[14,44)",M,2,NA,2024-11-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7669,YX,86,"[84,Inf)",M,7,NA,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7670,PZ,63,"[44,64)",M,6,NA,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7671,XZ,60,"[44,64)",M,4,85.38496349709759,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7672,EW,83,"[74,84)",F,7,NA,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7673,ZV,92,"[84,Inf)",M,8,NA,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7674,QO,90,"[84,Inf)",M,8,NA,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7675,PI,86,"[84,Inf)",M,7,NA,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7676,AS,53,"[44,64)",M,5,NA,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7677,DC,67,"[64,74)",F,7,NA,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7678,QX,60,"[44,64)",F,5,90.37211409625607,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7679,ZU,76,"[74,84)",M,6,NA,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7680,YU,40,"[14,44)",M,4,107.63292505379536,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7681,LC,32,"[14,44)",F,3,NA,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7682,VH,76,"[74,84)",F,6,49.43955063725768,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7683,BV,65,"[64,74)",M,6,NA,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7684,TI,78,"[74,84)",M,6,53.25357833475052,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7685,MX,89,"[84,Inf)",F,8,NA,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7686,BP,74,"[74,84)",M,8,NA,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7687,KL,76,"[74,84)",M,8,NA,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7688,KU,84,"[84,Inf)",F,9,NA,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7689,LA,83,"[74,84)",M,7,NA,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7690,NV,81,"[74,84)",F,8,NA,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7691,MJ,73,"[64,74)",M,8,63.76372726635138,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7692,UJ,64,"[64,74)",M,5,NA,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7693,GO,43,"[14,44)",M,3,NA,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7694,ID,63,"[44,64)",M,5,NA,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7695,IZ,77,"[74,84)",M,8,NA,2024-11-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7696,QE,49,"[44,64)",F,3,NA,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7697,HG,73,"[64,74)",M,7,NA,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7698,KD,92,"[84,Inf)",M,8,NA,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7699,BY,80,"[74,84)",F,7,NA,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7700,AM,58,"[44,64)",F,4,NA,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7701,WH,68,"[64,74)",M,5,116.68082227857262,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7702,DP,66,"[64,74)",M,7,98.60289830261264,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7703,ZL,87,"[84,Inf)",M,8,NA,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7704,VR,57,"[44,64)",F,4,NA,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7705,UT,95,"[84,Inf)",M,8,NA,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7706,LU,76,"[74,84)",F,7,NA,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7707,XT,85,"[84,Inf)",M,8,NA,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7708,NS,80,"[74,84)",F,7,NA,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7709,HY,65,"[64,74)",F,4,NA,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7710,WO,74,"[74,84)",F,5,NA,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7711,TZ,87,"[84,Inf)",M,9,NA,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7712,JZ,55,"[44,64)",F,4,55.79120172665731,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7713,YT,89,"[84,Inf)",M,6,NA,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7714,ZF,70,"[64,74)",M,5,NA,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7715,FZ,69,"[64,74)",M,7,NA,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7716,NE,78,"[74,84)",M,7,NA,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7717,UC,77,"[74,84)",F,6,68.82127034533227,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7718,TV,79,"[74,84)",F,6,NA,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7719,WH,61,"[44,64)",F,6,NA,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7720,FM,0,"[0,1)",F,NA,NA,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7721,MP,89,"[84,Inf)",M,9,NA,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7722,ON,64,"[64,74)",M,7,NA,2024-11-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7723,CJ,100,"[84,Inf)",F,9,NA,2024-11-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7724,HG,97,"[84,Inf)",M,8,NA,2024-11-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7725,AD,62,"[44,64)",F,7,NA,2024-11-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7726,GA,67,"[64,74)",M,6,NA,2024-11-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7727,NJ,66,"[64,74)",M,6,NA,2024-11-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7728,DF,84,"[84,Inf)",F,9,NA,2024-11-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7729,XE,64,"[64,74)",F,7,NA,2024-11-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7730,TM,61,"[44,64)",M,6,NA,2024-11-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7731,FG,92,"[84,Inf)",M,9,31.150384650677218,2024-11-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7732,VO,78,"[74,84)",M,7,NA,2024-11-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7733,QP,41,"[14,44)",F,4,96.98360761863539,2024-11-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7734,TT,44,"[44,64)",M,5,NA,2024-11-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7735,KW,48,"[44,64)",M,5,101.16588325174924,2024-11-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7736,CY,66,"[64,74)",M,4,91.18984358924938,2024-11-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7737,FQ,82,"[74,84)",F,6,NA,2024-11-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7738,RW,56,"[44,64)",M,5,NA,2024-11-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7739,YL,86,"[84,Inf)",M,9,NA,2024-11-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7740,YV,73,"[64,74)",M,7,66.20874110813152,2024-11-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7741,JC,64,"[64,74)",M,7,NA,2024-11-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7742,BR,55,"[44,64)",M,5,97.96269877806316,2024-11-23,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7743,QR,82,"[74,84)",M,6,49.48196910843105,2024-11-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7744,ZY,69,"[64,74)",M,5,NA,2024-11-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7745,WY,71,"[64,74)",M,7,NA,2024-11-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7746,KU,87,"[84,Inf)",F,7,NA,2024-11-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7747,NU,60,"[44,64)",F,5,NA,2024-11-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7748,GE,1,"[1,14)",F,NA,NA,2024-11-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7749,GI,37,"[14,44)",F,2,NA,2024-11-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7750,WM,96,"[84,Inf)",M,6,NA,2024-11-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7751,MU,81,"[74,84)",M,6,130.32026549089895,2024-11-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7752,EY,86,"[84,Inf)",F,7,NA,2024-11-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7753,YJ,57,"[44,64)",M,6,NA,2024-11-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7754,PQ,73,"[64,74)",F,7,NA,2024-11-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7755,XI,63,"[44,64)",M,5,NA,2024-11-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7756,JD,90,"[84,Inf)",M,8,NA,2024-11-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7757,KK,43,"[14,44)",F,4,139.93973138480325,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7758,UC,0,"[0,1)",M,NA,NA,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7759,ZE,38,"[14,44)",M,3,NA,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7760,GJ,50,"[44,64)",F,6,NA,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7761,FV,53,"[44,64)",M,5,NA,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7762,DG,85,"[84,Inf)",M,7,55.96339454339491,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7763,JM,52,"[44,64)",F,4,NA,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7764,JP,53,"[44,64)",M,5,120.76475081647531,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7765,VB,65,"[64,74)",M,5,123.40426615601825,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7766,GN,90,"[84,Inf)",M,8,NA,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7767,TR,56,"[44,64)",M,4,NA,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7768,CS,42,"[14,44)",M,3,NA,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7769,CQ,66,"[64,74)",M,6,NA,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7770,LE,57,"[44,64)",M,5,74.80564949723221,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7771,VO,58,"[44,64)",M,5,75.86154827249717,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7772,UM,77,"[74,84)",M,6,NA,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7773,MR,87,"[84,Inf)",M,7,NA,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7774,GT,64,"[64,74)",M,5,107.72708780665167,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7775,QE,58,"[44,64)",M,5,NA,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7776,CQ,75,"[74,84)",M,7,NA,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7777,CS,53,"[44,64)",M,4,NA,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7778,FD,69,"[64,74)",M,3,NA,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7779,KD,82,"[74,84)",F,9,NA,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7780,MG,54,"[44,64)",F,5,NA,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7781,VH,74,"[74,84)",M,8,80.94111496537735,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7782,MD,74,"[74,84)",M,6,NA,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7783,EU,73,"[64,74)",M,7,NA,2024-11-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7784,XQ,92,"[84,Inf)",F,8,NA,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7785,JJ,83,"[74,84)",M,8,38.52357874398669,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7786,UD,71,"[64,74)",F,6,50.73923415045371,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7787,PY,79,"[74,84)",M,6,NA,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7788,OJ,55,"[44,64)",M,5,NA,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7789,TX,86,"[84,Inf)",M,9,NA,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7790,NK,84,"[84,Inf)",M,6,NA,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7791,MM,55,"[44,64)",M,5,NA,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7792,LS,60,"[44,64)",F,6,NA,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7793,KZ,70,"[64,74)",F,7,NA,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7794,MH,72,"[64,74)",M,6,NA,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7795,XL,45,"[44,64)",M,5,75.18513780547225,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7796,RJ,83,"[74,84)",M,7,NA,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7797,NE,68,"[64,74)",M,6,93.15091025805656,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7798,FH,77,"[74,84)",M,6,NA,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7799,XA,74,"[74,84)",M,5,NA,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7800,PI,78,"[74,84)",M,6,47.44857940317475,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7801,VK,68,"[64,74)",M,5,84.93060714161525,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7802,ZD,84,"[84,Inf)",M,7,NA,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7803,FI,63,"[44,64)",F,7,NA,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7804,RM,76,"[74,84)",F,6,NA,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7805,YF,40,"[14,44)",F,4,NA,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7806,WN,88,"[84,Inf)",M,6,NA,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7807,OU,69,"[64,74)",M,6,86.57006841110054,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7808,HR,71,"[64,74)",M,7,NA,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7809,BR,40,"[14,44)",M,1,NA,2024-11-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7810,RG,57,"[44,64)",M,6,NA,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7811,JM,37,"[14,44)",M,2,NA,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7812,SG,84,"[84,Inf)",M,9,NA,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7813,OQ,72,"[64,74)",M,7,NA,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7814,CZ,60,"[44,64)",M,5,80.19895216797387,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7815,RG,79,"[74,84)",M,8,NA,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7816,ED,57,"[44,64)",F,6,NA,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7817,OF,69,"[64,74)",F,6,NA,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7818,AR,62,"[44,64)",M,6,NA,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7819,CA,80,"[74,84)",M,9,49.645741459631466,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7820,CX,70,"[64,74)",M,8,NA,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7821,WP,61,"[44,64)",M,7,NA,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7822,UP,47,"[44,64)",M,2,NA,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7823,JF,38,"[14,44)",M,3,NA,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7824,ER,89,"[84,Inf)",F,6,NA,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7825,CS,90,"[84,Inf)",M,7,NA,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7826,BA,67,"[64,74)",F,6,NA,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7827,PF,47,"[44,64)",F,3,NA,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7828,ZF,69,"[64,74)",M,5,NA,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7829,QM,41,"[14,44)",F,3,NA,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7830,QR,44,"[44,64)",M,7,NA,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7831,NT,61,"[44,64)",M,5,86.5086233081625,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7832,AM,71,"[64,74)",M,7,99.77476950189256,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7833,OE,60,"[44,64)",M,4,NA,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7834,FI,56,"[44,64)",M,6,98.73126360062682,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7835,XF,64,"[64,74)",M,7,109.74990254852734,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7836,CK,80,"[74,84)",F,7,NA,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7837,HA,71,"[64,74)",M,6,NA,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7838,IL,95,"[84,Inf)",F,9,NA,2024-11-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7839,PB,76,"[74,84)",M,7,NA,2024-11-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7840,KT,67,"[64,74)",M,6,NA,2024-11-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7841,IR,70,"[64,74)",F,7,NA,2024-11-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7842,CO,58,"[44,64)",F,3,NA,2024-11-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7843,FB,63,"[44,64)",F,6,NA,2024-11-27,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7844,PN,67,"[64,74)",M,6,NA,2024-11-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7845,AA,82,"[74,84)",M,8,NA,2024-11-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7846,GJ,87,"[84,Inf)",M,9,NA,2024-11-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7847,NH,76,"[74,84)",M,7,62.847815574107116,2024-11-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7848,MX,0,"[0,1)",F,NA,NA,2024-11-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7849,TJ,75,"[74,84)",M,7,NA,2024-11-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7850,TK,59,"[44,64)",M,4,65.78993827428853,2024-11-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7851,CW,80,"[74,84)",F,8,89.69151451188256,2024-11-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7852,NU,63,"[44,64)",M,5,NA,2024-11-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7853,ZR,79,"[74,84)",M,6,NA,2024-11-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7854,JQ,69,"[64,74)",F,6,NA,2024-11-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7855,MG,81,"[74,84)",M,7,NA,2024-11-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7856,LO,88,"[84,Inf)",M,7,42.826750065807715,2024-11-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7857,AH,73,"[64,74)",F,5,NA,2024-11-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7858,LG,83,"[74,84)",M,7,NA,2024-11-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7859,SP,87,"[84,Inf)",M,8,50.362016618965946,2024-11-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7860,OM,69,"[64,74)",F,6,NA,2024-11-28,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7861,BF,62,"[44,64)",F,6,82.96721058665321,2024-11-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7862,CB,46,"[44,64)",F,5,77.39319449784573,2024-11-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7863,JQ,89,"[84,Inf)",F,7,NA,2024-11-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7864,ZU,64,"[64,74)",M,5,NA,2024-11-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7865,YP,90,"[84,Inf)",M,9,41.537009705234254,2024-11-28,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7866,QS,50,"[44,64)",M,5,NA,2024-11-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7867,JV,62,"[44,64)",M,5,NA,2024-11-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7868,WN,60,"[44,64)",M,5,NA,2024-11-28,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7869,CD,59,"[44,64)",F,4,NA,2024-11-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7870,MT,68,"[64,74)",M,6,NA,2024-11-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7871,QA,0,"[0,1)",M,NA,NA,2024-11-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7872,SH,84,"[84,Inf)",M,6,NA,2024-11-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7873,EF,83,"[74,84)",M,6,NA,2024-11-28,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7874,UA,69,"[64,74)",F,7,NA,2024-11-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7875,WJ,60,"[44,64)",F,4,NA,2024-11-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7876,KT,52,"[44,64)",F,5,NA,2024-11-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7877,RI,67,"[64,74)",F,7,NA,2024-11-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7878,HR,68,"[64,74)",M,7,86.98602150650892,2024-11-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7879,ZJ,71,"[64,74)",M,8,NA,2024-11-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7880,AT,63,"[44,64)",M,5,NA,2024-11-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7881,NU,59,"[44,64)",M,6,NA,2024-11-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7882,HH,65,"[64,74)",F,6,NA,2024-11-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7883,AX,55,"[44,64)",F,5,NA,2024-11-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7884,CJ,50,"[44,64)",F,5,NA,2024-11-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7885,YC,77,"[74,84)",M,8,NA,2024-11-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7886,OD,73,"[64,74)",M,7,NA,2024-11-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7887,OC,88,"[84,Inf)",M,9,NA,2024-11-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7888,YQ,70,"[64,74)",F,6,NA,2024-11-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7889,SY,54,"[44,64)",F,6,NA,2024-11-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7890,LL,79,"[74,84)",M,7,NA,2024-11-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7891,XE,53,"[44,64)",F,4,121.72357079798546,2024-11-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7892,YB,77,"[74,84)",M,6,NA,2024-11-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7893,CJ,68,"[64,74)",M,7,NA,2024-11-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7894,SW,95,"[84,Inf)",M,9,NA,2024-11-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7895,XS,82,"[74,84)",M,8,NA,2024-11-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7896,NL,69,"[64,74)",M,7,NA,2024-11-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7897,QA,83,"[74,84)",M,7,52.56977997658735,2024-11-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7898,OG,39,"[14,44)",M,2,NA,2024-11-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7899,DN,71,"[64,74)",M,7,79.54273845250607,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7900,XX,92,"[84,Inf)",M,8,NA,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7901,FO,53,"[44,64)",M,6,91.3659108639479,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7902,HM,70,"[64,74)",M,6,NA,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7903,KH,80,"[74,84)",F,7,NA,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7904,SW,45,"[44,64)",M,5,NA,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7905,UA,89,"[84,Inf)",F,9,NA,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7906,OP,60,"[44,64)",M,6,NA,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7907,IG,59,"[44,64)",M,7,NA,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7908,ZA,86,"[84,Inf)",M,8,39.87415919178511,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7909,XR,82,"[74,84)",M,7,NA,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7910,AJ,71,"[64,74)",M,5,59.62852700876431,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7911,BB,82,"[74,84)",M,7,NA,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7912,UP,96,"[84,Inf)",M,8,NA,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7913,UW,95,"[84,Inf)",M,8,NA,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7914,PZ,65,"[64,74)",M,5,NA,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7915,FO,70,"[64,74)",M,8,NA,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7916,KZ,71,"[64,74)",F,9,NA,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7917,XO,79,"[74,84)",F,8,NA,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7918,HU,75,"[74,84)",F,8,NA,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7919,JJ,71,"[64,74)",M,8,NA,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7920,RZ,58,"[44,64)",M,5,NA,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7921,UE,62,"[44,64)",M,6,NA,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7922,YJ,41,"[14,44)",M,3,NA,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7923,HO,80,"[74,84)",F,5,NA,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7924,KE,67,"[64,74)",M,5,NA,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7925,VE,60,"[44,64)",M,6,NA,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7926,BW,72,"[64,74)",F,6,NA,2024-11-30,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7927,SH,57,"[44,64)",M,5,67.70667646883193,2024-12-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7928,CR,59,"[44,64)",F,5,NA,2024-12-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7929,IZ,82,"[74,84)",F,7,NA,2024-12-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7930,ZX,81,"[74,84)",M,6,NA,2024-12-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7931,QX,72,"[64,74)",M,7,NA,2024-12-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7932,WC,68,"[64,74)",M,7,67.8281844327527,2024-12-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7933,NP,87,"[84,Inf)",M,9,NA,2024-12-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7934,RJ,90,"[84,Inf)",M,8,NA,2024-12-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7935,XH,70,"[64,74)",F,7,62.0485919162374,2024-12-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7936,EU,59,"[44,64)",M,5,NA,2024-12-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7937,JW,80,"[74,84)",M,7,NA,2024-12-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7938,BZ,78,"[74,84)",M,7,66.02398583937011,2024-12-01,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7939,CL,33,"[14,44)",F,4,NA,2024-12-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7940,HT,68,"[64,74)",M,6,NA,2024-12-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7941,HH,85,"[84,Inf)",M,6,NA,2024-12-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7942,KI,52,"[44,64)",M,5,NA,2024-12-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7943,BF,36,"[14,44)",M,2,NA,2024-12-01,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7944,NS,68,"[64,74)",M,8,NA,2024-12-01,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7945,RK,81,"[74,84)",M,8,71.78069613828148,2024-12-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7946,KL,60,"[44,64)",F,4,NA,2024-12-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7947,YU,76,"[74,84)",F,6,NA,2024-12-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7948,MG,54,"[44,64)",M,4,76.80874418534044,2024-12-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7949,DM,86,"[84,Inf)",M,7,NA,2024-12-02,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7950,DY,61,"[44,64)",F,5,NA,2024-12-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7951,UH,49,"[44,64)",M,3,NA,2024-12-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7952,QC,76,"[74,84)",F,6,NA,2024-12-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7953,UZ,47,"[44,64)",M,5,NA,2024-12-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7954,XW,95,"[84,Inf)",F,6,43.1603621501717,2024-12-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7955,GL,80,"[74,84)",F,8,33.29783337500996,2024-12-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7956,FL,82,"[74,84)",F,6,NA,2024-12-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7957,WR,88,"[84,Inf)",M,8,37.5904340941085,2024-12-02,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7958,SF,67,"[64,74)",M,7,NA,2024-12-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7959,LD,84,"[84,Inf)",M,9,51.36764918087241,2024-12-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7960,BV,86,"[84,Inf)",M,8,NA,2024-12-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7961,DB,54,"[44,64)",M,6,72.55088956502064,2024-12-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7962,NW,34,"[14,44)",M,3,NA,2024-12-02,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7963,OC,68,"[64,74)",M,7,NA,2024-12-02,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7964,GN,70,"[64,74)",F,5,NA,2024-12-02,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7965,MK,69,"[64,74)",F,7,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7966,TY,78,"[74,84)",M,8,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7967,ZB,64,"[64,74)",M,5,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7968,GC,75,"[74,84)",F,8,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7969,BJ,64,"[64,74)",M,6,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7970,US,40,"[14,44)",M,5,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7971,XV,91,"[84,Inf)",M,9,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7972,SR,58,"[44,64)",F,6,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7973,EG,30,"[14,44)",F,3,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7974,WP,42,"[14,44)",F,4,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7975,FU,45,"[44,64)",F,4,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7976,MT,78,"[74,84)",M,6,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7977,XB,79,"[74,84)",M,6,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7978,YK,53,"[44,64)",F,5,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7979,VK,75,"[74,84)",F,6,35.93831475823146,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7980,QP,67,"[64,74)",F,6,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7981,UA,79,"[74,84)",M,7,53.57749206467879,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7982,IN,59,"[44,64)",M,6,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7983,BB,53,"[44,64)",F,1,57.65474296258587,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7984,YA,73,"[64,74)",M,6,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7985,YL,90,"[84,Inf)",M,9,34.3773442756374,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7986,RV,83,"[74,84)",F,8,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7987,TF,50,"[44,64)",M,5,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7988,CC,77,"[74,84)",M,7,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7989,OC,49,"[44,64)",M,4,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7990,NF,83,"[74,84)",M,7,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7991,ZP,66,"[64,74)",M,6,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7992,NS,53,"[44,64)",M,2,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7993,KF,95,"[84,Inf)",M,8,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7994,WR,78,"[74,84)",M,7,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7995,FG,58,"[44,64)",M,5,NA,2024-12-03,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7996,AT,61,"[44,64)",M,5,NA,2024-12-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7997,MB,48,"[44,64)",M,6,130.5199841578692,2024-12-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7998,YA,61,"[44,64)",M,7,NA,2024-12-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
7999,WR,64,"[64,74)",M,7,NA,2024-12-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8000,SH,89,"[84,Inf)",F,8,NA,2024-12-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8001,IA,83,"[74,84)",M,7,NA,2024-12-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8002,GL,49,"[44,64)",M,5,NA,2024-12-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8003,ED,45,"[44,64)",M,3,NA,2024-12-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8004,BT,51,"[44,64)",M,5,NA,2024-12-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8005,BM,61,"[44,64)",M,5,77.65683737683341,2024-12-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8006,CJ,44,"[44,64)",F,4,NA,2024-12-04,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8007,YQ,79,"[74,84)",F,6,NA,2024-12-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8008,TC,45,"[44,64)",F,5,71.86309346052126,2024-12-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8009,WD,75,"[74,84)",M,8,NA,2024-12-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8010,XE,74,"[74,84)",M,7,NA,2024-12-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8011,OQ,42,"[14,44)",F,3,NA,2024-12-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8012,KJ,51,"[44,64)",M,6,NA,2024-12-04,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8013,JR,55,"[44,64)",M,5,80.71647598803621,2024-12-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8014,PN,59,"[44,64)",M,5,NA,2024-12-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8015,LR,54,"[44,64)",F,6,NA,2024-12-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8016,ZR,46,"[44,64)",M,5,115.21257691426791,2024-12-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8017,SL,71,"[64,74)",F,5,NA,2024-12-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8018,TG,66,"[64,74)",M,4,NA,2024-12-04,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8019,NV,61,"[44,64)",M,5,NA,2024-12-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8020,LV,71,"[64,74)",F,7,NA,2024-12-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8021,EF,62,"[44,64)",F,6,NA,2024-12-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8022,JJ,94,"[84,Inf)",M,7,45.39585455771776,2024-12-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8023,HP,74,"[74,84)",M,6,NA,2024-12-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8024,DK,74,"[74,84)",M,7,NA,2024-12-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8025,KB,93,"[84,Inf)",M,9,NA,2024-12-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8026,RF,72,"[64,74)",M,7,NA,2024-12-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8027,DN,2,"[1,14)",M,NA,NA,2024-12-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8028,YZ,44,"[44,64)",F,3,NA,2024-12-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8029,AA,55,"[44,64)",M,4,NA,2024-12-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8030,SC,2,"[1,14)",F,NA,NA,2024-12-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8031,SF,44,"[44,64)",F,3,NA,2024-12-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8032,QI,61,"[44,64)",M,6,80.55353176508741,2024-12-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8033,ZG,56,"[44,64)",M,6,NA,2024-12-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8034,BL,73,"[64,74)",M,6,NA,2024-12-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8035,SQ,83,"[74,84)",M,7,NA,2024-12-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8036,GT,1,"[1,14)",F,NA,NA,2024-12-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8037,DL,96,"[84,Inf)",M,9,NA,2024-12-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8038,BY,94,"[84,Inf)",F,8,NA,2024-12-05,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8039,JQ,69,"[64,74)",F,6,NA,2024-12-05,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8040,KS,84,"[84,Inf)",M,9,NA,2024-12-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8041,FW,77,"[74,84)",F,8,NA,2024-12-05,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8042,EK,84,"[84,Inf)",F,8,35.394850655048245,2024-12-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8043,JY,89,"[84,Inf)",M,7,NA,2024-12-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8044,PO,40,"[14,44)",F,4,NA,2024-12-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8045,UQ,68,"[64,74)",M,5,77.68861421207627,2024-12-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8046,WN,50,"[44,64)",F,4,NA,2024-12-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8047,GJ,73,"[64,74)",M,7,NA,2024-12-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8048,XQ,51,"[44,64)",F,5,116.62869905999341,2024-12-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8049,DZ,65,"[64,74)",F,6,NA,2024-12-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8050,WJ,93,"[84,Inf)",M,9,NA,2024-12-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8051,CA,56,"[44,64)",F,6,NA,2024-12-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8052,AQ,76,"[74,84)",M,6,NA,2024-12-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8053,FO,76,"[74,84)",M,6,NA,2024-12-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8054,ZI,76,"[74,84)",M,7,NA,2024-12-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8055,SO,75,"[74,84)",M,6,NA,2024-12-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8056,EH,41,"[14,44)",M,4,NA,2024-12-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8057,OZ,87,"[84,Inf)",M,6,NA,2024-12-06,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8058,CR,69,"[64,74)",F,6,NA,2024-12-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8059,YZ,48,"[44,64)",M,4,NA,2024-12-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8060,PF,70,"[64,74)",M,5,72.49626304384034,2024-12-06,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8061,IL,42,"[14,44)",F,5,NA,2024-12-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8062,LI,64,"[64,74)",F,4,NA,2024-12-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8063,AJ,75,"[74,84)",M,7,47.66978221144879,2024-12-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8064,DL,85,"[84,Inf)",F,8,NA,2024-12-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8065,ZY,47,"[44,64)",M,4,NA,2024-12-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8066,YF,71,"[64,74)",F,7,NA,2024-12-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8067,XW,90,"[84,Inf)",M,8,NA,2024-12-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8068,UQ,54,"[44,64)",F,5,103.36248620730996,2024-12-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8069,NV,51,"[44,64)",M,5,NA,2024-12-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8070,LK,71,"[64,74)",M,5,NA,2024-12-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8071,YQ,95,"[84,Inf)",F,8,NA,2024-12-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8072,VW,52,"[44,64)",M,3,83.15926035699898,2024-12-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8073,FI,73,"[64,74)",M,6,NA,2024-12-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8074,PK,88,"[84,Inf)",M,9,53.31694863989622,2024-12-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8075,UW,75,"[74,84)",M,6,NA,2024-12-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8076,MR,83,"[74,84)",M,8,NA,2024-12-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8077,GB,30,"[14,44)",M,4,105.63061166292101,2024-12-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8078,OQ,60,"[44,64)",F,3,NA,2024-12-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8079,XU,80,"[74,84)",M,7,NA,2024-12-07,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8080,AX,52,"[44,64)",M,5,NA,2024-12-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8081,NB,65,"[64,74)",M,6,NA,2024-12-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8082,DY,68,"[64,74)",M,7,NA,2024-12-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8083,WR,91,"[84,Inf)",M,8,NA,2024-12-07,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8084,FA,27,"[14,44)",M,2,NA,2024-12-07,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8085,NZ,48,"[44,64)",M,5,83.05727311117363,2024-12-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8086,CX,80,"[74,84)",M,7,57.33624649892038,2024-12-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8087,DA,67,"[64,74)",M,5,NA,2024-12-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8088,YA,62,"[44,64)",F,4,NA,2024-12-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8089,KU,44,"[44,64)",F,4,NA,2024-12-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8090,XM,45,"[44,64)",M,5,NA,2024-12-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8091,KY,27,"[14,44)",M,3,NA,2024-12-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8092,RM,70,"[64,74)",F,6,NA,2024-12-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8093,UO,95,"[84,Inf)",M,7,43.63596679799596,2024-12-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8094,JO,67,"[64,74)",F,6,NA,2024-12-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8095,TP,58,"[44,64)",M,3,NA,2024-12-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8096,VQ,87,"[84,Inf)",M,7,NA,2024-12-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8097,RK,54,"[44,64)",F,6,NA,2024-12-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8098,DU,63,"[44,64)",M,7,NA,2024-12-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8099,KM,74,"[74,84)",M,8,NA,2024-12-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8100,MB,43,"[14,44)",M,6,NA,2024-12-08,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8101,LF,68,"[64,74)",F,8,NA,2024-12-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8102,ED,71,"[64,74)",F,6,NA,2024-12-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8103,BX,78,"[74,84)",M,7,39.84679799371057,2024-12-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8104,BP,59,"[44,64)",F,4,88.04317030434336,2024-12-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8105,JZ,82,"[74,84)",M,9,50.327882395210565,2024-12-08,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8106,DF,81,"[74,84)",F,8,NA,2024-12-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8107,NH,56,"[44,64)",F,7,71.87962025462268,2024-12-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8108,YW,79,"[74,84)",F,8,NA,2024-12-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8109,FC,55,"[44,64)",M,4,NA,2024-12-09,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8110,NP,73,"[64,74)",F,6,NA,2024-12-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8111,TY,71,"[64,74)",M,7,NA,2024-12-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8112,WO,84,"[84,Inf)",F,8,NA,2024-12-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8113,CL,78,"[74,84)",M,7,NA,2024-12-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8114,HL,53,"[44,64)",F,4,NA,2024-12-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8115,VU,79,"[74,84)",M,8,44.40768051809999,2024-12-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8116,HL,85,"[84,Inf)",M,9,NA,2024-12-09,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8117,NW,58,"[44,64)",M,6,59.54631940819832,2024-12-09,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8118,TZ,64,"[64,74)",M,5,83.95684694229203,2024-12-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8119,FF,49,"[44,64)",M,4,NA,2024-12-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8120,BO,0,"[0,1)",M,NA,NA,2024-12-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8121,ZG,0,"[0,1)",M,NA,NA,2024-12-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8122,NR,32,"[14,44)",M,2,NA,2024-12-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8123,BA,88,"[84,Inf)",F,9,52.140658481824254,2024-12-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8124,TF,53,"[44,64)",F,4,NA,2024-12-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8125,KZ,73,"[64,74)",F,8,NA,2024-12-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8126,SM,49,"[44,64)",M,3,NA,2024-12-10,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8127,PQ,62,"[44,64)",M,6,NA,2024-12-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8128,YY,40,"[14,44)",M,4,NA,2024-12-10,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8129,SR,92,"[84,Inf)",M,8,42.98422972787811,2024-12-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8130,KH,89,"[84,Inf)",M,7,NA,2024-12-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8131,AU,44,"[44,64)",M,2,NA,2024-12-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8132,MU,57,"[44,64)",M,6,83.0605113530707,2024-12-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8133,UG,45,"[44,64)",M,5,NA,2024-12-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8134,BL,66,"[64,74)",F,6,NA,2024-12-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8135,XL,76,"[74,84)",M,7,NA,2024-12-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8136,QU,63,"[44,64)",F,6,NA,2024-12-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8137,RO,66,"[64,74)",F,6,NA,2024-12-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8138,JX,91,"[84,Inf)",F,9,35.97212243915602,2024-12-10,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8139,CM,63,"[44,64)",F,5,NA,2024-12-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8140,OG,1,"[1,14)",M,NA,NA,2024-12-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8141,CP,75,"[74,84)",M,7,NA,2024-12-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8142,MG,52,"[44,64)",M,4,NA,2024-12-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8143,DE,57,"[44,64)",F,5,NA,2024-12-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8144,KC,54,"[44,64)",M,7,NA,2024-12-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8145,RL,65,"[64,74)",M,7,NA,2024-12-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8146,BZ,67,"[64,74)",F,4,NA,2024-12-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8147,EW,82,"[74,84)",M,9,44.485040688669415,2024-12-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8148,OV,84,"[84,Inf)",M,8,NA,2024-12-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8149,ZL,69,"[64,74)",M,5,NA,2024-12-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8150,HE,79,"[74,84)",M,8,NA,2024-12-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8151,RE,88,"[84,Inf)",M,8,NA,2024-12-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8152,GC,51,"[44,64)",F,5,95.383559470915,2024-12-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8153,LN,63,"[44,64)",F,4,67.27726691872184,2024-12-11,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8154,GW,38,"[14,44)",M,4,NA,2024-12-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8155,TG,86,"[84,Inf)",M,7,NA,2024-12-11,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8156,MT,58,"[44,64)",F,6,NA,2024-12-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8157,HI,66,"[64,74)",M,7,NA,2024-12-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8158,ZO,84,"[84,Inf)",M,7,NA,2024-12-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8159,ZS,94,"[84,Inf)",M,8,NA,2024-12-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8160,HU,47,"[44,64)",F,4,NA,2024-12-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8161,HM,1,"[1,14)",F,NA,NA,2024-12-11,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8162,OP,56,"[44,64)",M,5,NA,2024-12-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8163,ZZ,81,"[74,84)",M,9,NA,2024-12-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8164,JO,87,"[84,Inf)",M,6,NA,2024-12-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8165,KJ,62,"[44,64)",M,5,89.24128771800623,2024-12-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8166,RZ,85,"[84,Inf)",F,8,NA,2024-12-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8167,NB,46,"[44,64)",M,5,NA,2024-12-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8168,TG,74,"[74,84)",M,8,NA,2024-12-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8169,YB,94,"[84,Inf)",M,6,NA,2024-12-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8170,YK,87,"[84,Inf)",M,9,NA,2024-12-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8171,WF,87,"[84,Inf)",F,8,NA,2024-12-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8172,UB,84,"[84,Inf)",M,9,NA,2024-12-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8173,LS,93,"[84,Inf)",M,8,61.919638249769626,2024-12-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8174,RC,90,"[84,Inf)",M,8,NA,2024-12-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8175,DX,95,"[84,Inf)",M,9,NA,2024-12-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8176,WP,92,"[84,Inf)",M,9,NA,2024-12-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8177,NF,63,"[44,64)",M,7,NA,2024-12-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8178,EF,95,"[84,Inf)",M,9,NA,2024-12-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8179,CT,56,"[44,64)",M,6,NA,2024-12-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8180,ZZ,77,"[74,84)",M,8,53.05481267988835,2024-12-12,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8181,SC,52,"[44,64)",M,6,62.00424499829636,2024-12-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8182,WA,77,"[74,84)",M,5,54.20078708154131,2024-12-12,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8183,RY,70,"[64,74)",M,5,NA,2024-12-12,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8184,SZ,1,"[1,14)",M,NA,NA,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8185,JW,73,"[64,74)",M,7,NA,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8186,DD,87,"[84,Inf)",M,7,NA,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8187,YI,80,"[74,84)",M,7,NA,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8188,WQ,87,"[84,Inf)",F,8,NA,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8189,GF,68,"[64,74)",M,7,NA,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8190,IJ,81,"[74,84)",M,9,NA,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8191,RZ,89,"[84,Inf)",M,8,NA,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8192,KS,58,"[44,64)",M,6,NA,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8193,ZY,88,"[84,Inf)",F,7,NA,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8194,XD,81,"[74,84)",F,7,NA,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8195,TB,1,"[1,14)",F,NA,NA,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8196,YA,56,"[44,64)",F,5,NA,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8197,LY,54,"[44,64)",F,5,NA,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8198,BB,76,"[74,84)",M,6,NA,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8199,GK,89,"[84,Inf)",M,8,NA,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8200,LD,66,"[64,74)",M,7,68.44082381193695,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8201,MA,88,"[84,Inf)",F,9,NA,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8202,RN,71,"[64,74)",M,5,NA,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8203,VR,24,"[14,44)",M,3,NA,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8204,TG,76,"[74,84)",M,6,NA,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8205,ZN,65,"[64,74)",M,6,NA,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8206,IQ,58,"[44,64)",M,5,62.63213547363333,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8207,DW,80,"[74,84)",F,6,NA,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8208,SM,83,"[74,84)",M,8,NA,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8209,UE,50,"[44,64)",M,5,NA,2024-12-13,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8210,CS,90,"[84,Inf)",M,8,NA,2024-12-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8211,XU,60,"[44,64)",M,5,110.72870469820862,2024-12-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8212,RY,87,"[84,Inf)",F,7,NA,2024-12-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8213,XX,73,"[64,74)",F,7,59.398826502254565,2024-12-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8214,JK,73,"[64,74)",M,7,91.74562834707928,2024-12-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8215,YJ,63,"[44,64)",M,5,105.37991842847282,2024-12-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8216,TI,64,"[64,74)",M,6,NA,2024-12-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8217,DS,76,"[74,84)",M,8,NA,2024-12-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8218,RM,77,"[74,84)",M,7,NA,2024-12-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8219,PM,82,"[74,84)",F,8,43.0978156908346,2024-12-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8220,JK,60,"[44,64)",M,4,NA,2024-12-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8221,AP,0,"[0,1)",M,NA,NA,2024-12-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8222,FK,94,"[84,Inf)",M,8,NA,2024-12-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8223,NZ,70,"[64,74)",M,6,NA,2024-12-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8224,VY,62,"[44,64)",M,5,NA,2024-12-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8225,CL,68,"[64,74)",M,5,NA,2024-12-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8226,FX,53,"[44,64)",M,5,NA,2024-12-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8227,NL,58,"[44,64)",M,4,NA,2024-12-14,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8228,HN,58,"[44,64)",M,6,NA,2024-12-14,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8229,TR,73,"[64,74)",F,8,NA,2024-12-14,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8230,VC,76,"[74,84)",M,8,NA,2024-12-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8231,KG,49,"[44,64)",M,4,NA,2024-12-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8232,HJ,46,"[44,64)",M,2,102.09282879291732,2024-12-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8233,AA,50,"[44,64)",F,4,NA,2024-12-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8234,WV,43,"[14,44)",M,5,96.84810297993832,2024-12-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8235,JB,49,"[44,64)",M,4,NA,2024-12-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8236,NG,55,"[44,64)",M,6,NA,2024-12-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8237,OT,77,"[74,84)",F,7,39.27510904380538,2024-12-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8238,LC,73,"[64,74)",M,7,NA,2024-12-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8239,EJ,71,"[64,74)",F,7,NA,2024-12-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8240,OP,57,"[44,64)",F,6,NA,2024-12-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8241,KK,96,"[84,Inf)",F,9,37.97895011664558,2024-12-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8242,LX,70,"[64,74)",M,5,NA,2024-12-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8243,VE,78,"[74,84)",M,7,NA,2024-12-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8244,RM,55,"[44,64)",M,7,NA,2024-12-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8245,XL,43,"[14,44)",M,3,NA,2024-12-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8246,DT,72,"[64,74)",F,5,NA,2024-12-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8247,AW,62,"[44,64)",M,6,NA,2024-12-15,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8248,UE,1,"[1,14)",M,NA,NA,2024-12-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8249,LV,70,"[64,74)",M,4,NA,2024-12-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8250,PY,81,"[74,84)",M,8,NA,2024-12-15,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8251,WF,67,"[64,74)",F,6,NA,2024-12-15,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8252,BD,88,"[84,Inf)",M,8,NA,2024-12-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8253,AY,75,"[74,84)",F,7,42.03814755633895,2024-12-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8254,ZU,86,"[84,Inf)",M,9,NA,2024-12-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8255,ED,77,"[74,84)",M,6,NA,2024-12-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8256,EI,76,"[74,84)",M,6,50.9157627496836,2024-12-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8257,QY,64,"[64,74)",M,6,NA,2024-12-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8258,YI,86,"[84,Inf)",M,8,NA,2024-12-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8259,ZX,52,"[44,64)",F,4,NA,2024-12-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8260,FZ,97,"[84,Inf)",M,8,42.58205729055891,2024-12-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8261,QY,95,"[84,Inf)",M,8,NA,2024-12-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8262,EO,83,"[74,84)",M,8,35.522967961859145,2024-12-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8263,NA,59,"[44,64)",M,4,NA,2024-12-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8264,DD,90,"[84,Inf)",M,7,47.37398821236902,2024-12-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8265,HQ,74,"[74,84)",M,7,NA,2024-12-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8266,OU,78,"[74,84)",M,8,NA,2024-12-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8267,BL,65,"[64,74)",F,8,NA,2024-12-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8268,LJ,82,"[74,84)",F,7,NA,2024-12-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8269,SG,78,"[74,84)",M,7,59.767711117927604,2024-12-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8270,PL,33,"[14,44)",M,3,NA,2024-12-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8271,OS,75,"[74,84)",M,6,NA,2024-12-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8272,ZO,53,"[44,64)",M,5,NA,2024-12-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8273,WK,94,"[84,Inf)",M,6,NA,2024-12-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8274,CX,57,"[44,64)",M,5,NA,2024-12-16,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8275,QD,83,"[74,84)",M,9,NA,2024-12-16,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8276,ZO,77,"[74,84)",F,6,45.61054962215191,2024-12-16,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8277,CI,63,"[44,64)",M,7,NA,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8278,HE,83,"[74,84)",M,8,NA,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8279,TW,69,"[64,74)",F,6,NA,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8280,KB,62,"[44,64)",F,6,NA,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8281,FH,90,"[84,Inf)",F,8,NA,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8282,RY,88,"[84,Inf)",M,8,46.91659460592845,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8283,EC,76,"[74,84)",F,5,NA,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8284,VR,91,"[84,Inf)",F,8,37.19793270662261,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8285,KL,74,"[74,84)",M,7,NA,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8286,FR,96,"[84,Inf)",M,9,NA,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8287,GX,26,"[14,44)",M,1,109.5186987723951,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8288,KB,87,"[84,Inf)",M,8,NA,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8289,XJ,82,"[74,84)",F,7,NA,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8290,NI,66,"[64,74)",M,6,NA,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8291,UR,73,"[64,74)",M,7,64.25953921865873,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8292,YV,72,"[64,74)",F,6,NA,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8293,YS,54,"[44,64)",M,4,NA,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8294,KO,61,"[44,64)",M,4,64.38410597452882,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8295,YS,83,"[74,84)",M,8,NA,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8296,QI,91,"[84,Inf)",F,7,NA,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8297,DV,86,"[84,Inf)",M,8,NA,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8298,CO,59,"[44,64)",M,6,NA,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8299,IM,76,"[74,84)",M,7,39.116623869800875,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8300,NW,76,"[74,84)",M,6,NA,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8301,UZ,84,"[84,Inf)",M,7,NA,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8302,CT,43,"[14,44)",M,4,NA,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8303,ME,75,"[74,84)",M,6,64.46551671985877,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8304,PP,84,"[84,Inf)",M,8,NA,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8305,PA,52,"[44,64)",M,4,NA,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8306,JQ,75,"[74,84)",M,7,NA,2024-12-17,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8307,XP,87,"[84,Inf)",F,7,NA,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8308,SG,90,"[84,Inf)",F,8,NA,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8309,JL,74,"[74,84)",M,5,NA,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8310,WG,61,"[44,64)",M,5,127.2865353867242,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8311,EO,92,"[84,Inf)",M,9,NA,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8312,NY,68,"[64,74)",F,5,NA,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8313,YC,70,"[64,74)",M,6,120.28120926870095,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8314,ZT,0,"[0,1)",M,NA,NA,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8315,LX,63,"[44,64)",F,6,NA,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8316,EN,81,"[74,84)",M,6,NA,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8317,VX,84,"[84,Inf)",M,8,NA,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8318,XS,77,"[74,84)",M,9,47.02831561428315,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8319,PQ,88,"[84,Inf)",M,8,39.55101987397899,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8320,MP,57,"[44,64)",F,5,NA,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8321,KG,56,"[44,64)",F,4,NA,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8322,IL,92,"[84,Inf)",F,7,NA,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8323,BA,83,"[74,84)",M,8,44.128992296994205,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8324,ZQ,64,"[64,74)",F,6,90.50765116769516,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8325,RZ,42,"[14,44)",M,3,NA,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8326,DO,88,"[84,Inf)",F,7,39.453962894799105,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8327,KS,63,"[44,64)",F,6,NA,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8328,DF,67,"[64,74)",F,7,NA,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8329,LB,0,"[0,1)",M,NA,NA,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8330,MT,88,"[84,Inf)",M,6,NA,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8331,GF,70,"[64,74)",M,7,76.99905624347198,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8332,EF,80,"[74,84)",M,7,58.27458411208033,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8333,UG,35,"[14,44)",M,4,80.15767899051546,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8334,OJ,88,"[84,Inf)",F,7,NA,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8335,LO,71,"[64,74)",M,7,NA,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8336,LH,97,"[84,Inf)",M,9,NA,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8337,ZM,76,"[74,84)",M,7,NA,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8338,XJ,67,"[64,74)",M,7,NA,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8339,PA,81,"[74,84)",M,6,NA,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8340,LQ,70,"[64,74)",F,6,NA,2024-12-18,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8341,WL,68,"[64,74)",F,6,104.42845885275015,2024-12-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8342,MM,59,"[44,64)",M,5,NA,2024-12-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8343,NB,83,"[74,84)",M,7,NA,2024-12-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8344,BM,88,"[84,Inf)",F,8,NA,2024-12-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8345,XY,46,"[44,64)",M,4,NA,2024-12-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8346,GA,97,"[84,Inf)",F,9,NA,2024-12-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8347,EY,80,"[74,84)",M,8,NA,2024-12-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8348,YN,82,"[74,84)",M,8,NA,2024-12-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8349,VR,57,"[44,64)",M,4,NA,2024-12-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8350,LA,62,"[44,64)",F,6,NA,2024-12-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8351,GH,82,"[74,84)",M,8,NA,2024-12-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8352,FX,29,"[14,44)",M,4,NA,2024-12-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8353,TU,57,"[44,64)",M,5,NA,2024-12-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8354,ZJ,73,"[64,74)",F,5,NA,2024-12-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8355,SD,72,"[64,74)",F,7,NA,2024-12-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8356,CZ,63,"[44,64)",F,6,NA,2024-12-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8357,RG,76,"[74,84)",M,7,NA,2024-12-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8358,AT,54,"[44,64)",F,4,67.22125028570508,2024-12-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8359,XL,60,"[44,64)",F,4,NA,2024-12-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8360,GN,75,"[74,84)",M,8,NA,2024-12-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8361,TB,62,"[44,64)",M,7,NA,2024-12-19,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8362,HE,79,"[74,84)",M,7,54.03554893068587,2024-12-19,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8363,YQ,1,"[1,14)",M,NA,NA,2024-12-19,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8364,BI,47,"[44,64)",M,4,NA,2024-12-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8365,ZI,86,"[84,Inf)",M,7,NA,2024-12-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8366,NZ,93,"[84,Inf)",F,9,NA,2024-12-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8367,EX,85,"[84,Inf)",M,7,NA,2024-12-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8368,VR,89,"[84,Inf)",M,8,NA,2024-12-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8369,IZ,80,"[74,84)",M,8,NA,2024-12-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8370,PS,81,"[74,84)",M,9,NA,2024-12-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8371,ON,47,"[44,64)",F,6,NA,2024-12-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8372,MM,92,"[84,Inf)",M,7,NA,2024-12-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8373,FC,94,"[84,Inf)",M,7,NA,2024-12-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8374,ES,51,"[44,64)",M,4,NA,2024-12-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8375,TK,85,"[84,Inf)",M,6,NA,2024-12-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8376,JO,72,"[64,74)",M,7,NA,2024-12-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8377,BP,75,"[74,84)",M,7,NA,2024-12-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8378,PV,42,"[14,44)",M,6,NA,2024-12-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8379,GI,75,"[74,84)",F,6,NA,2024-12-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8380,HL,66,"[64,74)",M,7,NA,2024-12-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8381,SR,87,"[84,Inf)",M,7,NA,2024-12-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8382,IN,77,"[74,84)",M,8,62.43140711662003,2024-12-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8383,UP,85,"[84,Inf)",F,7,NA,2024-12-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8384,DS,73,"[64,74)",F,7,NA,2024-12-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8385,AH,69,"[64,74)",M,5,NA,2024-12-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8386,QB,82,"[74,84)",M,8,NA,2024-12-20,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8387,QD,80,"[74,84)",F,8,56.39055117912277,2024-12-20,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8388,NV,83,"[74,84)",F,7,NA,2024-12-20,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8389,TR,73,"[64,74)",F,8,NA,2024-12-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8390,EF,77,"[74,84)",F,7,NA,2024-12-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8391,QB,49,"[44,64)",M,3,NA,2024-12-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8392,VO,56,"[44,64)",M,4,NA,2024-12-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8393,NW,75,"[74,84)",F,6,64.95911205976317,2024-12-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8394,ZV,93,"[84,Inf)",M,9,NA,2024-12-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8395,SJ,94,"[84,Inf)",M,9,NA,2024-12-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8396,RB,51,"[44,64)",M,3,63.96374874877455,2024-12-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8397,IM,46,"[44,64)",F,4,NA,2024-12-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8398,PI,1,"[1,14)",M,NA,NA,2024-12-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8399,CE,78,"[74,84)",M,6,62.17395343136508,2024-12-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8400,NM,70,"[64,74)",M,7,NA,2024-12-21,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8401,FK,83,"[74,84)",M,7,52.69351008371562,2024-12-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8402,BJ,86,"[84,Inf)",F,7,NA,2024-12-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8403,QO,70,"[64,74)",M,8,NA,2024-12-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8404,SF,94,"[84,Inf)",M,9,NA,2024-12-21,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8405,QH,95,"[84,Inf)",M,8,NA,2024-12-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8406,WI,57,"[44,64)",M,6,NA,2024-12-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8407,RT,70,"[64,74)",M,6,NA,2024-12-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8408,KJ,91,"[84,Inf)",M,8,53.93506153149863,2024-12-21,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8409,KU,0,"[0,1)",M,NA,NA,2024-12-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8410,BP,77,"[74,84)",F,7,NA,2024-12-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8411,PW,66,"[64,74)",F,5,NA,2024-12-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8412,MM,80,"[74,84)",M,7,43.97426970578688,2024-12-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8413,NI,63,"[44,64)",F,7,110.60655270407554,2024-12-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8414,WK,73,"[64,74)",M,5,NA,2024-12-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8415,CO,84,"[84,Inf)",M,7,NA,2024-12-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8416,OK,89,"[84,Inf)",M,8,58.633914996816166,2024-12-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8417,DZ,83,"[74,84)",M,8,NA,2024-12-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8418,BT,55,"[44,64)",M,5,NA,2024-12-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8419,OC,80,"[74,84)",M,8,NA,2024-12-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8420,OM,95,"[84,Inf)",F,8,NA,2024-12-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8421,DK,85,"[84,Inf)",M,8,51.47928147326037,2024-12-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8422,PA,65,"[64,74)",M,6,NA,2024-12-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8423,RD,91,"[84,Inf)",M,8,39.205926677693,2024-12-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8424,AW,49,"[44,64)",F,5,NA,2024-12-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8425,JE,99,"[84,Inf)",F,9,NA,2024-12-22,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8426,DT,84,"[84,Inf)",M,8,43.877180958304415,2024-12-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8427,JQ,70,"[64,74)",M,6,NA,2024-12-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8428,GS,89,"[84,Inf)",M,6,NA,2024-12-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8429,KT,81,"[74,84)",M,7,NA,2024-12-22,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8430,AQ,41,"[14,44)",M,3,NA,2024-12-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8431,RB,54,"[44,64)",F,4,95.7815823767779,2024-12-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8432,DG,77,"[74,84)",M,7,60.401860396311825,2024-12-22,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8433,NO,33,"[14,44)",M,2,NA,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8434,DN,36,"[14,44)",M,1,NA,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8435,BS,53,"[44,64)",M,6,NA,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8436,XH,87,"[84,Inf)",F,8,NA,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8437,WA,78,"[74,84)",F,7,40.92629467647167,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8438,SS,75,"[74,84)",M,7,NA,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8439,OL,72,"[64,74)",F,7,NA,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8440,ND,81,"[74,84)",M,8,NA,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8441,DY,44,"[44,64)",M,5,NA,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8442,FP,66,"[64,74)",M,6,NA,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8443,VP,80,"[74,84)",F,6,52.1359999223557,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8444,EO,94,"[84,Inf)",F,8,NA,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8445,AT,67,"[64,74)",M,5,NA,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8446,AU,84,"[84,Inf)",M,5,NA,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8447,WL,86,"[84,Inf)",M,8,NA,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8448,FZ,81,"[74,84)",F,7,NA,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8449,RM,51,"[44,64)",F,5,NA,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8450,KF,62,"[44,64)",F,5,NA,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8451,UC,69,"[64,74)",F,7,53.074219035042915,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8452,NN,57,"[44,64)",F,4,122.65584869354863,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8453,YP,64,"[64,74)",F,5,NA,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8454,PL,74,"[74,84)",M,6,NA,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8455,QZ,59,"[44,64)",M,5,NA,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8456,CM,90,"[84,Inf)",M,7,NA,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8457,ZZ,83,"[74,84)",F,5,NA,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8458,JT,61,"[44,64)",M,6,NA,2024-12-23,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8459,UM,85,"[84,Inf)",F,8,39.29729111429408,2024-12-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8460,EA,65,"[64,74)",M,6,NA,2024-12-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8461,LX,67,"[64,74)",M,7,NA,2024-12-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8462,TM,43,"[14,44)",F,5,129.43277465381226,2024-12-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8463,NS,96,"[84,Inf)",M,8,NA,2024-12-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8464,LR,49,"[44,64)",M,4,NA,2024-12-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8465,WC,94,"[84,Inf)",F,8,NA,2024-12-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8466,GO,85,"[84,Inf)",M,8,NA,2024-12-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8467,HM,63,"[44,64)",M,5,NA,2024-12-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8468,FU,76,"[74,84)",M,6,NA,2024-12-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8469,NM,67,"[64,74)",F,6,NA,2024-12-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8470,HE,55,"[44,64)",M,6,NA,2024-12-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8471,GP,65,"[64,74)",M,6,NA,2024-12-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8472,QU,30,"[14,44)",M,4,77.68608671639448,2024-12-24,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8473,BR,1,"[1,14)",M,NA,NA,2024-12-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8474,EB,60,"[44,64)",M,5,NA,2024-12-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8475,YN,51,"[44,64)",F,4,NA,2024-12-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8476,XK,73,"[64,74)",F,4,NA,2024-12-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8477,EJ,94,"[84,Inf)",F,9,NA,2024-12-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8478,JY,75,"[74,84)",M,6,NA,2024-12-24,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8479,RC,53,"[44,64)",M,6,NA,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8480,RI,80,"[74,84)",F,9,49.5315586835644,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8481,YW,66,"[64,74)",F,5,NA,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8482,KA,41,"[14,44)",F,3,NA,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8483,CC,66,"[64,74)",M,6,63.80186422263062,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8484,VL,76,"[74,84)",F,8,41.48776886175562,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8485,FL,82,"[74,84)",M,7,NA,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8486,KU,57,"[44,64)",M,6,NA,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8487,KJ,87,"[84,Inf)",M,7,NA,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8488,PZ,63,"[44,64)",F,6,NA,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8489,BV,69,"[64,74)",M,8,NA,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8490,MX,63,"[44,64)",F,4,NA,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8491,JC,75,"[74,84)",M,5,NA,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8492,VL,86,"[84,Inf)",M,7,47.38034215020282,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8493,WD,65,"[64,74)",M,5,NA,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8494,HT,73,"[64,74)",F,7,72.44913654811575,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8495,IA,84,"[84,Inf)",F,9,NA,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8496,II,60,"[44,64)",M,5,NA,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8497,TH,52,"[44,64)",F,4,143.01523981037462,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8498,OS,66,"[64,74)",M,4,NA,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8499,HM,51,"[44,64)",F,4,NA,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8500,NB,63,"[44,64)",F,7,NA,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8501,RC,83,"[74,84)",F,9,NA,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8502,TO,86,"[84,Inf)",F,7,36.54671638065353,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8503,TW,74,"[74,84)",F,7,NA,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8504,HR,79,"[74,84)",M,7,NA,2024-12-25,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8505,SJ,80,"[74,84)",M,7,NA,2024-12-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8506,MD,26,"[14,44)",F,1,NA,2024-12-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8507,EK,91,"[84,Inf)",F,6,NA,2024-12-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8508,DQ,45,"[44,64)",M,3,NA,2024-12-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8509,CB,89,"[84,Inf)",M,8,43.71761704818498,2024-12-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8510,OA,67,"[64,74)",F,5,71.36602644775043,2024-12-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8511,SS,68,"[64,74)",M,6,NA,2024-12-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8512,IP,65,"[64,74)",F,4,NA,2024-12-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8513,NG,66,"[64,74)",F,6,92.84211503756208,2024-12-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8514,EU,90,"[84,Inf)",M,8,NA,2024-12-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8515,QU,70,"[64,74)",M,7,NA,2024-12-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8516,YS,82,"[74,84)",M,8,NA,2024-12-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8517,VF,86,"[84,Inf)",F,8,NA,2024-12-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8518,MC,66,"[64,74)",F,6,NA,2024-12-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8519,IJ,80,"[74,84)",M,6,NA,2024-12-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8520,PO,52,"[44,64)",F,7,NA,2024-12-26,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8521,JN,76,"[74,84)",M,7,NA,2024-12-26,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8522,NF,34,"[14,44)",M,2,NA,2024-12-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8523,OG,25,"[14,44)",M,2,146.7984584202658,2024-12-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8524,SK,86,"[84,Inf)",M,5,45.40310574140623,2024-12-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8525,RO,86,"[84,Inf)",M,7,NA,2024-12-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8526,QX,83,"[74,84)",F,8,NA,2024-12-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8527,JR,47,"[44,64)",M,5,78.1926933521697,2024-12-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8528,IP,56,"[44,64)",M,6,NA,2024-12-27,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8529,EU,95,"[84,Inf)",M,8,NA,2024-12-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8530,JN,86,"[84,Inf)",M,7,NA,2024-12-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8531,FP,98,"[84,Inf)",M,8,NA,2024-12-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8532,US,77,"[74,84)",M,8,NA,2024-12-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8533,PI,64,"[64,74)",M,5,NA,2024-12-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8534,BQ,20,"[14,44)",M,1,NA,2024-12-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8535,NG,49,"[44,64)",M,5,NA,2024-12-27,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8536,XS,68,"[64,74)",M,7,NA,2024-12-27,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8537,HC,67,"[64,74)",M,6,NA,2024-12-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8538,PK,66,"[64,74)",M,7,NA,2024-12-27,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8539,DA,79,"[74,84)",M,7,NA,2024-12-27,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8540,MB,89,"[84,Inf)",M,8,NA,2024-12-27,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8541,HZ,53,"[44,64)",F,8,NA,2024-12-27,K. pneumoniae,Piperacillin with tazobactam,NA,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8542,FC,63,"[44,64)",M,7,NA,2024-12-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8543,JH,46,"[44,64)",M,5,NA,2024-12-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8544,RD,75,"[74,84)",M,6,58.55769306985025,2024-12-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8545,MR,53,"[44,64)",F,5,NA,2024-12-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8546,MX,69,"[64,74)",M,5,NA,2024-12-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8547,HB,80,"[74,84)",M,6,NA,2024-12-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8548,IU,55,"[44,64)",F,4,NA,2024-12-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8549,CG,54,"[44,64)",M,5,111.15149863499289,2024-12-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8550,JR,91,"[84,Inf)",M,5,NA,2024-12-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8551,RD,47,"[44,64)",M,3,NA,2024-12-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8552,BD,68,"[64,74)",M,6,101.85660722457546,2024-12-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8553,GM,67,"[64,74)",M,7,NA,2024-12-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8554,HY,36,"[14,44)",M,3,NA,2024-12-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8555,RH,57,"[44,64)",M,4,NA,2024-12-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8556,BI,86,"[84,Inf)",M,8,NA,2024-12-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8557,XS,83,"[74,84)",F,7,NA,2024-12-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8558,VT,61,"[44,64)",F,5,74.9638049351619,2024-12-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8559,XA,73,"[64,74)",F,6,NA,2024-12-28,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8560,JN,69,"[64,74)",M,8,NA,2024-12-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8561,MC,2,"[1,14)",F,NA,NA,2024-12-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8562,BU,65,"[64,74)",F,6,NA,2024-12-28,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8563,MF,95,"[84,Inf)",M,8,NA,2024-12-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8564,HM,50,"[44,64)",M,4,NA,2024-12-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8565,DG,64,"[64,74)",M,5,NA,2024-12-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8566,ZF,78,"[74,84)",F,6,47.38555261086419,2024-12-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8567,TD,71,"[64,74)",M,7,NA,2024-12-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8568,WL,96,"[84,Inf)",F,8,NA,2024-12-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8569,YD,62,"[44,64)",M,7,NA,2024-12-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8570,SI,39,"[14,44)",M,2,NA,2024-12-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8571,TZ,73,"[64,74)",F,7,NA,2024-12-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8572,RR,53,"[44,64)",M,5,NA,2024-12-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8573,GD,71,"[64,74)",M,6,NA,2024-12-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8574,XW,95,"[84,Inf)",F,7,NA,2024-12-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8575,RC,98,"[84,Inf)",M,9,NA,2024-12-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8576,BN,83,"[74,84)",M,7,NA,2024-12-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8577,TF,84,"[84,Inf)",M,7,NA,2024-12-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8578,OZ,78,"[74,84)",F,7,NA,2024-12-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8579,QG,75,"[74,84)",F,7,41.04044499884339,2024-12-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8580,AN,32,"[14,44)",M,2,79.20072899252676,2024-12-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8581,KV,84,"[84,Inf)",M,7,NA,2024-12-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8582,HQ,59,"[44,64)",F,5,146.98705897538827,2024-12-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8583,NC,51,"[44,64)",M,5,NA,2024-12-29,K. pneumoniae,Piperacillin with tazobactam,S or I,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
8584,PE,62,"[44,64)",M,5,NA,2024-12-29,K. pneumoniae,Piperacillin with tazobactam,R,Simulated data loosely based on aggregates from ESPAUR report 2024 table 2.4
